<SEC-DOCUMENT>0001144204-16-097384.txt : 20160429
<SEC-HEADER>0001144204-16-097384.hdr.sgml : 20160429
<ACCEPTANCE-DATETIME>20160429080029
ACCESSION NUMBER:		0001144204-16-097384
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20160614
FILED AS OF DATE:		20160429
DATE AS OF CHANGE:		20160429
EFFECTIVENESS DATE:		20160429

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lipocine Inc.
		CENTRAL INDEX KEY:			0001535955
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				990370688
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36357
		FILM NUMBER:		161602547

	BUSINESS ADDRESS:	
		STREET 1:		675 ARAPEEN DRIVE, SUITE 202
		CITY:			SALT LAKE CITY
		STATE:			X1
		ZIP:			84108
		BUSINESS PHONE:		801 994 7383

	MAIL ADDRESS:	
		STREET 1:		675 ARAPEEN DRIVE, SUITE 202
		CITY:			SALT LAKE CITY
		STATE:			X1
		ZIP:			84108

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MARATHON BAR CORP
		DATE OF NAME CHANGE:	20111130
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>v437648_def14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 12pt"><B>SCHEDULE
14A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(RULE 14a-101)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SCHEDULE 14A INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Filed by Registrant <FONT STYLE="font-family: Wingdings">x</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Filed by a Party other than the Registrant <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="width: 95%"><FONT STYLE="font-size: 10pt">Preliminary Proxy Statement</FONT> &nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Confidential, for Use of the Commission Only&nbsp; (as permitted by Rule&nbsp;14a-6(e)(2))</FONT> &nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">x</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Definitive Proxy Statement</FONT> &nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Definitive Additional Materials</FONT> &nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Soliciting Material Under Rule&nbsp;14a-12 </FONT>&nbsp;&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 12pt"><B>LIPOCINE
INC.</B></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Name of Registrant as Specified In Its
Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Name of Person(s) Filing Proxy Statement,
if other than the Registrant)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Payment of Filing Fee (Check the appropriate box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">x</FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">No fee required.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Title of each class of securities to which transaction applies:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Aggregate number of securities to which transaction applies:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule&nbsp;0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(4)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Proposed maximum aggregate value of transaction:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(5)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Total fee paid:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">Fee paid previously with preliminary materials:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">Check box if any part of the fee is offset as provided by Exchange Act Rule&nbsp;0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Amount Previously Paid:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Form, Schedule or Registration Statement No.:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Filing Party:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(4)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Date Filed:</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="tlogo.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">April 29, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Stockholder:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">You are cordially
invited to attend Lipocine Inc.&rsquo;s 2016 Annual Meeting of Stockholders (the &ldquo;Annual Meeting&rdquo;) to be held on June
14, 2016. The meeting will be held at Lipocine&rsquo;s offices located at 675 Arapeen Drive, Suite 202, Salt Lake City, Utah 84108
at 10:00 a.m Mountain Standard Time. The formal meeting notice and proxy statement for the Annual Meeting are attached.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Whether or not you
plan to attend the Annual Meeting, it is important that your shares be represented and voted at the meeting. Therefore, you are
urged to access the proxy materials and vote via the Internet in accordance with the &ldquo;notice and access&rdquo; letter you
will receive, or if you request paper copies of the proxy materials by mail, complete, sign, date and promptly return the proxy
card. Returning your completed proxy card or voting via the Internet will ensure your representation at the Annual Meeting. If
you later decide to attend the Annual Meeting and wish to change your vote, you may do so simply by voting in person at the meeting.
Due to voting rules that may prevent your bank or broker from voting your uninstructed shares on a discretionary basis in the election
of directors and other non-routine matters, it is important that you cast your vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We look forward to seeing you at the Annual
Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sincerely,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mahesh V. Patel, Ph.D.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">President, Chief Executive Officer and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Chairman of the Board of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LIPOCINE INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>675 Arapeen Drive, Suite 202</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Salt Lake City, Utah</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(801) 994-7383</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TO BE HELD JUNE 14, 2016</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>TO OUR STOCKHOLDERS</B>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">NOTICE IS HEREBY
GIVEN that the 2016 Annual Meeting of Stockholders (the &ldquo;Annual Meeting&rdquo;) of Lipocine Inc., a Delaware corporation
(the &ldquo;Company&rdquo;), will be held on June 14, 2016, at 10:00 a.m. Mountain Standard Time at 675 Arapeen Drive, Suite 202,
Salt Lake City, Utah 84108. The Annual Meeting will be held for the following purposes, as more fully described in the proxy statement
accompanying this notice:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.15in"></TD><TD STYLE="width: 0.15in; text-align: left">1.</TD><TD STYLE="text-align: justify"><B>ELECTION OF DIRECTORS.</B> To elect the five (5) directors
named in the attached proxy statement;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.15in"></TD><TD STYLE="width: 0.15in; text-align: left">2.</TD><TD STYLE="text-align: justify"><B>AMENDMENT AND RESTATEMENT OF THE COMPANY&rsquo;S AMENDED
AND RESTATED 2014 STOCK AND INCENTIVE PLAN. </B>To approve an amendment and restatement of our Amended and Restated 2014 Stock
and Incentive Plan to increase the authorized number of shares of common stock of the Company issuable under all awards granted
under such plan from 1,271,906 to 2,471,906;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.15in"></TD><TD STYLE="width: 0.15in; text-align: left">3.</TD><TD STYLE="text-align: justify"><B>RATIFICATION OF AUDITORS. </B>To ratify the appointment
of KPMG LLP as our independent registered public accounting firm for the year ended December 31, 2016; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.15in"></TD><TD STYLE="width: 0.15in; text-align: left">4.</TD><TD STYLE="text-align: justify"><B>ANY OTHER BUSINESS</B> that may properly come before
the Annual Meeting or any adjournments or postponements thereof.</TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The foregoing items
of business are more fully described in the Proxy Statement accompanying this notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We recommend that
stockholders vote &ldquo;FOR&rdquo; the matters listed above. Only stockholders of record at the close of business on April 15,
2016 are entitled to receive notice of and to vote at the Annual Meeting and any adjournments or postponements thereof. Our stock
transfer books will remain open between the record date and the date of the meeting. A list of stockholders entitled to vote at
the Annual Meeting will be available for inspection at our principal executive offices and at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We will be using the
Securities and Exchange Commission&rsquo;s Notice and Access model (&ldquo;Notice and Access&rdquo;), which allows us to deliver
proxy materials via the Internet, as the primary means of furnishing proxy materials. We believe Notice and Access provides stockholders
with a convenient method to access the proxy materials and vote, while allowing us to conserve natural resources and reduce the
costs of printing and distributing the proxy materials. On or about April 29, 2016, we will mail to stockholders holding shares
in &ldquo;street name&rdquo; a Notice of Internet Availability of Proxy Materials (&ldquo;Notice&rdquo;) containing instructions
on how to access our proxy statement and our Annual Report for the fiscal year ended December 31, 2015, or Annual Report, online
and how to vote via the Internet. The Notice also contains instructions on how to receive a paper copy of the proxy materials and
our Annual Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">All stockholders are
cordially invited to attend the Annual Meeting in person. However, to assure your representation at the Annual Meeting, you are
urged to access the proxy materials and vote via the Internet in accordance with the Notice you will receive, or if you request
paper copies of the proxy materials by mail, sign, date and promptly return the proxy card. To ensure that all your shares are
voted, please vote once for each Notice or proxy card you receive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">You may revoke your
proxy at any time prior to the Annual Meeting. If you attend the Annual Meeting and vote by ballot, your proxy will be revoked
automatically and only your vote at the Annual Meeting will be counted. If your shares are held in the name of a bank, broker,
or other holder of record, you must obtain a proxy, executed in your favor, from the holder of record in order to be able to vote
in person at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Please note: If you
hold your shares in the name of a broker, bank or other nominee, your nominee may determine to vote your shares at its own discretion,
absent instructions from you. However, due to voting rules that may prevent your bank or broker from voting your uninstructed shares
on a discretionary basis in the election of directors and other non-routine matters, it is important that you cast your vote. Accordingly,
please provide appropriate voting instructions to your broker or bank to ensure your vote will count.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B><U>Important Notice
Regarding the Availability of Proxy Materials for the Annual Meeting of Stockholders to be held on June 14, 2016</U>: This notice
of annual meeting of stockholders, the proxy statement, and our annual report on Form 10-K for 2015 are available at http://ir.lipocine.com/annuals-proxies.cfm.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Sincerely,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Mahesh V. Patel, Ph.D.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">President, Chief Executive Officer and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Chairman of the Board of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Salt Lake City, Utah</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">April 29, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>YOUR VOTE IS VERY IMPORTANT.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>IN ORDER TO ASSURE YOUR REPRESENTATION AT THE MEETING,
WE URGE YOU TO VOTE USING INTERNET VOTING OR IF YOU REQUEST TO RECEIVE THESE PROXY MATERIALS BY MAIL, BY COMPLETING, SIGNING, DATING
AND RETURNING THE ENCLOSED PROXY CARD AS PROMPTLY AS POSSIBLE.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>LIPOCINE INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>675 Arapeen Drive, Suite 202</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Salt Lake City, Utah</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(801) 994-7383</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 35%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PROXY STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 35%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The enclosed proxy
is solicited on behalf of Lipocine Inc., a Delaware corporation, by its Board of Directors (the &ldquo;Board&rdquo;) for use at
its 2016 Annual Meeting of Stockholders (the &ldquo;Annual Meeting&rdquo;) to be held at 10:00&nbsp;a.m. Mountain Standard Time
on June 14, 2016, or at any adjournments or postponements thereof, for the purposes set forth in this proxy statement and in the
accompanying notice. The Annual Meeting will be held at 675 Arapeen Drive, Suite 202, Salt Lake City, Utah 84108. Directions to
the Annual Meeting may be obtained by calling (801) 994-7383, for stockholders who plan to attend the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have elected to
provide access to this year&rsquo;s proxy materials primarily over the Internet under the Securities and Exchange Commission&rsquo;s
&ldquo;notice and access&rdquo; rules. On or about April 29, 2016, we mailed a Notice of Internet Availability of Proxy Materials
(the &ldquo;Notice&rdquo;) to each of our stockholders entitled to notice of and to vote at the Annual Meeting. This Notice contained
instructions on how to access this Proxy Statement, our Annual Report for the fiscal year ended December 31, 2015 (the &ldquo;Annual
Report&rdquo;) and how to vote via the Internet and e-mail. The Notice also included instructions on how you can receive a paper
copy of your proxy materials. The Proxy Statement and the Annual Report both are available online at: www.proxyvote.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Stockholders who owned
Lipocine Inc. common stock at the close of business on April 15, 2016 (the &ldquo;Record Date&rdquo;) are entitled to receive notice
of, attend and vote at the Annual Meeting. On the Record Date, there were 18,258,901 shares of common stock outstanding and approximately
137 shareholders of record according to information provided by our transfer agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>We will provide,
without charge, a copy of our Annual Report on Form&nbsp;10-K to each stockholder of record as of the Record Date that requests
according to the instructions included in the Notice. Any exhibits listed in the annual report on Form&nbsp;10-K report also will
be furnished upon request at the actual expense we incur in furnishing such exhibit.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>References to the
&ldquo;Company,&rdquo; &ldquo;Lipocine,&rdquo; &ldquo;our,&rdquo; &ldquo;us&rdquo; or &ldquo;we&rdquo; mean Lipocine Inc.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 92%"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="width: 8%; text-decoration: none; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt; text-decoration: none"><B STYLE="text-decoration: none">Page</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-transform: uppercase"><A HREF="#def14a_001">ANNUAL MEETING OF STOCKHOLDERS</A></TD>
    <TD STYLE="text-align: right; text-transform: uppercase">2</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="text-align: right; text-transform: uppercase">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-transform: uppercase"><A HREF="#def14a_002">VOTING AND RELATED MATTERS</A></TD>
    <TD STYLE="text-align: right; text-transform: uppercase">5</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="text-align: right; text-transform: uppercase">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-transform: uppercase"><A HREF="#def14a_003">EXECUTIVE OFFICERS AND DIRECTORS</A></TD>
    <TD STYLE="text-align: right; text-transform: uppercase">8</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="text-align: right; text-transform: uppercase">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-transform: uppercase"><A HREF="#def14a_004">BOARD OF DIRECTORS</A></TD>
    <TD STYLE="text-align: right; text-transform: uppercase">10</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="text-align: right; text-transform: uppercase">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-transform: uppercase"><A HREF="#def14a_005">EXECUTIVE COMPENSATION</A></TD>
    <TD STYLE="text-align: right; text-transform: uppercase">13</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="text-align: right; text-transform: uppercase">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-transform: uppercase"><A HREF="#def14a_006">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</A></TD>
    <TD STYLE="text-align: right; text-transform: uppercase">16</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="text-align: right; text-transform: uppercase">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-transform: uppercase"><A HREF="#def14a_007">Certain Transactions</A></TD>
    <TD STYLE="text-align: right; text-transform: uppercase">17</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="text-align: right; text-transform: uppercase">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-transform: uppercase"><A HREF="#def14a_008">SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE</A></TD>
    <TD STYLE="text-align: right; text-transform: uppercase">18</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="text-align: right; text-transform: uppercase">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-transform: uppercase"><A HREF="#def14a_009">REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS</A></TD>
    <TD STYLE="text-align: right; text-transform: uppercase">19</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="text-align: right; text-transform: uppercase">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-transform: uppercase"><A HREF="#def14a_010">PROPOSAL NO. 1 &ndash; election of directors</A></TD>
    <TD STYLE="text-align: right; text-transform: uppercase">20</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#def14a_011">PROPOSAL NO. 2 - AMEND 2014 STOCK AND INCENTIVE PLAN</A></TD>
    <TD STYLE="text-align: right">21</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-transform: uppercase"><A HREF="#def14a_012">PROPOSAL NO. 3 &ndash; RATIFICATION OF APPOINTMENT OF KPMG LLP</A></TD>
    <TD STYLE="text-align: right; text-transform: uppercase">31</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="text-align: right; text-transform: uppercase">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-transform: uppercase"><A HREF="#def14a_013">OTHER BUSINESS</A></TD>
    <TD STYLE="text-align: right; text-transform: uppercase">33</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="text-align: right; text-transform: uppercase">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-transform: uppercase"><A HREF="#def14a_014">ANNUAL REPORT ON FORM 10-K</A></TD>
    <TD STYLE="text-align: right; text-transform: uppercase">33</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="text-align: right; text-transform: uppercase">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-transform: uppercase"><A HREF="#def14a_015">STOCKHOLDER Proposals</A></TD>
    <TD STYLE="text-align: right; text-transform: uppercase">33</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#def14a_016">APPENDIX I</A></TD>
    <TD STYLE="text-align: right">34</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#def14a_017">APPENDIX II</A></TD>
    <TD STYLE="text-align: right">49</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="def14a_001"></A>ANNUAL MEETING
OF STOCKHOLDERS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have sent you this Proxy Statement and
the enclosed proxy card because our Board is soliciting your proxy to vote at our 2016 Annual Meeting of Stockholders to be held
on Tuesday, June 14, 2016 (the &ldquo;Annual Meeting&rdquo;), at our offices at 675 Arapeen Drive, Suite 202, Salt Lake City, Utah
84108, at 10:00&nbsp;a.m., Mountain Standard Time, and at any adjournments or postponements thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">This Proxy Statement summarizes information about the proposals
to be considered at the Meeting and other information you may find useful in determining how to vote.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: -18.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">The proxy card is the means by which you actually authorize
another person to vote your shares in accordance with your instructions.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: -18.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have elected to provide access to
this year&rsquo;s proxy materials primarily over the Internet under the Securities and Exchange Commission&rsquo;s
&ldquo;notice and access&rdquo; rules. On or about April 29, 2016, we mailed a Notice of Internet Availability of Proxy
Materials (the &ldquo;Notice&rdquo;) to the holders of the Company&rsquo;s common stock of record as of April 15, 2016 (the
&ldquo;Record Date&rdquo;). This Notice contained instructions on how to access this Proxy Statement, our Annual Report for
the fiscal year ended December 31, 2015 (the &ldquo;Annual Report&rdquo;) and how to vote via the Internet and e-mail. The
Notice also included instructions on how you can receive a paper copy of your proxy materials. The Proxy Statement and the
Annual Report both are available online at: www.proxyvote.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Information About the Annual Meeting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>When is the Annual Meeting?</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Annual Meeting will be held at 10:00&nbsp;a.m.,
Mountain Standard Time, on Tuesday, June 14, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Where is the Annual Meeting?</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Annual Meeting will be held at our
offices at 675 Arapeen Drive, Suite 202, Salt Lake City, Utah 84108.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>What is the purpose of the Annual Meeting?</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">At the Annual Meeting, stockholders will
act upon the matters listed in the Notice of Annual Meeting of Stockholders and any other matters that properly come before the
Annual Meeting or any adjournments or postponements thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Who can attend the Annual Meeting?</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">All stockholders as of the Record Date,
or their duly appointed proxies, may attend the Annual Meeting. Each stockholder may be asked to present valid picture identification,
such as a driver&rsquo;s license or passport. If you hold your shares through a broker or other nominee, you must bring a copy
of a brokerage statement reflecting your stock ownership as of the Record Date. All stockholders must check in at the registration
desk at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>What is &ldquo;Notice and Access&rdquo; and why did Lipocine
use it?</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are making the proxy solicitation materials available to
stockholders electronically via the Internet under the Notice and Access rules and regulations of the Securities and Exchange Commission,
or SEC. On or about April 29, 2016, we mailed to stockholders the Notice in lieu of mailing a full set of proxy materials. Accordingly,
our proxy materials are first being made available to our stockholders on or about April 29, 2016. The Notice includes information
on how to access and review the proxy materials and how to vote via the Internet. All stockholders will have the ability to access
the proxy materials on the website referred to in the Notice or request a printed set of the proxy materials. Instructions on how
to access the proxy materials over the Internet or to request a printed copy may be found in the Notice. In addition, stockholders
may request to receive proxy materials in printed form by mail or electronically by email on an ongoing basis. We believe this
method of delivery will decrease costs, expedite distribution of proxy materials to you and reduce our environmental impact. We
encourage stockholders to take advantage of the availability of the proxy materials on the Internet to help reduce the environmental
impact of our Annual Meeting. Stockholders who received the Notice but would like to receive a printed copy of the proxy materials
in the mail should follow the instructions in the Notice for requesting such materials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>What constitutes a quorum?</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A quorum of stockholders is necessary to
hold a valid meeting for the transaction of business. The presence at the Annual Meeting, in person or by proxy, of the holders
entitled to cast at least a majority of votes which all stockholders are entitled to cast as of the Record Date will constitute
a quorum. Broker non-votes, abstentions and votes withheld count as shares present at the Annual Meeting for purposes of calculating
whether a quorum is present. On the Record Date, there were 18,258,901 shares of our common stock outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>What are the recommendations of the Board?</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Unless you instruct otherwise on your proxy
card, via the Internet or in person at the Annual Meeting, the persons named as proxy holders will vote in accordance with the
recommendations of the Board. The Board&rsquo;s recommendations are set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">Proposal No. 1: &ldquo;FOR&rdquo; the election of each Board nominee set forth in this proxy statement
unless the authority to vote for such directors is withheld;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: center"></TD><TD STYLE="width: 0.25in; text-align: left">2.</TD><TD STYLE="text-align: justify">Proposal No. 2: &ldquo;FOR&rdquo; the approve of an amendment
and restatement of the Company&rsquo;s Amended and Restated 2014 Stock and Incentive Plan;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">Proposal No. 2: &ldquo;FOR&rdquo; the ratification of the Audit Committee's appointment of KPMG
LLP as our independent registered accounting firm for the year ending December 31, 2016.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The proxy holders will vote in their own
discretion with respect to any other matter that properly comes before the Annual Meeting or any adjournments or postponements
thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Information About Voting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Who can vote at the Annual Meeting?</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">All stockholders of record at the close
of business on the Record Date, April&nbsp;15, 2016, are entitled to vote at the Annual Meeting and any adjournments or postponements
of the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>What are the voting rights of the holders of the common stock?</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Holders of our common stock will vote on
all matters to be acted upon by the stockholders at the Annual Meeting. Each outstanding share of common stock will be entitled
to one vote on each matter to be voted upon at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>How do I vote?</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">You may attend the Annual Meeting and vote
in person. Alternatively, you may vote your shares over the internet by following the Internet voting instructions in the Notice.
If you request to receive a printed copy of the proxy materials from us by mail, you may vote by mail by completing, signing and
dating your Proxy Card and returning it to us on or prior to June 13, 2016 (proxy cards received after June 13, 2016 (i.e., on
or after the Annual Meeting date) will not be counted). Please note that by casting your vote by proxy you are authorizing the
individuals named as proxy holders to vote your shares in accordance with your instructions and in their discretion with respect
to any other matter that properly comes before the Annual Meeting or any adjournments or postponements thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If you want to vote in person at the Annual
Meeting and you hold shares of our common stock in street name, you should follow the instructions in the Notice or your broker
should give you instructions for voting your shares. In these cases, you may vote by Internet or mail, as applicable. You may vote
your shares beneficially held through your broker in person if you attend the Annual Meeting and you obtain a valid proxy from
your broker giving you the legal right to vote the shares at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Is my vote confidential?</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Yes. Proxy cards, ballots and voting tabulations
that identify stockholders are kept confidential except in certain circumstances where it is important to protect the interests
of Lipocine and its stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>What happens if I do not vote my shares?</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If you are a stockholder of record and
you do not vote by proxy card, via the Internet or in person at the Annual Meeting, your shares will not be voted at the Annual
Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If you hold shares of our common stock
in street name and you do not direct your broker or nominee how to vote your shares, your broker or nominee may vote your shares
only on those proposals for which it has discretion to vote. Under the rules of the New York Stock Exchange, your broker or nominee
does not have discretion to vote your shares on non-routine matters such as Proposal 1 and Proposal 2. We believe that Proposal
3 &mdash; ratification of our auditor &mdash; is a routine matter on which brokers and nominees can vote on behalf of their clients
if clients do not furnish voting instructions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Can I change my vote after I vote via the Internet or return
my proxy card?</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Yes. Even after you have voted over the
Internet or submitted your proxy card, you may change your vote at any time before the proxy is exercised by filing a notice of
revocation with the Secretary of Lipocine. You may also change your vote at any time before the proxy is exercised by either casting
a new vote over the Internet or sending a duly executed proxy card bearing a later date. The powers of the proxy holders will be
suspended if you attend the Annual Meeting in person and request to recast your vote. Attendance at the Annual Meeting will not,
by itself, revoke a previously granted proxy. For information regarding how to vote in person, see &ldquo;<I>How do I vote?</I>&rdquo;
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>What vote is required to approve each proposal?</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>Proposal 1: Election of Directors.</I>
The affirmative vote of a plurality of the votes cast at the Annual Meeting is required for the election of directors, provided
a quorum is present in person or by proxy. A plurality means that the five nominees receiving the most votes for election to a
director position are elected as directors.&nbsp; Thus, the five candidates with the most affirmative votes will be elected at
the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>Proposal 2: Amendment and Restatement
of the Company&rsquo;s Amended and Restated 2014 Stock and Incentive Plan. </I>The proposal to approve an amendment and restatement
of the Company&rsquo;s Amended and Restated 2014 Stock and Incentive Plan to increase the authorized number of shares of common
stock of the Company issuable under all awards granted under such plan from 1,271,906 to 2,471,906 shares will be approved if a
majority of the shares of common stock outstanding as of the Record Date that are present or represented and entitled to vote at
the Annual Meeting are voted in favor of the amendment and restatement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Proposal 3:&nbsp;
Ratification of Auditors.</I>&nbsp; The proposal to ratify the appointment of KPMG LLP as our independent registered public accounting
firm to audit our financial statements for the year ending December 31, 2016 will be approved if a majority of the shares of common
stock outstanding as of the Record Date that are present and represented and entitled to vote at the Annual Meeting vote in favor
of the proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>What is a broker non-vote?</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A broker non-vote occurs when a broker
does not vote on a particular proposal with respect to shares of common stock held in a fiduciary capacity (typically referred
to as being held in &ldquo;street name&rdquo;) because the broker has not received voting instructions from the beneficial owner.
Under the rules&nbsp;that govern brokers who are voting with respect to shares held in street name, brokers have the discretion
to vote such shares on routine matters, but not on non-routine matters. Routine matters include the ratification of auditors. Non-routine
matters include matters such as the election of directors, the approval of, and amendments to, stock plans and the approval of
an amendment to a company&rsquo;s certificate of incorporation.&nbsp; Therefore, if you do not give your broker or nominee specific
instructions, your shares will not be voted on non-routine matters and may not be voted on routine matters. However, shares represented
by such &ldquo;broker non-votes&rdquo; will be counted in determining whether there is a quorum present at the Annual Meeting for
the purpose of transacting business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Who can help answer my other questions?</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If you have more questions about the Annual
Meeting, or require assistance in submitting your proxy or voting your shares, please contact Morgan R, Brown, our corporate secretary,
at 1-801-994-7383 or by email at mb@lipocine.com. If your broker, dealer, commercial bank, trust company or other nominee holds
your shares, you should also call your broker, dealer, commercial bank, trust company or other nominee for additional information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="def14a_002"></A>VOTING AND
RELATED MATTERS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Voting Procedures</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As a stockholder of Lipocine, you have
a right to vote on certain business matters affecting us. The proposals that will be presented at the Annual Meeting and upon which
you are being asked to vote are discussed below in the &ldquo;Proposals&rdquo; section. Each share of Lipocine common stock you
owned as of the Record Date entitles you to one vote on each proposal presented at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Methods of Voting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">You may vote over
the Internet, by mail or in person at the Annual Meeting. Please be aware that if you vote over the Internet, you may incur costs
such as Internet access charges for which you will be responsible.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Voting over the
Internet.</B> &nbsp;You may vote your shares over the internet by following the Internet voting instructions in the Notice. You
can use the Internet to transmit your voting instructions up until 11:59 p.m. Eastern Time on June 13, 2016. &nbsp;Internet voting
is available 24 hours a day. &nbsp;If you vote via the Internet, you do not need to return a proxy card.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Voting by Mail.</B>
&nbsp;If you request to receive a printed copy of the proxy materials from us by mail, you may vote by mail by completing, signing
and dating your proxy card and returning it to us on or prior to June 13, 2016 (proxy cards received after June 13, 2016 (i.e.,
on or after the Annual Meeting date) will not be counted). Please promptly mail your proxy card to ensure that it is received prior
to the closing of the polls at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Voting in Person
at the Meeting.</B> If you attend the Annual Meeting and plan to vote in person, we will provide you with a ballot at the Annual
Meeting. If your shares are registered directly in your name, you are considered the stockholder of record and you have the right
to vote in person at the Annual Meeting. If your shares are held in the name of your broker or other nominee, you are considered
the beneficial owner of shares held in street name. As a beneficial owner, if you wish to vote at the Annual Meeting, you will
need to bring to the Annual Meeting a legal proxy from your broker or other nominee authorizing you to vote those shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Revoking Your Proxy</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">You may revoke your
proxy at any time before it is voted at the Annual Meeting. To do this, you must:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 13.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">enter a new vote over the Internet or by signing and returning a replacement proxy card;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -13.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 13.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">provide written notice of the revocation to our Corporate Secretary at our principal executive
office, <FONT STYLE="font-weight: normal">675 Arapeen Drive, Suite 202, Salt Lake City, Utah 84108</FONT>; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -13.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 13.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">attend the Annual Meeting and vote in person.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">&nbsp;<B>Quorum and Voting Requirements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Stockholders of record
at the close of business on April 15, 2016, are entitled to receive notice and vote at the meeting. On the Record Date, there were
18,258,901 issued and outstanding shares of our common stock. Each holder of common stock voting at the meeting, either in person
or by proxy, may cast one vote per share of common stock held on the Record Date on all matters to be voted on at the meeting.
Stockholders may not cumulate votes in the election of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The presence, in person
or by proxy, of the holders of a majority of the outstanding shares of common stock entitled to vote constitutes a quorum for the
transaction of business at the meeting. Assuming that a quorum is present:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">a plurality of the shares present in person or represented by proxy at the meeting and entitled
to vote on the election of directors will be required to elect Board nominees;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify">the amendment and restatement of our Amended and Restated 2014 Stock and Incentive Plan to increase
the authorized number of shares issuable under all awards granted under such plan from 1,271,906 to 2,471,906 will be approved
if a majority of the shares of common stock outstanding as of the Record Date that are present or represented and entitled to vote
at the Annual Meeting are voted in favor of the amendment and restatement; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(3)</TD><TD STYLE="text-align: justify">the ratification of the appointment of KPMG LLP as our
independent registered accounting firm for the year ending December 31, 2016 will be approved if a majority of the shares of common
stock outstanding as of the Record Date that are present and represented and entitled to vote at the Annual Meeting vote in favor
of the proposal.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Votes cast by proxy
or in person at the meeting will be tabulated by the election inspectors appointed for the meeting and who will determine whether
a quorum is present. The election inspectors will treat abstentions and broker non-votes (i.e., shares held by a broker or nominee
that are represented at the Annual Meeting, but with respect to which such broker or nominee is not instructed to vote on a particular
proposal and does not have discretionary voting power) as shares that are present for purposes of determining the presence of a
quorum. With regard to Proposal One, broker non-votes and votes marked &ldquo;withheld&rdquo; will not be counted towards the tabulations
of votes cast on such proposal presented to the stockholders, will not have the effect of negative votes and will not affect the
outcome of the election of the directors. With regard to Proposal Two and Proposal Three, abstentions will be counted towards the
tabulations of votes cast on such proposal presented to the stockholders and will have the same effect as negative votes, whereas
broker non-votes will not be counted for purposes of determining whether such proposal has been approved and will not have the
effect of negative votes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If your shares are
held by a bank or broker in street name, it is important that you cast your vote if you want it to count in the election of directors,
the vote to approve an amendment and restatement of our Amended and Restated 2014 Stock and Incentive Plan and other non-routine
matters as determined by the New York Stock Exchange. Voting rules may prevent your bank or broker from voting your uninstructed
shares on a discretionary basis in the election of directors and other non-routine matters. Accordingly, if your shares are held
by a bank or broker in street name and you do not instruct your bank or broker how to vote in the election of directors or any
other non-routine matters, no votes will be cast on your behalf.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Voting of Proxies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">When a vote is properly
cast via the Internet or proxy card, the shares it represents will be voted at the meeting as directed. If no specification is
indicated, the shares will be voted:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">&ldquo;for&rdquo; the election of each Board nominee set forth in this proxy statement unless the
authority to vote for such directors is withheld;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">&ldquo;for&rdquo; the approval of the amendment and restatement
of the Company&rsquo;s Amended and Restated 2014 Stock and Incentive Plan;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(3)</TD><TD STYLE="text-align: justify">&ldquo;for&rdquo; the ratification of the Audit Committee's appointment of KPMG LLP as our independent
registered accounting firm for the year ending December 31, 2016; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(4)</TD><TD STYLE="text-align: justify">at the discretion of your proxy holder, on any other matter that may be properly brought before
the meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Voting Results</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Voting results will
be announced at the Annual Meeting and published in a Current Report on Form 8-K that will be filed with the Securities and Exchange
Commission within four business days after the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Householding of Proxy Materials</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are sending only
one Notice to certain street-name stockholders who share a single address, unless we received contrary instructions from any stockholder
at that address. This practice, known as &ldquo;householding,&rdquo; is designed to reduce our printing and postage costs. However,
if you are residing at such an address and wish to receive a separate Notice in the future, you may telephone our Corporate Secretary
at (801) 994-7383, by email at mb@lipocine.com or write to Morgan R. Brown at Lipocine Inc., 675 Arapeen Drive, Suite 202, Salt
Lake City, Utah 84108. If you are receiving multiple copies of the Notice, you may request householding by contacting the Corporate
Secretary in the same manner.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Proxy Solicitation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We will bear the cost
of this solicitation. In addition, we may reimburse brokerage firms and other persons representing beneficial owners of shares
for reasonable expenses incurred in forwarding solicitation materials to such beneficial owners. Proxies also may be solicited
by our directors, officers or employees, personally, by telephone, facsimile, Internet or other means, without additional compensation.
We may retain a proxy solicitor to assist in the distribution of proxies and proxy solicitation materials, and in the solicitation
of proxies. Generally, the fee for such services is approximately $15,000 plus expenses. If we do elect to retain a proxy solicitor,
we will pay the proxy solicitor reasonable and customary fees. Except as described above, we do not presently intend to solicit
proxies other than by e-mail and mail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><U>Important Notice Regarding the Availability
of Proxy Materials for the Annual Meeting of Stockholders to be held on June 14, 2016</U>:</B> <B>The notice of annual meeting
of stockholders, this proxy statement, and our annual report on Form 10-K for 2015 are available at http://ir.lipocine.com/annuals-proxies.cfm.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: left"><B><A NAME="def14a_003"></A>EXECUTIVE
OFFICERS AND DIRECTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-weight: normal">Our executive
officers and directors and their ages as of March 31, 2016, are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 30%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 63%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Position(s)</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Mahesh V. Patel, Ph.D.<I>*</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">58</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">President, Chief Executive Officer and Chairman of the Board of Directors</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Morgan R. Brown, M.B.A.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">47</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Executive Vice President and Chief Financial Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Jyrki Mattila, M.D, Ph.D., M.B.A</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">61</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Business Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 13.4pt; text-indent: -13.4pt"><FONT STYLE="font-size: 10pt">Dr. Stephen A. Hill, M.A., F.R.C.S.<I>*+&dagger;</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">57</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 13.4pt; text-indent: -13.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Mr. Jeffrey A. Fink<I>*</I><FONT STYLE="font-style: normal">+</FONT></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">58</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Director</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">John W. Higuchi, M.B.A.<I>*</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">48</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Director</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Dr. Richard Dana Ono, Ph.D.<I>*+</I><FONT STYLE="font-style: normal">&dagger;</FONT></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">61</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Director</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><I>*</I></TD><TD><I>Nominee for election to Board</I></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><I>+</I></TD><TD STYLE="text-align: justify"><I>Member of the Audit Committee</I></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&dagger;</TD><TD><I>Member of the Compensation Committee</I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Executive Officers</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Mahesh V. Patel,
Ph.D.</I>, is our President, Chief Executive Officer and Chairman of the Board of Directors. Dr. Patel&rsquo;s biographical information
can be found under &ldquo;Directors&rdquo; below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Morgan R. Brown</I>,
<I>M.B.A</I> has served as our Executive Vice President and Chief Financial Officer since September 2013. Mr.&nbsp;Brown served
as Executive Vice President and Chief Financial Officer at Innovus Pharmaceuticals, Inc., a pharmaceuticals company, from May 2013
to September 2013. From August 2012 to May 2013, Mr.&nbsp;Brown consulted for Heartware International Inc., a medical device company.
From August 2009 to August 2012, Mr.&nbsp;Brown served as Executive Vice President and Chief Financial Officer at World Heart Corporation,
a medical device company. From August 2008 to August 2009, Mr.&nbsp;Brown served as Chief Financial Officer and Senior Vice President
at Lifetree Clinical Research, a clinical research organization. Previously, Mr.&nbsp;Brown served as Vice President Finance and
Treasurer at NPS Pharmaceuticals, Inc., a biotechnology company. Mr. Brown received a B.S. in Accounting from Utah State University
and a M.B.A from the University of Utah.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Jyrki Mattila,</I>
M.D., Ph.D, M.B.A has served as our Executive Vice President and Chief Business Officer since May 2015. Prior to joining Lipocine,
Dr. Mattila served as Chief Business Officer of iCeutica Operations Inc. from 2013 to 2015 and as President and Chief Executive
Officer of LZ Therapeutics, Inc. from 2010 to 2013. Prior to these positions, Dr. Mattila was Executive Vice President of Business
Development, Product Development and Technical Operations at Auxilium Pharmaceuticals, Inc. from 2003 to 2010 and President of
Orion Pharma from 1986 to 2003, where under his leadership several innovative products were developed, partnered and commercialized
for global markets. Dr. Mattila has negotiated and closed over 50 business agreements, including licensing, co-marketing, collaboration
and product acquisition arrangements. He received his M.D. and Ph.D. in Pharmacology from the University of Helsinki Medical School
and an M.B.A. from the Helsinki School of Economics.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Mahesh&nbsp;V.&nbsp;Patel,
Ph.D</I> has served as our President and Chief Executive Officer since 1997, as a member of our Board of Directors since 1997 and
currently serves as the Chairman of our Board of Directors. Dr.&nbsp;Patel has more than 25&nbsp;years of experience in strategic
planning, technology assessment/development, technical management and product research and development in the area of drug discovery
support, drug delivery and product line extensions. Prior to co-founding Lipocine in 1997, he led drug delivery research and development
at Pharmacia and Upjohn. Dr.&nbsp;Patel received a B.Pharm from Karnataka University in India, a M.S. in Physical Pharmacy at the
University of Cincinnati and a Ph.D. in Pharmaceutics from the University of Utah. We believe Dr.&nbsp;Patel&rsquo;s dual role
as an executive officer and director gives him unique insights into the day-to-day operations of our company and our strategic
planning and clinical development.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>Dr. Stephen A. Hill, M.A., F.R.C.S.
</I>has served as a member of our Board of Directors since January 2014 and has been a member of the Board and Chief Executive
Officer of Faraday Pharmaceuticals since August 2015. From December 2012 until its merger with Catalyst Biosciences in August 2015,
Dr. Hill was President and CEO of Targacept, Inc., a Nasdaq listed biotechnology company. From May 2012 to November 2012, Dr. Hill
served as president and chief executive officer of QUE Oncology, a start-up biotechnology company, and, from March 2011 to December
2011, he served as president and chief executive officer of 21<SUP>st</SUP> Century Biodefense, a biodefense company. From April
2008 until its acquisition in December 2010, he served as president and chief executive officer of Solvay Pharmaceuticals, Inc.,
a pharmaceutical company. Prior to Solvay, he served as president, chief executive officer and director of ArQule, Inc., a biotech
company, from April 1999 to March 2008. Dr. Hill is a member of the Board of Directors of the publicly-traded companies Cellectar
Biosciences and Catalyst Biosciences. Dr. Hill is a Fellow of the Royal College of Surgeons of England and holds his scientific
and medical degrees from St. Catherine's College at Oxford University.&nbsp; We believe Dr. Hill brings to the Board extensive
experience across a broad range of senior management positions with both pharmaceutical and biotechnology companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-size: 10pt"><I>Jeffrey
A. Fink</I> has served as a member of our Board of Directors since January 2014 and has over 20 years of finance and strategy experience
within the life science and healthcare industry. Mr. Fink is currently the managing director of Gambel Oaks Advisors, LLC, a strategic
and financial advisory firm dedicated to the life sciences and allied industries, where he has worked since 2010. Mr. Fink spent
over twenty years in the investment banking industry advising life science clients in the U.S. and Europe on the full range of
financing and strategic advisory assignments. He was head of Healthcare Investment Banking for Robert W. Baird &amp; Co. in Chicago
until he retired in 2007, and prior to that was a partner in the Healthcare Group at Dresdner Kleinwort Wasserstein (the successor
firm to Wasserstein Perella) and head of Mergers and Acquisitions for Prudential Vector Healthcare, a dedicated biotechnology and
life sciences investment bank.</FONT> <FONT STYLE="font-size: 10pt">Mr. Fink received a BA in Economics, cum laude, from Kalamazoo
College and holds an MBA in finance, with distinction, from the University of Michigan. We believe that Mr. Fink&rsquo;s knowledge
of accounting and finance and his extensive experience in the life science industry will greatly benefit the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>John&nbsp;W.&nbsp;Higuchi</I>,
<I>M.B.A</I> has served as a member of our Board of Directors since 2003. Since 2003, Mr.&nbsp;Higuchi has served as President
and Chief Executive Officer of Aciont Inc., an ocular therapeutics company. From 1997 to 2003, Mr.&nbsp;Higuchi served as our Vice
President of Business Development and Corporate Treasurer. Mr.&nbsp;Higuchi also has worked for the American Chemical Society.
Mr.&nbsp;Higuchi received a B.S. in Chemistry from Hope College and an M.B.A. and Master of Science in Information Systems from
The George Washington University. We believe that Mr.&nbsp;Higuchi&rsquo;s business development and management experience in the
therapeutics industry, together with his significant knowledge of our company obtained while serving as a director of our company,
will greatly benefit our Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Dr. Richard Dana
Ono, Ph.D</I> has served as a director of the Company since January 2014 and brings 30 years of experience managing public and
private life science companies. Throughout his career, he has been engaged in strategic planning, product management, technology
acquisition, and commercial development for multiple early stage life science companies and has been involved in a number of key
advances for the industry. Dr. Ono has founded several biotech companies in the U.S., including IntraImmune Therapies, Inc., a
biotechnology company which he sold to Abgenix, Inc. (now Amgen), along with several successful early stage biotech companies in
the Boston area. Currently, he is an executive-in-residence to several U.S. universities where he is involved in the creation of&nbsp;new
commercial opportunities.&nbsp; Additionally, Dr. Ono serves as a member of the Board of Directors of Hedgepath Pharmaceuticals,
Inc. We believe that Dr. Ono&rsquo;s extensive experience with life science companies at each phase of development will greatly
benefit the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Currently, directors
and officers are elected on an annual basis. The term of each director&rsquo;s service expires at our next annual meeting of stockholders
and at such time as his or her successor is duly elected and qualified. Officers serve at the discretion of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">There are no family
relationships between any of our director nominees or executive officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="def14a_004"></A>BOARD OF
DIRECTORS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"><B>Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our Bylaws provide
that the size of our Board is to be determined by resolution of the Board. Our Board has fixed the number of directors at five.
Our Board currently consists of five members.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our common stock is
listed on The NASDAQ Capital Market and we comply with The NASDAQ Capital Market&rsquo;s listing standards on determining the independence
of directors. Under these standards, an independent director means a person other than an executive officer or one of our employees
or any other individual having a relationship which, in the opinion of the Board of Directors, would interfere with the exercise
of independent judgment in carrying out the responsibilities of a director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Board has nominated
Dr. Mahesh V. Patel, Dr. Stephen A. Hill, Mr. Jeffrey A. Fink, Dr. Richard Dana Ono and Mr. John W. Higuchi for election at the
Annual Meeting. Dr. Hill is currently serving as the Lead Independent Director and Mr. Fink and Dr. Ono are also serving as independent
directors. The nominees have agreed to serve if elected, and management has no reason to believe that the nominees will be unavailable
for service. If any nominee is unable or declines to serve as a director at the time of the Annual Meeting or any adjournment or
postponement thereof, the proxies will be voted for such other nominees as may be designated by the present Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are subject to
a number of technological, regulatory, product, legal and other types of risks. The Board and its constituent committees are responsible
for overseeing these risks, and we employ a number of procedures to help them carry out that duty. For example, Board members regularly
consult with executive management about pending issues and expected challenges, and at each Board meeting directors receive updates
from, and have an opportunity to interview and ask questions of, key personnel and management. Furthermore, because our Chief Executive
Officer serves as a member of our Board, we believe that the Board has a direct channel and better access to insights into our
performance, business and challenges.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Board Leadership Structure</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Board does not
have a policy regarding the separation of the roles of Chief Executive Officer and Chairman of the Board as the Board believes
it is in the best interests of the Company to make that determination based upon the position and direction of the Company and
the membership of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Board currently
combines the role of Chairman of the Board with the role of Chief Executive Officer, coupled with a Lead Independent Director position
to further strengthen the governance structure. The Board believes this provides an efficient leadership model for the Company.
Combining the Chairman and CEO roles fosters clear accountability, effective decision-making and alignment of corporate strategy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Board has instituted
the Lead Independent Director position to provide an additional measure of balance, ensure the Board&rsquo;s independence and enhance
its ability to fulfill its management oversight responsibilities. Dr. Stephen A. Hill currently serves as the Lead Independent
Director. The Lead Independent Director:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">presides over all meetings of the directors at which the Chairman is not present, including executive
sessions of the independent directors;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">frequently consults with the Chairman and CEO about strategic policies;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">provides the Chairman and CEO with input regarding Board meetings;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">serves as a liaison between the Chairman and CEO and the independent directors; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">otherwise assumes such responsibilities as may be assigned to him by the independent directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">No single leadership
model is right for all companies at all times. The Board recognizes that depending on the circumstances, other leadership models,
such as a separate independent chairman of the Board, might be appropriate. Accordingly, the Board periodically reviews its leadership
structure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Committees of the Board of Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Board has established
an Audit Committee and a Compensation Committee. Each committee operates pursuant to a charter that may be viewed on our website
at www.lipocine.com. The inclusion of our web site address in this proxy statement does not include or incorporate by reference
the information on our web site into this proxy statement. The Board does not have a Nominating Committee or other committee of
the Board that performs similar functions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B><I>Audit Committee.</I></B>
Our Audit Committee oversees our accounting and financial reporting processes and is responsible for (i) retaining, evaluating
and, if appropriate, recommending the termination of our independent registered public accounting firm, (ii) approving the services
performed by our independent registered public accounting firm and (iii) reviewing and evaluating our accounting principles, financial
reporting practices, and system of internal accounting controls. The Audit Committee is also responsible for maintaining communication
between the Board and our independent registered public accounting firm, and has established procedures for the receipt, retention
and treatment of complaints regarding accounting, internal accounting controls or auditing matters, and for the confidential, anonymous
submission by our employees of concerns regarding questionable accounting or auditing matters. In addition, all related person
transactions are reviewed and approved by the Audit Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our Audit Committee
consists of Mr. Fink, Dr. Hill and Dr. Ono with Mr. Fink serving as the Audit Committee Chairman. The Board has determined that
all members of our Audit Committee are independent under the rules of the Securities and Exchange Commission, The NASDAQ Stock
Market Rules and the standards adopted by our Board and that Mr. Fink qualifies as an &ldquo;audit committee financial expert,&rdquo;
as defined by the rules of the Securities and Exchange Commission. During the fiscal year ended December 31, 2015, the Audit Committee
held 5 meetings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B><I>Compensation
Committee</I></B><I>.</I>&nbsp;Our Compensation Committee assists our Board in determining the compensation of our executive officers
and directors. The Compensation Committee is responsible for approving the compensation package of each executive officer and
recommending each executive officer&rsquo;s compensation to the Board. The Compensation Committee currently administers our Amended
and Restated 2014 Stock and Incentive Plan. The Compensation Committee may form and delegate any of its responsibilities to subcommittees
when appropriate. The Compensation Committee intends to engage a compensation consultant to advise the Compensation Committee
in the future. Dr. Patel makes recommendations to the Compensation Committee regarding the compensation of the other executive
officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our Compensation
Committee consists of Drs. Hill and Ono with Dr. Hill serving as the Compensation Committee Chairman. The Board has determined
that all members of our Compensation Committee are independent under the rules of the Securities and Exchange Commission, The
NASDAQ Stock Market Rules and the standards adopted by our Board. During the fiscal year ended December 31, 2015, the Compensation
Committee held 2 meetings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B><I>Nominating Committee
Functions</I>.</B> Given the relatively small size of our Board of Directors and the desire to involve the entire Board of Directors
in nominating decisions, we have elected not to have a separate Nominating Committee. Since we do not have a Nominating Committee,
all of the members of the Board of Directors participate in the consideration of director nominees. Our Board of Directors may
employ a variety of methods for identifying and evaluating director nominees. If vacancies are anticipated or arise, our Board
of Directors considers various potential candidates which may come to our attention through current board members, professional
search firms, stockholders or other persons. These candidates may be evaluated by our Board of Directors at any time during the
year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In evaluating a director candidate, our
Board of Directors will review his or her qualifications including capability, availability to serve, conflicts of interest, general
understanding of business, understanding of the Company&rsquo;s business and technology, educational and professional background,
personal accomplishment and other relevant factors. Our Board of Directors has not established any specific qualification standards
for director nominees and we do not have a formal diversity policy relating to the identification and evaluation of nominees for
director, although from time to time the Board of Directors may identify certain skills or attributes as being particularly desirable
to help meet specific needs that have arisen. Our Board of Directors may also interview prospective nominees in person or by telephone.
After completing this evaluation, the Board of Directors will determine the nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Board has not adopted a formal process
for considering director candidates who may be recommended by stockholders.&nbsp;&nbsp;However, our policy is to give due consideration
to any and all such candidates.&nbsp;&nbsp;A stockholder may submit a recommendation for director candidates to us at our corporate
offices, to the attention of Morgan R. Brown.&nbsp;&nbsp;We do not pay fees to any third parties to assist us in identifying potential
nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Board Meetings and Attendance at Annual
Meetings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Board held a total
of 7 meetings during 2015. Each incumbent director attended more than 75% of the aggregate of the total number of meetings of the
Board held during 2015 and the total number of meetings of all committees of the Board on which that director served during the
periods of such service. Although we do not have a formal policy regarding attendance by directors at our annual meeting, we encourage
directors to attend. We held our annual meeting of stockholders for the 2014 fiscal year on June 16, 2015 and one of our directors
was in attendance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0"><B>Director Compensation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-size: 10pt">The
following table provides information regarding compensation of non-employee directors who served during 2015.</FONT> <FONT STYLE="font-size: 10pt">In
2015, each non-employee director received an annual retainer of $30,000; members of the Audit Committee received an additional
$5,000 for such service and members of the Compensation Committee received an additional $4,000 for such service. Also in 2015,
the Chair of the Audit Committee received $15,000, the Chair of the Compensation Committee received $10,000 and the Lead Independent
Director received $20,000 per year.</FONT> <FONT STYLE="font-size: 10pt">Finally, we reimbursed our directors for reasonable travel
expenses incurred in attending the meetings of the Board of Directors during 2015. Beginning in January of 2016, non-employee director
will receive an annual retainer of $35,000 per year; members of the Audit Committee will receive an additional $5,000 per year
for such service and members of the Compensation Committee will receive an additional $5,000 per year for such service. The Chair
of the Audit Committee will receive $16,500 per year and the Chair of the Compensation Committee will receive $10,000 per year.
The lead independent director will receive $25,000 per year.</FONT> <FONT STYLE="font-size: 10pt">We will continue to reimburse
our directors for reasonable travel expenses incurred in attending the meetings of the Board of Directors. In June 2015, each director
received a stock option grant to purchase 20,000 shares of common stock of the Company at an exercise price of $7.29 per share.
Each new director will receive an initial stock option grant to purchase 10,000 shares of common stock of the Company at an exercise
price per share equal to the closing price of our common stock on the date of grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Director Compensation for 2015</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; border-bottom: Black 1pt solid">Name</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Fees&nbsp;Earned</B><BR>
<B>or&nbsp;Paid&nbsp;in&nbsp;Cash<BR>
($)</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Option</B><BR>
<B>Awards<BR>
($)(5)</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Other <BR>
Compensation <BR>
($)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Total<BR>
($)</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%; text-align: left">Jeffrey A. Fink (1) <BR></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">45,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">98,347</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">143,347</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">John&nbsp;W.&nbsp;Higuchi (2)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">98,347</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">128,347</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Stephen A. Hill (3) <BR></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">65,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">98,347</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">163,347</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">R. Dana Ono (4) <BR></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">98,347</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">137,347</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(1)</TD><TD>As of December 31, 2015, Mr. Fink had 30,000 option awards outstanding.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(2)</TD><TD>As of December&nbsp;31, 2015, Mr.&nbsp;Higuchi had 201,490 option awards outstanding.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(3)</TD><TD STYLE="text-align: justify">As of December&nbsp;31, 2015, Dr.&nbsp;Hill had 30,000 option awards outstanding.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(4)</TD><TD STYLE="text-align: justify">As of December&nbsp;31, 2015, Dr. Ono had 30,000 option awards outstanding.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">(5)</TD><TD STYLE="text-align: justify">The amounts in this column do not reflect compensation
actually received by our non-employee directors nor do they reflect the actual value that will be recognized by the non-employee
directors. Instead, the amounts reflect the aggregate grant date or modification date fair value computed in accordance with Financial
Accounting Standards Board Accounting Standards Codification (&ldquo;ASC&rdquo;) 718 of awards of stock options made to non-employee
directors for the fiscal year ended December&nbsp;31, 2015 but excludes an estimate for forfeitures. The fair value of each option
award is estimated on the date of grant or modification using the Black-Scholes option-pricing model. Additional information about
the assumptions used in the calculation of these amounts is included in footnote 2 to our audited financial statements for the
fiscal year ended December&nbsp;31, 2015 included in our Annual Report on Form&nbsp;10-K filed with the Securities and Exchange
Commission on March 10, 2016.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Codes of Ethics and Business Conduct</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have adopted a
corporate Code of Ethics and Business Conduct, which may be viewed on our website at www.lipocine.com. The Code of Ethics and Business
Conduct applies to all our officers, directors and employees, including our principal executive officer, principal financial and
accounting officer and controller, or persons performing similar functions. If we effect an amendment to, or waiver from, a provision
of our Code of Ethics and Business Conduct, we intend to satisfy our disclosure requirements by posting a description of such amendment
or waiver on the website above. The inclusion of our web site address in this proxy statement does not include or incorporate by
reference the information on our web site into this proxy statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Stockholder Communications with Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Stockholders wishing
to communicate with the Board or with a particular member or committee of the Board should address communications to the Board,
or to an individual member or committee as follows: c/o Lipocine Inc., Attention: Corporate Secretary, Lipocine Inc., 675 Arapeen
Drive, Suite 202, Salt Lake City, Utah 84108. All communications will be relayed to the addressee. From time to time, the Board
may change the process through which stockholders communicate with the Board or its members or committees. There were no changes
in this process in 2015. Please refer to our website at www.lipocine.com for any future changes in this process. The Board or the
particular director or committee of the Board to which a communication is addressed will, if it deems appropriate, promptly refer
the matter either to management or to the full Board depending on the nature of the communication. The inclusion of our web site
address in this proxy statement does not include or incorporate by reference the information on our web site into this proxy statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><B><A NAME="def14a_005"></A>EXECUTIVE
COMPENSATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Summary Compensation Table</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following information
presents the compensation paid to our principal executive officer and our next two most compensated executive officers in 2015.
We refer to these executive officers as the Named Executive Officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom">Name and Principal Position</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Year</TD><TD NOWRAP STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Salary</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>($)</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Bonus</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>($)</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Stock<BR> Awards<BR> ($)(1)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center; vertical-align: bottom">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Option<BR> Awards<BR> ($)(2)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center; vertical-align: bottom">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">All Other<BR> Compensation<BR> ($)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center; vertical-align: bottom">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Total</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>($)</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 11%; text-align: left; padding-bottom: 1pt; text-indent: -17.1pt; padding-left: 17.1pt">Mahesh&nbsp;V.&nbsp;Patel,&nbsp;Ph.D.</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 10%; text-align: center; padding-bottom: 1pt; vertical-align: top">2015</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right; vertical-align: top">400,000</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; padding-bottom: 1pt; text-align: right; vertical-align: top">137,196</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: right; vertical-align: top">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; padding-bottom: 1pt; text-align: right; vertical-align: top">&mdash;</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; padding-bottom: 1pt; text-align: right; vertical-align: top">&mdash;</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right; vertical-align: top">12,702</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left; vertical-align: top">(3)</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right; vertical-align: top">549,898</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left; padding-left: 0.125in">President, Chief Executive Officer and Chairman of the Board of Directors</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1pt; vertical-align: top">2014</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">370,800</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right; vertical-align: top">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: right; vertical-align: top">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right; vertical-align: top">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right; vertical-align: top">585,743</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">9,854</TD><TD STYLE="padding-bottom: 1pt; text-align: left; vertical-align: top">(3)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">966,397</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -17.1pt; padding-left: 17.1pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -17.1pt; padding-left: 17.1pt">Morgan R. Brown</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">283,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">59,908</TD><TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">10,600</TD><TD STYLE="text-align: left; vertical-align: top">(4)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">353,508</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left; padding-left: 0.125in">Executive Vice President and Chief Financial Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">263,333</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">25,000</TD><TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">190,953</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">7,713</TD><TD STYLE="text-align: left; vertical-align: top">(4)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">486,999</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -17.1pt; padding-left: 17.1pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -17.1pt; padding-left: 17.1pt">Jyrki Mattila</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">202,454</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">75,000</TD><TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">471,043</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">&mdash;</TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">748,497</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left; padding-left: 0.125in">Executive Vice President and Chief Business Officer (5)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">&mdash;</TD><TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">&mdash;</TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; vertical-align: top">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(1)</TD><TD STYLE="text-align: justify">Reflects the aggregate grant date fair value of restricted stock and restricted stock units computed
in accordance with ASC Topic 718 but excludes an estimate for forfeitures. The fair value of each restricted stock and restricted
stock unit is the closing price of our common stock on the date of grant. Additional information about the assumptions used in
the calculation of these amounts is included in footnote 8 to our audited financial statements for the fiscal year ended December&nbsp;31,
2015 included in our Annual Report on Form&nbsp;10-K filed with the Securities and Exchange Commission on March 10, 2016.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(2)</TD><TD STYLE="text-align: justify">Reflects the aggregate grant date fair value of stock option awards computed in accordance with
ASC Topic 718 but excludes an estimate for forfeitures. The fair value of each option award is estimated on the date of grant using
the Black-Scholes option-pricing model. Additional information about the assumptions used in the calculation of these amounts is
included in footnote 8 to our audited financial statements for the fiscal year ended December&nbsp;31, 2015 included in our Annual
Report on Form&nbsp;10-K filed with the Securities and Exchange Commission on March 10, 2016.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(3)</TD><TD>Includes $2,102 and $2,054, respectively, in life insurance premiums we paid on behalf of the executive officer in 2015 and
2014 and $10,600 and $7,800, respectively, in 401(k) plan matching contributions in 2015 and 2014.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">(4)</TD><TD STYLE="text-align: justify">Includes $10,600 and $7,713, respectively, in 401(k)
plan matching contributions in 2015 and 2014.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(5)</TD><TD>Dr. Mattila was hired as our Executive Vice President and Chief Business Officer effective May 15, 2015.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Executive Employment Agreements and Change-in-Control Arrangements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We entered into employment
agreements with the following executive officers: Dr. Mahesh V. Patel, Mr. Morgan Brown and Dr. Jyrki Mattila. Below is a description
of such employment agreements and separation agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Dr. Mahesh V. Patel:</I>
We have entered into an Employment Agreement with Dr. Mahesh V. Patel, who has served as our President and Chief Executive Officer
since 1997. Under the terms of the Employment Agreement between the Company and Dr. Patel, dated January 7, 2014 (the &ldquo;Dr.
Patel Agreement&rdquo;), Dr. Patel received an initial base salary of $370,800 per year, which has been subsequently increased
by the Board to $435,000 per year and is subject to further adjustment by the Board. Dr. Patel will be eligible to participate
in the Company&rsquo;s cash bonus plan, described in more detail below. In the event Dr. Patel&rsquo;s employment is terminated
without Cause or for Good Reason, as such terms are defined in the Dr. Patel Agreement, Dr. Patel will be entitled to receive,
among other severance benefits, up to 104 weeks of severance pay at his then-applicable base salary, full vesting of all outstanding
equity awards and, in the case of outstanding options to purchase common stock, extension of the exercise period to at least three
years after such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Mr. Morgan R. Brown:</I>
The Company has entered into an Amended and Restated Employment Agreement with Mr. Morgan R. Brown, who was appointed Executive
Vice President and Chief Financial Officer of the Company in September 2013. Mr. Brown serves as the Company&rsquo;s principal
financial officer and principal accounting officer. Under the terms of the Amended and Restated Employment Agreement between the
Company and Mr. Brown, dated January 7, 2014 (the &ldquo;Mr. Brown Agreement&rdquo;), Mr. Brown received an initial base salary
of $257,500 per year, which has been subsequently increased by the Board to $305,000 per year and is subject to further adjustment
by the Board. Mr. Brown is eligible to participate in the Company&rsquo;s cash bonus plan. In the event Mr. Brown&rsquo;s employment
is terminated without Cause or for Good Reason, as such terms are defined in the Mr. Brown Agreement, Mr. Brown will be entitled
to receive among other severance benefits, 52 weeks of severance pay at his then-applicable base salary, full vesting of all outstanding
equity awards and, in the case of outstanding options to purchase common stock, extension of the exercise period to at least three
years after such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Dr. Jyrki Mattila:
</I>The Company has entered into an Employment Agreement with Dr. Jyrki Mattila, who was appointed Chief Business Officer of the
Company in May 2015.<I> </I>Under the terms of the Employment Agreement between the Company and Dr. Mattila, dated May 15, 2015
(the &ldquo;Dr. Mattila Agreement&rdquo;), Dr. Mattila received an initial base salary of $300,000 per year, which has been subsequently
increased by the Board to $338,000 per year and is subject to further adjustment by the Board. Dr. Mattila is eligible to participate
in the Company&rsquo;s cash bonus plan. In the event Dr. Mattila&rsquo;s employment is terminated without Cause or for Good Reason,
as such terms are defined in the Dr. Mattila Agreement, Dr. Mattila will be entitled to receive among other severance benefits,
52 weeks of severance pay at his then-applicable base salary and full vesting of all outstanding equity awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Outstanding Equity Awards at Fiscal Year End</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table presents for each named executive officer,
information regarding outstanding stock options and stock awards held as of December&nbsp;31, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="14" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Option&nbsp;Awards</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Stock Awards</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number&nbsp;of <BR> securities<BR> underlying<BR> unexercised<BR> options<BR> exercisable(1)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of<BR> securities<BR> underlying<BR> unexercised<BR> options<BR> unexercisable</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Option<BR> exercise<BR> price ($)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Option<BR> expiration<BR> date</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Numbers<BR> of&nbsp;shares<BR> or units<BR> of stock<BR> that<BR> have&nbsp;not<BR> vested</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; border-bottom: Black 1pt solid; text-align: center">Market<BR> value of<BR> shares&nbsp;or<BR> units of<BR> stock&nbsp;that<BR> have not<BR> vested (8)($)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 22%; text-align: left">Mahesh&nbsp;V.&nbsp;Patel,&nbsp;Ph.D.</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">136,518</TD><TD STYLE="width: 1%; text-align: left">(2)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">2.81</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">&nbsp;08/12/2020</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,978</TD><TD STYLE="text-align: left">(3)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.81</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;12/16/2020</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">83,421</TD><TD STYLE="text-align: left">(4)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.81</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;07/10/2021</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,844</TD><TD STYLE="text-align: left">(5)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.81</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;12/15/2021</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">67,587</TD><TD STYLE="text-align: left">(6)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,931</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.81</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">01/31/2023</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,000</TD><TD STYLE="text-align: left">(7)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.10</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12/09/2023</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">46,719</TD><TD STYLE="text-align: left">(9)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">58,397</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.43</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">08/14/2024</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Morgan R. Brown</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,231</TD><TD STYLE="text-align: left">(9)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,037</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.43</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;08/14/2024</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">37,500</TD><TD STYLE="text-align: left">(9)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;09/16/2023</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,000</TD><TD STYLE="text-align: left">(7)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.10</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;12/10/2023</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,790</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Jyrki Mattila</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">(9)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">80,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7.66</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;05/15/2025</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">(9)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7.32</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">06/11/2025</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(1)</TD><TD STYLE="text-align: justify">The options have not been, and may never be, exercised and actual gains, if any, on exercise will
depend on the value of the shares of common stock on the date of exercise.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(2)</TD><TD STYLE="text-align: justify">These options replaced all of the executive officers&rsquo; prior stock option grants and were
fully vested on the date of grant with a ten-year life.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(3)</TD><TD STYLE="text-align: justify">Vesting of these stock options were originally solely subject to the achievement of certain milestones
related to the successful development of our product candidates. The stock options would vest on December 31st of the calendar
year in which the specific milestone is accomplished as determined by the Board of Directors or on June&nbsp;30, 2014, for any
milestone accomplished prior to that date in 2014. Any shares that remained unvested as of June&nbsp;30, 2014, would expire unless
extended by our Board of Directors. Based upon milestones achieved in 2011, the Board of Directors determined that for 2011, 10%
of such stock options and stock awards had vested as of December&nbsp;31, 2011. No milestones were achieved in 2012. In January
2013, the vesting of these stock options was modified such that the stock options and stock awards will vest as follows: (i)&nbsp;100%
upon first dosing in the pivotal clinical study for LPCN 1021, or (ii)&nbsp;50% of the unvested portion on January&nbsp;31, 2014,
and 50% of the remaining unvested portion on January&nbsp;31, 2015. In addition, the option expiration date was extended to the
10-year anniversary of the date of grant. Vesting of these options occurred on February 10, 2014 which was the date of first dosing
in the pivotal clinical study for LPCN 1021.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(4)</TD><TD STYLE="text-align: justify">This option was fully vested on the date of grant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(5)</TD><TD STYLE="text-align: justify">Vesting of this stock option was originally solely subject to the achievement of certain milestones
related to the successful development of our product candidates. Based upon milestones achieved in 2012, the Board of Directors
determined that for 2012, 30% of such options had vested as of December&nbsp;31, 2012. In January 2013, the vesting of this stock
option was modified such that the stock option will vest as follows: (i)&nbsp;100% upon first dosing in the pivotal clinical study
for LPCN 1021, or (ii)&nbsp;50% of the remaining unvested potion on January&nbsp;31, 2014, and 50% of the remaining unvested portion
on January&nbsp;31, 2015. Vesting of these options occurred on February 10, 2014 which was the date of first dosing in the pivotal
clinical study for LPCN 1021.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(6)</TD><TD STYLE="text-align: justify">Vesting of the stock option is 1/36th a month over a three-year term.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(7)</TD><TD STYLE="text-align: justify">Vesting of the stock option is cliff vesting on December 31, 2014.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(8)</TD><TD STYLE="text-align: justify">The market value of shares was determined by multiplying the number of shares subject to the award
by $12.93, which was the closing market price on NASDAQ Capital Markets as of December 31, 2015.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(9)</FONT></TD><TD><FONT STYLE="font-size: 10pt">Vesting of the stock option is over a three-year term with cliff vesting of one-third with the
remaining two thirds vesting at 1/24th a month over the next 24 months.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="def14a_006"></A>SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table
shows information regarding the beneficial ownership of our common stock as of March 15, 2016 by (a) each stockholder, or group
of affiliated stockholders, that we know owns more than 5% of our outstanding common stock; (b) each of our named executive officers;
(c) each of our directors; and (d) all of our current directors and executive officers as a group. The table is based upon information
supplied by directors, executive officers and principal stockholders, and Schedules 13D and 13G filed with the Securities and Exchange
Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Percentage ownership
in the table below is based on 18,258,901 shares of common stock outstanding as of March 15, 2016. Beneficial ownership is determined
in accordance with the rules of the Securities and Exchange Commission, and generally includes voting power and/or investment power
with respect to the securities held. Any securities not outstanding but which are subject to options or warrants exercisable within
60 days of March 15, 2016 are deemed outstanding and beneficially owned for the purpose of computing the percentage of outstanding
common stock beneficially owned by the stockholder holding such options or warrants, but are not deemed outstanding for the purpose
of computing the percentage of common stock beneficially owned by any other stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Unless otherwise indicated,
each of the stockholders listed below has sole voting and investment power with respect to the shares beneficially owned. The address
for each director or named executive officer is c/o Lipocine Inc., 675 Arapeen Drive, Suite 202, Salt Lake City, Utah 84108.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold">Name and Address of Beneficial Owner</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Shares&nbsp;Beneficially&nbsp;Owned</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Percent</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Directors and Named Executive Officers</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; text-align: left">Mahesh&nbsp;V.&nbsp;Patel,&nbsp;Ph.D.<FONT STYLE="font-size: 10pt"><SUP>(1)</SUP></FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">1,131,709</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">6.1</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Morgan R. Brown, M.B.A.<FONT STYLE="font-size: 10pt"><SUP>(2)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">96,380</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">*</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Jyrki Mattila, M.D., Ph.D, M.B.A</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">*</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">John&nbsp;W.&nbsp;Higuchi, M.B.A.<FONT STYLE="font-size: 10pt"><SUP>(3)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">639,538</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.5</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Stephen A. Hill, M.A., F.R.C.S<I>.</I>.<SUP>(4)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">*</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Jeffrey A. Fink<FONT STYLE="font-size: 10pt"><SUP>(5)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">*</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">R. Dana Ono, Ph.D.<FONT STYLE="font-size: 10pt"><SUP>(6)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">*</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">All executive officers and directors as a group (7 persons)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,895,628</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10.0</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">5% Stockholders Not Listed Above</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Entities affiliated with Venrock <FONT STYLE="font-size: 10pt"><SUP>(7)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,269,921</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7.0</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Invesco Ltd.<FONT STYLE="font-size: 10pt"><SUP>(8)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.075,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.9</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Visium Balanced Master Fund, Ltd <FONT STYLE="font-size: 10pt"><SUP>(9)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">977,768</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.4</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">*</FONT> <FONT STYLE="font-size: 10pt">Less
than 1.0%.</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(1)</TD><TD STYLE="text-align: justify">Includes (i)&nbsp;418,597 shares Dr.&nbsp;Patel has the right to acquire through the exercise of
options within 60&nbsp;days of March 15, 2016 and (ii)&nbsp;2,261 shares held by his spouse.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(2)</TD><TD STYLE="text-align: justify">Includes 79,380 shares Mr. Brown has the right to acquire through the exercise of options within
60&nbsp;days of March 15, 2016.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(3)</TD><TD STYLE="text-align: justify">Includes (i)&nbsp;181,490 shares Mr.&nbsp;Higuchi has the right to acquire through the exercise
of options within 60&nbsp;days of March 15, 2016.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(4)</TD><TD STYLE="text-align: justify">Includes 6,667 shares Dr. Hill has the right to acquire through the exercise of options within
60&nbsp;days of March 15, 2016.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(5)</TD><TD STYLE="text-align: justify">Includes 6,667 shares Mr. Fink has the right to acquire through the exercise of options within
60&nbsp;days of March 15, 2016.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(6)</TD><TD STYLE="text-align: justify">Includes 6,667 shares Dr. Ono has the right to acquire through the exercise of options within 60&nbsp;days
of March 15, 2016.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(7)</TD><TD STYLE="text-align: justify">Includes 718,490 shares held by Venrock Healthcare Capital Partners, L.P., 131,431 shares held
by VHCP Co-Investment Holdings, LLC, 298,846 shares owned by Venrock Healthcare Capital Partners II, L.P. and 121,154 shares owned
by VHCP Co-Investment Holdings II, LLC. The address for Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings,
LLC, Venrock Healthcare Capital Partners II, L.P. and VHCP Co-Investment Holdings II, LLC is 530 5th Avenue, 22nd Floor, New York,
New York 10036. The information regarding the number of shares beneficially owned or deemed to be beneficially owned by Venrock
Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, Venrock Healthcare Capital Partners II, L.P. and VHCP Co-Investment
Holdings II, LLC was taken from a Schedule 13G filed by that entity with the Securities and Exchange commission on February 16,
2016.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(8)</TD><TD STYLE="text-align: justify">The address for Invesco Ltd. is 1555 Peachtree Street NE, Suite 1800, Atlanta, Georgia 30309. The
information regarding the number of shares beneficially owned or deemed to be beneficially owned by Invesco Ltd. was taken from
a Schedule 13G filed by that entity with the Securities and Exchange commission on February 10, 2016. According to the Schedule
13G, Invesco Ltd. has sole voting power and the sole dispositive power for the shares held by Invesco Ltd.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(9)</TD><TD STYLE="text-align: justify">The address for Visium Balanced Master Fund, Ltd. is 888 Seventh Avenue, 22<SUP>nd </SUP>Floor,
New York, New York 10019 c/o Visium Asset Management, LP. The information regarding the number of shares beneficially owned or
deemed to be beneficially owned by Visium Balanced Master Fund, Ltd. was taken from a Schedule 13G filed by that entity with the
Securities and Exchange commission on February 12, 2016.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><B><A NAME="def14a_007"></A>Certain Transactions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Since January 1, 2015,
there has not been, nor has there been proposed, any transaction, arrangement or relationship or series of similar transactions,
arrangements or relationships, including those involving indebtedness not in the ordinary course of business, to which we or our
subsidiaries were or are a party, or in which we or our subsidiaries were or are a participant, in which the amount involved exceeded
or exceeds the lesser of $120,000 or 1% of the average of our total assets at year-end for the last two completed fiscal years
and in which any of our directors, nominees for director, executive officers, beneficial owners of more than 5% of any class of
our voting securities or any member of the immediate family of any of the foregoing persons, had or will have a direct or indirect
material interest, other than as described above under the heading &ldquo;Executive Compensation&rdquo; and other than the transactions
described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indemnification Agreements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have entered into
indemnification agreements with each of our executive officers and directors that require us to indemnify such persons against
any and all expenses, including judgments, fines or penalties, attorney&rsquo;s fees, witness fees or other professional fees and
related disbursements and other out-of-pocket costs incurred, in connection with any action, suit, arbitration, alternative dispute
resolution mechanism, investigation, inquiry or administrative hearing, whether threatened, pending or completed, to which any
such person may be made a party by reason of the fact that such person is or was a director, officer, employee or agent of our
company, provided that such director or officer acted in good faith and in a manner that the director or officer reasonably believed
to be in, or not opposed to, our best interests. The indemnification agreements also set forth procedures that will apply in the
event of a claim for indemnification thereunder. We believe that these provisions and agreements are necessary to attract and retain
qualified persons as directors and officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Spriaso LLC Assignment and Services Agreements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On July&nbsp;23, 2013,
we entered into assignment/license and services agreements with Spriaso LLC, an entity that is majority-owned by Dr. Mahesh&nbsp;V.&nbsp;Patel,
Gordhan Patel, John&nbsp;W.&nbsp;Higuchi, Dr. William&nbsp;I.&nbsp;Higuchi, and their affiliates. Dr. Mahesh&nbsp;V.&nbsp;Patel
is our President and Chief Executive Officer and a Chairman of our Board of Directors. Mr. Higuchi is a member of our Board of
Directors and Gordhan Patel and Dr.&nbsp;William I. Higuchi, former Board members, were each a member of our Board of Directors
at the date the license and agreements were entered into.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under the assignment
agreement, we assigned and transferred to Spriaso all of our rights, title and interest in our intellectual property for the cough
and cold field. In addition, Spriaso was assigned all rights and obligations under our product development agreement with a co-development
partner. In exchange, we are entitled to receive a potential cash royalty of 20% of the net proceeds received by Spriaso, up to
a maximum of $10&nbsp;million. Spriaso also granted back to us an exclusive license to such intellectual property to develop products
outside of the cough and cold field. The assignment agreement will expire upon the expiration of all of Spriaso&rsquo;s payment
obligations thereunder and the expiration of all of the licensed patents thereunder. Spriaso has the right to terminate the assignment
agreement with 30&nbsp;days written notice. We have the right to terminate the assignment agreement upon the complete liquidation
or dissolution of Spriaso, unless the assignment agreement is assigned to an affiliate or successor of Spriaso.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under the services
agreement, we agreed to provide facilities and up to 10% of the services of certain employees to Spriaso for a period of up to
18&nbsp;months which expired January 23, 2015. Effective January 23, 2015, we entered into an amended services agreement with Spriaso
in which we agreed to continue providing up to 10% of the services of certain employees to Spriaso at a rate of $230/hour for a
period of six months. Effective July 23, 2015, we entered into an amended services agreement with Spriaso in which we agreed to
continue providing services of certain employees for an additional six-month period. Finally, effective January 23, 2016, we entered
into an amended services agreement with Spriaso in which we agreed to continue providing services of certain employees for an additional
six-month period, however the agreement may be extended upon written agreement of Spriaso and us. Additionally, Spriaso filed its
first NDA in 2014, as an affiliated entity of Lipocine, it used up the one-time waiver of user fees for a small business submitting
its first human drug application to FDA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><B><A NAME="def14a_008"></A>SECTION
16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;16(a)
of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), requires our directors, officers, and persons
that own more than 10&nbsp;percent of a registered class of our equity securities to file reports of ownership and changes in ownership
with the SEC. Officers, directors and greater than 10&nbsp;percent stockholders are required by SEC regulations to furnish us with
copies of all Section&nbsp;16(a) forms they file.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Based solely upon
our review of the copies of such forms received by us during the year ended December 31, 2015, we believe that each person who,
at any time during such year, was a director, officer, or beneficial owner of more than 10% of our common stock met the filing
requirements during such year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><B><A NAME="def14a_009"></A>REPORT OF
THE AUDIT <FONT STYLE="font-family: Times New Roman, Times, Serif">COMMITTEE</FONT> OF THE BOARD OF DIRECTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Audit Committee
has reviewed and discussed our audited financial statements with our management and has discussed with KPMG LLP the matters required
to be discussed by the Statement on Auditing Standard No. 16, as amended<I>.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Audit Committee
has received the written disclosures and the letter from KPMG LLP required by applicable requirements of the Public Company Accounting
Oversight Board regarding the independent registered public accountant&rsquo;s communications with the Audit Committee concerning
independence, and has discussed with KPMG LLP its independence from us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Based on its review,
the Audit Committee recommended to the Board of Directors that the audited financial statements for our fiscal year ended December
31, 2015 be included in our Annual Report on Form 10-K for our fiscal year ended December 31, 2015, which was filed on March 10,
2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3.25in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt"><B>Members of the Audit Committee</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-size: 10pt">Jeffrey A. Fink</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-size: 10pt">Dr. Stephen A. Hill</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-size: 10pt">Dr. Richard Dana Ono</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3.25in"><B>&nbsp;&nbsp;</B></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROPOSALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><A NAME="def14a_010"></A>PROPOSAL
NO. 1 &ndash; election of directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"><B>Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">There are currently
five members of our Board. The terms of all of our directors are scheduled to expire at the 2015 Annual Meeting of Stockholders,
at which time all five of the incumbents will stand for re-election. The five director nominees, if elected, will serve a one-year
term until the 2016 Annual Meeting of Stockholders and until their successors are duly elected and qualified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Nominees</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Board has nominated
the following individuals to serve on the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">John&nbsp;W.&nbsp;Higuchi, MBA</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Jeffrey A. Fink</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Dr. Richard Dana Ono</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Dr. Mahesh V. Patel</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Dr. Stephen A. Hill</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Business background and biographical information
on John W. Higuchi, Jeffrey A. Fink, Dr. Richard Dana Ono, Dr. Mahesh V. Patel and Dr. Stephen A. Hill is set forth above under
&ldquo;Executive Officers and Directors&mdash;Directors.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Vote Required</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">A plurality of the
shares present in person or represented by proxy at the meeting and entitled to vote on the election of directors will be required
to elect Board nominees. The five nominees receiving the highest number of affirmative votes cast at the Annual Meeting will be
elected as our directors. Proxies cannot be voted for a greater number of persons than the number of nominees named.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"><B>Recommendation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Board recommends
that stockholders vote &ldquo;<B>FOR</B>&rdquo; the election of each of the above-listed nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Unless marked otherwise, proxies received
will be voted &ldquo;FOR&rdquo; the election of each of these director nominees.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B><A NAME="def14a_011"></A>PROPOSAL
NO. 2 &ndash; approval of AN AMENDMENT AND RESTATEMENT TO our AMENDED AND RESTATED 2014 stock AND incentive plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"><B>Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Board has approved
an amendment and restatement of our Amended and Restated 2014 Stock and Incentive Plan (the &ldquo;Plan&rdquo;) and is submitting
the Amendment to the Company&rsquo;s stockholders for their approval. The Board believes that the remaining number of shares of
common stock of the Company authorized for issuance under the Plan is not sufficient for future granting needs. Accordingly, the
proposed amendment and restatement of the Plan increases the number of shares of common stock of the Company authorized for issuance
under all awards under the Plan from 1,271,906 to 2,471,906 shares. The Board believes that these additional shares would result
in an adequate number of shares of common stock of the Company being available for grant under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of March 31, 2016,
there were 1,103,384 shares of common stock of the Company subject to outstanding awards under the Plan and 163,077 shares were
available for issuance under the Plan. The outstanding options had a weighted average exercise price of $10.59.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our directors and
executive officers have an interest in the amendment and restatement of the Plan because they are eligible for awards under the
Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Board believes
that the Plan is vital to promote the interests of the Company and its stockholders by aiding the Company in attracting and retaining
employees, officers, consultants, advisors and non-employee Directors capable of assuring the future success of the Company, to
offer such persons incentives to put forth maximum efforts for the success of the Company&rsquo;s business and to compensate such
persons through various stock-based arrangements and provide them with opportunities for stock ownership in the Company, thereby
aligning the interests of such persons with the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Certain provisions
of the Plan are summarized below. A copy of the Plan is attached to this proxy statement as <I><U>Appendix I</U></I> and is incorporated
herein by reference. The following summary of the material terms of the Plan does not purport to be a complete description of the
Plan and is qualified in its entirety by reference to the complete copy of the Plan in <I><U>Appendix I</U></I>. Because this summary
may not contain all of the information that is important to you, you should review the Proxy Statement, including <I><U>Appendix
I</U></I>, before deciding how to vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Summary of the Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Plan
provides for the grant of nonqualified stock options, incentive stock options, restricted stock, restricted stock units,
stock appreciation rights (SARs), dividend equivalents and performance awards to employees, officers, consultants, advisors,
non-employee directors and independent contractors designated by the Compensation Committee (the &ldquo;Committee&rdquo;) of
the Board of Directors. Under the Plan, the maximum number of shares of common stock which may be issued, subject to
adjustment as described below, is 2,471,906 shares of common stock, which includes 271,906 shares that were rolled over from
our 2011 Equity Compensation Plan, as amended. In addition, any shares subject to outstanding awards under our 2011 Equity
Compensation Plan that, after June 10, 2014, are forfeited or reacquired by the Company due to termination or cancellation of
such awards shall also be permitted to be granted under the Plan. For stock options and SARs, the aggregate number of shares
with respect to which such awards are exercisable, rather than the number of shares actually issued upon exercise, will be
counted against the number of shares available for awards under the Plan. If awards under the Plan expire or otherwise
terminate without being exercised, the shares not acquired pursuant to such awards again become available for issuance under
the Plan in accordance with its terms. However, under the following circumstances, shares will not again be available for
issuance under the Plan: (i) shares unissued due to a &ldquo;net exercise&rdquo; of a stock option, (ii) any shares withheld
or shares tendered to satisfy tax withholding obligations with respect to a stock option or SAR, (iii) shares covered by a
SAR that is not settled in shares upon exercise and (iv) shares repurchased using stock option exercise proceeds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">No employee will be
eligible to receive performance awards denominated in shares of common stock for more than an aggregate of 400,000 shares of common
stock during any calendar year, subject to adjustment as described below. The aggregate amount payable pursuant to performance
awards denominated in cash to any one participant in any calendar year is limited to $2,000,000 in value, whether payable in cash,
common stock or other property. Directors who are not also employees of the Company may not be granted awards in the aggregate
for more than 30,000 shares per year of the common stock available for awards under the Plan, subject to adjustment under the express
terms of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Administration</U><B> </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Plan will be administered
by the Committee. The Board of Directors will fill vacancies on and from time to time may remove or add members to the Committee,
and the Committee will be so constituted to permit awards granted under the Plan to be exempt from Section 16(b) of the Securities
Exchange Act of 1934 (the &ldquo;Exchange Act&rdquo;) and to permit grants of performance-based compensation under the plan to
comply with Section 162(m) of the Code, or any other statutory rule or regulatory requirements, unless otherwise determined by
the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Subject to the express
provisions of the Plan, the Committee has authority to administer and interpret the Plan, including the authority to determine
who is eligible to participate in the Plan and to whom and when awards are granted under the Plan, to grant awards, to determine
the number of shares of common stock subject to awards and the exercise or purchase price of such shares under an award, to establish
and verify the extent of satisfaction of any performance criteria applicable to awards, to prescribe and amend the terms of the
agreements evidencing awards made under the Plan, and to make other determinations deemed necessary or advisable for the administration
of the Plan. Also, subject to the requirements of Delaware General Corporation Law and any limitations under applicable stock exchange
rules, the Committee also has the power to delegate to officers the authority to grant and determine the terms and conditions of
awards granted under the Plan. These delegated officers shall not be permitted to grant awards to any person subject to Rule 16b-3
under the Exchange Act or Code Section 162(m).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Eligibility</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Participants under
the Plan are limited to employees, officers, non-employee directors, consultants, independent contractors or advisors providing
services to the Company, or any person to whom an offer of employment or engagement with the Company is extended. In determining
to whom awards will be granted and the nature of such each award, the Committee may take into account the nature of the services
rendered by the respective participant, their present and potential contributions to the success of the Company or such other factors
as the Committee, in its discretion, deems relevant. We estimate that approximately 30 persons are currently eligible to participate
in the Plan, which includes 23 employees, 3 executive officers and 4 non-employee directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>General Terms and Conditions of Awards</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Nonqualified Stock
Options</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Committee may
grant nonqualified stock options under the Plan which do not meet the requirements of Section 422 of the Code and which will be
subject to the following terms and conditions. The option exercise price per share will be determined by the Committee but will
not be less than 100% of the &ldquo;fair market value&rdquo; of the common stock on the date of grant of such option. The term
&ldquo;fair market value&rdquo; means either (a) if the common stock is listed on any established stock exchange, the closing price
for the common stock on the date of grant or (b) if the common stock is not listed on any established stock exchange, the average
of the closing &ldquo;bid&rdquo; and &ldquo;asked&rdquo; prices quoted on the OTC Bulletin Board, the National Quotation Bureau,
or any comparable reporting service on the date of grant. The exercise price of an option may be paid through various means specified
by the Committee, including in cash or check, by delivering to the Company shares of common stock or by a reduction in the number
of shares issuable pursuant to such option. Every option which has not been exercised within ten years of its date of grant will
lapse upon the expiration of the ten-year period, unless it has lapsed at an earlier date as determined by the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">During the lifetime
of a participant, except as otherwise may be provided by the Committee in its discretion, options granted to that participant under
the Plan generally will be nontransferable and exercisable only by the participant. A participant will have the right to transfer
any options granted to such participant upon such participant&rsquo;s death either by the terms of such participant&rsquo;s will
or under the laws of descent and distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Incentive Stock
Options</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Committee may
grant incentive stock options under the Plan which meet the requirements of section 422 of the Code. Under the Plan, the aggregate
fair market value, determined at the time the option is granted, of the common stock with respect to which incentive stock options
are exercisable for the first time by any participant during any calendar year (under the plan and any other incentive stock option
plans of the Company) may not exceed $100,000, or any other limit as may be prescribed by the Code from time to time. The option
exercise price per share will be determined by the Committee but will not be less than 100% of the &ldquo;fair market value&rdquo;
of the common stock on the date of grant of such option. In the case of a grant of an incentive stock option to a participant who,
at the time such option is granted, owns stock possessing more than 10% of the combined voting power of all classes of stock of
the Company, the option exercise price per share under such option will not be less than 110% of the &ldquo;fair market value&rdquo;
of the common stock on the date of grant of such option and such option will expire and no longer be exercisable no later than
five years from the date of grant of such option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>SARs</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The committee may
grant SARs under the Plan. Subject to the express provisions of the Plan and as discussed in this paragraph, the Committee has
discretion to determine the grant value, term, methods of exercise, dates of exercise, methods of settlement and any other terms
and conditions of any SAR. The grant value of each SAR granted under the Plan will be determined by the Committee and will be equal
to or greater than the closing market price of a share of common stock on the date of grant of the SAR, provided, however, that
if the SAR being granted is in substitution for a SAR previously granted by an entity that is acquired by or merged with the Company,
the grant value of such SAR may be lower than the closing market price of a share of common stock on the date of grant of the SAR.
Every SAR which has not been exercised within ten years of its date of grant will lapse upon the expiration of such ten-year period,
unless it has lapsed at an earlier date as determined by the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Restricted Stock
and Restricted Stock Units</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Committee may
grant restricted stock or restricted stock units under the Plan. Restricted stock and restricted stock units will be subject to
such restrictions as the Committee may impose (including, without limitation, any limitation on the right to vote a share of restricted
stock or the right to receive any dividend or other right or property with respect thereto), which restrictions may lapse separately
or in combination at such time or times, in such installments or otherwise as the Committee may deem appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Any restricted stock
granted under the Plan shall be issued at the time such awards are granted and may be evidenced in such manner as the Committee
may deem appropriate. In the case of restricted stock units, no common stock shall be issued at the time such awards are granted.
Upon the lapse or waiver of restrictions and the restricted period relating to restricted stock units evidencing the right to receive
common stock, such common stock shall be issued and delivered to the holder of the restricted stock units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Except as otherwise
determined by the Committee, if a director resigns or is removed or if the employment of an employee holding restricted stock or
restricted stock units terminates during the applicable restricted period, the restricted stock and/or restricted stock units held
by such director or employee will be forfeited and reacquired by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Dividend Equivalents</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The holder of a dividend
equivalent will be entitled to receive payments (in cash, shares, other securities or other property) equivalent to the amount
of cash dividends paid by us to our stockholders, with respect to the number of shares determined by the Compensation Committee.
Dividend equivalents will be subject to other terms and conditions determined by the Committee, but the Committee may not (i) grant
dividend equivalents in connection with options or SARs and (ii) pay a dividend equivalent with respect to an award prior to the
date on which all condition or restrictions on such award have been satisfied, waived or lapsed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Performance Awards</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Committee may
grant performance awards under the Plan. Each performance award will confer upon the participant the opportunity to earn future
payments tied to the achievement of one or more performance criteria during such performance periods as the Committee shall establish.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Plan authorizes
the grant of performance awards pursuant to which a participant may become entitled to receive an amount payable in cash, stock,
other securities, other awards, other property or a combination thereof on satisfaction of such performance criteria as are specified
by the Committee. For purposes of qualifying performance awards as &ldquo;performance-based&rdquo; compensation under Section 162(m)
of the Code, the Committee may set performance criteria based upon the business measurements described below under &ldquo;Qualifying
Performance Criteria.&rdquo; Subject to the express provisions of the Plan and as discussed in this paragraph, the Committee has
discretion to determine the terms of any performance awards, including the performance goals to be achieved during any performance
period, the length of any performance period, the amount of any performance award granted, the amount of any payment or transfer
to be made pursuant to any performance award and such further terms and conditions, in each case not inconsistent with the Plan,
as the Committee may determine from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Qualifying Performance Criteria</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section 162(m) of
the Code generally does not allow a publicly held company to obtain a tax deduction for compensation of more than $1 million paid
in any year to its chief executive officer or its three highest paid executive officers excluding the chief financial officer unless
such payments are &ldquo;performance-based&rdquo; as defined in that section. One of the requirements for compensation to be &ldquo;performance-based&rdquo;
under Section 162(m) is that the Company must obtain stockholder approval of the material terms of the qualifying performance criteria
for such compensation. The material terms which the stockholders approve constitute the framework within which the actual performance
criteria are set by the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Accordingly, to enable
us to receive tax deductions for compensation earned by our chief executive officer and other executive officers under grants of
performance-based awards under the Plan, the Board of Directors is requesting stockholder approval of the material terms of the
qualifying performance criteria for those types of awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Subject to stockholder
approval, the qualifying performance criteria will be any one or more of the following performance criteria, either individually,
alternatively or in any combination, applied to either the Company as a whole or to a business unit or subsidiary, either individually,
alternatively or in any combination, and measured either annually or cumulatively over a period of years, on an absolute basis
or relative to a pre-established target, to previous years&rsquo; results or to a designated comparison group, in each case a specified
by the Committee in the award:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Economic value added</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Sales or revenue</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Costs or expenses</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Net profit after tax</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Gross profit</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Income (including, without limitation, operating income, pre-tax income and income attributable
to the Company)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Cash flow (including, without limitation, free cash flow and cash flow from operating, investing
or financing activities or any combination thereof)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Earnings (including, without limitation, earnings before or after taxes, earnings before interest
and taxes (EBIT), earnings before interest, taxes, depreciation and amortization (EBTDA) and earnings (whether before or after
taxes), EBIT or EBITDA as a percentage of net sales</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Earnings per share (EPS) (basic or diluted)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Earnings per share from continuing operations</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Returns (including one or more of return on actual or pro forma assets, net assets, equity, investment,
revenue, sales, capital and net capital employed, total stockholder return (TRS) and total business return (TBR))</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Margins (including one or more of gross, operating and net income margin)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Ratios (including one or more of price-to-earnings, debt-to-assets, debt-to-net assets and ratios
regarding liquidity, solvency, fiscal capacity, productivity or risk)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Budget comparisons</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Unit volume</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Stock price</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Net working capital</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Value creation</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Market share</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Market capitalization</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Workforce satisfaction and diversity goals</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Employee retention</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Production metrics</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Development</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Implementation or completion of key projects</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Strategic plan development and implementation</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Research and development milestones and objectives</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Clinical trial milestones</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Clinical trial objectives</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Manufacturing objectives</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Commercialization objectives</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Financing or fund raising objectives</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Committee may
specify any reasonable definition of the above criteria at the time it sets the goals for an award. In order to qualify as performance-based
under Section 162(m) of the Code, the Committee must establish the performance goals no later than 90 days after the start of each
performance period (or no later than after 25% of the performance period has elapsed if the performance period is less than 12
months). In addition, the Committee must certify the achievement of the performance goals prior to payment of any qualifying performance-based
compensation. If approved by the stockholders, this proposal would not limit our right to award or pay other forms of equity incentives
under the Plan to the Company&rsquo;s executive officers that are not performance-based, including restricted stock and restricted
stock units that vest based upon the continued employment of a participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Transferability</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Generally, no award
(other than fully vested and unrestricted shares) and no right under any such award shall be transferable by a participant other
than by will or by the laws of descent and distribution, and no award (other than fully vested and unrestricted shares) or right
under any such award may be pledged, alienated, attached or otherwise encumbered. If a transfer is allowed by the Compensation
Committee (other than for fully vested and unrestricted shares), the transfer will be for no value and shall comply with the Form
S-8 rules. The Committee may establish procedures to allow a participant to designate a beneficiary or beneficiaries, to exercise
the rights of the participant and receive any property distributable with respect to an award in the event of the participant&rsquo;s
death.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Corporate Transactions</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In the event of any
Change-in-Control Event (as defined in the Plan), reorganization, merger, consolidation, split-up, spin-off, combination, plan
of arrangement, take-over bid or tender offer, repurchase or exchange of common stock or other securities of the Company or any
other similar corporate transaction or event involving the Company, the Committee or the Board of Directors, in its sole discretion,
can provide for one or more of the following to be effective upon the consummation of the event (or immediately prior to the consummation
of the event, provided the consummation of the event subsequently occurs):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">either (a) terminate any award in exchange for an amount of cash and/or other property equal to
the gain that would have been attained upon the exercise of the award or the realization of the rights under the award (in no event
less than the Black-Scholes value of the Award) or (b) replace the award with other rights or property of comparable value selected
by the Committee or the Board of Directors;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">that the award be assumed by the successor or survivor corporation or be substituted for by similar
options, rights or awards covering the stock of the successor or survivor corporation;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">that the award be exercisable or payable or fully vested with respect to all common stock covered
thereby; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">that the award cannot vest, be exercised or become payable after a certain date in the future.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Notwithstanding the
above, if an award (or a portion thereof) is not assumed or substituted as discussed in the second bullet point above, then the
portion of the award that is not assumed or substituted shall become fully vested, exercisable and payable with respect to all
covered shares. Furthermore, in the event the Committee or the Board uses its discretion under the first bullet point above to
terminate an unexercised option or SAR held by a participant who has not terminated employment or otherwise separated from service
with the Company and its affiliates, and if the Black Scholes value of the option or SAR (determined at the time the award is terminated)
exceeds the gain that would have been realized upon exercise of the option or SAR, the Company shall pay an additional cash bonus
equal to the excess of the Black Scholes value over the gain (if any) that would have been realized upon exercise. In such event
where the Black Scholes value exceeds the gain that would have been realized upon exercise of the option or SAR, the excess shall
be treated as a short-term deferral for purposes of Section 409A, payable upon the Change-in-Control Event to participants who
are then in employment or service with the Company and its affiliates and solely in connection with the termination of the option
or SAR as described in the first bullet point above, and not in connection with any exercise of the option or SAR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Amendment and Termination</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">No awards may be granted
pursuant to the Plan after the ten-year anniversary of the effective date of the plan which, if the shareholders approve the amendment
and restatement of the Plan, will the date on which such approval was obtained. Except to the extent stockholder approval or participant
consent is required as provided by the Plan, the Board may amend, modify or terminate the plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Committee may
amend, modify or terminate an outstanding award, provided, however, that, except as expressly provided in the Plan, the Committee
may not, without the participant&rsquo;s consent, amend, modify or terminate an outstanding award unless it determines that the
action would not adversely alter or impair the terms or conditions of such award. However, the Committee reserves the right to
reprice any previously granted &ldquo;underwater&rdquo; option or SAR by (i) lowering the exercise price, (ii) canceling the underwater
option or SAR and granting a substitute award, or (iii) repurchasing the underwater option or SAR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"><U>Certain Federal Income Tax Consequences
</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following is a
summary of the principal U.S. federal income tax consequences generally applicable to awards made under the Plan. The summary does
not contain a complete analysis of all the potential tax consequences relating to awards granted under the Plan, including state,
local or foreign tax consequences.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Nonqualified Stock
Options</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">A participant will
not be deemed to have received taxable income upon the grant of a nonqualified stock option. Upon the exercise of a nonqualified
stock option, a participant generally will be deemed to have received taxable ordinary income in an amount equal to the excess
of the fair market value of the common stock received on the date of exercise over the option price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Upon the exercise
of a nonqualified stock option, we will ordinarily be entitled to a deduction for federal income tax purposes in an amount equal
to the amount included in income by the participant as a result of such exercise. This deduction will be available to us in the
tax year in which the participant recognizes the income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The income arising
from a participant who is an employee exercising a nonqualified stock option will be treated as compensation income for income
and payroll tax withholding purposes, and the Committee may allow the participant to satisfy the tax withholding obligation by
withholding a portion of the shares that would otherwise be delivered upon exercise. The basis of shares received upon the exercise
of a nonqualified stock option will be the option exercise price paid plus the amount recognized by the participant as taxable
income attributable to such shares as a result of the exercise. Gain or loss recognized by the participant on a subsequent disposition
of any such shares will be capital gain or loss if such shares constitute a capital asset in the hands of the participant. A participant&rsquo;s
holding period will commence on the date of exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Incentive Stock
Options</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Participants will
not be deemed to recognize taxable income upon the grant or exercise of an incentive stock option. If a participant makes no disqualifying
disposition of the common stock received upon exercise within the one year period beginning after the transfer of such common stock
to the participant nor within two years from the date of grant of the incentive stock option, and if the participant at all times
from the date of the grant of the incentive stock option to a date three months before the date of exercise has been an employee
of ours, any gain recognized on the disposition of the common stock acquired upon exercise will be long-term capital gain. The
difference between the fair market value of the common stock at the time of exercise and the exercise price will, however, be an
item of tax preference, and may subject a participant to the alternative minimum tax. We will not be entitled to any deduction
with respect to the grant or exercise of the incentive stock option or the transfer of common stock acquired upon exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If the participant
makes a disqualifying disposition of the common stock before the expiration of the one or two year holding periods described above,
the participant will be deemed to have received taxable ordinary income at the time of such disposition to the extent that the
fair market value of the common stock at the time of exercise, or, if less, the amount realized on such disposition, exceeds the
exercise price. To the extent that the amount realized on such disposition exceeds the fair market value of the common stock at
the time of exercise, such excess will be taxed as capital gain if the common stock is otherwise a capital asset in the hands of
the participant. To the extent the participant recognizes ordinary income on a disqualifying disposition of the common stock, we
may be entitled to a deduction for federal income tax purposes in an amount equal to the ordinary income recognized by the participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>SARs</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">A participant will
not be deemed to have received taxable income upon the grant or vesting of a SAR. Upon the exercise of a SAR, a participant generally
will be deemed to have received income, taxable for federal income tax purposes at ordinary income rates, equal to the fair market
value at the time of exercise of any common stock received plus the amount of any cash received, and we will ordinarily be entitled
to a deduction for federal income tax purposes equal to the amount of ordinary income recognized by the participant as a result
of such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The income arising
from a participant who is an employee exercising a SAR will be treated as compensation income for withholding tax purposes and
the Committee may allow the participant to satisfy the tax withholding obligation by withholding a portion of the shares that would
otherwise be delivered upon exercise. The basis of shares received upon the exercise of a SAR will equal the fair market value
of the shares at the time of exercise. Gain or loss recognized by the participant on a subsequent disposition of any such shares
will be capital gain or loss if such shares constitute a capital asset in the hands of the participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Restricted Stock</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The federal income
tax consequences of the issuance of restricted stock will depend upon whether the participant elects to be taxed at the time of
grant of the restricted stock under Section 83(b) of the Code. If no election is made, the participant will not be deemed to have
received taxable income upon the grant of restricted stock, but rather recognition of income will be postponed until such time
as the restrictions on the shares of restricted stock lapse. At that time, the participant will be deemed to have received taxable
ordinary income in an amount equal to the fair market value of the restricted stock when the restrictions lapse. If a Section 83(b)
election is made, the participant will be deemed to have received taxable ordinary income at the time of the grant of the restricted
stock equal to the fair market value of the shares of restricted stock at that time determined without regard to any of the restrictions
on the shares, and the participant will not recognize ordinary income on the lapse of the restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We will ordinarily
be entitled to a deduction for federal income tax purposes in the taxable year in which the participant recognizes any ordinary
income as a result of the lapse of restrictions on the restricted stock or as a result of a Section 83(b) election. The amount
of the deduction will equal the amount of ordinary income recognized by the participant. In the case of employees, such income
will be treated as compensation income for income and payroll tax withholding purposes, and the Committee may allow the participant
to satisfy the tax withholding obligation by withholding a portion of the shares whose restrictions have lapsed. The basis of any
shares received will equal the amount recognized by the participant as taxable income attributable to such shares as a result of
the lapse of restrictions on the restricted stock or as a result of a Section 83(b) election. Gain or loss recognized by the participant
on a subsequent disposition of any such shares will be capital gain or loss if such shares constitute a capital asset in the hands
of the participant. For purposes of determining the holding period of any such shares, there will be included only the period beginning
at the time the restrictions lapse or, if a Section 83(b) election is made, at the time of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Restricted Stock
Units </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">A participant will
not be deemed to have received taxable income upon the grant of restricted stock units. The participant will be deemed to have
received taxable ordinary income at such time as shares are distributed to the participant. Upon the distribution of shares to
a participant with respect to restricted stock units, we will ordinarily be entitled to a deduction for federal income tax purposes
in an amount equal to the taxable ordinary income recognized by the participant. In the case of employees, such income will be
treated as compensation income for income and payroll tax withholding purposes, and the Committee may allow the participant to
satisfy the tax withholding obligation by withholding a portion of the shares that would otherwise be delivered. The basis of the
shares of common stock received will equal the amount of taxable ordinary income recognized by the participant upon receipt of
such shares. Gain or loss recognized by the participant on a subsequent disposition of any such shares will be capital gain or
loss if such shares constitute a capital asset in the hands of the participant. A participant&rsquo;s holding period will commence
on the date the shares are distributed to the participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Code Section 409A
of the Internal Revenue Code</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Committee intends
to administer and interpret the Plan and all award agreements in a manner designed to satisfy the requirements of Code Section
409A of the Internal Revenue Code and to avoid any adverse tax results thereunder to a holder of an award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Clawback or Recoupment</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">All awards under the
Plan will be subject to forfeiture or other penalties pursuant to any clawback policy we may adopt or amend from time to time,
as determined by the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>New Plan Benefits</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The awards made to
eligible persons under the Plan are subject to the complete discretion of the Committee, compensation programs and policies adopted
by the Committee or the Board, the speed and nature of new hires and other factors and, therefore, we cannot currently determine
the benefits or number of common stock subject to awards that may be granted in the future to our named executive officers, all
executive officers as a group or to all employees as a group under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have generally
granted a stock option to purchase 10,000 shares of the Company&rsquo;s common stock to each non-employee director when such director
is initially elected or appointed to the Board and a stock option to purchase 10,000 shares of the Company&rsquo;s common stock
to each non-employee director immediately after each annual meeting of the Company&rsquo;s stock holders assuming such director
continues to serve as a director after such annual meeting. Although we are not obligated to make such grants, we currently expect
that we will continue to grant options to our directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Historical Awards under the Plan</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table
sets forth information with respect to stock options granted pursuant to the current version of the 2014 Plan to our named executive
officers, the director nominees and the other groups set forth below as of December 31, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">Name and Principal Position</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Options<BR> Granted</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 77%; font-style: italic; text-align: left"><FONT STYLE="font-weight: normal; font-style: normal">Mahesh&nbsp;V.&nbsp;Patel,&nbsp;Ph.D.
    </FONT><BR>President, Chief Executive Officer, Director Nominee</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 20%; text-align: right">105,116</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left"><FONT STYLE="font-weight: normal; font-style: normal">Morgan R. Brown, M.B.A.
    </FONT><BR>Executive Vice President and Chief Financial Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,268</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left"><FONT STYLE="font-weight: normal; font-style: normal">Jyrki Mattila, M.D.,
    Ph.D, M.B.A</FONT> <BR>Chief Business Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">90,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left"><FONT STYLE="font-weight: normal; font-style: normal">John&nbsp;W.&nbsp;Higuchi,
    M.B.A.</FONT> <BR>Director Nominee</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Stephen A. Hill, M.A., F.R.C.S<I>.</I>.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Director Nominee</I></P></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left"><FONT STYLE="font-weight: normal; font-style: normal">Jeffrey A. Fink</FONT>
    <BR>Director Nominee</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left"><FONT STYLE="font-weight: normal; font-style: normal">R. Dana Ono, Ph.D.
    </FONT><BR>Director Nominee</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">All executive officers as a group (3 persons)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">229,384</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">All non-executive directors as a group (4 persons)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">80,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">All nominees for election as a director as a group (5 persons)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">185,116</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">All employees (other than executive officers) as a group (17 persons)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">247,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Securities Authorized for Issuance Under
Equity Compensation Plans</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table
sets forth information as of December 31, 2015 relating to all of our equity compensation plans:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; border-bottom: Black 1pt solid">Plan Category</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>(a) Number of shares</B></FONT><BR> <FONT STYLE="font-size: 10pt"><B>to be issued upon</B></FONT><BR> <FONT STYLE="font-size: 10pt"><B>exercise of</B></FONT><BR> <FONT STYLE="font-size: 10pt"><B>outstanding</B></FONT><BR> <FONT STYLE="font-size: 10pt"><B>options<SUP>(1)</SUP></B></FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>(b) Weighted-</B></FONT><BR> <FONT STYLE="font-size: 10pt"><B>average</B></FONT><BR> <FONT STYLE="font-size: 10pt"><B>exercise price of</B></FONT><BR> <FONT STYLE="font-size: 10pt"><B>outstanding</B></FONT><BR> <FONT STYLE="font-size: 10pt"><B>options<SUP>(2)</SUP></B></FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">(c) Number of<BR> securities<BR> remaining<BR> available<BR> for future issuance<BR> under equity<BR> compensation<BR> plans (excluding<BR> securities reflected<BR> in column (a))</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 61%; text-align: left; text-indent: -0.25in; padding-left: 0.25in">Equity compensation plan approved by stockholders</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">1,725,552</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">5.21</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">727,687</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.25in; padding-left: 0.25in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.25in; padding-left: 0.25in">Equity compensation plans not approved by stockholders</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">TOTAL</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,725,552</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">5.21</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">727,687</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">Includes 3,000 shares of common stock issuable upon the vesting of restricted stock pursuant to
our 2011 Equity Incentive Plan, as amended. The remaining balance consists of shares of common stock issuable upon the exercise
of outstanding stock options granted under our 2011 Equity Incentive Plan, as amended, and our 2014 Equity and Incentive Plan.
Shares available for issuance under the 2014 Equity and Incentive Plan, may become subject to stock options, stock appreciation
rights, restricted stock, restricted stock units, performance shares, performance units or other equity awards, with such terms
and conditions, performance requirements, restrictions, forfeiture provisions, contingencies and other limitations as determined
by the Compensation Committee.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(2)</TD><TD>The weighted-average exercise price does not take into account shares of common stock issuable upon vesting of outstanding
restricted stock or restricted stock units, which have no exercise price.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Market Value</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The closing stock price of or common stock
on The NASDAQ Capital Market on April 15, 2016 was $11.89 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Vote Required</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The proposal to approve
an amendment and restatement of our Amended and Restated 2014 Stock and Incentive Plan to increases the number of shares of common
stock of the Company authorized for issuance under all awards under such plan from 1,271,906 to 2,471,906 shares will be approved
if a majority of the shares of common stock outstanding as of the Record Date that are <B>present or represented </B>and entitled
to vote at the Annual Meeting are voted in favor of the amendment and restatement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"><B>Recommendation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Board recommends
that stockholders vote &ldquo;<B>FOR</B>&rdquo; the approval of an amendment and restatement of our Amended and Restated 2014 Stock
and Incentive Plan to increase the number of shares of common stock of the Company authorized for issuance under all awards granted
under such plan from 1,271,906 shares to 2,471,906</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Unless marked otherwise, proxies received
will be voted &ldquo;FOR&rdquo; Proposal No. 2.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: left"><B><A NAME="def14a_012"></A>PROPOSAL NO.
3 &ndash; RATIFICATION OF APPOINTMENT OF KPMG LLP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"><B>Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Audit Committee
has engaged the registered public accounting firm of KPMG LLP as our independent registered public accounting firm to audit our
financial statements for the year ending December 31, 2016. KPMG LLP audited our financial statements since the year ended December
31, 2013. Stockholder ratification of such selection is not required by our Bylaws or other applicable legal requirement. However,
our Board is submitting the selection of KPMG LLP to stockholders for ratification as a matter of good corporate practice. In
the event that stockholders fail to ratify the selection, our Audit Committee will reconsider whether or not to retain that firm.
Even if the selection is ratified, our Audit Committee in its discretion may direct the appointment of a different independent
registered public accounting firm at any time during the year if our Audit Committee believes that such a change would be in our
and our stockholders&rsquo; best interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><FONT STYLE="font-size: 10pt"><B>PRINCIPAL
ACCOUNTANTS</B></FONT><BR>
<BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Principal Accountant Fees and Services </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table
sets forth the aggregate fees billed to the Company by KPMG for fiscal years ended December 31, 2015 and 2014:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2014</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left; text-indent: -0.15in; padding-left: 0.15in">Audit fees</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 15%; text-align: right">280,723</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 15%; text-align: right">197,911</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.15in; padding-left: 0.15in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.15in; padding-left: 0.15in">Tax fees</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.15in; padding-left: 0.15in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -0.15in; padding-left: 0.15in">Total audit and tax fees</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">280,723</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">197,911</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Audit fees</I>
consist of KPMG's fees for services related to their audits of our annual financial statements, their review of financial statements
included in our quarterly reports on SEC Form&nbsp;10-Q, their review of SEC filed registration statements, and fees for services
that are normally incurred in connection with statutory and regulatory filings or engagements, such as the issuance of consents
and comfort letters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Audit-related
fees</I> consist of fees for assurance related services by KPMG that are reasonably related to the performance of the audit or
review of our consolidated financial statements but are not considered &quot;audit fees.&quot; We did not incur any fees under
this category in 2015 or 2014.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Tax
fees</I> consist of advisory services consisting primarily of tax advice rendered by KPMG. We did not incur any fees under this
category in 2015 or 2014.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>All
other fees</I> consist of fees for professional services rendered by our independent registered public accounting firm for permissible
non-audit services, if any. We did not incur any fees under this category in 2015 or 2014.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Audit Committee Pre-Approval Policies and Procedures </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Audit Committee
charter provides that the Audit Committee will pre-approve all audit services and non-audit services to be provided by our independent
auditors before the accountant is engaged to render these services. The Audit Committee may consult with management in the decision-making
process but may not delegate this authority to management. The Audit Committee may delegate its authority to pre-approve services
to one or more committee members, provided that the designees present the pre-approvals to the full committee at the next committee
meeting. In 2015, all audit and non-audit services performed by our independent accountants have been pre-approved by our Audit
Committee to assure that such services do not impair the auditors&rsquo; independence from us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Determination of Independence</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">There were no fees billed by KPMG for non-audit
services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Attendance at Annual Meeting </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Representatives from
KPMG are expected to be present at the annual meeting, will have the opportunity to make a statement if they desire to do so, and
are expected to be available to respond to appropriate questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt"><B>Vote Sought</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The proposal to ratify
the appointment of KPMG LLP as our independent registered public accounting firm to audit our financial statements for the year
ending December 31, 2016 will be approved if a majority of the shares of common stock outstanding as of the Record Date that are
present and represented and entitled to vote at the Annual Meeting vote in favor of the proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"><B>Recommendation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Board recommends
that stockholders vote &ldquo;<B>FOR</B>&rdquo; the proposal to ratify the appointment of KPMG LLP as our independent registered
public accounting firm to audit our financial statements for the year ending December 31, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Unless marked otherwise, proxies received
will be voted &ldquo;FOR&rdquo; Proposal No. 3.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><B><A NAME="def14a_013"></A>OTHER BUSINESS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We know of no other
matters to be submitted to the stockholders at the Annual Meeting. If any other matters properly come before the stockholders at
the Annual Meeting, the proxy holders intend to vote the shares they represent as the Board may recommend.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><A NAME="def14a_014"></A><B>ANNUAL REPORT
ON FORM 10-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On March 10, 2016,
we filed our annual report on Form 10-K for the year ended December 31, 2015. A copy of the annual report on Form 10-K has been
made available with this proxy statement to all stockholders entitled to notice of and to vote at the annual meeting.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><A NAME="def14a_015"></A>S<FONT STYLE="font-family: Times New Roman, Times, Serif"><B>TOCKHOLDER
Proposals</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Stockholders may present
proposals for action at a future meeting if they comply with SEC rules, state law and our Bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pursuant to Rule 14a-8
under the Exchange Act, some stockholder proposals may be eligible for inclusion in the proxy statement for our 2017 Annual Meeting
of Stockholders (the &ldquo;2017 Annual Meeting&rdquo;). These stockholder proposals, along with proof of ownership of our stock
in accordance with Rule 14a-8(b)(2), must be received by us not later than December 30, 2016, which is 120 calendar days prior
to the anniversary date of when our proxy statement was released to stockholders in connection with the Annual Meeting. Stockholders
are also advised to review our Bylaws which contain additional advance notice requirements, including requirements with respect
to advance notice of stockholder proposals (other than non-binding proposals presented under Rule 14a-8) and director nominations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our bylaws provide
that, except in the case of proposals made in accordance with Rule 14a-8, for shareholder nominations to the Board of Directors
or other proposals to be considered at an annual meeting of shareholders, the shareholder must have given timely notice thereof
in writing to us not less than 90 nor more than 120 calendar days prior to the anniversary date of the preceding year&rsquo;s annual
meeting. To be timely for the 2017Annual Meeting of Shareholders, a shareholder&rsquo;s notice must be delivered or mailed to and
received by us between February 14, 2017 and March 16, 2017. However, in the event that the date of the annual meeting is advanced
more than 30&nbsp;days prior to or delayed by more than 30&nbsp;days after the anniversary of the preceding year&rsquo;s annual
meeting, notice by the stockholder to be timely must be so received not earlier than the close of business on the one hundred twentieth
120<SUP>th</SUP>&nbsp;day prior to such annual meeting and not later than the close of business on the later of the 90<SUP>th</SUP>&nbsp;day
prior to such annual meeting or the 10&nbsp;day following the day on which public announcement of the date of such meeting is first
made. In no event shall an adjournment or a postponement of an annual meeting for which notice has been given, or the public announcement
thereof has been made, commence a new time period for the giving of a stockholder&rsquo;s notice as described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The proxies to be
solicited by us through our Board for our 2017 Annual Meeting will confer discretionary authority on the proxy holders to vote
on any stockholder proposal presented at that meeting, unless we receive notice of such stockholder&rsquo;s proposal no later than
March 14, 2017, which is 45 calendar days prior to the anniversary date of when our proxy statement was released to stockholders
in connection with the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Stockholder proposals
must be in writing and should be addressed to c/o Lipocine Inc., Attention: Corporate Secretary, 675 Arapeen Drive, Suite 202,
Salt Lake City, Utah 84108. It is recommended that stockholders submitting proposals direct them to our corporate secretary and
utilize certified mail, return receipt requested in order to provide proof of timely receipt. The Chairman of the Annual Meeting
reserves the right to reject, rule out of order or take other appropriate action with respect to any proposal that does not comply
with these and other applicable requirements, including conditions set forth in our Bylaws and conditions established by the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have not been notified
by any stockholder of his or her intent to present a stockholder proposal from the floor at this year&rsquo;s Annual Meeting. The
enclosed proxy grants the proxy holders discretionary authority to vote on any matter properly brought before this year&rsquo;s
Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">By Order of the Board
of Directors</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">Mahesh V. Patel, Ph.D.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>President, Chief Executive Officer and</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Chairman of the Board of Directors</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">April 29, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Salt Lake City, Utah</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><A NAME="def14a_016"></A>Appendix I&nbsp;<FONT STYLE="font-size: 10pt">&nbsp;</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>SECOND
amended and restated LIPOCINE INC.<BR>
2014 stock and INCENTIVE PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in"><B>Section 1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purpose</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The purpose of the Plan is to promote the
interests of the Company and its stockholders by aiding the Company in attracting and retaining employees, officers, consultants,
advisors and non-employee Directors capable of assuring the future success of the Company, to offer such persons incentives to
put forth maximum efforts for the success of the Company&rsquo;s business and to compensate such persons through various stock-based
arrangements and provide them with opportunities for stock ownership in the Company, thereby aligning the interests of such persons
with the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>Section 2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Definitions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As used in the Plan, the following terms
shall have the meanings set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<I>Affiliate</I>&rdquo;
shall mean any entity that, directly or indirectly through one or more intermediaries, is controlled by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<I>Award</I>&rdquo;
shall mean any Option, Stock Appreciation Right, Restricted Stock, Restricted Stock Unit, Performance Award or Dividend Equivalent
granted under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<I>Award
Agreement</I>&rdquo; shall mean any written agreement, contract or other instrument or document evidencing an Award granted under
the Plan (including a document in an electronic medium) executed in accordance with the requirements of Section 9(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<I>Board</I>&rdquo;
shall mean the Board of Directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<I>Code</I>&rdquo;
shall mean the Internal Revenue Code of 1986, as amended from time to time, and any regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<I>Change-in-Control
Event</I>&rdquo; shall mean the occurrence, in a single transaction or in a series of related transactions, of any one or more
of the following events:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD>any Exchange Act Person becomes the Owner, directly or indirectly, of securities of the Company representing more than fifty
percent (50%)&nbsp;of the combined voting power of the Company&rsquo;s then outstanding securities other than by virtue of a merger,
consolidation or similar transaction. Notwithstanding the foregoing, a Change-in-Control Event shall not be deemed to occur (A)&nbsp;on
account of the acquisition of securities of the Company by an investor, any affiliate thereof or any other Exchange Act Person
that acquires the Company&rsquo;s securities in a transaction or series of related transactions the primary purpose of which is
to obtain financing for the Company through the issuance of equity securities or (B)&nbsp;solely because the level of Ownership
held by any Exchange Act Person (the &ldquo;Subject Person&rdquo;) exceeds the designated percentage threshold of the outstanding
voting securities as a result of a repurchase or other acquisition of voting securities by the Company reducing the number of shares
outstanding, provided that if a Change-in-Control Event would occur (but for the operation of this sentence) as a result of the
acquisition of voting securities by the Company, and after such share acquisition, the Subject Person becomes the Owner of any
additional voting securities that, assuming the repurchase or other acquisition had not occurred, increases the percentage of the
then outstanding voting securities Owned by the Subject Person over the designated percentage threshold, then a Change-in-Control
Event shall be deemed to occur;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD>there is consummated a merger, consolidation or similar transaction involving (directly or indirectly) the Company and, immediately
after the consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior
thereto do not Own, directly or indirectly, either (A)&nbsp;outstanding voting securities representing more than fifty percent
(50%)&nbsp;of the combined outstanding voting power of the surviving Entity in such merger, consolidation or similar transaction
or (B)&nbsp;more than fifty percent (50%)&nbsp;of the combined outstanding voting power of the parent of the surviving Entity in
such merger, consolidation or similar transaction, in each case in substantially the same proportions as their Ownership of the
outstanding voting securities of the Company immediately prior to such transaction;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD>there is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated
assets of the Company and its Subsidiaries, other than a sale, lease, license or other disposition of all or substantially all
of the consolidated assets of the Company and its Subsidiaries to an Entity, more than fifty percent (50%)&nbsp;of the combined
voting power of the voting securities of which are Owned by stockholders of the Company in substantially the same proportions as
their Ownership of the outstanding voting securities of the Company immediately prior to such sale, lease, license or other disposition;
or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD>individuals who, on the date this Plan is adopted by the Board, are members of the Board (the &ldquo;Incumbent Board&rdquo;)
cease for any reason to constitute at least a majority of the members of the Board;&nbsp;provided, however,&nbsp;that if the appointment
or election (or nomination for election) of any new Board member was approved or recommended by a majority vote of the members
of the Incumbent Board then still in office, such new member shall, for purposes of this Plan, be considered as a member of the
Incumbent Board.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Notwithstanding the foregoing definition
or any other provision of this Plan, (A)&nbsp;the term Change-in-Control Event shall not include a sale of assets, merger or other
transaction effected exclusively for the purpose of changing the domicile of the Company, and (B)&nbsp;the definition of Change-in-Control
Event (or any analogous term) in an individual written agreement between the Company or any Affiliate and the Participant shall
supersede the foregoing definition with respect to Awards subject to such agreement;&nbsp;provided, however,&nbsp;that if no definition
of Change-in-Control Event or any analogous term is set forth in such an individual written agreement, the foregoing definition
shall apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<I>Committee</I>&rdquo;
shall mean the Compensation Committee of the Board or such other committee designated by the Board to administer the Plan. The
Committee shall be comprised of not less than such number of Directors as shall be required to permit Awards granted under the
Plan to qualify under Rule 16b-3, and each member of the Committee shall be a &ldquo;non-employee director&rdquo; within the meaning
of Rule&nbsp;16b-3 and an &ldquo;outside director&rdquo; within the meaning of Section&nbsp;162(m).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<I>Company</I>&rdquo;
shall mean Lipocine Inc., a Delaware corporation, and any successor corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&ldquo;<I>Director</I>&rdquo; shall mean a member of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<I>Dividend
Equivalent</I>&rdquo; shall mean any right granted under Section 6(e) of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<I>Eligible
Person</I>&rdquo; shall mean any employee, officer, non-employee Director, consultant, independent contractor or advisor providing
services to the Company or any Affiliate, or any such person to whom an offer of employment or engagement with the Company or any
Affiliate is extended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<I>Entity</I>&rdquo;
means a corporation, partnership, limited liability company or other entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<I>Exchange
Act</I>&rdquo; shall mean the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<I>Exchange
Act Person</I>&rdquo; means any natural person, Entity or &ldquo;group&rdquo; (within the meaning of Section&nbsp;13(d) or 14(d)
of the Exchange Act), except that &ldquo;Exchange Act Person&rdquo; shall not include (i)&nbsp;the Company or any Subsidiary of
the Company, (ii)&nbsp;any employee benefit plan of the Company or any Subsidiary of the Company or any trustee or other fiduciary
holding securities under an employee benefit plan of the Company or any Subsidiary of the Company, (iii)&nbsp;an underwriter temporarily
holding securities pursuant to a registered public offering of such securities, (iv)&nbsp;an Entity Owned, directly or indirectly,
by the stockholders of the Company in substantially the same proportions as their Ownership of stock of the Company; or (v)&nbsp;any
natural person, Entity or &ldquo;group&rdquo; (within the meaning of Section&nbsp;13(d) or 14(d) of the Exchange Act) that, as
of the Effective Date, is the Owner, directly or indirectly, of securities of the Company representing more than fifty percent
(50%)&nbsp;of the combined voting power of the Company&rsquo;s then outstanding securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<I>Fair
Market Value</I>&rdquo; with respect to one Share as of any date shall mean (a) if the Share is listed on any established stock
exchange, the price of one Share at the close of the regular trading session of such market or exchange on such date, as reported
by The Wall Street Journal or a comparable reporting service, or, if no sale of Shares shall have occurred on such date, on the
preceding date on which there was a sale of Shares; (b) if the Shares are not so listed on any established stock exchange, the
average of the closing &ldquo;bid&rdquo; and &ldquo;asked&rdquo; prices quoted by the OTC Bulletin Board, the National Quotation
Bureau, or any comparable reporting service on such date or, if there are no quoted &ldquo;bid&rdquo; and &ldquo;asked&rdquo; prices
on such date, on the next preceding date for which there are such quotes for a Share; or (c) if the Shares are not publicly traded
as of such date, the per share value of a Share, as determined by the Board, or any duly authorized Committee of the Board, in
its sole discretion, by applying principles of valuation with respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&ldquo;<I>Incentive Stock Option</I>&rdquo; shall mean an option granted under Section 6(a) of the Plan that is intended to meet
the requirements of Section&nbsp;422 of the Code or any successor provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(q)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&ldquo;<I>Non-Qualified Stock Option</I>&rdquo; shall mean an option granted under Section 6(a) of the Plan that is not intended
to be an Incentive Stock Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(r)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<I>Option</I>&rdquo;
shall mean an Incentive Stock Option or a Non-Qualified Stock Option to purchase shares of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(s)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<I>Own</I>,&rdquo;
&ldquo;<I>Owned</I>,&rdquo; &ldquo;<I>Owner</I>,&rdquo; &ldquo;<I>Ownership</I>&rdquo; a person or Entity shall be deemed to &ldquo;Own,&rdquo;
to have &ldquo;Owned,&rdquo; to be the &ldquo;Owner&rdquo; of, or to have acquired &ldquo;Ownership&rdquo; of securities if such
person or Entity, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares
voting power, which includes the power to vote or to direct the voting, with respect to such securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(t)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&ldquo;<I>Participant</I>&rdquo; shall mean an Eligible Person designated to be granted an Award under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(u)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<I>Performance
Award</I>&rdquo; shall mean any right granted under Section 6(d) of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>&ldquo;Performance
Goal&rdquo;</I> shall mean one or more of the following performance goals, either individually, alternatively or in any combination,
applied on a corporate, subsidiary, division, business unit or line of business basis:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>economic value added (EVA);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>sales or revenue;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>costs or expenses;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>net profit after tax;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>gross profit;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>income (including without limitation operating income, pre-tax income and income attributable to the Company);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>cash flow (including without limitation free cash flow and cash flow from operating, investing or financing activities or any
combination thereof);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>earnings (including without limitation earnings before or after taxes, earnings before interest and taxes (EBIT), earnings
before interest, taxes, depreciation and amortization (EBITDA) and earnings (whether before or after taxes), EBIT or EBITDA as
a percentage of net sales;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>earnings per share (EPS) (basic or diluted);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>earnings per share from continuing operations;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>returns (including one or more of return on actual or pro forma assets, net assets, equity, investment, revenue, sales, capital
and net capital employed, total stockholder return (TSR) and total business return (TBR));</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>margins (including one or more of gross, operating and net income margin);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>ratios (including one or more of price-to-earnings, debt-to-assets, debt-to-net assets and ratios regarding liquidity, solvency,
fiscal capacity, productivity or risk);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>budget comparisons;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>unit volume;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>stock price;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>net working capital;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>value creation;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>market share;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>market capitalization;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>workforce satisfaction and diversity goals;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>employee retention;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>production metrics;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>development;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>implementation or completion of key projects;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>strategic plan development and implementation;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>research and development milestones and objectives</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>clinical trial milestones</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>clinical trial objectives</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>manufacturing objectives</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>commercialization objectives; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>financing or fund raising objectives.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each such Performance Goal may be based
(i) solely by reference to absolute results of individual performance or organizational performance at various levels (e.g., the
Company&rsquo;s performance or the performance of a subsidiary, division, business segment or business unit of the Company) or
(ii) upon organizational performance relative to the comparable performance of other companies selected by the Committee. To the
extent consistent with Section 162(m), the Committee may, when it establishes performance criteria, also provide for the exclusion
of charges related to an event or occurrence which the Committee determines should appropriately be excluded, including (X) asset-write
downs, litigation or claim judgments or settlements, reorganizations, the impact of acquisitions and divestitures, restructurings,
discontinued operations, extraordinary items, and other unusual or non-recurring charges, (Y) foreign exchange gains and losses
or an event either not directly related to the operations of the Company or not within the reasonable control of the Company&rsquo;s
management, or (Z)&nbsp;the cumulative effects of tax or accounting changes in accordance with U.S. generally accepted accounting
principles (or other accounting principles which may then be in effect). To the extent that Section 162(m) or applicable tax and/or
securities laws change to permit Committee discretion to alter the governing performance measures without disclosing to stockholders
and obtaining stockholder approval of such changes and without thereby exposing the Company to potentially adverse tax or other
legal consequences, the Committee shall have the sole discretion to make such changes without obtaining stockholder approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(w)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<I>Person</I>&rdquo;
shall mean any individual or entity, including a corporation, partnership, limited liability company, association, joint venture
or trust.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<I>Plan</I>&rdquo;
shall mean the Second Amended and Restated Lipocine Inc. 2014 Stock and Incentive Plan, as amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(y)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&ldquo;<I>Prior Stock Plan</I>&rdquo; shall mean the Lipocine Inc. 2011 Equity Incentive Plan, as amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(z)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<I>Restricted
Stock</I>&rdquo; shall mean any Share granted under Section 6(c) of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(aa)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<I>Restricted
Stock Unit</I>&rdquo; shall mean any unit granted under Section 6(c) of the Plan evidencing the right to receive a Share (or a
cash payment equal to the Fair Market Value of a Share) at some future date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(bb)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<I>Rule&nbsp;16b-3</I>&rdquo;
shall mean Rule&nbsp;16b-3 promulgated by the Securities and Exchange Commission under the Securities Exchange Act of 1934, as
amended, or any successor rule or regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(cc)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>&ldquo;Section&nbsp;162(m)&rdquo;</I>
shall mean Section&nbsp;162(m) of the Code, or any successor provision, and the applicable Treasury Regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(dd)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>&ldquo;Section&nbsp;409A&rdquo;</I>
shall mean Section&nbsp;409A of the Code, or any successor provision, and applicable Treasury Regulations and other applicable
guidance thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(ee)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<I>Securities
Act</I>&rdquo; shall mean the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(ff)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<I>Share</I>&rdquo;
or &ldquo;<I>Shares</I>&rdquo; shall mean the common stock of the Company (or such other securities or property as may become subject
to Awards pursuant to an adjustment made under Section 4(c) of the Plan).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(gg)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>&ldquo;Specified
Employee&rdquo;</I> shall mean a specified employee as defined in Section&nbsp;409A(a)(2)(B) of the Code or applicable proposed
or final regulations under Section&nbsp;409A, determined in accordance with procedures established by the Company and applied uniformly
with respect to all plans maintained by the Company that are subject to Section 409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(hh)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<I>Stock
Appreciation Right</I>&rdquo; shall mean any right granted under Section 6(b) of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<I>Subsidiary</I>&rdquo;
means, with respect to the Company, (i)&nbsp;any corporation of which more than fifty percent (50%)&nbsp;of the outstanding capital
stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether,
at the time, stock of any other class or classes of such corporation shall have or might have voting power by reason of the happening
of any contingency) is at the time, directly or indirectly, Owned by the Company, and (ii)&nbsp;any partnership, limited liability
company or other entity in which the Company has a direct or indirect interest (whether in the form of voting or participation
in profits or capital contribution) of more than fifty percent (50%).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>Section 3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Administration</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Power
and Authority of the Committee</U>. The Plan shall be administered by the Committee. Subject to the express provisions of the Plan
and to applicable law, the Committee shall have full power and authority to: (i)&nbsp;designate Participants; (ii)&nbsp;determine
the type or types of Awards to be granted to each Participant under the Plan; (iii)&nbsp;determine the number of Shares to be covered
by (or the method by which payments or other rights are to be calculated in connection with) each Award; (iv)&nbsp;determine the
terms and conditions of any Award or Award Agreement, including any terms relating to the forfeiture of any Award and the forfeiture,
recapture or disgorgement of any cash, Shares or other amounts payable with respect to any Award; (v)&nbsp;amend the terms and
conditions of any Award or Award Agreement, subject to the limitations under Section 7; (vi) accelerate the exercisability of any
Award or the lapse of any restrictions relating to any Award, subject to the limitations in Section 7, (vii)&nbsp;determine whether,
to what extent and under what circumstances Awards may be exercised in cash, Shares, other securities, other Awards or other property
(excluding promissory notes), or canceled, forfeited or suspended, subject to the limitations in Section 7; (viii) determine whether,
to what extent and under what circumstances amounts payable with respect to an Award under the Plan shall be deferred either automatically
or at the election of the holder thereof or the Committee, subject to the requirements of Section 409A; (ix)&nbsp; interpret and
administer the Plan and any instrument or agreement, including an Award Agreement, relating to the Plan; (x)&nbsp;establish, amend,
suspend or waive such rules and regulations and appoint such agents as it shall deem appropriate for the proper administration
of the Plan; (xi)&nbsp;make any other determination and take any other action that the Committee deems necessary or desirable for
the administration of the Plan; and (xii) adopt such modifications, rules, procedures and subplans as may be necessary or desirable
to comply with provisions of the laws of non-U.S. jurisdictions in which the Company or an Affiliate may operate, including, without
limitation, establishing any special rules for Affiliates, Eligible Persons or Participants located in any particular country,
in order to meet the objectives of the Plan and to ensure the viability of the intended benefits of Awards granted to Participants
located in such non-United States jurisdictions. Unless otherwise expressly provided in the Plan, all designations, determinations,
interpretations and other decisions under or with respect to the Plan or any Award or Award Agreement shall be within the sole
discretion of the Committee, may be made at any time and shall be final, conclusive and binding upon any Participant, any holder
or beneficiary of any Award or Award Agreement, and any employee of the Company or any Affiliate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Delegation</U>.
The Committee shall have the right, from time to time, to delegate to one or more officers of the Company the authority of the
Committee to grant and determine the terms and conditions of Awards granted under the Plan, subject to the requirements of Section
157(c) of the Delaware General Corporation Law (or any successor provision) and such other limitations under applicable exchange
rules. In no event shall any such delegation of authority be permitted with respect to Awards to any members of the Board or to
any Eligible Person who is subject to Rule 16b-3 under the Exchange Act or Section 162(m). The Committee shall also be permitted
to delegate, to any appropriate officer or employee of the Company, responsibility for performing certain ministerial functions
under the Plan. In the event that the Committee&rsquo;s authority is delegated to officers or employees in accordance with the
foregoing, all provisions of the Plan relating to the Committee shall be interpreted in a manner consistent with the foregoing
by treating any such reference as a reference to such officer or employee for such purpose. Any action undertaken in accordance
with the Committee&rsquo;s delegation of authority hereunder shall have the same force and effect as if such action were undertaken
directly by the Committee and shall be deemed for all purposes of the Plan to have been taken by the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Power
and Authority of the Board</U>. Notwithstanding anything to the contrary contained herein, (i) the Board may, at any time and from
time to time, without any further action of the Committee, exercise the powers and duties of the Committee under the Plan, unless
the exercise of such powers and duties by the Board would cause the Plan not to comply with the requirements of Rule 16b-3 or Section
162(m); and (ii) only the Committee (or another committee of the Board comprised of directors who qualify as independent directors,
to the extent required by applicable law or independence rules of any applicable securities exchange where the Shares are then
listed) may grant Awards to Directors who are not also employees of the Company or an Affiliate</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification</U>.
To the full extent permitted by law, (i) no member of the Board, the Committee or any person to whom the Committee delegates authority
under the Plan shall be liable for any action or determination taken or made in good faith with respect to the Plan or any Award
made under the Plan, and (ii) the members of the Board, the Committee and each person to whom the Committee delegates authority
under the Plan shall be entitled to indemnification by the Company with regard to such actions and determinations. The provisions
of this paragraph shall be in addition to such other rights of indemnification as a member of the Board, the Committee or any other
person may have by virtue of such person&rsquo;s position with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>Section 4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares
Available for Awards</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Shares
Available</U>. Subject to adjustment as provided in Section 4(c) of the Plan, the aggregate number of Shares that may be issued
under all Awards under the Plan shall be the sum of (i) 2,200,000 (the authorized net increase of Shares in connection with the
adoption of the Plan), (ii) 271,906 (the remaining Shares available for future awards under the Prior Stock Plan as of June 10,
2014), and (iii) any Shares subject to any outstanding award under the Prior Stock Plan that, after June 10, 2014, are not purchased
or are forfeited or reacquired by the Company, or otherwise not delivered to the Participant due to termination or cancellation
of such award. The aggregate number of Shares that may be issued under all Awards under the Plan shall be reduced by Shares subject
to awards issued under the Plan (or issued under the Prior Stock Plan after June 10, 2014, if any) in accordance with the share
counting rules described in Section 4(b) below. On and after stockholder approval of this Plan, no awards shall be granted under
the Prior Stock Plan, but all outstanding awards previously granted under the Prior Stock Plan shall remain outstanding and subject
to the terms of the Prior Stock Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Counting
Shares</U>. For purposes of this Section 4, if an Award entitles the holder thereof to receive or purchase Shares, the number of
Shares covered by such Award or to which such Award relates shall be counted on the date of grant of such Award against the aggregate
number of Shares available for granting Awards under the Plan. For purposes of determining the number of Shares covered on the
date of grant by an Option or a Stock Appreciation Right, the aggregate number of Shares with respect to which the Option or Stock
Appreciation Right is to be exercised shall be counted against the number of Shares available for Awards under the Plan (without
regard to the number of actual Shares issued upon exercise or settlement). If any Shares covered by an Award or to which an Award
relates are not purchased or are forfeited or are reacquired by the Company (including shares of Restricted Stock and Restricted
Stock Units, whether or not dividends have been paid on such shares), or if an Award otherwise terminates or is cancelled without
delivery of any Shares, then the number of Shares counted pursuant to Section 4(b) of the Plan against the aggregate number of
Shares available under the Plan with respect to such Award, to the extent of any such forfeiture, reacquisition by the Company,
termination or cancellation, shall again be available for granting Awards under the Plan. Notwithstanding anything to the contrary
in this Section 4, the following Shares will not again become available for issuance under the Plan: (i) any Shares which would
have been issued upon any exercise of an Option but for the fact that the exercise price was paid by a &ldquo;net exercise&rdquo;
pursuant to Section 6(a)(iii)(B) or any Shares tendered in payment of the exercise price of an Option; (ii) any Shares withheld
by the Company or Shares tendered to satisfy any tax withholding obligation with respect to an Option or Stock Appreciation Right;
(iii) Shares covered by a Stock Appreciation Right issued under the Plan that are not issued in connection with settlement in Shares
upon exercise; or (iv) Shares that are repurchased by the Company using Option exercise proceeds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustments</U>.
In the event that any dividend (other than regular cash dividends) or other distribution (whether in the form of cash, Shares,
other securities or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation,
split-up, spin-off, combination, repurchase or exchange of Shares or other securities of the Company, issuance of warrants or other
rights to purchase Shares or other securities of the Company or other similar corporate transaction or event affects the Shares
such that an adjustment is necessary in order to prevent dilution or enlargement of the benefits or potential benefits intended
to be made available under the Plan, then the Committee shall, in such manner as it may deem equitable, adjust any or all of (i)&nbsp;the
number and type of Shares (or other securities or other property) that thereafter may be made the subject of Awards, (ii)&nbsp;the
number and type of Shares (or other securities or other property) subject to outstanding Awards, (iii)&nbsp;the purchase price
or exercise price with respect to any Award and (iv) the limitations contained in Section 4(d)(i) below; <I>provided</I>, <I>however</I>,
that the number of Shares covered by any Award or to which such Award relates shall always be a whole number. Such adjustment shall
be made by the Committee or the Board, whose determination in that respect shall be final, binding and conclusive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Award
Limitations Under the Plan</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD><U>Section 162(m) Limitation for Performance Awards Denominated in Shares</U>. No Eligible Person may be granted any Performance
Awards denominated in Shares, for more than 400,000 Shares (subject to adjustment as provided for in Section 4(c) of the Plan),
in the aggregate in any calendar year.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD><U>Section 162(m) Limitation for Performance Awards Denominated in Cash</U>. The maximum amount payable pursuant to all Performance
Awards denominated in cash to any Participant in the aggregate in any taxable year shall be $2,000,000 in value, whether payable
in cash, Shares or other property. This limitation contained in this Section 4(d)(ii) does not apply to any Award or Awards subject
to the limitation contained in Section 4(d)(i). The limitation contained in this Section 4(d)(ii) shall apply only with respect
to any Award or Awards granted under this Plan, and limitations on awards granted under any other stockholder-approved incentive
plan maintained by the Company will be governed solely by the terms of such other plan.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD><U>Limit on Awards to Non-Employee Directors</U>. Directors who are not also employees of the Company or an Affiliate may not
be granted Awards in in any calendar year of more than 30,000 Shares, subject to adjustment as provided in Section 4(c) of the
Plan.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1in"><B>Section&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Eligibility</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Any Eligible Person shall be eligible to
be designated as a Participant. In determining which Eligible Persons shall receive an Award and the terms of any Award, the Committee
may take into account the nature of the services rendered by the respective Eligible Persons, their present and potential contributions
to the success of the Company or such other factors as the Committee, in its discretion, shall deem relevant. Notwithstanding the
foregoing, an Incentive Stock Option may only be granted to full-time or part-time employees (which term as used herein includes,
without limitation, officers and Directors who are also employees), and an Incentive Stock Option shall not be granted to an employee
of an Affiliate unless such Affiliate is also a &ldquo;subsidiary corporation&rdquo; of the Company within the meaning of Section&nbsp;424(f)
of the Code or any successor provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1in"><B>Section&nbsp;6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Awards</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Options</U>.
The Committee is hereby authorized to grant Options to Eligible Persons with the following terms and conditions and with such additional
terms and conditions not inconsistent with the provisions of the Plan as the Committee shall determine:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD><U>Exercise Price</U>. The purchase price per Share purchasable under an Option shall be determined by the Committee and shall
not be less than 100% of the Fair Market Value of a Share on the date of grant of such Option; <I>provided, however,</I> that the
Committee may designate a purchase price below Fair Market Value on the date of grant if the Option is granted in substitution
for a stock option previously granted by an entity that is acquired by or merged with the Company or an Affiliate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD><U>Option Term</U>. The term of each Option shall be fixed by the Committee at the time but shall not be longer than 10 years
from the date of grant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD><U>Time and Method of Exercise</U>. The Committee shall determine the time or times at which an Option may be exercised in
whole or in part and the method or methods by which, and the form or forms, including, but not limited to, cash, Shares (actually
or by attestation), other securities, other Awards or other property, or any combination thereof, having a Fair Market Value on
the exercise date equal to the applicable exercise price, in which, payment of the exercise price with respect thereto may be made
or deemed to have been made.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(A)</TD><TD><U>Promissory Notes</U>. Notwithstanding the foregoing, the Committee may not accept a promissory note as consideration.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(B)</TD><TD><U>Net Exercises</U>. The Committee may, in its discretion, permit an Option to be exercised by delivering to the Participant
a number of Shares having an aggregate Fair Market Value (determined as of the date of exercise) equal to the excess, if positive,
of the Fair Market Value of the Shares underlying the Option being exercised on the date of exercise, over the exercise price of
the Option for such Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD><U>Incentive Stock Options</U>. Notwithstanding anything in the Plan to the contrary, the following additional provisions shall
apply to the grant of stock options which are intended to qualify as Incentive Stock Options:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(A)</TD><TD>The Committee will not grant Incentive Stock Options in which the aggregate Fair Market Value (determined as of the time the
Option is granted) of the Shares with respect to which Incentive Stock Options are exercisable for the first time by any Participant
during any calendar year (under this Plan and all other plans of the Company and its Affiliates) shall exceed $100,000.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(B)</TD><TD>All Incentive Stock Options must be granted within ten years from the earlier of the date on which this Plan was adopted by
the Board or the date this Plan was approved by the stockholders of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(C)</TD><TD>Unless sooner exercised, all Incentive Stock Options shall expire and no longer be exercisable no later than 10 years after
the date of grant; <I>provided</I>, <I>however</I>, that in the case of a grant of an Incentive Stock Option to a Participant who,
at the time such Option is granted, owns (within the meaning of Section&nbsp;422 of the Code) stock possessing more than 10% of
the total combined voting power of all classes of stock of the Company or of its Affiliates, such Incentive Stock Option shall
expire and no longer be exercisable no later than five years from the date of grant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(D)</TD><TD>The purchase price per Share for an Incentive Stock Option shall be not less than 100% of the Fair Market Value of a Share
on the date of grant of the Incentive Stock Option; <I>provided</I>, <I>however</I>, that, in the case of the grant of an Incentive
Stock Option to a Participant who, at the time such Option is granted, owns (within the meaning of Section&nbsp;422 of the Code)
stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or of its Affiliates,
the purchase price per Share purchasable under an Incentive Stock Option shall be not less than 110% of the Fair Market Value of
a Share on the date of grant of the Incentive Stock Option.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(E)</TD><TD>Any Incentive Stock Option authorized under the Plan shall contain such other provisions as the Committee shall deem advisable,
but shall in all events be consistent with and contain all provisions required in order to qualify the Option as an Incentive Stock
Option.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock
Appreciation Rights</U>. The Committee is hereby authorized to grant Stock Appreciation Rights to Eligible Persons subject to the
terms of the Plan and any applicable Award Agreement. A Stock Appreciation Right granted under the Plan shall confer on the holder
thereof a right to receive upon exercise thereof the excess of (i)&nbsp;the Fair Market Value of one Share on the date of exercise
over (ii)&nbsp;the grant price of the Stock Appreciation Right as specified by the Committee, which price shall not be less than
100% of the Fair Market Value of one Share on the date of grant of the Stock Appreciation Right; <I>provided, however, </I>that
the Committee may designate a grant price below Fair Market Value on the date of grant if the Stock Appreciation Right is granted
in substitution for a stock appreciation right previously granted by an entity that is acquired by or merged with the Company or
an Affiliate. Subject to the terms of the Plan and any applicable Award Agreement, the grant price, term, methods of exercise,
dates of exercise, methods of settlement and any other terms and conditions of any Stock Appreciation Right shall be as determined
by the Committee (except that the term of each Stock Appreciation Right shall be subject to the term limitation in Section 6(a)(ii)
applicable to Options). The Committee may impose such conditions or restrictions on the exercise of any Stock Appreciation Right
as it may deem appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Restricted
Stock and Restricted Stock Units</U>. The Committee is hereby authorized to grant an Award of Restricted Stock and Restricted Stock
Units to Eligible Persons with the following terms and conditions and with such additional terms and conditions not inconsistent
with the provisions of the Plan as the Committee shall determine:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD><U>Restrictions</U>. Shares of Restricted Stock and Restricted Stock Units shall be subject to such restrictions as the Committee
may impose (including, without limitation, any limitation on the right to vote a Share of Restricted Stock or the right to receive
any dividend or other right or property with respect thereto), which restrictions may lapse separately or in combination at such
time or times, in such installments or otherwise as the Committee may deem appropriate. Notwithstanding the foregoing, rights to
dividend or Dividend Equivalent payments shall be subject to the limitations described in Section 6(e).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD><U>Issuance and Delivery of Shares</U>. Any Restricted Stock granted under the Plan shall be issued at the time such Awards
are granted and may be evidenced in such manner as the Committee may deem appropriate, including book-entry registration or issuance
of a stock certificate or certificates, which certificate or certificates shall be held by the Company or held in nominee name
by the stock transfer agent or brokerage service selected by the Company to provide such services for the Plan. Such certificate
or certificates shall be registered in the name of the Participant and shall bear an appropriate legend referring to the restrictions
applicable to such Restricted Stock. Shares representing Restricted Stock that are no longer subject to restrictions shall be delivered
(including by updating the book-entry registration) to the Participant promptly after the applicable restrictions lapse or are
waived. In the case of Restricted Stock Units, no Shares shall be issued at the time such Awards are granted. Upon the lapse or
waiver of restrictions and the restricted period relating to Restricted Stock Units evidencing the right to receive Shares, such
Shares shall be issued and delivered to the holder of the Restricted Stock Units.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD><U>Forfeiture</U>. Except as otherwise determined by the Committee, upon a Participant&rsquo;s termination of employment or
resignation or removal as a Director (in either case, as determined under criteria established by the Committee) during the applicable
restriction period, all Shares of Restricted Stock and all Restricted Stock Units held by such Participant at such time shall be
forfeited and reacquired by the Company; <I>provided</I>, <I>however</I>, that the Committee may waive in whole or in part any
or all remaining restrictions with respect to Shares of Restricted Stock or Restricted Stock Units.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Performance
Awards</U>. The Committee is hereby authorized to grant to Eligible Persons Performance Awards that are intended to be &ldquo;qualified
performance-based compensation&rdquo; within the meaning of Section 162(m). A Performance Award granted under the Plan (i)&nbsp;may
be denominated or payable in cash, Shares (including, without limitation, Restricted Stock and Restricted Stock Units), other securities,
other Awards or other property and (ii)&nbsp;shall confer on the holder thereof the right to receive payments, in whole or in part,
upon the achievement of one or more objective Performance Goals during such performance periods as the Committee shall establish.
Subject to the terms of the Plan, the Performance Goals to be achieved during any performance period, the length of any performance
period, the amount of any Performance Award granted, the amount of any payment or transfer to be made pursuant to any Performance
Award and any other terms and conditions of any Performance Award shall be determined by the Committee. Performance Awards shall
be conditioned solely on the achievement of one or more objective Performance Goals established by the Committee within the time
prescribed by Section 162(m), and shall otherwise comply with the requirements of Section 162(m), as described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD><U>Timing of Designations; Duration of Performance Periods</U>. For each Performance Award, the Committee shall, not later
than 90 days after the beginning of each performance period, (i) designate all Participants for such performance period and (ii)
establish the objective performance factors for each Participant for that performance period on the basis of one or more of the
Performance Goals, the outcome of which is substantially uncertain at the time the Committee actually establishes the Performance
Goal. The Committee shall have sole discretion to determine the applicable performance period, provided that in the case of a performance
period less than 12 months, in no event shall a performance goal be considered to be pre-established if it is established after
25 percent of the performance period (as scheduled in good faith at the time the Performance Goal is established) has elapsed.
To the extent required under Section 162(m), the terms of the objective performance factors must preclude discretion to increase
an amount paid in connection with an Award, but may permit discretion to reduce such amount.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD><U>Certification</U>. Following the close of each performance period and prior to payment of any amount to a Participant with
respect to a Performance Award, the Committee shall certify in writing as to the attainment of all factors (including the performance
factors for a Participant) upon which any payments to a Participant for that performance period are to be based.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Dividend
Equivalents</U>. The Committee is hereby authorized to grant Dividend Equivalents to Eligible Persons under which the Participant
shall be entitled to receive payments (in cash, Shares, other securities, other Awards or other property as determined in the discretion
of the Committee) equivalent to the amount of cash dividends paid by the Company to holders of Shares with respect to a number
of Shares determined by the Committee. Subject to the terms of the Plan and any applicable Award Agreement, such Dividend Equivalents
may have such terms and conditions as the Committee shall determine. Notwithstanding the foregoing, (i) the Committee may not grant
Dividend Equivalents to Eligible Persons in connection with grants of Options or Stock Appreciation Rights to such Eligible Persons,
and (ii) no dividend or Dividend Equivalent payments shall be made to a Participant with respect to any Performance Award or other
Award subject to performance-based vesting conditions prior to the date on which all conditions or restrictions relating to such
Award (or portion thereof to which the dividend or Dividend Equivalent relates) have been satisfied, waived or lapsed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>General</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD><U>Consideration for Awards</U>. Awards may be granted for no cash consideration or for any cash or other consideration as
may be determined by the Committee or required by applicable law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD><U>Awards May Be Granted Separately or Together</U>. Awards may, in the discretion of the Committee, be granted either alone
or in addition to, in tandem with or in substitution for any other Award or any award granted under any other plan of the Company
or any Affiliate. Awards granted in addition to or in tandem with other Awards or in addition to or in tandem with awards granted
under any other plan of the Company or any Affiliate may be granted either at the same time as or at a different time from the
grant of such other Awards or awards.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD><U>Forms of Payment under Awards</U>. Subject to the terms of the Plan and of any applicable Award Agreement, payments or transfers
to be made by the Company or an Affiliate upon the grant, exercise or payment of an Award may be made in such form or forms as
the Committee shall determine (including, without limitation, cash, Shares, other securities (but excluding promissory notes),
other Awards or other property or any combination thereof), and may be made in a single payment or transfer, in installments or
on a deferred basis, in each case in accordance with rules and procedures established by the Committee. Such rules and procedures
may include, without limitation, provisions for the payment or crediting of reasonable interest on installment or deferred payments
or the grant or crediting of Dividend Equivalents with respect to installment or deferred payments.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD><U>Limits on Transfer of Awards</U>. Except as otherwise provided by the Committee in its discretion and subject to such additional
terms and conditions as it determines, no Award (other than fully vested and unrestricted Shares issued pursuant to any Award)
and no right under any such Award shall be transferable by a Participant other than by will or by the laws of descent and distribution,
and no Award (other than fully vested and unrestricted Shares issued pursuant to any Award) or right under any such Award may be
pledged, alienated, attached or otherwise encumbered, and any purported pledge, alienation, attachment or encumbrance thereof shall
be void and unenforceable against the Company or any Affiliate. If the Committee does permit the transfer of an Award other than
a fully vested and unrestricted Share, such transfer shall be for no value and in accordance with the rules of Form S-8. The Committee
may establish procedures as it deems appropriate for a Participant to designate a person or persons, as beneficiary or beneficiaries,
to exercise the rights of the Participant and receive any property distributable with respect to any Award in the event of the
Participant&rsquo;s death.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD><U>Restrictions; Securities Exchange Listing</U>. All Shares or other securities delivered under the Plan pursuant to any Award
or the exercise thereof shall be subject to such restrictions as the Committee may deem advisable under the Plan, applicable federal
or state securities laws and regulatory requirements, and the Committee may cause appropriate entries to be made with respect to,
or legends to be placed on the certificates for, such Shares or other securities to reflect such restrictions. The Company shall
not be required to deliver any Shares or other securities covered by an Award unless and until the requirements of any federal
or state securities or other laws, rules or regulations (including the rules of any securities exchange) as may be determined by
the Company to be applicable are satisfied.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(vi)</TD><TD><U>Option and Stock Appreciation Right Repricing</U>. The Committee may effect any repricing of any previously granted, &ldquo;underwater&rdquo;
Option or Stock Appreciation Right by: (i) amending or modifying the terms of the Option or Stock Appreciation Right to lower the
exercise price; (ii) canceling the underwater Option or Stock Appreciation Right and granting either (A) replacement Options or
Stock Appreciation Rights having a lower exercise price; or (B) Restricted Stock, Restricted Stock Units, Performance Award or
Other Stock-Based Award in exchange; or (iii) repurchasing the underwater Option or Stock Appreciation Right. An Option or Stock
Appreciation Right will be deemed to be &ldquo;underwater&rdquo; at any time when the Fair Market Value of the Shares covered by
such Option or Stock Appreciation Right is less than the exercise price.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(vii)</TD><TD><U>Section 409A Provisions</U>. Notwithstanding anything in the Plan or any Award Agreement to the contrary, to the extent
that any amount or benefit that constitutes &ldquo;deferred compensation&rdquo; to a Participant under Section 409A and applicable
guidance thereunder is otherwise payable or distributable to a Participant under the Plan or any Award Agreement solely by reason
of the occurrence of a change in control or due to the Participant&rsquo;s disability or &ldquo;separation from service&rdquo;
(as such term is defined under Section 409A), such amount or benefit will not be payable or distributable to the Participant by
reason of such circumstance unless the Committee determines in good faith that (i) the circumstances giving rise to such change
in control, disability or separation from service meet the definition of a change in ownership or effective control, disability,
or separation from service, as the case may be, in Section 409A(a)(2)(A) of the Code and applicable proposed or final regulations,
or (ii) the payment or distribution of such amount or benefit would be exempt from the application of Section 409A by reason of
the short-term deferral exemption or otherwise. Any payment or distribution that otherwise would be made to a Participant who is
a Specified Employee (as determined by the Committee in good faith) on account of separation from service may not be made before
the date which is six months after the date of the Specified Employee&rsquo;s separation from service (or if earlier, upon the
Specified Employee&rsquo;s death) unless the payment or distribution is exempt from the application of Section 409A by reason of
the short-term deferral exemption or otherwise..</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>Section 7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amendment
and Termination; Corrections</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendments
to the Plan and Awards</U>. The Board may from time to time amend, suspend or terminate this Plan, and the Committee may amend
the terms of any previously granted Award, provided that no amendment to the terms of any previously granted Award may, (except
as expressly provided in the Plan) adversely alter or impair the terms or conditions of the Award previously granted to a Participant
under this Plan without the written consent of the Participant or holder thereof. Any amendment to this Plan, or to the terms of
any Award previously granted, is subject to compliance with all applicable laws, rules, regulations and policies of any applicable
governmental entity or securities exchange, including receipt of any required approval from the governmental entity or stock exchange.
For greater certainty and without limiting the foregoing, the Board may amend, suspend, terminate or discontinue the Plan, and
the Committee may amend or alter any previously granted Award, as applicable, without obtaining the approval of stockholders of
the Company in order to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD>amend the eligibility for, and limitations or conditions imposed upon, participation in the Plan;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD>amend any terms relating to the granting or exercise of Awards, including but not limited to terms relating to the amount and
payment of the exercise price, or the vesting, expiry, assignment or adjustment of Awards, or otherwise waive any conditions of
or rights of the Company under any outstanding Award, prospectively or retroactively;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD>make changes that are necessary or desirable to comply with applicable laws, rules, regulations and policies of any applicable
governmental entity or stock exchange (including amendments to Awards necessary or desirable to avoid any adverse tax results under
Section 409A, and no action taken to comply with Section 409A shall be deemed to impair or otherwise adversely alter or impair
the rights of any holder of an Award or beneficiary thereof); or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD>amend any terms relating to the administration of the Plan, including the terms of any administrative guidelines or other rules
related to the Plan.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9pt; text-indent: 0.5in">For greater certainty, prior approval
of the stockholders of the Company shall be required for any amendment to the Plan or an Award that would:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD>require stockholder approval under the rules or regulations of the Securities and Exchange Commission, the NASDAQ Stock Market
or any other securities exchange that are applicable to the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD>increase the number of shares authorized under the Plan as specified in Section 4(a) of the Plan;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD>increase the number of shares or value subject to the limitations contained in Section 4(d) of the Plan or otherwise cause
Section&nbsp;162(m) to become unavailable with respect to the Plan;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD>permit the award of Options or Stock Appreciation Rights at a price less than 100% of the Fair Market Value of a Share on the
date of grant of such Option or Stock Appreciation Right, contrary to the provisions of Section 6(a)(i) and Section 6(b) of the
Plan; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD>increase the maximum term permitted for Options and Stock Appreciation Rights as specified in Section 6(a)(ii) and Section
6(b).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Corporate
Transactions</U>. In the event of any Change in Control Event, reorganization, merger, consolidation, split-up, spin-off, combination,
plan of arrangement, take-over bid or tender offer, repurchase or exchange of Shares or other securities of the Company or any
other similar corporate transaction or event involving the Company (or the Company shall enter into a written agreement to undergo
such a transaction or event), any such event defined herein as a &ldquo;Corporate Transaction&rdquo;, the Committee or the Board
may, in its sole discretion, provide for one or more of the following to be effective upon the consummation of the event (or effective
immediately prior to the consummation of the event, provided that the consummation of the event subsequently occurs), and no action
taken under this Section 7(b) shall be deemed to impair or otherwise adversely alter or impair the rights of any holder of an Award
or beneficiary thereof:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD>either (A)&nbsp;termination of any Award, whether or not vested, in exchange for an amount of cash and/or other property, if
any, equal to the gain that would have been attained upon the exercise of the Award or realization of the Participant&rsquo;s rights
or (B)&nbsp;the replacement of the Award with other rights or property of comparable value selected by the Committee or the Board,
in its sole discretion;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD>that the Award be assumed by the successor or survivor corporation, or a parent or subsidiary thereof, or shall be substituted
for by similar options, rights or awards covering the stock of the successor or survivor corporation, or a parent or subsidiary
thereof, with appropriate adjustments as to the number and kind of shares and prices;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD>that the Award shall be exercisable or payable or fully vested with respect to all Shares covered thereby, notwithstanding
anything to the contrary in the applicable Award Agreement; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD>that the Award cannot vest, be exercised or become payable after a date certain in the future, which may be the effective date
of the event.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Notwithstanding the foregoing, with respect to any Award, or
any portion thereof, that is neither assumed by the successor or survivor corporation nor substituted as provided in (b)(ii) above,
then the portion of the Award that is not assumed or substituted shall become fully vested, exercisable and payable with respect
to all shares covered thereby. Furthermore, in the event the Committee or the Board uses its discretion under Section 7(b)(i)(A)
above to terminate an unexercised Option or Stock Appreciation Right held by a Participant who has not terminated employment or
otherwise separated from service with the Company and its Affiliates, and if the Black Scholes value of the Option or Stock Appreciation
Right (determined at the time the Award is terminated) exceeds the gain that would have been realized upon exercise of the Option
or Stock Appreciation Right, the Company shall pay an additional cash bonus equal to the excess of the Black Scholes value over
the gain (if any) that would have been realized upon exercise. In such event where the Black Scholes value exceeds the gain that
would have been realized upon exercise of the Option or Stock Appreciation Right, the excess shall be treated as a short-term deferral
for purposes of Section 409A, payable upon the Corporate Transaction to Participants who are then in employment or service with
the Company and its Affiliates and solely in connection with the termination of the Option or Stock Appreciation Right as described
in Section 7(b)(i)(A) above, and not in connection with any exercise of the Option or Stock Appreciation Right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Correction
of Defects, Omissions and Inconsistencies</U>. The Committee may, without prior approval of the stockholders of the Company, correct
any defect, supply any omission or reconcile any inconsistency in the Plan or in any Award or Award Agreement in the manner and
to the extent it shall deem desirable to implement or maintain the effectiveness of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 51; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>Section 8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income
Tax Withholding</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In order to comply with all applicable federal,
state, local or foreign income tax laws or regulations, the Company may take such action as it deems appropriate to ensure that
all applicable federal, state, local or foreign payroll, withholding, income or other taxes, which are the sole and absolute responsibility
of a Participant, are withheld or collected from such Participant. In order to assist a Participant in paying all or a portion
of the applicable taxes to be withheld or collected upon exercise or receipt of (or the lapse of restrictions relating to) an Award,
the Committee, in its discretion and subject to such additional terms and conditions as it may adopt, may permit the Participant
to satisfy such tax obligation by (a)&nbsp;electing to have the Company withhold a portion of the Shares otherwise to be delivered
upon exercise or receipt of (or the lapse of restrictions relating to) such Award with a Fair Market Value equal to the amount
of such taxes (but only to the extent necessary to satisfy minimum statutory withholding requirements) or (b)&nbsp;delivering to
the Company Shares other than Shares issuable upon exercise or receipt of (or the lapse of restrictions relating to) such Award
with a Fair Market Value equal to the amount of such taxes. The election, if any, must be made on or before the date that the amount
of tax to be withheld is determined.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>Section 9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General
Provisions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Rights to Awards</U>. No Eligible Person, Participant or other person shall have any claim to be granted any Award under the Plan,
and there is no obligation for uniformity of treatment of Eligible Persons, Participants or holders or beneficiaries of Awards
under the Plan. The terms and conditions of Awards need not be the same with respect to any Participant or with respect to different
Participants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Award
Agreements</U>. No Participant shall have rights under an Award granted to such Participant unless and until an Award Agreement
shall have been signed by the Participant (if requested by the Company), or until such Award Agreement is delivered and accepted
through an electronic medium in accordance with procedures established by the Company. An Award Agreement need not be signed by
a representative of the Company unless required by the Committee. Each Award Agreement shall be subject to the applicable terms
and conditions of the Plan and any other terms and conditions (not inconsistent with the Plan) determined by the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Plan
Provisions Control</U>. In the event that any provision of an Award Agreement conflicts with or is inconsistent in any respect
with the terms of the Plan as set forth herein or subsequently amended, the terms of the Plan shall control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Rights of Stockholders</U>. Except with respect to Shares issued under Awards (and subject to such conditions as the Committee
may impose on such Awards pursuant to Section 6(c)(i) or Section 6(e)), neither a Participant nor the Participant&rsquo;s legal
representative shall be, or have any of the rights and privileges of, a stockholder of the Company with respect to any Shares issuable
upon the exercise or payment of any Award, in whole or in part, unless and until such Shares have been issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Limit on Other Compensation Arrangements</U>. Nothing contained in the Plan shall prevent the Company or any Affiliate from adopting
or continuing in effect other or additional compensation plans or arrangements, and such plans or arrangements may be either generally
applicable or applicable only in specific cases.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Right to Employment</U>. The grant of an Award shall not be construed as giving a Participant the right to be retained as an employee
of the Company or any Affiliate, nor will it affect in any way the right of the Company or an Affiliate to terminate a Participant&rsquo;s
employment at any time, with or without cause, in accordance with applicable law. In addition, the Company or an Affiliate may
at any time dismiss a Participant from employment free from any liability or any claim under the Plan or any Award, unless otherwise
expressly provided in the Plan or in any Award Agreement. Nothing in this Plan shall confer on any person any legal or equitable
right against the Company or any Affiliate, directly or indirectly, or give rise to any cause of action at law or in equity against
the Company or an Affiliate. Under no circumstances shall any person ceasing to be an employee of the Company or any Affiliate
be entitled to any compensation for any loss of any right or benefit under the Plan which such employee might otherwise have enjoyed
but for termination of employment, whether such compensation is claimed by way of damages for wrongful or unfair dismissal, breach
of contract or otherwise. By participating in the Plan, each Participant shall be deemed to have accepted all the conditions of
the Plan and the terms and conditions of any rules and regulations adopted by the Committee and shall be fully bound thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing
Law</U>. The internal law, and not the law of conflicts, of the State of Delaware shall govern all questions concerning the validity,
construction and effect of the Plan or any Award, and any rules and regulations relating to the Plan or any Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>.
If any provision of the Plan or any Award is or becomes or is deemed to be invalid, illegal or unenforceable in any jurisdiction
or would disqualify the Plan or any Award under any law deemed applicable by the Committee, such provision shall be construed or
deemed amended to conform to applicable laws, or if it cannot be so construed or deemed amended without, in the determination of
the Committee, materially altering the purpose or intent of the Plan or the Award, such provision shall be stricken as to such
jurisdiction or Award, and the remainder of the Plan or any such Award shall remain in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 52; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Trust or Fund Created</U>. Neither the Plan nor any Award shall create or be construed to create a trust or separate fund of any
kind or a fiduciary relationship between the Company or any Affiliate and a Participant or any other person. To the extent that
any person acquires a right to receive payments from the Company or any Affiliate pursuant to an Award, such right shall be no
greater than the right of any unsecured general creditor of the Company or any Affiliate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Other
Benefits</U>. No compensation or benefit awarded to or realized by any Participant under the Plan shall be included for the purpose
of computing such Participant&rsquo;s compensation or benefits under any pension, retirement, savings, profit sharing, group insurance,
disability, severance, termination pay, welfare or other benefit plan of the Company, unless required by law or otherwise provided
by such other plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Fractional Shares</U>. No fractional Shares shall be issued or delivered pursuant to the Plan or any Award, and the Committee shall
determine whether cash shall be paid in lieu of any fractional Share or whether such fractional Share or any rights thereto shall
be canceled, terminated or otherwise eliminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Headings</U>.
Headings are given to the sections and subsections of the Plan solely as a convenience to facilitate reference. Such headings shall
not be deemed in any way material or relevant to the construction or interpretation of the Plan or any provision thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>Section 10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Clawback
or Recoupment</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All Awards under this Plan shall be subject
to forfeiture or other penalties pursuant to any Company clawback policy, as may be adopted or amended from time to time, and such
forfeiture and/or penalty conditions or provisions as determined by the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>Section 11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Effective
Date of the Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Plan was adopted by the Board on April
15, 2014. The Plan shall be subject to approval by the stockholders of the Company at the annual meeting of stockholders of the
Company to be held on June 10, 2014, and the Plan shall be effective as of the date of such stockholder approval (the &ldquo;Effective
Date&rdquo;). On and after stockholder approval of the Plan, no awards shall be granted under the Prior Stock Plan, but all outstanding
awards previously granted under the Prior Stock Plan shall remain outstanding and subject to the terms of the Prior Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>Section 12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Term
of the Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No Award shall be granted under the Plan,
and the Plan shall terminate, on April 15, 2024 or any earlier date of discontinuation or termination established pursuant to Section&nbsp;7(a)
of the Plan; <I>provided, however,</I> that no Performance Award shall be granted under the Plan after the first stockholder meeting
to occur in the fifth year following the year in which stockholders approved the Performance Goals unless and until the Performance
Goals or the Plan is re-approved by the stockholders. Unless otherwise expressly provided in the Plan or in an applicable Award
Agreement, any Award theretofore granted may extend beyond such dates, and the authority of the Committee provided for hereunder
with respect to the Plan and any Awards, and the authority of the Board to amend the Plan, shall extend beyond the termination
of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 53; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><A NAME="def14a_017"></A>&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: right; margin-bottom: 0pt"><B>Appendix II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><IMG SRC="tproxy1.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 54; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><IMG SRC="tproxy2.jpg" ALT="">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 55; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tlogo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tlogo.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 3 $- P$1  (1 0,1 ?_$ ,T   $$ @(#
M      H !P@)! 8%"P$" P$  P " P$               $"!08#! <($
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M<MT3#=\5]3^J>F("M*?EJ5JJ*:SE.SS-6/F(A\4QVD@R6RWK9P0IB&,F?+U
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%AUNJ_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tproxy1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tproxy1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@$"@,T P$1  (1 0,1 ?_$ )<  0 " P$  P$
M       '" 4&"00" PH! 0$                     $  !! ,!   % 0,&
M# ,# 1D% P0&!P ! @@1$A,4"146%U<AE-2U-Q@Q(B.T=39VEM>8&5E!XW11
M5-7887$R)"5WMS,FEPJ10E)R0[8G>!HZ-#BX*!$!
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M/D1)0:VFQD 2Z9K+:8F1+C>DW+93Y5D._P"3OG6\#W/2HL:L+;$23!@X-O\
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MX&-Z,&V\9$N%^'YGL.+Y^NZV@GWRW3ZYVIOGY^?B&Y8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8'YZV_A_V40K2O*/[A+."M/*5/^RX= KB@][!X[([ID%Y
M;6!5FXK9PVBQLQ4A!&*/%W9AV>9:X8$^4V;;EXV54((AK\5\6?DB6E'G A*)
M7)8W&(&L&9 A5?W)H<[JA(+Z7ED[D$ELIK,IO9[(T]LJDRXL,\%1]S*Q;9N,
M4"-$V UQPX1"SWI?P%*+P]RC[4<0M1_4LC7\HOYW*1]NR6'DNQM)"O9P>7Q;
MD&"/BSC5R_5NF)K-UAOT4G;1(@BLKQ\ZR;L(@\X>-OR#PST9Y_FMS6A/9!'H
M/&:E9%I ,N4>5CPJ'0^C7,&G-23D1(.B,AL$E*K.1Z.*/D1RGZHJ^0?N2[5X
M.X05#;[]\%>C+,MSU-*H\3* XS83_P!'SZK_ -C[PF=9N7-L&/'?C.IO/$ID
MR$)* E7#J'VM3LG6;??=ND!>M(O-)];7YUR%>91^/3W"QG!=2NR,OAD1D'H"
M_K0<+UY>; 4^XL^W9Q5DWC7HIYW*2;Q!FR QYD7!.QR8XFZ9NF2WVP=ZR+K*
M\A,4H_'KZ;*B)$;;2F<=V+W#_;$R D6_IZV!37^\1.?5<3G'E>3*-6<J1$IL
M(-1D>V-9-NT.Q()OTHP^U[364^8(O7_'Y[6D4IL@M;CV8VXV;>@JOM906XNX
M8!A=P,H1[E@%S1LO#P[<NF9B$EKSST"(!V:9!:/,V:R^AJ"1!'AH1:A:#U1Y
M"N:4>L)]=<&K,Q8=;SJ'>7!UF1.+^@"U/GK=CE0J^JQLDJSEXE) :8%0;);:
M@\N0Z^LQ&F&\:>L'#I%1QTF\#"WUXR]63WRKXLCZCU>>^EZ%%V^B9F+>XCP(
MU$9-8_DB_P"I(5)6M@/'01_/']=S^;QI)Z6=)_JA%!DN0Y2[55604"#[>\->
MZ^+E#?N&V5B%<PZ!2*'!I2GZ2L1R3D$=E/B^T8$N+.KR^R9$3YD++U9+V1OM
M%L$9,](L6YS]4=%-=-4 ]-F>"O:L9Z%L:1*30T"C=J1"<P2/27U'8!",,Y&O
M0]*A)?([)_6ID%LAU'UK@AY][T]!R;146L2<O&P<MHJ[03#;&OX^O5K:7\6'
M^V4XZF6I9^\'MQUZ>M5P$ZFC;\A[^RA;_48<23]F=C17C$L[CK9CMCIAPQ<=
M".T.N?AUR$F>6?&ED5!#?8O]X%W(XH0O?S=2(>7WI$K5E$OE[<_ :2DU>SHD
M+TB47DPJ8P=TWX*,2+!OSM_IRW^EWVLATFF%8(QY\_(C?-.UA=TS_;$C;5XP
M>>RQL)9WQ/*/#>4[P/'*\CU&WJM!%U!+R210!2E?LB!&*K,%7S8T])-%1BGZ
MT260"82GD[W=8<ICD G?9]E4<1L2;-9A+1WI20BW5S5U-_R'UI?O*C(-%GXZ
M31L>(\QBBL<[:.G:#I/E1<,VU^GJ<+KA;3U!YT]036^:A=4%8KJ$4K)8Z(#7
MTX6FQQH1A!+S\0/V=Y\-02-\*J\'=3^Q3? 6;I_6;=$HVS11=;<I<Z2T'-8G
M^/GV?((M#R>H7(04G@2:+84%.>NI9/CW5]E/&_K>FK*];Q^;%CW.P8>>6M:D
M$7_2-=I$5&H%V2['M7*ZK1P&WVYY/]55)"IK<SZ762\4)%/0+F]Q@6]+NDKJ
M>4T9]#4%**NK2.BHGW)R->(OZCCDL#=&X\+0<1%N9=N5%.4%G:N@G7S;7GHJ
MR/!\?:PUC8->'R'N"0V;#05@6C.WTD$^:1'L E*@@-.:S/KF7FHLYIYCRF+9
MNN>6[L5VBW1^=GTDIV%;)S^/3W''J:C$5K0[89PZU@'E<](1#[U9.RK60>CX
MO2%T0J\9=,74LFP22&8R6G1:(NW*P24QM\BX8I&1R;EZQTS<AMW?XZO4GZEZ
M>( 6:D&D4H%^T[$KDK%_1]CC8?*/1]\KT$9KJ:HC69W]3#[ L@4M!)/"['?8
MK:_;A)#OEW]382,1\]^X)U;3VU+$JZ3&(=*;:GLE@]*L?9\EKKNB"QH9YE8P
M&UI1**Y=IM) )C3*O)8DYCXCDMI@L15X:MGJ9AZY1"$8#X ];5?$8O#^:XD$
MKI*%/&HZ3><XAZPD==N+2>-IG[8)-)U'YTUD[1>,"FI6V(.?5&N'[%9QIMSW
MVFH\"-&JX;U_<#]RI0XN:.VQ.Y5?)[]L89+Y[&_3T]B.C]9$/QXQ"K6+")H%
MV9^&Q F\]=QOHVB]ZC6WO#WKHNK\FW3CC G,=0GM!G^.GFF'L3#%+;3MI%9*
M,:M2;,#ZU&=6^A(5FQ,LWNS8GN=<P_I77<8;SE*%*-_E8<J\,=['X$ TQX*]
MWB85!R]AV+)VMVUHCYCC]<2/?HJ?20!$045]9>C)%=+E]&DS+.+37;[S).HN
M(53+LGBI5JPX':[X^T35P)(\O>(KZC]=>WX]:]?.XX;O_P DTY1W#B1>CY+<
M9*TK?A4)]"@K3LI24$'BAJ!QBP9/9;%\S1X7;+_!==TJT9.>UD=!"!/P)[F#
MPXW75:*R.'R!C43^&Q>X1?JF;L0#>IM>,QU01;R^ K[]975C,DB_HGCF3H2[
MA#C;;AALFB0Z>OEF*87$_(-Y,]!SV"^?(-Y5,S076]:-+%"2F!1*UEXA-'A0
MS%!@VH)TE.IL>35*<5D99/NU>WK]V^07)I$4&S]RQ30Z"HA'P)[['V['#(VP
MY.G$'%NRF:)$Z^M"-1E_%)@9NX',#]SS=L1'#1<GU8=>-],W;1H%*+\Z9N1V
MQS=H5562!(/!WK>0QJ%=D:Q/.K;K:?28^:MI[[/GAM2T;5DGGGUQ5*?HR#PD
MF91C]5B!TSM6)%-LN.FA;3!%48F/^U$,]OPVF6>%/9(,GV JES,6CQ& QIM!
M+E<>KK 4'P",I>:I!$;5H\U CAQ\[ETLLWT00=2-*5+)N_I;-(O^WK=R 8-5
M0^T_X+]KQAF:C53S26I0+3)L7ZCQ7TY9*IR5N"=*>>@UN1)M.#9<[)XJ3MB8
M026,D#'#C?Z.0-]F$-(*N%E<"U$SH*\C/DZJH1'JJE(%E%K]W-IYYG2]82\C
M-IA1.RT\Z%UI_>%>EFKD<3%%SH.1*!4C70-%J&ZCZ!)9EOCM0.:$&_&O^0@%
M&X9!C4@,MPH[SDE 1 B/W>+>U]"F[BD+)A\XIN=)GFVS%B)3JQY B07,(!^^
MBNWJ+UT_'N13?CL+<0KQK[NC\LJP2VL14!6LGLPZK?&]6U("2\.KRG98RN'S
M9U6H#C?+7?,NF"+B)RP:V59)+15=-!7ZR*7TL".?-?@#V+PYK4/Z@FEGG8,/
MLV%R"_PSCT280$V:<BU >EHW+;6C.ZZ.-)DN(G-NS6'/U&9$F/7(;%MEW(9G
MV,YZ=A,GE>K_ %_8WAOU"3<VO+FUW6F)EU,^9)O*#L_BSA6GZ*!D*=I*UW;6
M1#TI174Z] [%$)F6,IC]$D5Y&W<\\K:9M=8&;\L^,;9C/J>O_04Y@1.N:\A$
M?]-@:LJJ37]*+AE%)A+.!^1A8V/N#B\E."9(RF\PK:?2+IKIV2:AM%FW/*FE
MNDTF0=EL!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#\YS/\ *)ZD(T0]ET2B
M53L1>H(PA0*7S*42*46&UM^6_C]F'L>/30TQ'Q0%#BT5C9>,<B7+/E%)<DDX
M^YUMOI#:#D/N&_E&O:CZM7$20=4UQRVOH=(X([&'[),-KW/VA ?.T?O$C>=C
M !D19, 'GF>E"W0MBX:L.'#)$D&<Z4<[?[9MPE&U/R/^Q*WD=J1]&K?,AI.K
M2'H",O"*LMM 9V8/^9_+]8>H)P4;C.0I#[$-+1TT>1X8V[<J.&"Z2!)=5PG\
M['80]=GY@+G>2^TJVI=*D(UVTB\HE$'L21+2!^UA?[GO1/FZJK+&3]D=X&;/
MZ(![?+)+NV@P>+".Q>_H/RR>^G"(2K'ORGV(*,[$+QRKR8J+V$RAAN.2BQG_
M '>%JJ69Z,N^I@DIHD(PCHT5(H#4S:O$GIG:R*BO0UH42VNAV*^Y?!8"B/>U
MV3>A_1MD656-8MIQ4GD>IO7,.C];226EP)L'<U*SFS8[7IUP="-"^SP(U7[I
MDX(,T=H/FSM%1)NBIQVGL*[6G^8DV,DI@/57/E=^ ""9>?\ VZL"Z'S")2'J
M!>4Z*]+%8'&BT:'E&3^=2%:VG AFGPJIIHV9_?=(N>D^V:@6K]/?D82\ZBP)
M8M$XW'?VO\;6#Z3BH2SI1^QYY_8$3E-*@AE.<M%$MZ>G'*%L=_=I-?JO$G#7
MCGA'KGO>]!5:9?D=]5.W<78C0WGRMA<ZO(&.B$E>EI6>5'597OY,Z^\268+L
M%(N.'!VQFQ8]-V;]F[8*\<A=]NT/F57Y:NL"SOX[?1EM>DXM=1PO(]=.FL3\
M[%*Z82M)E(VD/(V%YKA4U)<FW<?80@A*FKF8%U7CK_&9*J\]])H]-^?E^4(J
MC%\^JE_*OC.PR5XA",E->[F%*WO(OW81]D4MJ(N?9<MI% #'FK<CN/UB(5!,
M.>G'V[0B1VBW1;I.TN^EW*H??ZU](7%7GI:F'*%X05M4\:<@N)72-16Q#(]<
M5N&)YZQ8TY'4P\(G-)V:1M-K!H\/TQD(0'((L]T47((\.4E=,-8&/_';ZBOR
MU+$N*$V-.2%G-HS1<>L>73/1NBI1!(W=A:R[<B):/4V^I-9R]%5 2!PA)<,)
MFGTI<V28==O44UU7&U ]'XOYI[%F<1IR[[]F5B=4C:7E2K)"9(WU.//AMY-/
M0UD.H&]C,DIAE3D=#/X/7Y<44)MEA,B=[?.'A(2W:M$UF[OM<.>M#?D,]F30
M#XKJR0VZX>V(AZ]JRP/0<YW$HDW>V+Y!]'V^Q@E#0%TBC&T0 OD[()Z;![>C
M4FQ-355N>MK:[77[4#K'^2>[YM"HGX_6J&SW$6!W+Z6_9*12*(VO4U5\2F#:
M\S>B+('LQUMVI%9U!08]U)H0*?<]\-.G!/AMIHW5YVX^.PK1*OR?2.A;'\QT
M>P[A%O-I@YH6)6,2DUJL)?8C20>@)//P(<BI:\/C41J,XSC;J+\]:Z!BS';]
MLDZ^XX%?;\*N0@Q#\R5\O8S";8<1JGDQ\(C7IB07/3,5*/"SZ7NHIYWK6XZA
M"0FSN5I#""23)26D'SXN"*EF+^-L.R*B3%32H]L$R*?E6]);@LS/M*:I'LK4
MM-^K[CF3MY8GW02=C?/R-$I183"TZ[D5FMH8\DYB]$VA;14H07%:#**IHN.'
MR'T@Z*T_.+2]&P#T57%F&D:DLFG+N)4X6G?G4XISITF.A%66\).Q16R8L>[#
M.7("QFXH@@\9/>>E&[A5'KGA9+20<P::]A^AZRIGPV]ZG)_T':WK:@:AG! S
M>\K "H>%F]QWSY.I5V\0"UE6,?><@8XE;SXHT;I*?4ZZX[:==;TXX<-@^Y3\
MO?H<+%8_W*:1J'F56<G6?$!)Q67&G\,AW4@L;T=5\I(62O-WM=-5VI,[YS54
MCZ*947]5S(F@U9?M=O\ 7>!-GI_V[Z":^0O)5]UXXK^E"MZ#K><6*,,EX_8&
MF.PGBGTY;L985O,A#@K$"KQ:>UB/?B'7/2O!#?#5#OCI%9TCT$%R_P#+/Z6I
MV/BJ_F515#*+B&\(%B<R93K]G:I+QIIYKJ6^TP#PS8!:NT MCR#=D+M-N/N>
MVB+$0[*ICUD^.V"(3[^1OWQ;-*U6V'U7U6U02^9>3YU?R4MM^7-&)%H1%OZ^
MC+.M:?X:,S$6FUO#"-A</?IK].1ZFVS5#2*J9#[EH$5:_,R7&7)=0(I#JS-T
MG38*16Q+9_&"LQ1+PVB*Q]-A//%R2XJ)+CN#<B=P,5(OVH>+Z$!F23<(2:-=
MD>.4'_83O>GL#T%'JI_'=:#4I2/GN4>D+(/]3J.WO+'(*I@L4+>6K\MR*16=
M2KL8D<9R 8K%@ZBZ;/MEO9I#M+ZO;;GI)8*43K\R7HFQJZNQ2I*7C=0$V'G2
M>'8R7G\GC;F:5_/Q_C-GZF86-W$R<@8'YK!VWZKR+'-48MUIQ\$"ZZ^VFW3!
M )6>?DWO.I![^O/T.F+-E<8(S.DPX^067)%+@$SZF;)JRG2UM>BQ(Z+-= *W
MN$M-^RX59DQ;N$VKX-KX.ME=_9A9/S-^0BV;E]=R_P WR^IX:'!1(W<]?$9&
M%EX)G)F$RH-_'P9Z5JP@Q,W<V>5_99$FH\#<Z#-U!8QT+57=/N2'U40J3'OR
M!>R8S;T_+2<U1]CU[6<IM !8$*&=E@!$9&!OY-)_Y5BG$;^P%NUT;,#UXDT4
M[_55^63MJQ9[41^X?KO4@MKXD_([8'J4U<7<EI1E&XW#Z[(VE$&$9EL7-V"U
M:CI?+HHI64WA+27F9,WGBG48^/+E8<&0_4>'@_IMRJSTLX"$!?Y>3 6 A)W8
M;SR4Y9RZA+9O<=JOKJ,OT8(]C-#B+G@=(V6Z/@QS!E:!115^U7X:N.G+YDR[
M=I#FGR[1V&[0/\B]OQ6H/85GVA7[FV"%66%;Y&OA-4QQ^VA]=02%TC6=G1V(
M7A->DG2\3=/.Y8JM^J*,'2BS+KM?A+OCE)/84Q]4^ZO<$SXDHBF;CH>".*3@
M7I/N36'39,C,ZPMR4A&?BMO%9-"31F/R7K:5;A?6[EH[%*+.&Z$J%=+N%E^$
MD6? 78]]^R+@\YNXI1E?2^N(B=&0CS/)#]B6A+.4;(LSBR?3$5HXQ':3".@>
MP,OF(0>R=/9#VZ2WK7)X8DFDU[=Z=(A61/\ +O=]DV@C"*^0I43&Q%Q^8)!W
M+1^I*1_;.B[<MNY*V-P <.E'#$UJ<GU*Z':$&7(\!]T[)=-DA_/P0<N MUX_
M_)98'H*DO1%T3"D![)I4E&QKT)$HW7\TC$CD$E#2R%SV8-ZE)!1$HEQP;/P>
MH/RU_4'C08D56(\Z2'-E&KA' U^B?R+7A<MW5110T+YAE#J5G43LPMBK)_,)
MK5Z-=]U-&+8?Q2&.DQZ*Q&X0#8]RR>).G";'AF\'%.N$ON]CDP[/8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# Y]0KWS^/6>EX_#H?:U?$7,H(@&8)'<#E
M J//E9(,/@(>4_7BL,81AL!E3:.E0@8JLY3'$W8]X+:+JNFZ[;@/NY]K_C]=
M!RUFI3F"O?NN0\ >OVU7RQ[.)#'W4?)3N/I#HRA!5I[+:Q<Q0&]-,BK-D[C:
M@UBX>).=H(*J<!K*WY%/%ZTGLM@8-QT7%ZW/GP\SL*1@^D8^=4?5]Y_/H2&!
MJ(!R*EF1J7!O0,?&=OA_2N^^ND>>N%&KEFJL&<4]B_CN67 N'$OK3[Z\2G$2
M5T\JR0)$RQHC87]WQM&K6;N8+P_A!,Q93#N)-F<MY&JO"+15BEPITW4XX#,W
MQZH\F^?[5J>N).,C).Y)#,:[KZ,!0T1;+$H&*OR6/HRF7*2W8?\ 9Z$"C' L
MJ068."#-\99"WBC9!S]%3X!AFWY&/%3(Y PL<F&^^Y[-FM6NB"-=2V),82T'
MTE/KTC<EL#J41J-NH_5)&N8,_7#'>TNPKE'OM9NMMF@]<-@W"IQ7B3TT]C%F
MU7&8+*EZ/>2$ %8<PDI#.841L ?!)8X=D:UD@*-]H.SP< ")ARCL7O?;/Z;D
M>O\ 26Z[["&))^0_R8?G+6N9:+AARTHW[-7\DC:[D1^L"=AA3KA+[)];P^)$
MBZ\C&P#H.X[46<IM^'.V7S;ZY^3XX$K!_9G@Z?M#0[FP:^4;!P\B,F1$T@AZ
M*=)1@3%N[P+R'H1.HB$6>10E$PZTG:$$TE&!=N/7>-%7&VBW:02;57ISS!8$
M^?575,XC+V;)B%B_847'3(%L78QQK'VYEN$,O@(N/R@I!49$-;&1[!TZ?1]1
MRDW?(M5-_3T&IFO:/C..@0SE[9\15'/_ (2*. 0D6D4C.D2/%DGH'K<?@\<C
M)23D)9S9D:+M=,FK'LI]V*(+?2^5D[52#ZE/5'AUX"%6=W8U1/@47*<$@4TY
M%-WJ  S8E4%KX5(A2W =50:1E-4,'IUVNWZX46;IJZ7Z^M\R>!]Q7UKX^J>L
MX9<;V4"89!?0L@,D8:0'U?.&9ZU9*G'CLI.%T(4(A&YR>)K1"'ORJSQ<=UVL
M)9=._GZ;<Z5P,,9]X>(03 F&6M6,$Q$,(P07IA$X1,IN'_5C<'87'"AT-3AD
M0/#I21'UKRUE6T0OWBH<%I(FXTV:?(O@>U'V'X82/"HTRMBI53KLA"10Q@*8
M<O%$TBRM>&*X,[6'!UFX^&$GE\1Q<(=4[2"+.9(AMJZVJOU@;)8-U^1F-/MY
M7/2,$.5"+L8K4X(?U!'LY9/K.A4FD5?$X5!H&(C)TQ)Y& /QDLST@&'.^TTF
M#I3C_P"ET55.0B??KO\ '1%W[)QJ8U( YB-8G)X!E2=;D1T6&UW%8B.O:2)1
M"?)PQ**.'<;AI-O*GP(8_4*,VO?WJK3CY>N^0^@%Z\\9/+EI#SS6P0(:F=JS
M27.AHH95Q&(,X#(-T7+KB/G)'S)8E'VPF;%H*V21(B^.M25%O(6BKUJFT<_4
MV'M:>P_$4$/(4N=-UE7AA*82FK D)$1I0F":L5+;YJ=7LVO%HHK%J_ 2BU^4
M!:W)95DSV:51;J*=KJ)?,&\F?:/G^ >F9!Y@F;_J!SQR)J"3##3\,^_9:9E[
MH>6/'(R,=R04.="(\=5<U*JR;]'7#']476;M6/3A;GI+D-)[]^>"&P-N9[L8
M$BUCQV.0P*'_ '36/S*^7QN&R&W(<G#H)JOOVR+QX["*T)GQ)$4/7%/68-=P
MV7[TUZZX#ZW?L+QI-K7J+S7%]PVW2U_N%@2;0'%&YJ!-8XA2DE].C7!P\^"_
ML6<;O8LS8O\ D0V=.23;<B8/EFJ;=QI?8;K+/6WBY)!2(2&P:U+NXNR?FV$$
M?"?OGC+N'7;QYA_^ID?=!U?LWPV^'2<2;ZX2Y4X)*ZX3_P EOY\"'8-[\\$W
M=248M8R^C_ T\VJ"2NJ[DM5R*33H;*9O7SJ=P-(7"!T+,&YTX%10$45:'(\U
M)BN6@-^LW>;;LG':032*]6>+;PLZ.4X-G]=V?/>UVY.(,%(T]DP%4N1JP5;+
M1",S9W'W4&5E;^FI6W/I,FA+9-8 X[<\I;;\K=<A&UZ6#^/F202=Q&T)5#A<
M<L,U8X*QA<.0E$<EMC$:SM.!5A;=?GDZ['-)S,5#]BR(!&"H+6EUI5HJW8\(
MO47///02TAZ2\>7#&F/"LUKB=QER\J=D@+.@%"+9F7NBP9)4%7!R( \$VL$D
M)^RHD5 ;8.VZ#T>28+MWB;?M/KG0?.?W_P"0H)<Z$$L>00./6U(@&XFN8D<,
M>I,>PCV-R6=IP216NXC?4+$J$XG$RA9$"1,(.'3)HJX3;=IZ^;81DR]P?C])
MJLYFWGT([*V.28QEP2<5?,&LL*-8ZE"R@DQ,V;V"H2<-7(=O/X^Z:2,TDVC:
M*1A@JD]URY0Z[#+=>W/"08Q/)PVL>%<2H81C<+D9T) I2_FLX4(GSD4BX^%=
M!H<YE%T@E)%%23-LXC?)L>FL/<<Z4Y^BI\H;[7U]^2[(LL]6-<G83([ )"F,
MTD;0/"R'+(KR2 PJ>-^BDM[C:$7)RWF,S  86&*/U#+9D^:.EF_"?:?>!6"!
M?DP\5IW*=KYF.(U<5EDNGP,U.#59EHN/E-BUUZ$>^927$F?C@';E)H1G7#3E
ME(3': OK@HV;*.4GO2C5,+!PVZ_$]C\6;'(<^J^0-JK>';7G0M& =I#N7 U_
M(0D@M6/)OHNV86"@B7CY)@O(@/ZHET\04;[<[6W\FP^*?LWQ""XEY)K<M3#M
M(NA24U=#M)\*N':U# KQ Z,],1NUB:CFAB8PDQWW]7ZK)PU:([VX42;;"$V'
MY /!X"=P2F6:\;C,2DD(-%(R;[KLC'(=&R.K@%UG*J^F$9<15@7J,DUGST9T
M3ZD;$,/3<O67UE=*KH?,%@KK]$>7X3/FT!LDG#BUNQ6%%;.CL>-QIV55C8KH
M),BK,@^F?4=+1RME98RK4SRP[(/&*Q+D2Y^WX7^W[YY"O$.]X> 2@N:D2R4:
MKU$1;!B+2;HY5)#EB9E45"UI:4KL_;X1$WB3FM8L1GX5R]FY'EH'9/NV[ARZ
M0VLU44"S\YOGR_YGD(2*RLY&*S+6J>'%^?T:%F.1)$Y-I6&@XF3SN0Q*-O(]
M%]2Z:&V0MN6D#IDB_(+<(<+J*:WSH(=B7N'\?@T=*%H-8<"&M:_-)IO&$7K>
M5,'[T_.IX;KE?JO00N$(E+()'+%BQ 2^[C+<KWHDP62<[Y[2ZUH+$^9K^BOJ
M.BZ]OV#LG["(V4-(&(\@3[:J/%!;0X4"MGO?;-15#:)+D9]REK6_FTDKSKO7
M/?S<Z"=L!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#F!%_ 'F*05NSB8FUY!
M-X+!8SYRIZ0.&$OAY%GIIXOGEMRQE'I*3!#.$Q1E^4MLHRDB7/;99LFW1TCR
MS6X[[[" 8O\ AG\J%8&!%P^ST) 3@!L,E#)T.JGRA(&XF-L*U(0ME%IA&65,
MJ0>QS#^'3+1/LT>9NR^B735\W411[50<A/[G\5].+']D4;"LEB!9$X68CD1&
MH0 8)C;Z(@/)\<4T/V-A;/>F)IAXXBF^VO/*;9GVN_TTX03613;A EQ?CRG;
MN_&R%(V\ B4!N*X8#<GH9C(9R(U-)@XJ;UZZ]>=QAC7JM12-<T$CKB=+#AC@
M5)(H\:H&N?U=0DARUXV%PKJ\"Q2Y;>7M35QV_7;0_)*:FL_@T#=PUH%FLUH%
MZ2<U=)^SIF(&9G%B =$I]-QH019)NNF#%7X<*-U.G 53KG\.7GIE$Y*S:7E9
ME@#;!,"D9\9X_=5PWF8R,T9?_E*7@2+R)PD?VX.2VN;W.HG#2KA<[N1M4WNG
M*7?"C?87'\I>-(IY#8K!8=82[_N4'-E),EJM*)KW<U1"Q!C%HTP?,:MK:$<+
MN(XS'[?K/>==/7CYROTJIIKM)JB&-*_C]J,LS,(]2&;#R)GUN]]B=R04O'F,
MG'S][O>_T 2<3 ;>L(PSZWKIOOGK;]'OGGK3CXZU@4[9?AH\R1>$RZ$32];6
M?.[-FWGDR<DKTO6$+D1MS4[>:UNE&U7 .$B>Y!WZ"KRT#,2F:[_[XI(DC#G:
M*Z"ZJ>DPMO2WX\:?HST?.O1D2(N%BDQD%KRYI''L%J--:/2:\),A+[*>(64/
MK]G;Q@4^/\+J#QKTZLR&I/ET.>%$>6?#0(8A/XVG*$W]!7 0L$M45MV#ZSY]
M TN>K L.GC:FX\ ADVA+2/-A]FP;J/$F5H$;CL:4R,1V,[9LS$^><M'"BS5!
M]T&/W^(NFW(K46"WI=S6MU6J2LCAB#RLB2,GLX?2%D^=3%DG)*XKU61)'RD6
ML9Z[?#&CEH&X/-DG";1%/2C;L+ ^D_*<ZL]SY)4K2["M)-O-4JEIPO8 QE%"
MTTW'2GGJQJ<12$#YI#Y9!W;M9>8)+N^WS1'A!-+I='K2J?"?81W&OQT5!#(5
M!4:!NFQ*H*1R>,+$IVR(R^KR9O!#,CYE@_FM]'1;2;1.3Q281^2U17[8AI9T
MU<N^"^OOD5](\?0V$33C\7]=0R.6:QIJ=EB%NVAY*Y\C0F&VO8# -#GE/UG$
M(S&Z>'Z5#08_*V*_GF1[>R]H:%M%##D](R'WB_2+AAR/"U;?Q&'%^=/-=)12
MTIM!YCY<<1225[=,?814G*G-C"8)*H!,YO)0,S"2>*R1U9XBP9%V91>-5?J.
M3"KA+M-QPDKP%79=^&^J9_/C5@SOT+Z*FYPM$;!B')28$ZXD,J396E0SB@IG
MMS-W]>=R=<=V$7Z+C1**[4*--+N%4VG22O*206E8^'8R,]+#?0HZUK.:B!5L
MRZ^6U*<\PA2N]W%/:0?T!+)<J45B'=A=M"$)>:72&?K.F+8KTLXXX^1;2*8:
M@1_&[41(M<!A6:V.FO=!UH?D223V.:1'.F?IASZCX1#ZZCO7:;?J9NNF&]+;
M6Z_2_P#$^/U_BM@2C:7C2!6O-)S.2TNGH,O/2/ETF0_9HD+';%.O*-B2^RH&
MN"=]B'#Y@Y*G)DOR^6VIVISP@CTVV@KQOOH*T>=/Q.5)YVG ^QAUL6O-):T-
M18\\(2)O78_];)PZE+XH864/*1B$!2!R0%(A?I)Z7*/7#DB3-M$'*BW*>^V_
M0;!0'XZ:MIR:U)):XO>T#L%H63=G1-5+O:U*Q!S<8SSBKY,E<LDIH="TIGR8
M=P5'2[D.F3;L&1[IPOP@GPK]NF'VG/Q7>>3WHQWZ6<G[(0ECR\6UYJ1IL9"\
MPO1-O7+B+=0OD8I'U'NX(YLWM&R56>W.U.YVV3>_5^CK;;8:997XH//LBBM?
M+F)_)A3RBZLH.!0Z63$'4LYCP*-^;ZXN&MVIF4Q&QX*<@1ON2PNY2RA51XTY
M2:/6K1VS^TZ04TL$[5)X9I>I']8NX5*Y)TU@MN)7O$!7U84S%D2C;R&(\=_9
MI#(Q& 0GB+\U\@D4^F-;M$DB[CXI?39]<-=!#'?XXDYG>WK>\9=*5Z\/VY8E
M"RNAGM;F$)(^J4G02H&3<V:F+FL,YB;*47#.P3!25@=LB@Q\/!L_J.U7*RJB
M(9<'^,"% )8"E;*^KLZ5<SNJ[8N <LC5VVEXVM47I"=^IHY,I2JG7:;R)I/K
M.LXUI\-C:@@>J-[:-DTTM-?F5#Y>COQ;4YZ=O;N[[5LBT'S'2@IU^[W3B'+1
MT8FQK67U.:"QR1%8J_F\+A<HB,V?.2(L028I+G>M$>^]]_%/89L5X$.<%XK/
MN/:?I4A80V-/:[>V*W_<RV>G:++]UZ[[K00/&U:C'8?]=W6[%]^T09LT.]OG
MY%?3G7+ANFT"&0WX9//\9@L\KZ,RQ\. 296-LXT@^ISS8?[C,5C,S)S=E$I$
M],4ZZ,6LSV1(IH</I&[>E6J(YBNW=(D$%'RX3=2/XWJ^HR]8=>H*W+BDAF%U
MB(K-%G*B$2<%IDR$5]&JX;O;:GX>)AI[;R#87%TB+)E(GY!N+..%W33Z/&T$
M$ QROX[ZB,R*[&;VW)X4?V,L=*DHVB\@Z3R!@;(]-D?5:K-H@UC>B2HXA:Z1
MA-BY)?74Z&**M>>^^FW*O(;3Y2_'U2_C*2SF6P<OMT-.@GD7#LC<*J($M$H2
M\E)"7N01.=Q:!1R>3[7!!ZFWX=R,J15TQ8MN>]]N.5G*X5M$?A"\H"@\K!=2
MNWR8Z5U%+ZE50+G(H32')'KI:W#%YJW:/8<N/?S"LF8,+$ O3Y%TPW#0;48\
M;.N-K]+!E5_Q0T['![)![?$VAH"5A7]7V^ BL2\^5;"[KCE@6@ F'<*>@8O5
M85A$GALT*8 6C@#TS,+C5U6^W"SM=-RD$^>E?QZ5[Z<N2.W%*+#GT4) H.]@
MBHZ%LH&+?/1#D=-AW;+B>*Q!Q8S2-ETYVXV: ?JJ@ S]HT^LSYWPOTX"")I^
M'2C9L31)D["F#KINZD3-NA)8'1=BM6<+G4!I*$S^+,&-DU;+13-Z;=4.)*LC
M'+;9(4Z=/4$N^V:W+=,)5]3> Z@]DV/!C4CN2;!=U:$@':5<1)[7IL(.ZA=K
M-K%A4N&")5%Y.[@9PM*H*J*)%!FFCHP)']C]+):;==<A]+W\9U<I;K4O$K9M
M:&SJFAFT*OG _P#88L_C)CJTYA9RQQ<,>B!&/'.WW$]+ W+5TV[;*"'>_EY3
M=\).N MWYPHP'YJI. T?')')Y>(@(Y\Q0E,T6$N)6?7)FB9\@5/+ A((-V1>
M$BRW??VS-LCKX_#E/G7\F!-V P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P/J71
MY<(+(=]*\<+I*(]=H+*MU^>5.-\==(N$.TUD%>==?'GOCKGKG?\ +K>MZP/S
M;U/XO]PT[7M74]%X[=;%(?$*S; 'S/T.!?4C"1I"96::]=1>^X47L!8K:\QM
M8+(DDX^0T-D'+9=X.^V>!OTMVJH'CA'D?\@U2PM*.Q&(VR"?/8\R[K-O45ZP
M:#1R!>C!U.>3(3'K4]",>)N)1LVF!*%<'!RX?E"1<=H,'R>PR_91@Y3"R]1T
MQ^4 ?ZNBC.QY]+W/EP79\@CQ<WU:0)Z5>5#Y]5EDXH>8N1:!):0O9'Z:/W'Q
M'9JAWKI?],KEK]WK2;I+:@1C<7@_T?(_2GJ:R*]'W9%'!,CZQM"H+"B7H5:)
M)F;"L/R3X[A5*#@.VT_X/ 1;6WZ:.)%!+MH/"*Z'#?O>'8[E!/D+$>2JQ_(&
M%]ASN:>B)A8;NNWF[=Z=MMD(\^I20QX[((R[HT;#A7[_ "4/8_)X3&FR[9]^
MFUU$=:=)O]OB!?3MHX["*(KYM_(4UD*\R(S*Y!)>.6A56H5'0]\B1L$4KTSZ
M,].D+Q?&8&@6(00^1<4O,HGTFH:%DEFZC1GMDC]VT7YZ"KR?DW\E!VN8.4/!
MO0JMP5HR]816KK%?^CF+&SQINX?+\&C@&>S,>[]$6?%QC5K;47)M&JHXZ39?
MJ+O@HT"!&#G39N%KKAJS\D(TK9%24(G=7,5%65:DLKBWSE_Q4FQ)T^=\<!H/
M"*T9FIS.CEH]V A>K(LNV=FQO3$.;79F.W2R7?7201P_\L^OWET1VVJE@'HZ
MOWCZ'P&&0\CZ#],1ZXBL!C<,]>"K(+,K89=V7*^"+0C"RSA\-:).9<12%,UF
M*I3AQT@SY#(P7S5[[F?<)CTH->NZTK!%@)W:(Z4>NV[RT)!<XGS+?(2>SF,V
M%7ME%SHBDYC>9B#KAP;0B/1Y*#%GV@XL<HJW6"</(%??D&BWJ]A)+]YLR1UQ
M(J)B;2?EIK:()S"8M8;.HJ29NV5<Q"&V<9C<@7(6<"DW3O2T&CI 8NY>N=GS
M3-ZR02"NT;\P^ZJX,$8O7H+T2&9\WG:$HJ*0#O1X+FKX7*)I[TM*WIY:%Y1@
MM:#@Q:-76/YBE<>:BQ"HTTY9D61IK^E#2#_@FL%K?4]6>RI?Z2*.ZZ2M=_#B
M[>B6E6R&-6W'XSY_@D,%G)5_>KC%^5 _E@DG9,ELF'ODV@%SR#._3<.&'39T
M'Z'.G"P4(K/R#[DB];>8M<59Z0UOS8VICD#5T\]:1$A(&=Z O$'JBFK+L*)3
M$18LGCD=\_DK,F=>CF8OY7'+%)J5?M(X@T6<-G89"$><?RLDP4H&&"EX1<43
MF3U>'/2%Y#D[#BL*EHGQRTEB J32+T#?\W!NM%X;8JZ6E94[WQMTHLW09</D
M&:872MOOT9Y<\)71,'4QG+VQZ%])3:Q_.X.7V>7ETEN^L!-Z*EZC\YR&8*/)
M-*9:I=\%)?L<+0*JNRC=V18[6WM9KSO00,8\[_DS'N.8R)GE\2*T>X8'2#7O
MWZ #BJ$81LIY8D(RU(;)*Q4E:9[NVR/K(PY(1XVE''O8L4J&[;EVK00X']!.
MM,5Y[@LKT; )]<PV^JII$%)^I(X@!>](NW7=/HWYL\_1T)Q,@M26+(FAN+D[
MR$3%[T'Z>.F;U7>W;Y':3OE+8:)ZEH'WR9D=L3&LIE>"D=E7K#ZJL3@]KDE3
M?'F@5Y>BHB"ZJB)H>CO.02'(,_2ZQ-^;X0E ,R^UO2[GDB/1X8*AI:U-_DE0
M&S-B=4]/3.V' F!\NK1BWI:N*ZK"14DPB-"MY_64+K%M+'@B*^J9(] 39LSD
M;<>$;##9+9/B3],5&K-,/L;>>OR$$A5C2#1CTX%C0>(H:H>K7_J)FA:+6!&?
M5)@Q/X!+I6PL0L!.^@"'EK[D;&)$:,DN(XJ3&I:,\DF"I!$-,IOSA[VK"SJ-
M-1&&WZ$KISZ6NJ=2RO)U?L<)C!]<61ZLDDPW*;GE,0O+1*2V2C19E%7EN4%V
MFT*[:IB]]AB>EC3H)6]EUI^2B6>LR4B\YL;2 5F+'D!8PZ!NQH.A<BC)SR]:
MH#?6H>6NF.QN-R05Z&-@^](=P(J6^(] NE)&S?G]-2"';V\E>^EZRMVIF"_J
M:Y:KEU;3L)%8X']6B&-D.;IL'R-6$4$2693Z?V*"=%*-#7@RE_ZQ&EWK@5P0
M,(/4 KT:GI!$+.^N/-GI8R9\L32D 5C;F5:^4K6IV2O*XMH5 %@+R32OR@=D
M4=&<EY>%!,Y1/:OK": X\?X;.TPTE6$NEEF7"2+]J&UMJX]C<^.Y)'D&UY-7
MZ_IL9)X]6I"Z CSU8V\9)VE&"<BJK]^O-@.&"5K$X:W+],7*DQ4?MA#E 7LX
MD^XT[2"L4U\\_D3(PZ82>)&/3D:2<3SS^%%UG)/2>K,L='S2*@YI:R0HY>-7
MG1T=(7%W96P3DX5U,!)I\+8/&+8Z1TLMV4#13?G?\I4PF50161KW6_A[>OAL
M MR6E+O$BQ<T@4O\U6K$I&VEL;B_H=>)!IX"MJ1@T"'8^*R@TZ6&<'&\NWQO
M[/D)5\74%[_KR^*(XL$A=$2I&"5_6,=XB!:51Z6P(95\<\DQ2$$*SG*_7IV0
M(/;*%^C&#\ET1'0$B1<<<H+<RCH:HH.3#6+GIC\H\T]*W<1KWN[(!5<I3M:'
MLB 'T&T2%. 3NQZ.?53+:_T6NI\/AY?5? )3UM,3 XH\!+O5F3L@=[<:==!:
M2=TW[@"^.+@K"LY;8:\\&^JRKVOGYFQG,WMLWY"ZNP,?>QJ.V(8M*#29U*75
M7K$&@S]3F8$SRVXX9_JK%;Z+A,*0E/+?Y+APQ"3CBUO.U9(.H@%:)(;(H\P]
M!RFMX(8]XD(U#=N(YZ[@9=<E6I*UX#V155MCM^1'ZWM<B:6;$&[H,I:GE3WK
M9].W'6%MB/3UN6'):PCJ(N< O3$)K6G3L/CU.5 O^[IW54?L9!AKT 3O&+GE
M7)%NV&L557O3CN3JBU>!>PE"Q//WO9I'%247(^J9#(IF^]IDXD/ >I&HAW5%
MQR*^MK>))G9*9^SV0$E0$#H-HFW*QH9^NM?K]+?J0,L]<<K(AGG?FW\A@XS&
M)"%GMEFI)+K-L8_9_$QN5*45Q'VH#\C=63>C7L1@)R0/!<1BXWR>C(?JL 39
M!RX$ZT/?:5(:;<:"=/-M.>GROF&[ZWF[_P!*T[=$IJR,Q\?:-M^B MM$-^BD
M8 _93BTZE1C!Z6N(!5ZUB\-'K5AM\P:$$?J<H  Z.NTW05<6K#\I$L;0J>S<
M;<T=M&RFSR< H77'HZ(,JI\EW(7O9)WV"N89Q,1;&XZ5 ><@H9FDP'-92V7(
MHGN>&"3TPW>Z##T1XD]<QXM :O(+>@*PH85-Y$E8"D=]*N@LH.B^)/\ D[D_
MWXR:Q:Q"%C?LA)#UIU&_X;IO&CO:OT_JH(_:/^>0U#RU87J9E[F\U4S=L\O*
M4W,"=J+^AF;"XD"5.B*N'?C_  /V4?G=-#3.FO$K9>EG_3Y68(!M!BY=]Q]L
M:>;62', _2-@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#A577Y9;(>P>,R
MY[0@J50G]/B$6>2LM>T4CEA2.T9EXOD/L,&U[!*5=$*N"1?;&-=1]Z5<F!B2
M#EZF]Y:Z;(K<8&"U^66\'YB(E0]-56L@G!["C]@5&5L.R(;,@5Y<^D/&5,P
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M/*T\@'A=V8\'%AEV5/)9RSL+V'9-G4R9M<K7G4*OVN78^_)1+1K)CM@VXE:
MM8J[X<\+=H+Z3#I)[*]&5[9L"O[SI27OBN/*MVUF#0DENV,XB[J=F:VK<,6C
M+>P6,?Y2E,'9LIJMS+A 9=X,)N34:='V>TVZ))T.[T%7*3_'A"[/XJRZ*,]$
MUTM3+.+T$V+0B%TI*QL=/WMX>LKT'*8.^6<3*VREB1N,,O2]HO9)/(R?6)2P
MI*XY\KPXBLY?_,%]?#?DZQ?,H*RBEY7!&/1][VS+&DDL+T$SK0W7,TG3<8P[
M:@0LG8%;0LP4Q 0[;QTB "@.04=!L%]I-1W*RCITY"]> P& P& P& P& P&
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M_P GYJOK3C-*3?RQ8'5EM.8L3N4+6LC[N4;6L4G]GD:R@DC$R&NH88%FMDU
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MQPK7T)F,F="6B//U6:,+D<M<1E]RKUUWR;"OTOAK26M]!:/ 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M:$\G3[ADU2;K&3/($4"!Z*$U$]K./LV31M]7OKZ2*?'PXT&8P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P/@HIPDFHJIUKA-+CI13O?\ @YXXYWUUUO\
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MLHGSVJU55;*+-E5&_>]\==)]]\=;U\>=[U\-X'HP& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P&]?'^3?\NM_P F];_\<"A0GR[^/N-#)3]",U,K&H])5T)$+D=B
M.Y+"X&40C=C@EX6VCTIEY:+US'&L8M&3)?LPS;CQ"2!1SUIES_)UR&ES;S%^
M.B-_NBI^;QD01)V'-UF%;A2MEVI,)I*WDKKYYP]!F9"K-C$R-5'(Z]I_3%R*
M,/%H<\:AFS-1OW\C=+ FU]X_\?C6%G!"M:PYFQMUD57L!B3D1M+1!@8L\O:3
MIR*Y>2'2D.;MKAF3LZS5#;'Z''W^W37:+GKGO CZ$5#X"83N6>>XI'(+^\(
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MLS'KEV4PL%@D7?"SJCEOT6:I.=(\KH)]\!]SWR=X)X*V5.WD5KMH0'SP5,K
M/ZLHX/;5Y.A$Y_>ERY:=HS-N/I]P7G[[9HNR&<B&YQ\XZ6(HNNE>M]!K<H\D
M?CGA)NO1,KKNMP;R[A?= 5G&7\DDW,<F_7[C2$65%1B*<R'N*;FKKS] 5@ZD
MB1:IG'(%GRPZ?]IJ)HJ!),D\K^+KG?$+5-0N"332TT(S232@9,R^XU(9..XK
MU@53GB<?D[>,3 .P5IV.;<!S*3P4D[!MU>VVET]][#^S/SIXOO2UPUHRD% Y
MQ:*(BNYR.?#[!*\;*":GE1$[5T^(12.RQI'I-J 2HH\V&-O&+I1@HY6117XX
M443Z"+H_X=_'&Q@L8AL5A4 :127E0?%<O8_;\Q0.N%X!&Y)#@4:J:>CK"XF(
M:.Q>)R0V.3!1TBW%H,BA%';72;QWRJ&^AO,7AZP1A27L:9KENE8M.0?S04VZ
M#.8B74J6K7!&3UU6/ E1421BW4'5<=$Q6FR3,FRY1;.4E.=-6O:0;X*HGS(=
MH!Q6HIF+DM%$3',Z>%.+,E4DZ(R2.SEK8?,Y>6VM,'\S?20'/8\B1_5E#7;Q
ML[9<;^MS]+6N0\5)TKY&IR4/)=20FO0$DN5DMV->AIDJ=T>CJ1>0S1P&K0>2
MD1<?'X,F=,$RG8J-(LP^G2JSC:'SZWWH(S,^-_Q[E8Q,J^=UY4XT!$K!LRY[
M"$Q^:/H@^C4PO#DB0MHW-",8E08X' 6>R=K<FA;Y=,(38\<(K-NVR*7"89<K
MY#\-RZ2(J*1"&ZDDQ6+6@T812RY3&%Y*$D(*"1N3.F0.(340W*U5*Q-?1_DN
M'20[BY98:V7=M5E^=*;#8+9H[QCZ.-UI8=HCJYGI3E7F)UP>3G[I@QE?8N6B
M)JUBB*49E(P/8R0*<0QJ4:#GB9'@>38_<(II+<]];#51WB'P:<3L#ME6, DZ
M:Q&1!)VHO-)!*=1K;F,V7&#T%Y4>RPE^[Z,#HY<\I2YC;+8\4-_7G:J+1%57
MZF!!/K3P/Y;]@/QIA:V(Y!1,TFLB$6;N(.H:1(6X=DC6HXF<CC26.2&B@B5J
M"*>CPO;#CM^,WML@LJ)4(MV3MN%R9967ENY9G$;ADB,$F<K@C9=K&98TFBG3
M9DVKRPX9:"Z3M +(&X,UQ K(@X<K_P#3R+G])?-M=:^C]572@:^.\F^1WTOB
M=@ (1'>)*,>EIF%?1>;2<>.DBW5I'[<<&)," RIM'K)'@+=GA$VPT::DVH4L
M4549\MNUM_$-CY@?EB76VTLU!.M)!<+PN-VQ.L94S?2-V;KJO[#B;))JQ9FN
M^'#Z*UU>TA043X0WTBQ/]J*Z_P 9'OD*RD?.?XS7!.N("BQKUH7LLAJ%U>.@
MULS<,0./Z+I1&O3,9C!:"3ADX8;"46":AY$U2<(<F!+!DW*\N_MVG/ 2R;JW
MQ )AJTQ6CM9OXL4:7B^&JQPMV:U*=VG'TP=V#H<.!%G*TF*2X( X9.& Q-9?
MXH:203X4_DV$?SWSW^/"-ZL'J71:*\\3G<)HZPX>+F4[(M&A#T 2@5*19)[6
ML=D[AC!)A/W>@0U:2MQH\RLFEPLX?_*FHKH+Z18S%S K7,1/BY$,".%HXL[%
MGDI'IH1"?(S>"R)/AZ07[,,.^-<.>7"O3G2G_P!M_P ;>][#8\!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,#X]ZZWQWKCK7'>^>M<=[Y^?7'6];USUOCX\_-KG?
M\OP^.OC@< J._#I/8S;@"P;OFM$V'&Q\KHD](X&+K%!K%94M2 KUDPX-\0Y,
M,#@\>6DA#T@U>M1B8YUR$Z$=I]/R2BO+KD-FJ#\5UM4E+_/4C&R6@9QJAI#
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M$?LBKJVKAO&K:"68UG%7ZBY423E=H2S0KY3CYYJ.<.'K08MK>TA_:#P/J?\
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M%KN6! 6X68/T.'+51<:6:L2;!7M%36^DG"*2R>_Y.^>>M;U@9C 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M9A<1&1MD7W*KU%JLDLP2<=)L^440Z;X# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8')GQ;^3-YZRLN'P3JO:R0:SJ#6U-]*U+=CVVY53>JKF\=AR,<](1A6L8
M6QK W/.I!TH&Y2)DNEUQSI'Y/E3^MH(U'?F+9$8'%CB?G\@G.Y%^1+GQ Y@'
M=AM-J"X!NT6D*_O,=%]13XN8KU'2X]WP+^V3[[,/.1FG?S<].,"[_N/UDMY
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M HV$R29GIX23+%%BJVS\CY9<DNFZR^N>F[+>F"?TT=?XJ?\ +\/\.!+^ P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MH$V*<NT!ZCQBFDB61Z[<I_;=!Z!/XS?3IFN)(Q+F)&"?#*D]3KT1"37H=_\
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MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M[MVT8]N$N'CIJP[:)/G+=MUWI==NS4?H<J]\\[Y3Z63UUO6^^?B'JP,:4,B
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M;#PK?I@:=B.#F^NUR[M3@*K3&@/R,-+N]%'X<8G[" R.WHY845G,VMQ>4<
ML=O..RD4PK^NX[9$@$R& !JOV1Y=!U(-#Y BBR0"Z5E?W&W_ "%8_(T$]%^K
M^S[<!)/5XND8Z3K]O-71WV'<*RLJL='QA<PF9DHM8",T#RM(,_\ 2$FC)8@
M:.FFQY5)!P0'CU$G UL%S?;U+?D3L;RAYM@M-I2YW?8?SE)6-D3N,WB0@QF.
M^FD:N@H^&GBZH"Z*5 2(;U/43+I4ZMW+6PMPBGOB-D.'O2S0-=F'E/WYIU)9
MO')A<1$Y.Y7Z05M")\>HS8U&0T\\ORC9;4];5:U=3#4.IV8G:6 3,,&,A4Q*
MX%Z:4TY?-N%N%D D&!^:_34*\3G("!A5E1<\9]M6+<<GJ)CZ"9[N^7>99GZ7
M/SQY7;;T*RGO'#.PS=;DFWW2RDL167216&*F?F6V^Z"FD \9_D=CA/S)#AL/
MGL#KV'SQD2GZZ/J4B?UU5UA^BO0$MN>+3Q07>4? G)FXKFQ ^WKYO"Y,2D"W
M'W7!X>^9(ML"4/(7D?\ (#5%J>3F4G)6S"*@J>L?.L.6C#.UHY*X+%(G7?GW
MF"7-6D\9N[S+\2AS,[J8.C@MTQAYU?8U^)^F:$Z%;'(!OUO0OV-9_ICU_7=)
MV/8QNHZC8U]9 42!M:6U\<D4^O8U5/%R^8@D[*=CA$??0ZCJFE)6-.V[[EK'
MBMP#U-.!_;!%9$/,&IW\D4:Z="X_'[?Z@\_,0-M  I_TY'#<E\U5Y#_:Z-CE
M 5HR4U8)8O.9 =\[$G+!)P$>RA=1DW3 /'O:"*+I0-[LZL/0=._CRHV%$5_0
M,WO>3>DO+BEXL8?Z F3FTIJC+;_@K.UXL&N!Y-6W,0C)N#<+,%$FI8,$;,>E
M$]+,N5%'/(1X-\H>[]QJ0R&5%KM,I#AGGX7$ZB'^LC[2:K46CZ;O:;7/26IL
MTL,)&'MY(^>RD#CQ";OR";HUT(5:-#Z6E5R788YKYN]X]R&O'%B3V\*P\W#:
MZM\7<R+?U9LI8,/2/G?0YCS5-='6)5X3D)7R'5<A""YLNW.\]SPYV)>];,\Q
M?;@F$T4L)]J7A^..365*"LO2]'^B)9#K.4A "=%ZX?L*6C\JK>+OZ[J.3FNP
M:]1%[PH"NWI9HZZY#K#)),UEUEFBW/;I((&DE"?D7?W9Y_-5C ;BJZK('/*P
M*=-)=[(+VP>'U%NU[)=6E!['7)WJSC#P_P!UX:%)ICM1JPE%V/*#5*6\+"D/
MJ!]:'B?V0V*>0 TN&7+::<)=_CIL&4R\SZV+%XM7%A5-:"-@^U7MI1.9V"[<
M7%(9V709O@3AH/,-$MLDD6'0?ADEP]"0?95&_D9GWK K+O/J4VB]=,6!4.(D
MP"^B ( ?B9WRO:D54:.(F3NT7'XU(1GH60!77#5"OEUOE&MS7,EY6XT,0"(;
MR\1^XEZYMRK0:5]W)5$OKB> XA!D_9AH--$+LL3R95L-8V3+;$G=C,S!RIH[
M=0B7]EHPX(/!RC^0<$VX1^AQM%,+L>FO-_K.;Q^ -J.FA^!2.M_#%ZQ"(*B+
M1.1"(,/5QA*BPU3EI#&(\;8CI=T'C F8(#'I)L_%AUW?U]IZ6Z0[Y"B*'C/W
MF/W$++&C+V-3Z'QGT&'KIE*;^ 1V85Z(D,]\46"Q@CATCZ-MH80!VJPI6?#F
M?1&52?;(B:9_?*C1VT>!02R=\P?D$M=S<,OD9B[JW>GWIU>GXD']7/0;R$"9
MI[.>2(TBY_=Y/.HJA)!GE3KAFS4TJ^;A_J]LAZVUN>5=A;49Y^])"?.Q.HFI
MV9N7HSW,"D<.>&[B.2"5M_(;/U?&)FX#NK)-2(A,WJ+.D>"#5)F[(K%N6G/#
M+GK?>D^=!6\EY3]BQ_\ '!Y!H"D6LUJ^X:AJ:SX).6;.[&C20"I IY2OFM(B
M5$V)Q+3&B#)>Z9 !*!.TWN^Q"';5;I%I]ET@W"4KB\?7'(_'?O#SNP1L">C)
ME;H^3>;([);[E1F8D:Y'Q6@961C3.TY?..I5'^RMM1R7=-&Q<V@BBHZUSM1!
M@HGK@*OR?Q#[EAD(+\T <LJ'*V)*/1\ON*'<WV5-J%P,K_(< N"!Q:O A&W(
MM%H/-SWF202=NL["'(QP[7=+,R9=)VX3?)A+%MPKT]!O&/C*N)3KTG8\^)>O
M(X)LZ)0NWD8#<TBI<J_NF0-JWD5M12SW QJ-#0_@2R<=.YNORZ39)-'!YPZ[
M^_5"/8_YI_):W>0=M)9+<3^?(@*^2%V\(]4-6D&KBJ&%5RX/8E(SJ%$'A)K9
M-^%I4Y:\H3Y>)2!)T569&%'Z.A'VC@(B!^0_R$CXU!I47K2R)78\!KWU15\)
M+%?5$C!6 S"V\IX_--SDWY9^JI8R;%R"U<SULR:QZ;IM7K_D8OTK%4WO/88(
M9.,O<%)DZGJBYSOHDM9LGMV)*><H[";^G8UY X.6][L3LI=3H>%LV>,+M"/_
M #85:AW !Y)IP[AP80]1=*MQKU(SV'2#Q307Y((%,;()V[<15D2)Z"HR(E:S
M9*X*KG\@;6#+R)^6U%%0?HYQ)H3^L0MRQ;-EU6T,8,FO39IW&7';'E?@*74Y
M5'Y#;"I-M*H]&_1;P1-U&0^S6EH>J)23E=DE&M^6(396?5<8YORG3D$CL3K!
ML/"$(RXE-?IEV;UOI1L0T%XT3#[B'CO\GQ[SLI"KB9VU;A([03FNI##(=ZR'
M064D;G6\V<5Y#;(DU@;G(-&30")SI!_^NCW;UYV7<%FQ1<>849J)8%P?7OG#
MW3)XUY*C=%2J=QN.U]0I&&3(54<P Q<Y%+Z0958S@5C%'!>WZD!2"&Q,>$/-
M^N5-2YN@HXUOJ-E$W&_H!CS?ESWA%EI-:%?32S9':B;WUS:7<4DOI:3*5_9,
MNB'MJO;:\=5!J.E9,\B-=0.PO-HZ31%U^EL6+,0P-_2)\]]H(:3"!)-XT_)H
M5DK0/);-LZ<AC5$B1CY\SM 0YKW]I9;2]@)>@:TL09*+;#\D&,ONN4J<AUVT
M(D'VX?L3PW+B$PW'' :=<U(_D&J"F+1)B^;Z!G8O7,N"DYI ?2;O]DIU!C V
MK(Q0-04;6$?DA-W3]DU>3351?RA$$+30^P)/-D"B9KOE(-_D?EO\F1"70=W#
MY3?-?4\G,)>2JZO=7P%GEF4#R[M&&DAKR[)U(;[8#++ /HDR+*,VRBMI\AQ+
ME0+H>K]?2O(6<]XTU^1\K<W4\\63![N)LH)'[*;1$Q:_[+@2U\0!W(JN9UB_
M"DG'V2-9V16-RNY02^7C[/4BKH;TKK[ARGUL/!Y7\T^Y*L]D$2]JVO;\XI>-
M)S4"+E!V?#3\$L2KTX;#P50!C4?,6U()(G9<<)CUWA)XC" 2O9+A^Z6.$^"G
M278=H,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?GPJG\JGH(#1M:-[?AU0'+
MBL6H:%LJN)$A+)V\0L 3:G=\(EM'X17M./7[&=B6%!/BRK$4G^A(CGBJBQ%O
MP.4[=!M(K\V2;RK!4\7\^**R=YY;8^VW<#$6#R360\PEZ(C,E$SYN<XBG"+C
ME7TM)=P!QO[;239H/=E=[Z^G]GL+$-_R(V(P\6W/Z3E=+1:/3RGK@B50]Q<_
M9'[+5[)%IC+ZACS"9OI:^!$I!7L<&-;;3[()%A?WC906NISPHU5;N% B'7Y3
M[<[7G@]*FZ4Z[J%$-&+!EBMX'$*[*6#-_5Q_R3"SL.E'[MU4N*5&28:F<E!Q
M_P I.@C-!^QX:NG3/:O8; '_ "FR=Y*8S41NI(HE:=A3R6596Q&%V4N?KZPS
MM%6/-@/K"6PR1/8:V<+1>F:J #90ERLT466>DE!+C2:C-1PJ%4C'YC;5"QNE
M;5XB<3<5?'XW+W-C0?NQ A+T/:Q^'^!.?1RS@G%6];B0\1K=Y+)D*<ZD0K2/
M7+,=I[VQX8DDVB0;'=GY:_0K:D+5:1NL:QIBWX#7=N3$M,[ LIN- /!,)(5,
M##.Z:C1V(EWDHL'I];K?MU'I$@-^@HQ13^99$PP<\AT%]2>ZC_GVZ$:[$P6"
MGXY%(A2,\L163V.O%+$E :^;N,4;'PE!PI*,%T+#ED3+@E7Y-NY>,4U=NQS!
M'K2[_E5$,2)]JW45\8U7Z4XJBJTIW?=L4I *N@G[S)*I#Q8*^;5B%7Q0[.9G
MS -%-$PNY*H2?LQHMPFIRCRV06ZZ[VKH*>N_RL^@;$?/0E;TQ"ZY;=7[6%?!
M9Q8LE)?IW,?%^[*M\DVR'DX5P":D6AB6ZE[ER*=#T7C<)QRHW?\ ?#[EK]R$
MK ?RK2>QRU PNJZNK(I/+Q T>1=,SUMO.!->$;8E'HP,6&R/4>AQDQVYC(_S
MVZ410V@W6>/'7:'>F^F_:FPEGRE[SLCT&QERD]JJ&UWR]\OQCU'6JT'L<A-7
MBL,E4GM6%IA)?^N0.-M!,I9D*UY>\*-."+':1#Z/7Q[:]=N K[ ?<_J"5^#O
M??H5J]J5.:4;6T1F=$]&7SDDN'8'?#% >AU'-N<BHH!%DBB9RR'CSE=FR;L7
M:_2B'*+=FBGO865H7WI+;2]"B:>DD&K1F!EIOTA"XV^@UG/9388"4>4Y.&AL
M^.69 GD3$)Q> V$5(J.XP\3?+KZ'K"^G2>E"R?+<*GS'\@%[U._F=320G^V%
MF^)S7HRX?5#U$=%8\XL7SE'Q_"GD- @Z1CI !7+2\^;AC;LN=:L]?8I5Y+-I
M<_\ TNHG@8FR_P K5[U?/3*1R!4E) %31*[(S80>L;!/2X#8=KCYIX2#5C)*
MZG3F&,'+:$0\?Z^12F+9=IMV+69$_CI;;1I]<)RM/V?><T\ +W1%HM*:9N+K
MU)1_G]\-K]S6TKDY)G(O7M6TM+'-:\6NV5A@H],XC)G:#%I*VS94(27Z2=ZU
MTWTOV&A=>V/7_EUA,Q-ZUJK.QD;KCTAZ;$.[=FM:1B]F7GZJ7=-0J%1J=(^?
M8F=I#N9'K)LA^[>%FB[=D#AS))9ZFX(Z7XP-O'_DULA2R"E,DX=Y@%S"L"LI
M?6U8I?T@3!4/)8A&>?/[Q1A1TX?UHJ]DMD:8^@V:! 61:M$!)8;]FHNK^HME
MD@A<1^9>VI5 #TVC/E-BD@5>P@G6^C]A+LR&HC*SMBBG[.409K'W%C2>>@&]
M?;56&Q,89ZZZ7?)I:5[".M.0V9Y^7(A*I:4BXB)Q4!$I ,H@W3TXB5A/CY:R
M$)U)?+KF5J"'A.HRD+$LQD<OU7[L,>_0Y>@P9(.M#D^2J"[ ,K%_RJW(?<04
M&4I:CX::O0?7LDIN126\Y$TK:.1662N]H\0<7A*%:O;+1@RLA1O6@Z Q @B1
M+GF@W:J?:>UU@O-57LQI//!(WVP4AK?ASKS4_P#1!ZKX5)V\N<)H#H05FG[-
MQV1=#A7ZTD81$*)#7_;)LF\YZY5TGSSO?.@I=+OR.6T%'@B"W/FTE(H0SYF=
ME J@O-.PJQZC]IO*-J^BV-F6:4K\62J4,G._1?,@-/$QSE;J.0M<BW^=L]^T
MY#9;J]JW ?\ "]A6?"^A==7!!O7-4^7SI^JY; I/$SJ[OU74U138S4L^N6-(
M0%%G)8K+W3-%Y(1NFX QMPW<[[[8]+]! 5;_ )-;ZKV)V:,G$9%W(^I#7LJP
MK"*3.;P,5.P-9>?.O.BD%A+J4T-#"=%SZ9&TO1XUX8D0KD:(C@AJLB_05+-'
MB>PS%X?F0F-"@9HVD5;4?+Y[3$CE?-HLZ]MF?R2%RJ$QD!0TGV?JZ6MJA[%"
M^>&U\M1!-Q)UQB R1C_LDN7VG?*C</X7_*#?Q"^XZ+A<-I9>'S=K.Z^KJKBE
MJN.)@C-T_?E >, TVOU%E73Z15KV [EA@JD)&;))O$G2C%;>GC/E?88F0_E"
MNG:L:CL>%0H/J'^G*C@ELDY!.A1"U)X GWM^WJ9=Q6@:Z3K<0-G(?J'TT^&;
M<*J,2R.WW7":BSX4Y=.@^Y'\RMG.&0<2RHJI9/-K"0H$Y7O[MKF/V/%0(6]*
MAO>[^(_:SD77(XL L"+1BDNQ_;%FBX2>N"&GW':;9#I+L.FLM]#2:2^#YCZ,
M@B<5K"R'WE\E:<>%61-(AN+5?/3M5?MA&6EBS5%<A#48[&RA)JJ^)===#U1_
M&W/\J'>L"A\4],>H6E4UPWW;;(O+J]_(70GFST?*Y6A5-J\6#'K1D=(==QVE
MIU44 I2O& )>/6RER0>/(PH=%$$'@WX?733?\!F_;?NNU/)/MJ#INS;%[Y?'
M^4Y*<L. =A!?9,A=4]G9:)^?3(^2IL%9&S5DEAQ=C!T&/"VF3DA,&W?:>U4T
M^M!6_P N_E/],!0E*4[>-?)WK;(=]^C^D+8&=!*\;O"DU]@>@/.0!:OP P*/
M@W+"NOW0]=ODW#MLX+<)_:M.5"/Q^N$\Q_\ *G9_,,!V).ZGHF- A_FVGO3L
MXBJ=]&TK$DL6]$1FQI75\%\_@S58C&UJV$(85[MJ3144'-B)1YMJP[WMKWVJ
M$22/\O=XFJ.F3T+3E5599W=?VW/XO-K$N%,%56HC!_/PZZ&^PQ$G#2)9[:&O
MVB;)L!I,8U%%!S-P937Z9\*-N R<9_,!;B@N9M6WG9I,N('!#@=I+#]A *S=
MR>V*^C-=.I 2/L9&S$1T?&)H3FBB@MH(<.R'R?IW/TM:+H?:A96>>^#+3Q?3
MGN/];C\(K^ 7T*$>M1; >>>#1M:#)_,//]H#%.++A4(FT:)02>/QQMXFH/9N
MV:@=9GM9PVWVLN%+XA^0[UU7)]& 7?)HL4LVIXSU9UK@C427C0J0M_8DE\_L
M/&M:;1KROYG+^R,&-V?/8T@W##>7\E?5OK[ISQ]PY=<!9GSW^6,U=I#S;%7=
M)B04Q]-DR;> )-9V]>@7\?I:VKTK;UQ+.2#J*,E&K2FA-/#2[=JMKE9UW-A+
M);I!72RN!V=;N&[QN@[:+HNFKI%)PV<MU>%V[ANOQRJBN@LEUTFLBLGUKKGK
MG>^>N=ZWK?PP/NP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!R4J3V!Y-]%0 _
M+YYYZKJ >?8;$OUSJ76L;\O24<P#U]/% ,0%OJKB<WFD]BSE&4%5E0K1X(;]
MH/W&D4N.'KI-)0)#K'W#^/66MHHL.D%3P5U.Y+-?.%<C3@&-B2$R QB[2])L
MH\*1'-'.A<"G]K-%F0,:1VRT2(]J-^6OWB;A%,/N/6'^,^P*FE/G74VH<%40
M0W^LR"OHHH'@,/\ FJ<@:O0J39CA+$0#-0YK^Y8R1(O&?+@00;!":2BJND77
M'(;B[]&_CHAH<+!59YYL"1J7@P%<#8NR'Q-.,O(3)X[%)R"CY$8/%]!1M;/H
M]<P5_KM[RB#3YD[7ZG?/;]/2H>IKZ4_'S%$#X4;.Z !H>8_N8PL&$" 33BMM
M262;K$E'X$,'!^?K\EIIK]FGC6.IN-=F?_J8MS]W_D,#8_/!OR]Z.K&.^HJS
MJ:O]AY$$F$,CDL<0.#\2)_ Z[D$PJW@<Q,CFSQ3<)(#@CO0YIISI#0IYRGTD
ME\ZB6@Y_5[[V_'O9_G*D[%KWR2N?KA2 WA=[2J&E$U8E** :TG*:; 7GT3K+
MIWK0>;"(U>K"3\H DW3F01I-1VQZ=[=,4W8= 8!;_G?TYN672(@ BPH9YVEA
MX56WH!U#(_.QLF*A0# C8<C\ZEQ*,DEID-'B>N@3@B*02T3-#735E]UIMKOH
M(P >W?.Q>FO*DQ95#9@^&^B+J$5%54*>4[PR5K>4A+-(088?L<=SUU&*C91V
M7 DNF_+IRD43>*H(MFW3OE5-$-3*WI1X.PO5(&R?!TQC3B'5HQN"WY>RK&AK
M:7N4(RF;L+5K%X"I^9V%84EF,U)QIX1C;"0C&JZ#<6JX<;9_2YWL/:'ORH0,
MD\S2*!>(9#T%]EOZUFT1M6(1_P TB5F\LLV)G;)(FYL"W90JTG9J 0Q8F8D1
M=F)(I(-^W&T7+E57?"@=#1L+AP;GGD/$XT*YX"(QKCD:"%L>>(XV7=NF\?YT
MU:I:Y"(.7ZZG#37^0Y464ZUSK??6]ABVE7UHP:25@QKN#,F,S##HY,&32) &
M[25QX.#W&! &2MT1_")T,+C?6Q[9JZTJ@@QW]#CGE+_$P/JC=4U=#3Y*5Q"M
MH#%)29$!X^7DL;AT>!GRH".M&["/A"1@6.:D7P@&Q:)(LVRJG2+9)+CA/GGG
MG6M!GE(E%57YXJK&8^H4E0EB E!)0,.[?R0$,T4Y&A3SSIMMP8$CN3;W2#9Q
MTHBCIXO\G.OJJ?,&CM*%HT>!"Q9A3%3LHQ&Q\I$1V.-*ZB#8" %3ENHSFHP*
M(1#\#Q0^8-%>DBB*"::9!/K?*_*G.]ZP-E#UQ7D=BHB"Q^!0P%"(^X'O $-#
MQ<&,BH1V)+)'Q3H1'F3% 0-<##J'#UOVBCQTB[XY6XWI36NL#-/HY'R;M1^2
M!!B#Y4,0CBKU\+9.W:D?+*MEBH)1RN@HMV&)K,T>W#7?7T%NDN-]\[WSS\ C
M]I0E%CQ$,C["EJF9 :X.=2>O C2N8>V$0.2]N.W?<AA@U$-PRBYSIVKTKMVQ
MX0<;4ZWU\_QWO>!]+SSW09%C-1A"CZ@?C;),MI'8H]Y6D,=,9](63KM^S/35
MHN%[;RHRT?*]+).GW*ZZ:O6^^>M=;WO R_-.5#Q("$MXJNM^)46%! 123<P>
M,<R D#C3D<]C@8@9T+T2>"H^\#M%6+=13I%HJU1Z2YYZ3XWR$<75Y4IV\X'Q
M7TB"NHJ)06"J-'U<KMH<5;M0!!\4'!5MLF2HLQ&$WY-POL20:O!OW2NG.D-.
MDT5DPVVH*"J.AXV*B=60UA& XB#P:N&_":[T@\<0^MAKX3#1)$@3<O'I/](9
ME'7P67[[664<J=J=]]][W@94#2M-Q6.E8A%ZEK*-Q,Z/(B3D7 P.+!XZ9%F%
MGCDL-*A1XIN-(CRC@BX4<HK)=IK]KJ==ZZWWUO8>I2HZH5KY*I5:QKQ2JT&C
M=@C6:D+C?=?(L6CW@FU9I0SH;N.)M&Q%/EPFGIMKCA?G2FM:ZUK>!Z(_5M91
M,2Q Q6N8)&08P0: #0T?B,?#"1X&2.VS^1!&(X</;,V@@\^9HK/6R?'*+I5+
MCM7GKKGG>@U/?G'SSL)%XUNAJ8W'(0H:6A<?W5T'_1(@M)/CJ1*Q<5^A_8 %
M#^M[^]Z:)H[=?_K?FP-A;4[4;.2&9DSJRN6LOD1%@7D$J;0B,H20Z6%/!A 6
M4,G$AG),F1&OPC)=NNNKVHBLT1[XZUTEQOD/H)TK3Q@H%.DZKKMX?C7152,R
M%6&Q[]H8PN<+]R$PZC)[@?R7CSPG(%.B"ZS-9!51]O[C?6UO\? KS4'X^_+5
M.@+$CC.O&UC#[5*1@E._WT=M[6[D&H/HCN$LR*,M:/F+_F+KF7KA%VX16).7
MKU=V\<N72O2VPM (KN# 59<L(BH1AN>*CUIBDBQ1^UD&Q47$PH<D09=ZZ9J-
M6D3!-!_".N.4M-D.>/E_P_$/JCU8UM$HP'A,4KV#QF&1XBW+@(C'HF!"Q@&6
M:%-G&I0.!&L&PH81;&]_>)KHI<*<.O\ *ZZTI_C8&1,PF&2)UM]((C&#KW:(
MIOMX9 "B;K;<">:RD&AMP]:+K;1#2=B@1:<_'Y6[]'APGKE7CGO0:^XIVHGA
MN,R9W5E<.I)"W)Q[#I X@\97-Q-Y)WKDG)'<9*JB^GX)S(2+U9P^4:J)=NUU
MNU%=]]==;V'JZJJK^S4-DG=;P+N15T+7!U\?ZA\>Z-00*Y9Z'.1$-*[';?1@
M6X'\Z0[;L5$$NT=?)OG?/\F!K''G3SXG%?V%3HFFN(1^TW[:?L;Q6$)YBO[8
M_3Z2_:S]GM ]"/VF^EWOG[_Z/W7R[WKY_A@95>D:7=%9$><U%6#DY+XJG!)8
M97@,46*RB$)-&[!*&R(BH)Z>&XJFQ9I(\CG/:K32*7'&D_EYUK09I"M:Y:P=
M.L6L A3:M41N@J->H14$C!T@_/?U>1*<338<@4QO*G^-I#3?26NOY?E^.!]<
MFK"M9JWD;295Y!I:UF(L.#ES:31( >;RH+'GKPF #R-$J/=IG!8,D1<.&;=U
MI5)LNNHHGSSUWUO81RW\Q4TTLT#:;2*H,R\2K67U7#8X/VF,@,-C=BR%A);'
M>QB%#46@,7)K ?AAZ98ERGMTY;,$4M=<<[6TJ$QQF-@H;&X_#XN,;!(S% 8F
M-QT,RYZX9B 0)@W%B!C3GOKOKELP'M4TD];WO>N.-?R[P,Y@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,#DI7?XM/W=5X0JX5?+=&.,G8*20&0!_/M/Q^S8Q/H
M)=$:OFLY7)9\Q8=N;*;1>>Q5KV\'%6VVYEO\W*^^5-Z5T$'R;\9GH:.V5'6-
M9VRVD4!M.WZGN/U;/Y>^B0$M."U8>U9C[%[!-:V$U02V$'HD)P1%!%0$A%JK
M)N^>2F][:</'0;U&_P )]# 8(;KKJ>2#831:J6L(,AX57T?G,=K>LYJ://ZZ
MD\T:!%C%@M+'@LH*PX\Y=[;I+@2"W:39(@JN]6#90_XAH!$89W!X)>MG1L=+
M %S5G<A!R$@LB,6?1=Q3H;)=U>D[+@U$H4O7D+ #H='C#!/;EI'&G/"J2SKA
MLY;!G.OQ7AD'D;>B_0E@CU*2-F3GDE'J(P)XUH):3W$%NJ3LR_*HOES<;(J<
MCK(1Q^M*IK-@*.^4U/U+OLIL+8>:/.,C\ZU^C4'=G/+"@#".F^VA,]'@8F:D
M+%GMHVM9%D2TJO&V8J/(CBW4\8-F3!JT21:Z']]:^'U=ZV$&^??QF5!YRNVG
MKWA4PG"TIK#R&(\D'P[M0.A%+/81QI5@>/6]*PC(>@BVMEE%:J8A5R#3:?+X
M2FV;+\=<,&GTPM=YEH:-^7O/]2>>H@0=EHS4,)#P@*4?LA@YZ09!TMI)O'C(
M,V9BV[ISOK?:FD$N.-];WOX?RX$4"O&,2$T[4M.)3.4*B:D]"C_0XLRHW$:)
MESP^[)#=R<>))\M--. JAB0J,NNTN.7'VJ?/6NOJ?'K829&//P...?29'J0%
MRQCTO,'4HDY9ZW'</(^RU5D.J4'%P?:#?CYP4;!0[APVX7^IU]X\<J=;WM7K
M U.M/*,:K<UYQ,(RR02#GS+YI>>;X(/+M!&FB[0HC5;(M8+W[9HDHC,'PJIF
M3/\ R&TVZ;9TYXYXUI7>!9*.L2PT"&''S>Y*;8C&34O(>AS0/T<(H-TTWA78
MIAO;(;M^OSTK]!+?TTOF^7G^36L#,X# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8&&D8?<BCQZ/\EC(#HZ&*!^3L<><#I"%V38KL
MM%@)!5!TFQ,C=K_6:K=)*<I+\<];YZUKX;#\]U?%;=:.(3 91[-]+MHA<OY'
M_6'ER96;)K(A?!^'UOYN"^F))6$.@TF=01J.A<IGYNN [,J3WPJ0)-F2K9#M
M)5UOO06VAUN>FK'_ !,B+XBDU(R+T'#8:0M !+!X<2R<7T!H.U")L>FX#LAO
M /;?T_5$ Y;K;8-V[;K4DVLRTAS]'? 4:G'KVU+Q=V1<$;]:RZCO/,U\[>R_
M77DV11%U#! ^1CO,"U+U%5Z[MQ+HN6_:N!G3/,CG)$!O>MFV<H'Z6Z^V:II8
M&:N"6^AXF(]N7!_>9]*P^75Q^(T#[7CU8.II'=P.M[ZM:*>O^9$Q;Q@G">R'
M$8@Q.MQ&PHUX[52'.!OS*;5^936PZA^%SY<531,Q:LPFZ9,G.!+!!6Y?2M5>
M@"'"YX9&AD?8BIO7(X#'!J<C./OH,Q/2>W:SWOYD];TNEQ@>3\E<YON!T'"'
MOF>4L(K<A[TSYFB<5[,Z:ZCTH_7;AC")*N9.NZ:/=L(Q9@Y)0"0=H\?<LFA'
MMPCO2J7.!Q\$^\?8$#<U/Q85A329D?,U]^@[+][.Z_KII+*_'5)(_84PH&.U
MO+3HL:C^P=?TG58Z=RH025^W=$$JZ']+]]<KK_,$()^VO<$9<'I""G]NEB[N
M:RTU'(7/[.J)S'/7 AM^4Z!>=X;&?*+G44^SJA&!QCM>+SG9TJV[8BI.+>=,
M'.G*9)L'='S9=$NGGA"S[O+VB7D5TK!+T.V4*?AV@!7SG=D1'&Q\H\\CH7UP
MJ[CK.@Y #T'2X(J.WA?;7995=QR1X4Z#C9Y=]O>EAG- Q:S+WFR",NL3\9,T
M..)]:].7"L2A/H./WZUMAV2LZ#1&,,89&[&/0H7IM#"_'1<-V,7=M7G;1_I!
MJ%R?2OJ&W6-Y>@IY65_&."GGFZ/!];T%YKBA2%NH-Z,B7H<U!F=GKR .N&)R
M.<%)AW+)$*%$ASU+F.N(7TX;_)M$GI8(,D'J2^JY\T>4[SHWU%.?8'IST2OY
M=L&9^3GDWIL2.+2&RV\F<R,'%EOV=#.*8KUY,%5HTL&=.-ZX2!?21W^JMWBK
M@,C)/5$P'#J9N\;[@L*V*FCE0TY:ME+5C*JDKVWXE-["O:?#[).V;Y)L:(HJ
M6'4II\QY@#*'#9$E*X"I%R3!%F2D/7+O ME^6*TKZA<Y\NPZCIQ,HJZF$7]3
M20H,A]XU+Y[V:-5O"H$3AC\[8%RQ.70]8)'"1I=988LARD\Y6WVMOI!!3G85
M,\P^H;VOBTKFM C;MM'XM%ZRK"0Q DPMJKZIKAB4E/XUZ2N-UM_Y)+AWMI%'
M$@M*<$#22B9%PU;*OT>..ND&"FN@LHV]&RBXJ%_%!"W7I@I"$/3,#A[_ -(7
M37<PA >PEI*,\>2"W1T9U*7(LP(@Q6P9\"5(NE$FB"[EL'=,T?D365U@4&\U
M_E1]#26'Q7SW9LIFLAN6Y_2OG**QOT<P%1D-'8O&;L(^<I+4L4< V0)$>W=>
MC:1C]K2IDLW1^V'HB_I\_+I^PTF'8'\DDFD,8)^'>([?4]I+F=>U:QJV5H0B
M8QR*<3F"RX-*"!\(9YD 8OT^11>1IERGVV^@NCRX4YUW_EM? *1^;O8WI A[
MYC_G6T["+&899/M#\BI>FGG(\0@P/430/[SJT,TF:=-!26^R]%69'@1AHI]3
MEVY$2EERITK]HMO8?7ZX].^@*P_(E(6T?L^=!*BKJ2?CK#%@(ZR:O;PL6 OZ
MY);"[-8$?/TABCZQ;G-6&&21',W0 HS?@G>T7J'*OVJS=P&_5E[#L GX<\-6
M*9O9H^L*2>P:BA%Y2'HU$52BU?R?TK*JP>"I@@W;\-@P<GTY%".E_HMNM*JH
M\Z[Y4[^.PK=77H_T)<OKF+QAS<EL2"L46EO2YCJ ^AJ<I./:CC#\F/K.IHK)
MRC251QT2MZ+HU)7088T:"%^>U!P[G_&45>\+=!U)]PS&3*7#Y.H[]^LJ\V5?
M;W7H([8-JP@U&(C*5"M25N/DL*A0^:S ,="1]J^Z)DI"\X^A]9ZTBZB/?6V6
MWJ:@<=O'WLCVE;]\>=#=BV'9,4:VC=-&PLW-I1):]$>6I(-5\&41=TYHAK3;
M>)/IS&+WN9Q+"<LB;M1T&'K*JN$6[U3['@0]"R?Y6_2GHJEO1CQ:I;1F<*BM
M4^-N+\(LP=GU/#HR%*"[G)BC\UE=:V/&BI+T0V1AXKM#B("'PTB1VG]JT71?
M/&RZ83]%_=!R$^4?=EE&9TA8=O5QZB]<5M1%?JK"'4T)ED[>>UUYQK 7#F7#
M,V\VZDYL,+;-U&_3SOE;6N]]];^.PJ=4'I6U[0)Q#S)Z,]AV_P";2GFFF_4C
M^V;L,C(+1MGV78=/3BI5ZFLZQ1<[C!4*.!I>:;4#3<I'>6R# JY-_.[359,_
MI;":O$WK&Y[?]AS"I+HM"3QZN8G;/JY7S:643B#<7[,=P>?/XU)8_L@.1V]B
M(3S5""HYTSA_?#8N?4**&=JK#PG?&!:CU')9")_(-^.Z(C+ZGT"C5C[OW]M:
MH 3*.!XK8G[MX2SED._70!(,]-$?N#KQ1NM]FY;_ '2''*._C\N!P?@?Y+?>
M["'^?(>O(9/<WH!G#ZAM,1#V1&!P5MZKKCT![-J>.4QRZE9H.UC,<)\ GTGK
MF0N>.DN4.P:SWY/JO&_Q#]!_GOTG& 'X_P!UZRG%PF+D:@*\LJX;5E)L,WA)
M(++XQL^6L:I&L ZYTXK9:KY.*=Q-M&GO;DJ,6'<M7KAV^TNX6#DC"O3'L6;U
M5'//]IW+.(9Z0A]W[F$Z@LLDD3\;>A[VIJW*6.7!&XK2TOG\+/0YJK25L.)%
M'VK9TB+XDT>KI3I8FGSIYRX"]?HSTM-S/X>!'HJDK)LUS-Y? _-7,=L@@R@=
M9VS(G4XN&JH)('COABV/UA#9A,&9IZW[>#^'8!JN\^Y9=*--(]["G-S6'Z;I
M\=<,?EGH3T+YRD-*>*;:]BU9'K'N.HK>DMGW3'9>YB\=BDCE[:$<A9[6 A.*
MAFJD.9)IK+NISO:W>W2@_I$)UDOL*SV?X_?RJSU:YD0=[4I-_<:59<;+Q7<M
MK$=6H14G$Q8P0JVWM1I!>N._I*.VR^]II_.KUWS_ "X$A^[O01I[/VT1A'JE
MW14$A7BOU5Z983VM)/7W7[67;2Y&I&D2CLE*2 3)QIN(0H),W90G&T_HZ-<O
M4.G&^V[;Y.@YQ#?RF^C)55,7\^G;#7\]^C&=@7VI,?4UD#1G%21V4UM&;YOF
M:T[*Q"L<)K@Q5%5(=K!\2=+M7'Q#%]ZZY65'O=*!U'\579/OV4O:O2EAG"EE
MU1:=$MS;;TQ<->6M"8W&KA3B>^F5<^C:B @UK)0F8CDB]CS ^'$'6D@?MF2[
M5N+<#^L#KE@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@1Y)JBJB:18O!Y
MC6->2R%2 PO(CT/DT+C9Z+&Y Y*?K;DZ7CY0:Z$DC#@U_P#3?;I9'M?MU_E=
M];4_QL#=F(X>,'M! U@R'BA[)N.8#&+5!H/9#VB'#9JP:,D.$VS9DV;)\III
M<<\\<<<ZYUK6M?# CLS1U*R,'#(Q(:?JT]&JX>#R->QXS7\3* X&0$I:0%/H
M8)?"5V$7>#$>=<-U6*:':/.OAQO6L#;2L,AYW9[HY%(T9ZE4<YATHV5!"R.Y
M)$>=E=\Q8]MVU6V8CG.SK[>F+CZC;7WJ_P#B?Y93Y@C$?YD\[A8NM"8W2-71
M"(NIC#; >1R$PB/0H.^FE>R(++(7)7[&*L!"+TK'9%'&+ENJKKO>NFO'._CQ
MK?.PF F&#FDVB1D4-+)#R0\RP3)L6K]-D8$N>'@LJTX=)*\MB0UXGRJW7XUR
MJBISKKCK76M;P->1KFO6W$N2;P.&-TK 3=I3Q-&+A$N)LD__ %+;Y.7<<,>>
M9(F]V9>?5T\^MI3[M;YOC]7OY@QZM1U0NTC3!>L:\68PM^Z*PYDK"XVHTB91
M\0Y+/24:;=C=H@G[PIQIRJLUY244<:TIUO?>OC@;&SB45'[DFV$9C['<R?JE
M9?MF&'-OVJ*+BV01<E)/HMN/UQ^L%&MV?:SKZJG35NFEO>T^.>=!%3;R[YF9
M0\E7C/SK132 &2S0^8@S:HX A#RQT>G])@:)1E*/\!7Q9DE_BHN54.UD^?Y.
M>M:P,L$\^4)&2D+.1ND*@CYJMQQ$179@)6L,%%($),."+PL+A9!@%;NXL.*.
MS#M5P@Q[0274=+==\]=*][Z#(@Z3IJ,/S)6-5)6,>*2.5MIY(20.!142_.SA
MEV]49S,R\8"F[@I*VG9%QTD17Z[>)[74WRIKY^OB'A(T!0Y@_'Y66I.HRDIB
M4B+R^*R4C6\->GXS+9 6T?/2B/F'(94B&D1L[K3UX];*)N7+O7UE.^E/\; R
M]AT_4MNMQ+2UZNKJSV@%VJ_!M;#A,:FK<,_73X27>B49(,))CG:R2?//:B.N
M.^N>=:WOX:U@8=YY^H8A.DK1?TE43ZS$$VZ*-B/*VAKF=(I-!.@#5)*7+!>S
MZ:;8%SIDGSIQK7#37T=?!/\ Q<#6&?DCRF/C\@B3#S)Y[8Q66K!G$JC+.EZX
M;1^3.(ZX<NH^O( R,;X'&5@3IXLHSZ<IJ=-5%>^D]\[ZZWL)2YKJON%N'/,%
MAO+A,C'S":_,8":63+1-CR+BI3A73'7?!&,C.--QZ^M_59(:TFCUQQ_)@8^=
MU'5-I* %;.K&O;&5BCY0G%U)W"XW+U(V25VVZ5( .Y -(=!WRG3-'?2K?Z:F
M]I<?'?\ B\_ ,NW@<&:$1Y=K#(HV+"2DD."BC>.B$2(PU,NU5)>8'O4V?+ED
M4E2BW?1)PGURJ^WWUM;KO>]X& +4S3QZ>B;5.516IJT "+=N"L@M!8N1GH5N
MTVYVT0$S!X+6D(U%KMZM]/E%QQSQ];OX:U\W7Q#46GECS$P_:_['SC0[+]X(
MUX&GOVE05\W_ &W$$"+8P0%2_P"C'N/VE&OBS-%TL@]^LDJY2X5ZYWWSSUH/
M4:\S>;Y)^R'[1>?J1/?N^$CP,"_6JH@93]B 0E;[D4%B'WP%?]FA(QQKZC=L
MR^BBCW_C<<ZW_+@;Q/ZSKBUP.HK:5?PBRHQR_:E>8Y/XH!F('DHQTKID2T'D
M3 B/T_9Z6[^DM]/ZB?S]?+O7QW@>AQ (([Y6Y=0F(N>7$C!S!QRXC89;E>6Q
MA$2WC4I6THRZTK(X\W L>&+[KXN6G#)#E+OC2*>N0PDOIFG[!D4<E\]JFMIO
M+8?VFI$91+X+%Y+(HLHB[X()*1PV9%O203M)^EROSMLJEOE;G7>O\;6MX&O:
M\V>==3KJT=4%2NK,[-<R3NQ-59!OVZ[D7+CAWR>ZEWZ%^O\ 1KETGRKIUMQ]
M?2G.NOF^.M;P,Y+:3IF?.>7D[J.L9J\YD J6<NI; HK(W/,J C^1(.3<KF!+
MQ74@#"N--FCWX_<MV^M)I]\\?R8&PZ@,%TN/=:A42TY$RDE.1;C4<#_7&S4R
MV),B\P'J_9_49RDJS,O$7)!/?+M=)VMSVIURKWKH,5(:CJB72^-6#*ZQKR3S
MZ&?2_8^;R&%QLU+XI]!RH]1_9J2DAKDR"^B\5Z5Y^U62^57K?6O\;>]X'V(U
M35S=4&NA6T!17C#-@/C:R,.CR:L>'BBZ$A%L0:G [GL2S&GVJ3YNDWVGPB\3
MY6XUI3G76@R&Z_@6Q,@ [A$1V"EA9^?E07<;#;$R4Z4<).R9J0#OLOLS)8B[
M;IJKN7/"BRRG'/7?6]ZUO08*>TO3MJMGK.T*GK2R&A)$,V(M9[!(M,&S]O''
M91_'D'J$A%$4G2(%\<>K,N5-=<M57B_:6N>E5-]!M3N(Q1_'F\1?1B//(HT1
M$MVD8=A1KB/-6X%=FZ!H-PJS;L:@B%<CVZC3GE+7+91!/I/7.^.=Z##3"KZS
ML-]%2D_KN"SDG!3'$AA!&81$!)GT./I]ME>#D5=FA[UQ'C'"K-'K3EITBMKI
M+C?S?'GGX!ICSS1YQ(R>038AY_I)_,Y8U-,93+GE501U)Y*RDH]<1(V<@/+@
M>RIEJ?$N5&KU-RJIPZ;J=)JZZXZWSL/"S\J>7AP9C'1_FZ@V,?%RIM.AH)G3
MU>-0PZ;,VO#%I,6(M".\,FDJ:LD^44R"?'+OA+G7'*FN=:U@24K7=?++J.5H
M+#E7*Q,V;5<*Q@(HNJ9DPGL!)"ZBO3':G9.0 E.F3YQO>U7;3K:*O7:>_EP-
M>BU&TG!HGW H33U6PZ"]GV4K[A<6KZ)1Z)]R@:0&EQTD[C@D0T#]'V!4,S=(
MO-H_<).&B*G/>NTN.N0E+ 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# _,;<7L?T8*M'\@L.E]L6!4=:U2[]R%/)T]#%@*[6W
MK[K#R/$IP/HA^220[(P452L>,OID"C[KC2TX))OW7"^FD=6:/@TL]=-O,JW\
M0"65T6#PXN"Z)DE93'G\GX,B[E L1Y(D,W!Z(>BDXKIK5S3<P:=ON8NBU^+Y
M=IKK2FT^OEY"TU ]^R;2]>34I5\_MQ[4U/>J*PATRF4N]%1"P*%7H)EXOH"7
MS"J!=;;8DY9/+0/3*>=D6TR01%)KO'_W_;]1%/L>N%P?:]?&37I+P]P*O?T=
M6PJXKLDU4SJ*U9<L@@D5.1B+>:/1UN#NM!!R?:38XK,H6,5<O6_23EPS:?;=
M];2ZZU@<[H?Z=]/R]RRB]JSLW7-1.JM_-(\"W,%O-FRELT7H/UM$X=61HVSU
M#8_JKGM,A%MAQ+G]6)<K-5^M*_+OOX8&DRCT1-HSYB\56T[]GSR2@ /X_H7Z
M.L\%#O2\2AOI0W-#;L5)YM><=8V)&2=9>O!4?),2<;6KD@4&HCE.D6J2"SE^
MRY1#I)^2"6VTZE'A>$5 O>#K5OW!9;.1PJC[7 T+/I@' >:+6G0AJYFTO=BV
M L='SX5H1=,U%>5%]MM<;35^'270<R))=WL>K(?,75T>MI'_ 'SJ,N.C/.W5
M,Q&3 ?V&G%43#RS#+"L:R7M>(1L$K-Y.SW,I/)5IN@P8IMWL&ZTT39,$'S%0
M(YC%G>F97X^]A2R8^A_3E(SNAO+_ )KMN&P(EZ5<S2TRDOL&$'#K_P!)CIX+
MC3$<6\[7&.*-!XN/=O"[<7)HL8252&N$]H=ATTO4B9H;VAYJKN!^B;FDY<3X
M;]NV,,I*97X]/[N"S:C.TBI3:\TB1!U^T,U*ODK4E#?CX;UT018H[^'?Z3SM
M,.;B_IKUH&D?DACYH]2V!Z)=V1$?&?I&T@\@E4?E[>8VE(*P];V-;WG46\;#
M?H5Z)]$0VJNDQD52^BWC180R<M$6R?;CE8+VF/5=CS?\$%G^M*]M29*3J1U'
M=<ZK>T/O4H_-VXM[<<S9P!PF^<L.^8Z7'Q+IDSX[5;]=L-IZ^?GKM/?Q"&+G
M-WC3JAF!VS?-^^31XSR7ZW]-PDL=];<W0;E-V5"O3X2O6'-B2F*AN9%%HF+D
MCTBO7_+95D97?:5>I.^$N.. Q_AGT9ZKGWLRM6UNRZRZ_%V+;OKYN;YL"VV<
MFIZV4:P'EQCOS!4],?LZ\=U#;U+2D@..IKN28UT2B\?+;1X*\[>_IH7A]4E?
M4T7]>U_3=86D6XJGUD *VB21T6Y0G]1._(+&.G;%KVFN^1??R!/5PV01H*][
M67^I&.D#1%I\[HDARW#G)6OK:V([,O$$GY]>32PH'>$+\8W3[")2>91TE$JB
MM:Y9E)X>4A/2R#)HPIR#V+)#[H-J(J]MVPYQ$6W"2:+K3Y1T$3#O5_K*46DA
M)AMU6RR@#BQ:,'QST,YN >P\[4W&K<]]^T(I$)!;]3(1PTG:=<W=65>@(@#+
M_(FQ:K+B-]D1C=?LHF'2C\O5NW96DPI!&J=WD2"-?/OLJT9Q'Z)N5&G9 ,XK
M-_YG9B+9,=?LY+2-B JB8SDF_=1QD,*/'K1POV@/(+))LU@HA'/4?I@:/]Z6
MAKT.YMVQZ/BTS2K6;Q+TX [K0D0%>(*6F+F;P3P^Q"NFLUB29Z5F9H,>[<+H
M*:[Y4^CTBAI/ M38LWKT%95>T-$_R<W&O0AN(WS95@6YW?L.+R6%6I :DJD[
M6,#:^A/T7Y5 \NBTO.V*O&'#UTDM^B\;X12!==CU Y>(^UO=Q2OIY:LUMBW*
M:DIB$7N_ZM&064S:TT:DT#_&O&+<>>:X/0>XN]2JGT ZG,AZG$=(N7(G7;<*
M6326=]M]#%0N;+KHLY6>R:DJU]QF[*HR'FZ[D@8E)O5,>INT+$G$CI">'+5\
M_5I[)80DU%Y'(J*6;Q6>;CQYPBJ0;2-1J]):'L?M=!^@+RI93"Y/,U 6L,+S
M.0L+"IZNY:VD%BA@,>GIY,U%1;W9N8A8ISQ$QTC+=*[</.!.OTKZZG6V>]MM
MI;V$^X# A+T+KT=NKS&O*/=))W3]\&_0.O0J4[6J_0W]3;_M#^L<5NLA+-OM
MA_J_9?1ZTGIS\GU?\3XX'/'Z?Y[_ /WK\0G\P]F__$L"YGEWGW)R"F7]]17R
M@I)=D!_[O=^74+?0!<BOLG'ZK^V6K8<N'_1#9'Z7V_V.])_1^?Y_\;Y<"FZR
M?YZOK*_;NOQ$?0^JI]#ZS#V7];Z/S[^E]7Y"7R?5^G\/F^'\GQ_P8$P4%Q^6
MW5IQW?J-Q^.CNDOHF?VLYH)IZ72M/:_Z,^_9_P#9U2PWRT2Y1U(/MOO/N>=[
MVS^K]/X*?)@>KT+Q^6#=H%M^45_QY)TO^GAOT/GT*T])*VAHK^GI?M!LLI6[
MU&*;'[*_/]G]'G2FF_R_4^/?QP(1^G^>_P#]Z_$)_,/9O_Q+ N?Z5Y]P[AD,
M_N>*^4T[#T3Y_>'OTJA;JT,V'_2>_FU#.:N<('.2?Z[\OP^^WM+[3X__ *SX
M8%,/I_GO_P#>OQ"?S#V;_P#$L"Y]=<^X->=)5JVE?*?7K7["9?L0I72%N\>=
M-$]M5/W??M4C)7'=E],-/?D_6?M.]*;2^/VWPZ^&!3#Z?Y[_ /WK\0G\P]F_
M_$L"S'EWG\E',PD&_::WAQ2 ?LUU^RO/EUM?:$PU,/U0?\FY!U;#MP%ZC7Z+
M]U\=-M:=?=?2_E^G\^!$-G<?FDW8DUW3+G\7W-3;DI;]W/-G,O5W=B<P[[M3
M]"U->XJ0XC7<ETQ^3[O;'GEKM7X_3U\OPP,?!>/S<?MM$-V8Y_%=NN/VG!?M
M]J"L?6W,VW#/U1K^TVHAU("'8+F3["_6^PV]UMIIU\GU=?3^; GOU+S^1?J0
M17^Y.MXI3BWZ.]_;?7J5M>B\@W(/O>?T[<5ZJ5TW'<A_T[YOKZ=ZVO\ 7^'R
M_P"+@5:^G^>__P!Z_$)_,/9O_P 2P+GRKGW#_=E$<PE7RGKV5^FQK]?4E2%N
M[\R[,?JK7]L=B$!#CFU-#=A/K_IFEE-JZ=?)]?XI_-@4P^G^>_\ ]Z_$)_,/
M9O\ \2P+E^6>?<W(F9_WV%?)ZIW;\5^[W^ZRWM] 3R,^U>?K?[9ZMIRX>=O]
MO?M_M?L?E3TE]3ZG^-\N!3IRG^>?[EQ]FZ_$5]I]=;[3[EA[*^Y^V^IU]O\
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MV/--T@Y_&)S46S[[]W?-JLO5?=C\Q;Y]?INIIW$7Z<8Z/_3^/U]L>=-_C_\
M0Z^&!@H=Q^<']KHM^W[G\4^X'^T8/]MM0YCZZYEVXC^IM?VDU%NC1'H-S(]A
MOK?8[=ZVUTZ^3ZNOD^; L3ZGY_(=T7B']R5;Q@D!_3BO[?:]3MKP7+[+_<M/
MT3<0W4CINSY':9_<?=Z>ZVKM7Z?T_P#%^; JG]/\]_\ [U^(3^8>S?\ XE@7
M0-\^X/[K['F.*^5->T?TL+^I*&T+=WY?_6OVA;?M%MB@Q<:M?0O<4^M]EI13
MZOZC\GU?\C\V!2_Z?Y[_ /WK\0G\P]F__$L"X_E;GW9RSFO]]U7R6J0VZ!?N
MZ_NK(7$@SY9?1*?M+^VO[W'+A?IUM?[+['['X<:X^O\ 5^._IX%1""?YX/U!
M]^E.OQ(?I?WKK],_4&'L?]0_3_KJ?9???;$OM]O=-OE^K]/_ !/J?'Y?Y/A@
M291W'Y?=6G$]^DW'XW.Z3^N1_;GFCF?IY*T]MOT<C^D?LFI/7RL2Y7U(/M/N
M?O.=\_9_6^3_ "GR8&?]&\_E3W9;C?D=?\?:=/?HHG[7GT:T]&+67^T7R+_K
MNW'=9O$(O^B[4^G]IKGGZ^M?-]3_ ,,"!]I_GP^&_@Z_$'\?A_)\1_LWX?'_
M ,/C_P#5+_!@70]#<^X-UG"=>4%?*:=QZ)"_WC]>AD+=5K/H/^@/?UK]B>*W
M<(RGDEN4_;_:_?\ 6TOT_P"I]3_+?+@4P^G^>_\ ]Z_$)_,/9O\ \2P+I5'S
M[=U0LRU?"OE;OT_M*9?N^[J-"VTZ%Y7V$3_=]^V24R<JV%TEJ1_/^L_8]ZWM
ME\/MO@K\<"END_SX?^+K\0GQ_P#'X,/9O_Q+ L;YCY_)MJ>%-^S%_"*E8_LP
M\_1>?,;7T"C/-3/]2%?I^RG=JO%X_N,?I'WWUM)<_=_<_0^7?R?4P(UMGC\S
M&[)F>Z+<?C'YI_9QS^[SFV67JE2R=1OY4_L]3/N'OTXOT<^;YOJ;8\Z;_#X?
M+_XX&N1/C\XW[51G]NG7XI-PC]H0O[9:B;'UYS*MQ3]2;?M%J,]&"/0CF0[$
M?6^RVZUMMIS\GU=?)\V!8_U1S^0KHG#?[D:WC-(/IB9_>#KU0VNY<GT2^N/_
M &?_ &-W4CINUY8Z:_=?>??:VIM3Z7T_Y/GP*H?3_/?_ .]?B$_F'LW_ .)8
M%T"?/M_^ZZVY#*^5->T_TH7]XJ30MS?EW];_ &E;_K7VR#5QJV-"MP[ZNFOS
M*?6T3^3:G^0^.L"E_P!/\]__ +U^(3^8>S?_ (E@7"\J\^\>4)M_?>5\C*N=
MK ?W<_W54+D00Y0^0M^T_P"VW[W'+A3I;:GV/V'V'PYUS]?ZOQW]/ J853_.
MY^J$OT1U^)/]%_4'OZ/^JL/8OZIH5]RK^G:);:$M--D-,_D^M]+_ "?U/F^7
M_%^&!(M)<?F!U:41WZ.<?C8[I3[M]^WG-),_4"5I;8_I)#]-_9'N=OE8GR[_
M %W[7Z_WG.^/M/J_+_E/DP-G](<_E/W9/>_(:_X_TZ@_0A7T^?2#7T6M9/[3
M?,Z_7-]]UB\0C'Z%OGZ'VFM<_<?'Y_J;_P#H<" ]I_GP^&_@Z_$'\?A_)\6'
ML[X?'_P^/_U2_P &!<GT%S[JW6D"UY55\F)W%IV-_>AUZ"0N%6M.F'[/K_K'
M[!<5PY1E/#O<I^E]M^H]=<:'_-\_^6^&\"F_T_SW_P#O7XA/YA[-_P#B6!<>
MN.?=>O.TSU;JODOKUG]O+_W>*5PA</'G;3O]/3_8+]LT9,Y[LKIOHK\WZO\
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M=RNTY9(M^&/ _@?KGKCKE?2O\GT]:"YN P& P& P& P& P& P& P& P& P&
MP& P& P& P& P&!RV];_ )$;5\O>A*=H(/X4N"[%?1$F?P:BYU#K?\Z1:/S^
M;1^M3EJRZ/*#9_9,>D$3_9N+1@CUT[+-FC1VJU^1NHITHEKL/,T_*Y4ZTV9U
MX\KB;#Y<M^1D5^-QX&5-0EP^'V20HQM>#BQE6K4\JX<5P.9+[$]K)<].5"">
M]II](_#O \L>_*:+U*_R.C+/\T6[5T,_&=&3$HN6>+26JYNC+6C:NT+ECC*
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M;J_T' ?OY)_PIFW\W5_H. _?R3_A3-OYNK_0<!^_DG_"F;?S=7^@X#]_)/\
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M76MZT'/X[[6GT/OKT_'YA4SP?1WG4)2P$01"\QV0V+;MM7O( P& A8U].RF
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M]LL8ZA!G5EU\_P#&$N>]T?5IA#<0ETAC,K3CI)9J,;NN7R;1=Q\KA))7 [X
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MFW\WPT%#O_YQ#\07_L]3?_>3$_\ $' ?_P XA^(+_P!GJ;_[R8G_ (@X#_\
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M%..=:!H=:Z^"BW'88F'>3JRKTA1*$)1<@H1Y\[M(Y"89I=Z2TXL*V-$6\BL
MS("K]Z4(%^F$LDO/2?7QY57D+A7KK7TTN.0GV8Q"-6#$I1 YH&9R*'S2/&8I
M*@!'CKM@;CLA'.!)H2]XX[3[Z:D!SM1+OY>N>OE[W\-ZW_+@0=$_)5'Q!D*;
MM ,A./Q5J!KKU)YG/IU-IF3LJ-Q#BOXW(C\OE,A*R&0;C\&01$LVSQPLT19H
M)\Z2^;GYMA93 KV)\NTZ&.*GF@>0JJ:N1]?XH01G4U*1J,6P7;3-&02B)1L@
M><AHSJ2N;",O"+-FBDP=OWZCA1':NN.N0UJ">+?/%93.(3F"1(U&BL(C40C
M0:/GL]XBJJ$!K[BJ(:8/1'N2=QV42B/ULGR&1)D6SIYTS21^HIVHW;J)!:G
M8# 8# 8# 8# 8# 8# 8&IG(%!I,\X(22&1.0/TT.&J;XY'0Y9YPV3[44X;\.
M7[-PMRAPHKUUKC77RZWUO?P^.]X&'_=#4W\+Z[_W*C7_ ,,P'[H:F_A?7?\
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M6P *0B\.L8QYVMB15NE9 .(%3$B(0Y.:#!+=XN+[(ON&;M17A);I+Z>M!?O
M8%1O?/I$QX]\5>I/4<>C@Z72&B*1L"RX_&3+ARU#&CL: .WH9B879=IO>!"A
M+A+[K2'?"W2&N^4^N>]ZZT'+[TU*_P K7A_S9,O:,\]P^=K_ (U3(>+3^>4
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M10X[6U\H?H@XY^3CGGX_'Y>>>?C_ (/C\-:U\?A_+\,#Y8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'Y%OQ
MR?\ ]51^:K_^'ZK/ZD\Q8'ZZ<!@5VJC^U&ZO],L_\[+8%B<!@0MZ"_LL/?\
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MJ11KL*V;BFG2D#(?*IR\6WO6DO\ %_Q]_*'?/ 8%=JH_M1NK_3+/_.RV!8G
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M# 8# 8# 8# 8# KM5']J-U?Z99_YV6P+$X# A;T%_98>_P#4AOZV9X$DQ/\
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M$X^<E,C(("8]&@Y.0'BKK?6FHP,&9+D2A!SOCGOO2#)BV[4[^&M[^7G?PUO
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M,"QCTK.5YNU<P7R[*Q5>S27L9-6C@3)[(+\Z1:0"#H;GZ9IR?Z+;VPX5+-!
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MCE-3O7?'709(U=]+1N..IC(K>J\#$6(J.G7LI-3^*"XXS!S!Z_&Q(RZ./BR
MQN*E)$6Z;CG':ND7RS97A'KOI/O6@T@!ZM\_2&P+/J]&TX2,FU2\M'\H!G)9
M&!3YQ%W5:0FU^Y\#9N#.GQ2O6$2GS'IR9TEPQ07Y6XZ4^">^MA)=8V+';:@D
M<L:)*=+QJ5-%B 1UMV&(</1_#URS0?MGT>*FPKUD_P"6WUFZK=TMPH@IQU\=
M;WOG0;Y@,!@,!@,!@46F/Y":.@RUM<G MG<L:L;2SIF:0B;+]&M8I7UBQ"G[
M#CU4O7)YK^L&8/:\^#Q]_HGR);]/WW/3=9=LDNND%LJVFW-D06,SKB,2>&I2
M<;P40C<R1"MY*-;JJJ\M]$TXZ;D@/?3I#CE=+IJ^<I*(*\=:[_E^&@C3T!Z'
M">?64![?P"SK..V7,"$*B,-J8(!.2@@3#P&:668==-Y+*(B*2'C8C 2*_>]N
M]K**\II(I***<\X'UUCZEI:X%VNH!+QAEBM3L$O-X2V4!M.8_!+(%<2"(+2T
M,Y+IRJ(D"D:53)<IDA[5+[)37>E-[UUSR&'U[,\QJ3:M(2UNFMWREPQZ4':S
ME;&=0YW!)JYB,PAT%*12,RQ$]T-/S921SADB@+9;<.5=\JZ^&ND_EV$BJWY1
M:*LY16NFID5JP=LA]E)*V-#TU*\?DW2S$<RG''9C743=D'S=1%!-_IOVJJGU
MQSK?7.]:#29+ZU\]1LM3 'BTX7)C7H _'PM4"H=*XQ)2,M8R1N;<#IB)9#S7
M;HG ^>8^YY5+M.'#1/OCX?-O^7X!A_3/K>!>6.81U-(=:TTZF^YF\3;51#.9
MN1CL8KJ.;EDZF9X2F5'EE0$9!:TLJD,0(DU][UPV:+]_XN!(+;T9Y^=]&$T;
MPJ3:\=B0J?21HK8D2;OHW"#K46]#2Z1L7!9)X CA-H<9*(O'G"*"G+M'>NO\
MKQ\P>IMZ H=[S .V=V5&[XMAPZ:59VVLB'+\V4Z8O-#GK: ])&>]3%PS(;TW
M5X'?<=)K[^GUK77\F!X;RO(#1,>CQ<G%9W/STTEK."P6O:R",3\YFDH<ACLG
M<#0;(N8CP1'@5$XL4*NW#X@S;(LAZN_J;4^FGV&.KOU%Y\M)E"EHA;T <EK
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M'J?,#%_K(<NV;B1<E1:C(HP0<X'6O7Q^&OC\/C\/Y?A_@^/_ (_#_P"9@?W
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MA@7R\D[N0%":##S_ ,)/B#MQI\\=/D=\])(,$$MAH[+\9$_+6I:D[L:WX9,
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MDQ/_ %5C/^SX;^KFV!L& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P*[51_:C=7^F6?^
M=EL"Q. P(6]!?V6'O_4AOZV9X$DQ/_56,_[/AOZN;8&P8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# KM5']J-U?Z99_YV6P+$X# A;T%_98>_\ 4AOZV9X$DQ/_ %5C
M/^SX;^KFV!L& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P*>^^O5"WB?R-</IYO$A4X7JUC$W"<9.RA>% WO4IGT5
M@_W1J5-8_*W0,.'U)OO72Z0YXII!OUKE+KK>L"MD6_+CY=:,XB'M.8"F<Q)5
M^QETNE%-![0MGSA'Y$6K:6W+':Y'7ZZK2%AB$]F%3PD@=#"'K$:4?M$T^>6W
M*KIFFY"^]"W="/2%0P6\JU2E?%?V2'_:.&.9I#)-7YTO&UW3A$1(=Q68#0\C
M8")(R0X?C57+9+[P<X0<\:VFKQO82]@<Z?6?Y!0OEOTIY(\_KUX[FS3T)*4Q
M]GS=E(VXIMY_ATGFL*IBJIO(1*PUWT=8V/?]F HRV3Y<,_HZ5=.=]]\MNN.@
M\@_\JWDTY*+8AT85N25'JECMBRQTF HNSW0RP(W4MOA*"L<Y44B7CK6.V4)A
M]QF_T%^Z&NU&[9PT<K*=\M$=N-A$N_S*>6!W!>9/9$<EU9R&.5(>I]A5%1W?
M/;>D.Y[3MOW=(6\K@@Z ;3#]1Z"TP<?=Z;KK[8)"GG!'[1;E+A4,U/OS%>7H
M^)D!JLXS>'H$5%+E\NTG(#=0U++CT<;RCU4\KQS"TQQI0<BF9>C(A9HDHLS;
MI]+NE7S5@W^=ZOI+@.L'._FUKKX;U\=:W\.M;YWKXZ^/PWK?PWK?_P S Y>V
MA^28? ?=+[Q>QK%<LP;41))=NZ.Y(DD 9>BF4&EMQQ?S@_C/ S[O]7D%#P,M
M+.R/+W6D6B*27T.MK:4Y"+O-OYJ?,US5SYMYE(^SH[Z(O<72#+5&"Z7M/@^Z
MDENTY^][]K8(S/QX>[D]%IAA1E5C*4^NVCQL*6VGM3OGY>@DFK/RU^>9] J;
ML"6P6^J?#WC?4_\ /,0<6#4,O9"A\VA]T[HL'W*Y W&J"8^RG4W=,F;+:G??
MVSY=9LYVEMB\42#ST1^67S=99R@:MDLB?ZN"[0-9.DW\'K*Y'5(C9'<<3GTU
MJZ..+/ET&CK,"4L0#6)WH.R+<,G[A8:JGTCQUM+Z@=4\"NU4?VHW5_IEG_G9
M; L3@,"%O07]EA[_ -2&_K9G@23$_P#56,_[/AOZN;8&P8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M12++S&"O(R 7D/IL-Z_W"0O1"LG<E"P@9>XM4DGPS)-RKQD_6'/WSP>DR;-
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MVY=]HMU.])\?-WOGCK>M?#G?P#UX&-%F0YQNN["%1IAJU)%@SER+?-2#=N8
MDG08X*76:*K)HD@QABNT=H=;TJV<H]I*<\]\=<Z"+EO17GUL#F$F<7I3B$;K
MP^G%)_(5K.A20.#RA9WR/2C<P+*&^6$:/*O^](<LWJB+CI;?R:X^;^3 DE.2
M1U4PUCR1\*H??!59(R!IE&/9AY'4'35BL?:C>5]O7 5%Z_01Z=<<;0Y56XXW
MU\W?.MA]@<^"D*3Y< :$G$1A8H )+!R+,DD/.A':@\T%?*,EEN&A80_1[0=-
ME-\K-UN=\*<\]:WK TP-<M02(Y/(Q'[5K8[)*L510LZ/!YS&"9RN5G'*_;=*
M=B611=_$5%^6JN^.2";??6D^_A\?EW\ DG Q;PV%'/PXH@7%L"DA<.VH :\(
M-&K\XZ8,7!1\V#LUU>'!-PR&-57*O"//?2:"?:G6M<<[WH,I@,#&<&PRAE>.
M<%QG<A:C&AMT!X?M.C+8,_=O6# NN+TKM\B,>OAKE%%QTGI)15NIQSUOKCK6
M@U)Q;%6-;&8T\ZLNOVUMDP2DH&U:XF4=1L8A&4>W":TB8PA0ES)G8)+MFKST
M[3:]-^=I=ZWW_B]? ) P&!Y>WS)-XW'*.VJ9!VW=.VC'MPER\<M6/;1)ZY;M
MNN]++-V:C]#E7OGG?*?2R>NMZWWS\0\@LZ$-]$^0I@47Z"E7((SR+(-'_0DV
MS306>!R>FBRNV!5JBZ2Z4;J_(MQRISOKG6NM?$,K@1I.+IIRL3<1C5E6S6=>
MR.P'J@V!1^<3N+1,W-R*3H>R581$4>*CW\D>IO2[1'I)DFLII5TEQO7S*<:V
M&>C$_@DV=2AC#)K$I<^A$A=1*:,XQ(PYYW$)4R326>1F4-Q3QTL D#1%?CM1
MF[Y2<\<]\[ZXUK>M[#;<!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@<JI'^;;\7T6.2$$3]2CW7[*F3 $])(Y5-Z3"O&+^//W P_WJTHC6!NMG
M8L&_9K)/'Z!51BVZ04^HMSI/O?(=/8[(@$OCX.614T*DD7DX<9(8W(@3]J5"
M'@)IDB2$&@Y1BJNR)"B@]RFNW<(]]I+)=\]\=;YWK>!F,!@1#>M]T[YEK&17
M-?-@ *RK.+;')F95(57&FR;PR2:A@@D>Q8MWA8V=.F'R+1@/8MW#UZZ6X202
M44ZYYV%3J._*YX#]%V?':9JF_4W]FS#1/4/BDQK*Y*H=RYT&'.#)05%7EL5Y
M"!<C/,@[-=YV/9+KOOM&ZJVDMII*=<AT/P& P*6^G/R'>./',FC,)]#W2QA4
MVEX-U* ,)#Q"P[)F;B+LW_Z4K*'D3JV(S60!HSV5UTU2(/6S=FNZ3[124[43
M[YY#=O,/LKS/[*CLGD_FRUA-DL(2=0C4T8<")/$I5#S;P>B6',I5!YT#C$TC
MOZL+7Y<LE'@]%)ZA\5$.E.>>MZ"SF P*[51_:C=7^F6?^=EL"Q. P(6]!?V6
M'O\ U(;^MF>!),3_ -58S_L^&_JYM@;!@<@/RY5=.[BB%,5U"O(TG]#")T=G
M<%N2T:_&4D:M.A:!E4>'MK2'U&/NVQ*X"L+$O9FU:QE T@Z64CH[IZ2Y25=-
MF:"X=>&O'*;9NGPDHCQP@CQPBKU\ZJ7/*?//*2G?U%?G43UKX;W\W7QWK_#O
M_#@?QWQTHT=)\\_/UVW6XYXUU\OS]=)]<ZY^;XZ^7YM[^'Q_\,#AG2WX^+MK
MRF/,*9:Q;<YL:7<^4*W]'L:Y,PJAG=>>?J9K"X%7%8(2"FE(X<D20^?V+VW)
MF^"S\\1U]OVW7;\H?/H,3ZX >O*K:>JI=%CGI(>#@U5W<9C=IL[HY7KSOSX#
M\4+ 8#%XS'R$T=$V/J!CZD'Z,ZDCD&F3_D<.W)=1@NBRP/3)ZV]SKC_JP0-Z
MO%Q%X6N'7FN.&KW'J6!4,^)OJ+[K&5^IC+VV"KRQZA;% T\=IB7I*6)- #_E
MBY8J.%QZ30,N2AGNL0X]EL4HO?4RCDML^'$(2;)VD7"R5E%GWHN0D9*,KJ.1
M'T.V:'XC&J5>L^T.XP1J0F1"IMPSQ'9=!R0Z"?O,%4>EDB/@69WV"D+J>5EY
MX]1P6Y9)*CD?-289(I;-*/W7K"0$V4KEKH^0-1N$.5.G*1(SOYFN^G3U9=32
MRP2C[^IHO:<;\^R4/$;1G>J7]*U]9T@BU16)((%-'L1:#I& -O O >?5VU/$
M1*YQLX^BL_X73:<.=MOBIUTDJ&@U3$?5K;VA(Y#*4;:;U\K*;J?2B02*PQA2
MBI%4!H5!^/.D0K&LT)0^5BUB0XBR>_K+S@(-7Z52)]NWCU(@.^ 8?W.!]@'+
MS\_K>>P-E[B,>,UH>/R2&3E8='._L_0%<N+1!3")\VU60+[7=(M"W6G9H7.$
M2+=PNP'C&;W?WG8<[8=Y_P#RJQB(2) _+?218<<6I9].V)NY']E2QV"$C@#R
MPA%:-Q/H"JI$#(KS8T_<$DQ$LCCA^':KM4'*J:;)GV%D1%$_D70&(REM8%T]
MW!Q'PD'$/)E:PQ."-1BOXZ; &.CTBK(/-I17&I)S[.XCG9 EPF6>Z*H?<(.5
MAO;I1<+G?C^K:5P 7Z2*2*"7; !EDW^(FT-&>A[ 'V7;#\$S\U^>8 6*2"4-
M)U8SQ5MU.H.8;M$7I5=QPW;\]<<IMNVZ?(4IDM8^_)GZ+NCALVOZ#U-+98-"
MKNP-RD!['J,B/;GFPB-.0"0=W<1_9[1SR6VFBRZ<:B,-4&LW+@4[7-%^4G>P
M\C_S_P"NBDSH,#8,<]%3V/P2\J5.5^51NL8^AD)AE2>X[:EDP.^@&9NQTR%G
MERGG3B!+ GKYE(C"G0_X<*-"";]1R'33U=6MA6LE0<4AI^RH[%%+\&N[L?5;
M8I:KY M4256VNB^8/)1'3 *4)!GDZ< >5DQ3A,A\_P!/M/KCGCM3@.>L^I[W
MOQZ%]#)1N<>@N:\<UM882H2L)D -R/5A"GFF-Q6OQ[ [8GH9K&4+U'W\W(%D
MGCB"#BJKKYE7LGY&.>$TP^,%HJ_B#KP):MRUO>)HW1MX7L*-(@+EL%&3M(%/
M61YE6-BS:&R+T!*GZ<:V]Y:IE01&4S8@,$J\LU5GC+:S=$(6F?GKW#=P;V[%
M[)A%Y<P>7QD-(8'!^[N-((F+'K[TS+)3H=7DG3OIQOK<@I?0K333(57\77W]
MFR58].F"CSD+5+0GV03]K4[,(\[NZ+^;6T;I[H#'"A+DP/CT,&0><M+9B%ZJ
MF_1'*)"P"DC>"NE'SF)S0VZ7TQ59&6VFA+>@F?\ (#%?1$F&P+FE6%SF@R$=
MN5F^$419(ZKY>TN8O$AC3SO,9,:?RN&Z)UA$91R2[+LNW3MEMTY8N'H]ZT;K
M<<!4Z=Q#\C1I>Z( -3NYD4:0#U<ZCUJ1:QXB$AQR6V,_\T$**:UAIU,NSS A
M$D!$UX:<D13-F!WI=#>^TWB7U@["PJ%CZH@W$9C[R>2UD#3,/F&YK.I/8\S?
M].G3PKH7W,;".EY"3^5=?;=GI\_[Y;HZ32UWPEQSKD/SQZ\A?D>A$'.QN*]R
MH&:O^=17UI9DBH&<)U 8C-URNN[Y8V[7TT,J6>_>RXCN7OJ_44>L/MPA/H1K
MXM>4DN]=ANHZG?RF(K'D",LO?1YKYOF,?@KD=+QST1\$/)4KB$:!RF9E?13<
M)^^COTVHQ+\F=P0B?74TT<]R3@=R^:IAF_2OF+UZ7@5OU&T$^H[;J@U^]^/U
M($#>A4W4I[F<OJSRH1A4GM653JT!)67TTTFK&TVC@477)M&KA[]/D9TW4%=M
M0V\G6'Y"?WF>A2ADK?IN$N[.,%#D;A,H;Q5K-:,4]4Q&1PZ.4#*W/IA^XCL^
M&>5F1$4Z_0XY7"JBRKEN[>/2RK AR'0CPO7<\J+QY!X1)XG*HY-A"]P%$(E.
MI6$/35NG)K9L.6Q1I+ID'>R8,_DK\*;9]OGO*[[_ .F5>^U.E>]=_$.6M64C
M^1*;1HF#L;KTS P!"<-I=^G(7](8_*&3_P#N8WN#-!T)PV] 3Z<D(RV]1_LH
MMS]N_!!R9-)$DU!#A:JZ/03U1]/^K"'LJD[,O:)7(4(0H%8KN16$7L>-/J.%
MQJ<4%3L>C$6C-;L9HZ_2K(96$$D*1AX/!-OJN.G;A=XX:/!VDPRWY _*MY77
M?\)L2!B3DBJV(U7"PUJUV$YK%L\O*,,_24%F,MK01*9HGN20*6A8H)5D(E\)
M<BM$'0_]-5>M]NTW+8(&U4/Y(.X[Z42E\Q]#K&B<VC[Q+<)7;J )!PU]"R@\
MD[K-OQ[!CDQ6@#BE%6 \R.BCNI7GZ2J@BBDZ+LW7"H3[$*;O^.W9!+VDM37
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M(6]!?V6'O_4AOZV9X$DQ/_56,_[/AOZN;8&P8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M@)<&&K_IQPV"7IE[H\T0$O:X:3S&5-EZ0?# MH/QU0W&>CT8DQQ2O^0<,ZE
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M%AC1V[69C=</'RJ:;?A5'2G2R850*>E/R4^7K;\N,?8S+P[8M-^E_1,9\O\
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M2K4<Y7Y#\L.@BLT;Z9J<<M^5MC-[XTKI;_+X'EF'DB S2)W?#R1^8-A]\7;
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M58S_ +/AOZN;8&P8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M.%,33@X_X<F1Z' ]@KI9^U3UVZ3#GQ7_ .1"]#TT\?Q(X.IE8+?,KL",67/
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M,.;";SF/4==U55N-90Q2M[[/P.(E)>!G[[D@X0D4N:"C G7T/NT55$6X6_\
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M\T578(?]M_33.PF34&3:6'9^EW(5L&X<=!F:27"W*CGZZ85]N3W;ZQHZUA-
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MCD @;65P9L?EDADJ#%-VJY(<:;B.WZR>NG7*'7(3=4LN1LBK:SLC74?<]SV
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MR%@(3<?D!?T1W74$DL<6OA_6H:#(M@XN5*,B=>UBQ3GX^)AY3H;NOR:D(&7
MB1<LF;U0@R0/-^G''/"R&L#T2M.A:ADGCBB4X2S:;939X(H ;TC+FX2!N812
M-ELON0\BX%DH\[/M8#V1'-A)(B@\=L';ITAI;[)3X!_')/RK[KCYZ"].^[/!
MUM-PQ]1P-[LJ!=")E%3\B$@)C 9V+_8U\6Y#R>,E&K4W'2+AGP^8.$^''U4N
M^>0BY(3^/VJ_1$1A+)@#B%V577\55%@1*%F-H?!H1'8'/1L#E,\2&<]T^&=C
MZ_'R5B#/R7?!'[1N_:LW6]IK)\AY;<]9?CRL"OX=.[CF<>/0RO;.$V=%^Y-
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M1'=HR8::MUM^BM'(_IR@X76;JI]]-W+=94+&X# 8# 8# 8# 8# 8# 8# 8#
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MAOQM>'ZO%$U).1"/Y1'VW$4-H:=LF:_"#MT''J_%/GEXF]"JKC\3$4D ]/\
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M>02$>]Z5_47Y]]TFJWZZ0[0#9ZS\:MJEF5/SB)6Q+E3$"B]M1>P]G@<5))7
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M_IEG_G9; L3@,"%O07]EA[_U(;^MF>!),3_U5C/^SX;^KFV!L& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M=R$:+>BF6G/U^TR1>)%&#?GOGCM8B/<-.-;<I=I:#0('^0#R18-1+WH/N:+
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MW'<R("#>HP1:"$U5>%.UVTHZX%_#O7'S$U4VG/Q<*II]!87 8# 8# 8# 8#
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M@0R?$:Z %V<8B3$#*GIQXH_<C-N6@E9-!RGUKKO@/&0D=MF*>MX#<H^/;E$
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MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P&!7:J/[4;J_TRS_ ,[+8%B<"L5U><U+NGL.-G+&L>+P^(PR
M:LAP:MK%G5:FAMEG"L06C%DMB$,.BAY][&0@HFT29&VQ(?K[[>MMU$U7":@0
M> C%JQ:I?132X+&:6A)7-XB>QTF91*30E%2-"Z[IF,A]. )MNE'DC9'0%0B5
M5C':D:6+/G/33ELI]PS;!>V)_P"JL9_V?#?U<VP-@P*D^N0AE\+H*1,6;TF
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MF&T7U:J4$9$*+(%4.D^1_;'AR.447,D](AV K.KX)3L190.MH^C%XB.=$GK
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M)SIC97%F5]*C;T_Z#'B&IL+"J=?!/00004@CL@5:,?8I%RK%N2CU[V1&K/\
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M8TW;.5UUDBK/E9!TD]5#U20YXNKRYHW7RM QOF24Y .6BE@Q6@11"!^=(),
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MFS7PZD)I7]S5Y\DUE7(M:$3*JFKAZL?"3;D\.(:'E!;=+LFBOM+:*C9SKCO
MKJQ\_>%;3M&8>:(?*SIZQZTA R6&GT2F\<E"E6$6WIF=6P*Y>=N.)"P$6*&M
MHN5WV,,#5D%0_>V;ENNAM5+86?@M>>9Z%ESNO&EH-1UDS&C85"'4<E]NMN;(
M.UK43BUC3.8M&:Q0=*N'B;NQ9$Z?F&?*2:?T_P#);;IL^>4PY,1Z3_C" >>I
M3:;:56A,8595V7)YP RE_:5)-I7?T_MZ!1OS?-WT:>M9M%8PWY;5Y$&BVC$H
MZCY99!#9HAMVN^X=NPOA>U7TK=0;U+ XC::=9SH-57D^.W#8KJ?QQ,95$0J"
MS9Y:D79OUQ<A</X#/P0I0VZ=/B"+=MSP]'N.>W"2*W/ 2Y6;3SQ7K&@&-?>G
M@:PJ93FTIL#4?6M#3A+U;,Y[U(=S(@Y?M7S)I.7S&9R;9#Z(9MI!@[0;MD46
MZ"::&@\]V1>!>T5*YC5/^EP@HOY_O:.69/2M*6#&2U@QE#FN[1B+('RL,[DK
M2,DS3B6?/\I9BLV=LFSI'Z76^OFX#?>/&5 \@1\2ZBKU:(#_ #.=\C\Q=<Z4
M5%.Z4DOZ1R:"OU-N/U1V9?)!4N>R?3G[S?SJ=[[^IWOO KY+/Q7^=IU$0T1E
MLKNDVF,2GK%X;<S0&B;-!K$'5Z*.AEOLX@V#1M!-E58+A)U'V88EU]LX^NZ7
M_4BOWH;Y*OQW4%-I;;,ZE#VPS4IM;03XF2,E'O7\#4C5I";JCW4,>.@*SMXV
MCUG@61$8TD*A]B*;M]#&2+<.HL/4"U%7U@ J>N0%9 '\B*!@+-\VY*20RL2D
M9-P6(/BQ8D0*(<,N$G;\F276Y39I-&C/7>D6B+=NFDDF%:H3X"HJ$06SX&@[
ML"0-K@FU=3R=R.22E%U+3)>J",5(P33TT.$BM$UQG4.9INR;Y)V=-<Z[4)OW
MB_7UM!!4K_'.YLGTI94[G4S29T'-0UL_"LX8>F(YV4E%TPVN(;+9$1#$G+Z-
MQN0HM80X64*#E5-$5'G/7#)@M^H+$PZ$UQ5<4JSF=<Q3@CQJQ+(E=J2/]1?=
MOOGE<R4:*FNV/S\<?9CNNF7'TD-?'E/^7X;W\<"/S'F"K3DI.3!\C(-F9!>E
M=>B"/2)M9)KNQJN@,7K:*JHM]);Y2"<1F(,].&>M[Y77UVIO>M]_#02)4E7Q
M:E*UA=40C@@G$H$":1V/\%7W9(CR-9:ZTAIX_4XX[=+_  ZW\>]ZUO>!5RP?
MQ[T7852PBFG!>THM&(&*M:-#"<,G*H64D(9=X\V+M2%F#:HY]TY RYD<ZY4Z
M230?->FZ';5R@HG\W06*%4E!PTJL"8LDBO)BRZ^@%9R;:A+OMIU&*U3G*493
M'MOIZX8ON.+#(_76YWO:WQ2^.M?3U\0VFMX%'ZKKN!5?%.7G$6KB%Q:!1O@B
MZZ?D.8_#P;&/!^7[WOGCMZ\T.')Z55WK6U._CUO6OC@5&8_C[JD0 & 0%D^@
M@'4-,A2%/&1MJ.>B=#AH^"G<3%PJID2 E\#$Q5.'V8;$*Z(LBC]R.<H)+.E/
MTX9TR#(2KQ#7K/SWZ0I2G57<%6O?STC0K%Z4+&3(N)CHS2KNE*]=M.>G/ZUS
MR  =H=N%>7/3MRLEM7:GU=_-@8$G^.BE3XU1&1S*[#D@D.YFQM:;O;%WS+[O
MA]AL*]#3&N;3),@K)F3@Y:.U1'!G* UL*=M1XKE)NX2^Y?;=!*4Q\>U)-:EF
M--OE94PC,TN,C?#U\Q+,719A9!*V>+I[(,TCX@W'7P9"<)Z[Y%DA[\:HU_R"
MR"O&!K5?>%:<J[]TG$+,6./:U+"[)K?AB]E+8VTL. 6I+.IU*(I9G!L,04/,
M.9;O3UJNUZ8/D>M;2VOVAVHEV&]^;/+-<>68\6C%<$9F_$$>8ZP9-I<>1+IQ
MR,PX,G'XC$@#=D.$LT!0 5QOC[I=)P8(=][5(/7BWRJ<A'$O\!T3.)-:1\^Z
ML18=:X:U6)2$H3-PWA$9/W?"&5<VM/X4&Y9[<!)O,8@RVU6<=N'#5MVZ>+M6
MZ"[YXJN%V>=:YUKG7^#G6M:^/_LUKX8']P& P& P& P& P& P& P& P& P&
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M%!K9RGIQK;CG:05YEGXZ9S8%IU/;LPL:N.CHE4+NT8W%(A9,#@>THSZ9>>G
MCJO(I!;:C DG(>SS[H>0?R]$_P#J#Y%L=41T[14:. M_1GGTQYZH9.LX 5@O
M$[;%9V81F+Z$+(@GKJ;6I+[(7V9 AC8HH0^WW,G7'6]$..E'??;C>]?4[XV%
MI\!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@5VJC^U&ZO\
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M^=_X*UM_NF(_HV _NP^=_P""M;?[IB/Z-@/[L/G?^"M;?[IB/Z-@/[L/G?\
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M!!=-_P"LWH?_ .OHM_\ 8DJ3 G3 8# 8# @5M_\ Y/F?_K"QG_[(4LP)ZP&
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ME^:?_D[C7_&+ ?\ 6LE'_9R_-/\ \G<:_P",6 _ZUDH_[.7YI_\ D[C7_&+
M?]:R4?\ 9R_-/_R=QK_C%@/^M9*/^SE^:?\ Y.XU_P 8L!_UK)1_V<OS3_\
M)W&O^,6 _P"M9*/^SE^:?_D[C7_&+ ?]:R4?]G+\T_\ R=QK_C%@/^M9*/\
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M3C@* A?3-FR*;>);!@_HF[YTQ/>)_<\^D=22P94,.6N>W_)LCK6%QCF?0V#
M)%SU(W\CF1YB34AYS@";7'M78S_Z4XU]8*R$_:_J&'_W41-0>@[IOFU[23\D
M^HK BDSBM!OZWN6LI;1?HVTKTK^@)# TN9=%&E@+5_V$!QXP)9KASH!JJR>.
MFZ[W:X7F%>VI)W^*"I_>*UO/7<<:6S6]FS.Q/T@1PO)_-CGV</C4I:.!6A&F
M[5-Y0[]1'?*2"+U/Z6OAWRXUOK K<M[1N?TH:K*RQ%LV_P"7 !;\DM">2)=1
M7+^LV$AA#UI0+:5^AZFF;XY#)!T4,A;06X:=/&2J7Q1YWTW4TFOQ\H;UZ<EO
MH:CI5^3J6PKUAZ&-;\X>::4MRI(#(S%1N8D,F5YEK^9FF*G'54L'RPL5Q!!B
M0/AZ^438=I]=K]K\]=X&*L'TEZ=FDZY:3&RK+\K/VGY;*%\W+UC'9O2T@794
MU87DRE[#/P\A*6T3E(<NF3E#YP705;+:(,-F%F_:W\G'"09KS5[3])&O>(/S
M=:\Z=$HK/?7GY%RU0/$@8%HREGG>A3=D5?U5)1XS#H][DE VC%1KOZW"O#QX
M%DXO:_2O22_70:![$]E^J:,]E>@I'#IE.WE24C8_E:(IPQ*0TP0K59E;M9#E
MW,!)4R[C?]X6<RZS;#/CV8\S&2?/Z&L]X>+IJ#QY!!4--/\ K_U?4$+!22M_
M1$K]56&:\W>(O54+K(L-KHAJ[[\]!&K?BTT\KQ%.!0<4_!0"WH.&7DL;;)?7
M>PY>'*D^W2HGD@CT'1BI+,F;^S?QL%07IZ47M![^\[W68G9_0Z+!X/:QL''H
M/.Q%A,XLSC+,O#";(O+7;)N.Y=I;'#DDF+M)1RW46Z#J_@,!@<2OR,WC<%;7
M3/U('Z>/T*RIC\?=F^EX;&6K.L24/LZXXK9+$-%HA.@,ZBI@U+!$PXY3!\#0
MI 4355(:TS7X>=(=Z" )Q^6ST?+ZPN-Q5\.I^!R)OYJL#T16D[+=665C00-4
MER5S45@BWBLS@42'V.[2=V%RHF9#MNHZ/?#W3/M9[SQR[Z"X4J_(7<,.])L:
M$5I4!+V,%*>88M=DTBY"2M JYWU!)'D<$EZW,F!W$991Z#?237Z0-ODB$E<)
MO1X[CAXTXY=!URP& P& P& P& P& P& P& P& P& P&!Q3_)/<UDU7;@^4A_
M04BAM7TY0BUQSZM*;M*IX3>,;Y8S@ETO=;FJ[BB[F-^H:Q4"QA<*O%&YT4]0
M=<J)MD'A H/VV#:Y+[+N*KIQ[,&EF\(.FX?<_C2L*P(&3DE!U%"PGJ-\-CL<
MF%B#7S54Y&&T21/).SVF[SZ9IZFFBCL;];YTP@UG^5'TB[<V$JQKCS8?!>?Q
MLED=O&8[/IL0;SP'$_9-B>673:H5^!O; 60+AZ_7-\+%5G2#$E_]2^^5^.NG
MZ(:W8_Y3;_E<3]?!Z?YIH$_AWDKTIZ4HNU]!9T_#-(]05FL:T*KJCI?^AO+%
M5(M#B;UH<3#BH^S+,EFOTBS3G;K86ONK\A4S\_KSB/2QM2,O/0ZA/--IBY#'
M)03 Q6?2>]/4TR\_F0$59DR!M^N.C8L(/<H]).7:ZI)]I%37'/:7Q#7)A[S]
M0PJFI1>Y.JJ:)0\YZ7D?E&IP,5+SH[*ATQ$>NI!Y?&V/9/;Y"/ EXN6;1MR5
M_16+EJ[X?]LQG)#OIYTY:!>[R#>$K]"4D-L&<Q!A"I:VF%D04\*$E!Y40[(5
MQ/9#!E3HS3 P>4"H'M M.E!#QTL0"N%%&#KOM=OVIV%!G_L]9A^,RP[BE%WA
MX;Z0N+R%ZN]450.(&1 PO&$A@0P3BP.!LBJ/+-]Q3#F61@-TEUPNNL_^15?A
M11QW\0R%/>Z[SFDWK^O% ]-<<SZR+D\OQT:<D,B=WA$[?H6G)+.BEK7#"&"8
MYCJMY<9@KKE0:QZ9/A[ V#=_>+_J.T&X14)_(!Z4#>?:#,0F*U5+9K+:/_(1
M?5BEK5FLS<LN&/BZU8Q'EHO$G  $@1<\SG4TZ;-'#[7.@#1!'I3DAVEM-<+3
M>4/15[7#ZJ]%1V:2ZI4J>$0J@9M5M<L11!G:((5;59HS9DLZ*=F>FA]I\VW2
M1%S]KVEV[;_!KM!--1/84R]E>D?1L(N+U%-*DN4SQ:_F^\?&%4^=/'VW\=80
M#T+&+V!5N4GO[:1Y0 0F<E(3)W.),U8FF#CCJ/?L1M9MSSI GRX#$UE^9&Y/
M2-D5Q6U!4[5 _5JVFU QF;65*)BL";5#:<!M"R_.%FJBHX,;O2Q6?Q*B9BNY
M$).6_&E&"/'+M+GOM7@-^J;\LUOVM8=4QYG0D9'1\BKYCBEJJ]2?GYMS'T6]
M(A'1^NI.=+QIDI#H,5:?49LW(UV4E/+0@T;;:O&G/#@) ;>Y_9'?DFHO3+NJ
MO/RSKT4\JA6M(3"Y%+IC)XJ!ET/FLPE:[R*G"5=$KODC(7&6;AJ%BSAH5X:N
MWRO+=[P)ZZ?!/]6^GS%C7#XLDX&0MI%6GLCR18$_<A([P9<1&.S"L5JBE(J9
M19S+(U%)FU#G1EM%!3WDD/8.%NFPK:C9NMPKQT'1O 8# 8# 8# 8# HQ^1^:
M2> ^2I6=B5@'JL*O;4\OPQU/XP5& C\<C-C^IJ8KR:N!1PPR(C0SMU#90_;Z
M=JH]Z;:6VIKX=<ZWH.1Z/Y4[8H U=U=#9I%?5M>^?+U$ F5LR])YU.YW2DVE
MU7P9ALM/H"!B-*C'D"LT_+HBTD76R3^2%HKVQ[$:<H/""H6!&^^/5%;5S,W$
M[4IRWK(E'Y![(\C5RPA,<.L-5B/!26X238I8<9ZE[%[(&&XA7#9C'62;P4^*
M/"#7:[U3I;ZG0=4?*=SF_0GGVM;@DL58PJ0S 62Z-1P5(Q,L$LR8*0%XT]<A
MSX5V^8O@Q=<-T\::VKTX0;..$G&N7'"O.@L+@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@5VJC^U&ZO],L_P#.RV!8G 8&B69%7$TA)N/LU.$WKI%%9EM7KY$NW;)R
MB\015[^&_D37Z1^3?7_Y/S?'_P ,"&P=QR*,B1\?D=9ROLH&:(#E5A[7O;9R
MFS2Y;HN.==(]<ZZ423UO?R=]I[W_ "\[^&]:T&5_?^I_#.<?S/\ \K _F[^[
MWK>MUE-]ZWK>MZVR^.MZW_)O6];1^&];U@0S$1_GV  9G%H)XZB,*C%C=*=V
M%'(G4<)CH&=]*I.$%=S(0(CS,?)]J(NU>-_>IK_'E7O7^#KKXA"MFTC3=O\
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MT>^N.?ASUO6P^F&IT173M)_7WD6-05\C)R<U1>0ZJX=&72,R-AGL=,2U)P%
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MG./YG_Y6!\>K^<[YWI&L)MVMO7P2X[:]<<=*;_DXYZZX;*]\ZWU_XZYZW_\
M,W@9NFXQ(62LMF4I9_I9>:D^'NA.];Y49-4NW2W'UT]]==)***.]ZUQU_C\\
M<:WU\.NMZT$XX# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
F8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tproxy2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tproxy2.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@#\ ,T P$1  (1 0,1 ?_$ +T  0 " @,! 0$!
M       '" 8)! 4* P(!"P$!  $$ P$               ,$!08' 0(("1
M  8#  $ !@,)#P,"!  / @,$!08'  $("1$2$Q05"I<86"%5%A>WUWC8&2(C
MD]-4E-25U9;65SB8.3$D=D&9,G6U-E%"N,$S0S0E)B=A<9$H:1$!  (" 0,#
M P,# @<       $" P0%$1(&(1,',10(42(503(682-QL4)B,S08_]H # ,!
M  (1 Q$ /P#W\8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# U\>5?K:?
M<)>/GIGK6KF"(RF>TK#V20QQ@GB=Y5Q%R5.<YBL8/*>DT?>&!X-3EH7TTP&B
M%A O:@!Z1>KZ=;"N]D><OAZEYY+*SLX^]$S[5UGP>D[BET1YTMN:U;7%I6-#
M&Z7P6/O<VB\>>4 S)V%?M&S)TOOBY6L+$#V.@:T8(.W#YN.(B*I:[4>@= 1H
M3AUL+AM;5CYSS9I=Y1WITV+*YDUUD_U(WLSA+D[H_L*<L:$1!"@!YRHDCTZ.
MV,LL.P+\TW%BJIF"QFP-\/4YDMZ3#F5KY;9:$L-TZYW?U>LY,FGM7+:%2-AD
MG;GR&1%22[N:D\1;8D;U!1ABK0C  V'0S/SG\"P^M*"LPE[NN;E])R.WH'6M
M>UQ0%HS2XM6?1'P<%JU3+:J:F <RAUB1)0]E%GM[@E)_<A&=H>TVM'""*^:_
M.=75TP7JF?R_F/JV*$T3V6]<F5W!(=SU;MBV/;;DG <F8R$C"VQ%&6SV4!4P
M.JJ2Q]082"'I#&\IP5>V6$>V"8]^;?B)7 .:YW& = S]9UH/H%LI2M*]YWL^
M96^_3+F Y&EN6O'2N&5E4O\ 'YI%EJSV>R58"TI@2C3M*-)@;.P(RCWG!IFU
M.G_'A3-"5A:UH53WK6%H64V70AKN=ED0O\ Y497?X-+F(N/&%$*HK.FYP*FR
MU4K*31)*G3&GZ,*<"#@AC?=7F,=^%?*/RAR38<%C!O*=XTTW2VUKJ]U?]2>E
M)7,[=<J<K^521U [!B374I\W.96MS/6(RS$IKOI1[UH)6DYH=I1/F?B@J&!/
M^DXD^.=PSCLSKGF&B*%Y5JRP;9M.W&[FBPY PK':,U^UKI.\KU#!"VDMRD3D
M-2D:4FS0[U['VQ)0@Y*[SE4C*^D/'E3="UQ:-O0#N9+>!KE:+;7-AIE=2/5/
M'%Q9SA$AA)D7 ZI9;#9Z<+4\+7F(M0ID**7J@F)W!,<$.'5GG"H!NYBYILVW
M7>4WA:U[5M;=RJV'C7F:]I,0S4O4-GR.OYE=CW6;X.36!7561%4VDHEJ]Y5C
M,6+RSA(BS2_W!86$LSS+\-57/VR$/4HL]Z9RXW2$MLJW(C2]CR&E>>V+I7W'
M=!J^B[%3L);73QMI%N2<Q 0ZA+/3DG@-6@2E""/81YYF/(1;WC[K_E)ZJ%YY
MHARWH7JR,4!*;*ZQ#,M4W6$6?X'/92JG,B50F7PQS0)FE;%2-&G&*1DA3C'K
M8-;V$8 K+QKYO3GZ(]IRCL)ZH&=UWRQ.*$@]>=-<&,MM3ZF.H)K?[:K^"4S2
ML4D1LLF$TN:-2@"1J6(6A:Y)QJ7 O8MIRRA&C"Z:KS+\;):?9+0"FOM9+GZ_
MUO+"3F5#0=AJ>L4_0S2R%2M[JMPHD+9J3HWQEA9Y;TI4"W\-TV'%&@4CV:6
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M4=B>/"P^!9O1YD8U[XY-\]N:.VZ"RFV=C>1Z9W>-*H\4%O) UB/3+RR5I:H
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MQSG=</TGN:Q0LC6WV:MN&NK B<I:$L+C3/LA"WHRBS1*%)PQ*?8F&$#"I0/
MVR1WC'J?B.M>BGR$5S.>I67K?BB3#C3[)IYQ/930YQ63%DM,I?K$5/UD(R)5
M'E1I*D]6W+_=GE<$XTXXX1VP^?37@K';-/<4<\U-?\?@U%<J<_RGGU_J6TJF
M=[:K6<&2J,LK)]8-% &RTZ]CF^@HVY-ZQP;%S^!_;$ZUS-.]UV+1@5 1P_?+
M[/L@IE]JE3U6U)U#QXC:;\6X'TBF56R$YE0W<JME-= FPRSMF&@>VXPMN,8M
M* [).")1I<((M$A#GVCX&+&M'LADZ??NMHH]ML#ZUYFZKK%+.*+?9I;4)0T&
M=$O?>;(O9*NZ4,>@_/SUJ.GJTR)FCB5PTX*2C%JA8!.("@,IB'A'N9HG#1&Y
M5V>P2;DXGR=2SRBN].HN? ,5D&V@*R%ME5_5[?;@K1=49=;('TY,H>1&,6W)
M:>E'I.<E)4>R(#Y0_P #[I%HKS_'#.G42\RD*V\KL /7!J,Y-J3&>3)Q=EZ5
MV GW8I_PD-/;<_5,)V-1\<]3TA&@]/HT':Q[Q;OO'SG7%U+YVNZ+IVJO$A!_
M&OTKSQ#^?'676KT/!*F:I/IN?*51M]FI@1^02]UDW_>LBLAZT8A(&G*/]H?H
MXD,U^7RX;LSC?BE8^7^TS1JZ!OZ8IY5*&VSCFY39T.J"LHNRTMS'5\U/:CU*
M$AS@](P5L&8C 8/;>J<5"<>_: '@8E/?"7/9=)[?J%OZP;&GQ\]"]M)N][@Y
M^44L6ONQ5:QDYC-H2:N(E?>I^F;&2I9?8\21NAOM8R>]("PC2)U7LQB,V&R;
MA[CE5QX5UN!581-@BZA[@Z![%*$3&1QG4+)O)1&3P5^,(WU]^.F1K\'MZVY:
MVDTJ]K_^S%>K^Z")_'MXPZBX;BLI^)-%5VK<,AO:]KA3WKJF8O%K&;6RY9\]
MS%+#@R8Y1(Y2:1%D+SMOT?IQ !06'>PDD@W[/05K4^&'9W)EFT"CZ'-9;-</
M(U,/)71URM]:)5*&J[E5W#JVH T26OW*5J4MC,$;&(QL< C<&[;DG.V86%,,
M -:"/Y)X6[GN*+]5'WYV(PNMI>0NS>? ]Q2BJZ//@<;D7+'.[*?'V#FJBF%T
MLR4.59+Y8V'F%.TP<5SZN,*4&@ CUZ=#V%,/(1XU>E47"_%_C>K%_OCH.Y(3
MT$OBO-/6\ J]%$67F;CYW:%],S>&].V(=,EK<'X+S5:#HQIU2).F42D+0ET6
MB"I3FC-#>_UCP5%[]\<EB>.VMI&EIJ%22AF"@H/(?P>W*DL$B\50L+3'Q?@Z
M4[QS;N! TL!1/L]+$VQ>GUO7U_TV&IEV^7,BY]W=8W,R=#)6Q1T=<_(%L1F/
MJJK/7HJL2T#:\4NNXXTB-U8:<MV#?EAQ,A8(\DIOTT__ *PI<+7K;#,:U\%M
MCQ#OJO>VY?U?$['<:KZLNJ_8^KDU(/[E>LR@=V1:8QK=06!=CQ=#H05'JB0R
M<I+$TK&P-3.F3$#V<A&,PG24()3?+GV,UTGRY  =+4+.IKQJJZ.KZG7"VN7)
M!+ZVD_/70DB3S?;-:4$;[T87)=<5>STQ6Z-3\UNB!K-*- C5-AY81'##91RO
MXGFSEOH2!W2P6HQ.;-"/&TQ\"ZA3%3\>KEO7O:6[W^[Y'<+<@B#RGBT402-\
MD9Y?X-H6T)*86_:>^&B]/I#5S./EIK#E_/M!\V']LQ=]KBI^/9IR^X,]C<]O
MTXC<<E[_ &=.;+2=%4; ]7NR12O[@<2I:G8'%T<BGU84U( C1'$'B*VF"VU@
M^$.6S OI1>3?]0O2[H.K?'E7[I";;Y98;<J!R#PQ!I1$GAMF<3DD\"]GQZWE
M$CTI(61]SCTFBPDX=I'0X0A[&%[?%KP*Z^.GGB24H[6R;9PI1;TVM9 S,S?+
M&&J:;:I<0RI4%-T9%IU/;0E\9JJ)%,OM4B=P?G%08L5J3Q##[7U A1:O?"K:
MU U-Q$?SWUG%X]U+PI-.RG: 67/J,5RZH;"@/:MCR:<V'7T]JM!:+#(DIC&!
MV0:;G9ND9)X%;>,8B=E*=E$A(?,?AB+YRN?B&[S>A5-@3'FA_P"^+-N9P=*X
M2,IU]W3WUJ*J)U,&1.V2@;95<?B2V-!+0M11#KLU'L !J-&:,--"V?9?$]@]
M#](^/_IVJK>C-933B"V+,E9[),Z\6V!'+$@-V5[JKK*CP -DQAJZ.RDN)C.^
M#N'M%2=,L.T:<G."7HH84IJKPB$0*L."ZJ?[^*E<>XVO?M&VI'[&N5+*=:T=
M[!0W8U+H8D&"=+1PI9$&ZXQ@^(^LX^^#1[$$A/[76BPX7C*\(X_']<L7L%[L
MZC[(C].5;)ZCIA5$>8&JN[F=6F3NJ4T4QNBWG.>SI>^R]OBJ,#,,B-HXXTN1
M>]JE:<9^@Z"&37EX(N?NP>HNNNF.R9M-;=6WY#8'5%.1*%RRT*9;: J*&Q%:
MTKXBJ' [-0HK<W+)FXFR%66]I-M@5GH !'ZHC-C#ZTEX@;&KQ\HB4V'U6ELR
M2TMXM[2\:)KN"J%3 ?*FJ7SAL>83:*D1]C/AJ15#X:P(&M4VB&H&Y*21JM*R
M/7]CH,<J[PEN-<1TYA%T<C=MF^%4/B+TI!5AJ'0%X9!-'S\?6BMSY5O:;T2W
M17X.>MZW[QZWQ+]WZ A#ME^!VZGB%OM<U)VQ%*[B=N>,7G[QR]!&23G 4]>9
M,DYRB"Z*QBQ*Y/U;D:3P8N7)W,\IT;U078:=,8/W=1[P(D],'1W]\OO9-Y76
MBLAQ[ AZZ-QIPXUD]<(;#H.06%-ZD<^46N!M+G7M12-1>+/&:TJ&W%,0/>'A
M.VL@'@US6:"<M/)"H][#;QQWQ*HY4:>V6P^QRIQOK[M#HKK8@XN+"CVH"1?#
M?%4)4#-+$_O'X2&1C<:V+;CK:+2OVWH]W)]7TB#1W'OE?XZT?BD6K>I2E[O6
M'CBN;B%0,FH%"1IDMEV)%>@8#"^BU;5NS%!9"^NH1?RM 6TB$<<H"B!L#@GT
M:,.@SV6_+CM[K9K)*FBYZ4>(Q,ZKXXKOH!/<7*S9;\O/<.1:WAM6CD="+I#9
M)4*K\FY(C"4B9W0R%BE9;8<'WM$/V^@^J$N5GX$V*K>WU/0[)8M*.M+CZ_E'
M;;?$Y7S,UROHAELN3JU$B_%TQ7M()ZOCC%64>GZH;VV+4<3)E2/?_9@<=%[$
M;L,@Y^\+-CU X<JMLCZ@BDL@?&W7W6W1=2-C;2[@Q2A[A7547L]$YP6=/QUF
MN;>JDD9EEHJ5I;LD0DISD:<";W0 A>W"'21_P9E0ZB> *KD5QJK88N#^6N_N
M?I-%&"&)(&\]&-G:56NU?JTD?D+Q-G=KJ5R8TJX19)ZO3P0<:8$1@R !WO H
M1XU><_(/+>P>57N=LG2M?POB3Q_7[RY#9YTWRK *.:*R=GW<$A5'1R/H8[;M
MA!Z<ES<RQ,M?(9$B4MT=7HFM*642E4&GB4!ZT:A8;'B]6U_'+@G[;:MILD29
M&RP;)9X@EK]JG,M1H227R4-\(0N+NCBB1Y7@&>! 4J4 3!'ZFABUKTX%"Y%X
M[53[SUY)Z*U;)"4SR!6S<%G)9-N%C.!58+4J6L:Q S'M/X3E[F(F0==[6[/"
MH;?>-*]%>S+]G[088)VGXKFOK^:65/G2?0XIT?HMQZ"!Q6QJE2VE6J.;<DV%
MT3,0;M.&+Y4S$657%IL'0JYD<V<LUK5H2R??$R[WGV7L@L9P5Q[OCVNIQ'UZ
M#G=ID5C3\^=/++R]SQ'^<*DCI)<>88TTQYDC"%YE<JDYR)*Q[//>9"\N+DH/
M5#++VG2%)TI0:_Y=X.(M*N:^%JH*O%9'+CXELJ,R-)=C!"1(R;9JI)T QWY,
M:,G,/#+=#4PJ1R6)LB])[5Q4[:GYC2KR@;T(\@T)UCWCBMUNL*$0]XZ*B3CQ
MA5?7\O[;KZI45/JV^[0V7*+%G-S-E:R>XS+"61ARJ2%W'82Y]1B3Q9,_*DY"
M1N4+1$E&FJ @N'^&V?M%;Q"&/73K"1):<I"*T]2,VB].GD;8W2E^PX7UYS]8
MTUCK[83NADZ]BD$"0-LE:4YR%*])Q'B3'(-C#H =]?GBTO[J53 +>Z0NSEV^
M+YK.9SY9#*SMCD@Z8\41ZKK&AD(BLAKMJJ9RMD=J%R<U_KUOE(9:HF"E>6Z;
M.0EI0-AGL=!;=!X_& [QSS#@!VET<C"&P*NLR"R*;T;44*I.*M+S:+G(GYW=
MX73<8]O$F:/('>0B#IJ4GKC'1&6(#FK6*%*I2:%;^>_&%<L [I9>^[:OJEWB
MQ-0!UJ29U52G.CS5M.2:-"B+1'&>U6]H?;FG;A'.CS@Q-F;'"1@&>D-AB M@
M+1 +*)6!"X6^'Z^>NSK?ZTL)O@=D%611E!T]'X1,*U87]3!%M*S"[I4LE+5)
MWPUT%Z9;^-TDD:8A&DV0)J",1IVQ@"2&/W;P1'+YFG83K,)NO00WKGC*!<@N
MT?8&<A*]PI'#GGH)T.G;0^J5JI"N7GAO$'NJ,U $E.:TZ$,9P#]EEA6YX\>'
M6EM*+"EE^]CP-;:,VH9GX^23"F.?%=>HF/FI]GK1+N@W=*RRFU;"WJ_KU:V1
M,VDO 3PL40]B!0A:E!NA>N%5NL/&S-&GF3F3@*J'NVI:R-_4REBY^LV%P?:7
M?+/#,NCCG .AJ=NZU5[ZN3.3,EYMLR816+.)@4[N_CTRIAE'N"(]Q-#=;T#0
M[[:5!KZ>IRW)=S#)FH,&5U?9=8$E^]0%TK:0L$BB[<KC E;<VRZO''4=+:7Z
M.J#B4KRP*52$1A6CM&@#5]8_BHO?H4[HVT+[Z"HQ!T-;G/,7YYA3Q0_.;_7E
M7-C;#;DBEZMTVMV/R2Y)O-[<E#E,X2@1E!$^-I# S&KB$&MFKCS]AB%B^&^V
MK?Z60]"V/T#3<A>6SIKGKJ=GE3Y1,ZF-PQ)PIJ3UK*W3G2MYG)[Y50^L^>%[
MI"5NVX+/&T\A*)<]E+EJWT*S%P?.?^%^42[\#WE?+N2[8D%16WV@ZU?&^F.5
M72XZH<Z3[+NXCHEUCE@1'=N,#F5<M5V<8H"SRM@<&M*M91"1*VW>U!AP FX'
MB8TDIB^ZC;+=B+$"\/'Q">)#5<+HB+5O$8O((]->DYT_VHP5E!'UEBC.R/SQ
MT0=[".(]$;2A;_6-<%1ZDP[0?WKWQ,-_4LZLJRUT]KY:_/3YR)-*^A-N4PEM
MFH2I3RW'.BH8Y-%N0E9+F,=AP6TXCT6Y)#4Z12SKV14F(7)E)IY0 Z#).9/&
M.HH>9\Z6$?)J&C+G3MA=)V/(Z_YOYI8*!J1T67]6,(J]M88K'F>4O+PG+@S-
M!4HC7E_6O[V]#%L!AR9.6F3D!C%8^/&^N5G:,670]P5_-)E!.7>MJ<U&IS6#
MF F4RZV;SFW3%-O+*L26FPHV5/&;$D2=J?4J\\TIU:RQ#)4MQH]&%A=+JOF=
M]ZTH.$5;(I8TPB1-%O\ +=S21T1L!LF953G0-W5K=;Y&$#:H=6DW2"5J(*:V
M$J33A[2%J@G"*/\ 4V4,/QUGS');M8Z??Z8G<<IVZN=[I;+WJ.3R""[G,!5R
M4B"SNKI)%;#A;9((:Z/,2F=<V6\-QYB!U;W% >:0K3G;&G]D8%=J&\=DQK:\
MZWZ5LB\VNP+<33_JRVKG^ 5N.&PV73?I>$T/7#6U5XS'S&1N,'A54P/G]F;$
MI2]8]N#ML(U2E26<8,.!VU!>.U922GB109;9,CUR!">M8>H "%F-7XP-].RB
M-2,A>7O<G7_@WJ%:CWLA%;TN]_V;ZVA)_5]406JX_H(WE?ERA><3Y2";G4I6
M$4KHR7EL^X^7(QQIM*;Q.X&03D\":PK=E>O[':I1ZGI]'KB_ZX%05WCSG##2
M%<QBK+M8(]>E&=H7UV=3UC2BMU4A@P7R]K/Z DTCK*?01!-&5Z>H>X5GT0\1
ME6J;WIN7>W 2Y$>R&7I+L,CI7QG4XP-<5F'1Z&.=!]'M=Y6+TPZ6Z6ROD#9V
MNX[,F+-+W VOH6BEKO\  (C%"XHQM;2E<%SLJ]R92!J3SCC#A""'ZT\4/XE*
MIY9*J*WVB%=.<KVS;4Y:+X;ZU 0SVK75_P!QR*Q+QHRW($CE:53*8/8<=>DB
M?9XW;WULD;$UOB48#4GNQ@6=ZJXV>^B["9+"8+1:*^<F'E[J/G9$F?JJB]ML
MAZSHQVHYT)DK_$)PI-A\MC; 73IB1QC[BB-(>D;J87[PD$6$S85 X]\3LBYU
MG,,E<EM&M$4$B-V+KW:>8Z%K2>P+FV&3=#2DRI>,.E70^QKEMIR@2E659+T^
M/A*-26V*W,MK]V1I1(#%"L*XQ;P43TBQDEB3GI.LY-*&2*]:04^U"Z(EZ[H&
MZFKJ&F+'JH$MZ#MF:7Q+C'R3P)1,TBQ.VQYO88ZH"E/"%&1LY)[@$[])^'PJ
MW7N@)Y&G7EN9SVIN4X5R-)$G7G*J?HZNE\8@BDQUB]IUW&"[(@KI K*C[V[.
MPA$&.#BU.Z)Q G6%^E(2=@;=J5K%LI6GZNJ!F&V&M=8P")01$H98I&H(TJBH
MNQHF?WQMA4,;VF(Q)&L$DV:6VMB5.@1!'HD@L!0 AT$G8# 8# B&_+6/HZG+
M!ME-!9'92B#,!KR1"(HX11F>'XW2A.E+)^/3N016&1MI2"4Z4.+HZ.*1"V-Q
M)ZHX?J$[UL-9/.OF-KB[W]#%'NL28T[)>IH'RG-I)75UU7T%4D5EUQ5)(+-I
MB0([7K%Q4L$C9IP^L(8>H(++3KV>5+4J503LLX)V!CMT^9^/U?3$:OYAYZ7/
MU52@%[R-CFMB]"T#0$=EE>4G8S_ F]VK97:<L;%UC3RW6^.FR",QMN2[$:QJ
M49JQ8D-6)R3 X"WR'2"P;]I5MIF6V&A@MB=.<9,\ACTSB-;?"SJ=Z+X0O_HY
M#'(?I"R'39N=W9UB#,K=AN2U0L3.";:9"<6C,-+&$'7/YLWMYK'L6"0>M?Q&
M= 5MQ1T#U)42Q-<G.G0DMCA5+*8LSN;#=E55Q)YMNF[6(73IM/2QU[]_3*_4
M5IQ*=*49Q&@L!9/D:NXT^)U:]TC-.0KV^L%X_'4V-SM^JNT4\_Y9Z9ZPCE)2
M=R2O,152!DCDL3A3.3/(6L80+F!0L2GHU2@LXI2$.9S)YO.=.G>D8-1$6:X^
MC9;H?;"C-&2]LO:E9M-Y,\5NSR62+Q6;043E2^UZ.:);&8<Y+V!4])1^\EDE
M$K@-JQ4F3&A)GD-\I3+X^' U3+J8W*H+'Z]W9TQFCY?E"TT>XL1#@[)G.*4=
M"+.F35-+\M5F;V4Q8I8VI&F)T!4A( M&L6%)]!)7(?4MU7STMWQ7,XK B*U5
MS_:=4QBDY:4_QE8IDT;FW/\ 6-H#"]-3:N4OR9T=?PS ^%FJB2"TR%V3MX@>
M]HE0A<QTZ^OT$+B\QU&-ZF/HI'7EAQU8MYBOCHB5IUHV,T4%?^?GZPHW*J->
MC"5NR#K,=G.GY:%N++%[%3IA-V'>]##Z/:T?@]\@[.+9S\7R?&;6#'Y9Q'"Z
M]J^['W>'F,.GGU^6Q1->L:./'R7'3FM:.[']W2)Z=L]<<_R74B8B]+UF<&3)
M/T_;..;1..?^Z9I?I^O:R\ORGUVTSNGZNL&IY_7UB61T9*N<I;''5?'EP*B>
MH_#(!,&N83)T0J]I!0^5AMZ((D2@KU?^[D!(1?= +6[);\0O)MSQ[F_+O&N9
MXWDO&>+\8U^;U\^.F:D\CBS;6YK9-;6QWKW?<Z_\;R67+2W7_;T[S']T)/Y_
M#7+CP9L=Z9KYIQS$]/V3%:S$VG])[Z1'^MH1RM\S-2L5:I;(EM,VE&D[U)N;
MQQ1A4GQY6\2.F^FT,SD,,O5.6D6#"DA['#*TD;L[$&?]PC3M!@1;](M;UD^#
M\&/,^0\JOXMPW.\1MY,&IS<;&:L9JX\')\%?5P[7$S-JQW;.7:WM+7U[U_9D
MOLUF/2)A#/DVO3![^3%DK$VQ](].LTR]TUR?\(K6TS_6.BZ[;UY''.A.F.AR
M(7(PP?G-]Z/:"_65M0E%FH^912!JFC]$C2CS$Q#4YR^(.[6A$H$'9@T.SM^@
MLP.:&VOA7E-3Y%\4^,\F_J_S_D^OPF2?VY.W1MSOLY-7#LQ,1:<F/6V=?8RQ
M2)Z1E[(ZVK*Z5Y&EM3/N16WM89R1_3]WM=8M,?Z3,3$=?TZJAN'E:50Z$/\
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MDI$9XPWGNI,5O?I-.G2>MHF+5ZS'3MZ_2>D]-KV>.60& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P&!6_K;F2&]@T'-.?YV]R
M.-,,M60YY)D,5#'U#NRR*OIO'+%A[G\(E['*(;)6U'*XHB&M:7EL<&EU1Z-2
MJTYI!HPX%*6WQ$4^*INL*TF%VWU,WCL-+4"ZPK+VJJN"RV!SNBDI)-7SZCFR
ML:NAD)JQSABII:E3<D2-9J%*K:23M%B--5#/#Z7)XAZ/M!SKDV+6?;%*L,'Y
M5:>+'&/UV@I]U,?N>V#3KIGCK'([,JN?26IY4 +ZK)5R"(*61V7IC0 .-$),
MC,3AD,6\4% Q=3#%)<VMUPW#''G9Q3 4/\=1;<C.;.4K Y!B1:Q2S15L7)-/
MU=6.N7.1B(U*?IZ+(.2#2E V0(("B_@NHQFA"RO9!T%T'*HN5RG<?%<4:B&[
MGVOT4.H2Y4,$0/!2)+6%'0TM_M-!JN&LW<O>/B#PX&D>E8,[7H#H+"L?C#AA
MS^JF]L]#]"WW9.IMS"]L5A66X5B2^QN!<C7 7=]45,WHH56D3CJB..DZ]JID
M[FH1&R"1&&^N>N#LE-[$,CYV\=K+S7/(LX0KH_H1PI"LELW74[S$Z+ZV1U?7
MOX>?%]*V9;(XW7+%;=EQ&'%/RHJ+M$HD3NB82Q%>H$TQ*D-3A@/6_B>JKKFS
MK9L207/<U:I^@*,:>?+OCE>H:95G2^ QLF=%1]/&)W8M3SRQJE'L%B.1;L5%
MG5J2/I&RP+"A[",9@6FI+E9OHFV[QM.-V5.7Y)?*"I%$HKZ2)X:*+MDXJ2JX
MK322<L#BT15ME*)=*X'!&<AQ1'+5#:!0CV>F(($<9K?,=.L=W7MZ^HU)3;Q6
MW7.YA8DN>*HYUT;9?6-:]</[8FZSM\AKU*:X1OZ8^N41 N.CSTM2V.MF<A7R
M1K]J(U<LD*[83RPC $'TOX'\O_ O'N$XSA=+F?)^SBO#=[QS#DMX[QLY/M]V
MV&T;MI_R6(MR.E75T\6CL=L5Q8]/7B<=IK:;8;EX#:RY+Y+8\/6^Q7-,>[?I
MUKU_;_X?[+=UIM']9M/J[KHSQH]%=,3CH6Q)E7//<;E'2-/P.H9:MA'6UP-/
MX,!KZ:1J:M=BP3WSCAP&QV2Y*()'$*Q>/9Q9C?'D)82@[ (0Z#XP_*KXQ^*?
M'_&?&>#Y3R7:XCQ;F]ODM>FUX[QN3W_O-7/JY-+;[?):1ET:5V]W+BPQ%9KF
MW=BTWF+1$=]W@]W>RYLV6F&N3/CK2>W->.G;:+1:O^S/2T]M8F?TK#*[B\?/
M0=U36"35_H_E)A%7G-EE<KL4:B_4URH8N96EAPYR@2(]<W*^05HSI'6T7D;V
MGCBG1@0(=/JW8P&[&'U+/X1^2GQKX'P/(\#QOD'F.Q')^5:/D&7/L<!QE\\;
MVELTV[12]?)*1&#>SX-6^[28F<OVF"*VIVSUDV>'W-K+3+?%KQV8+8HB,M^G
M;:)K]/9^M8FT5G^G=+L7/D_O^'\=#Y3JV)<V$PN.<M7!0B-B7=+V&\+K.>+%
MA&V,%@S]V=^0V=4OL'XZ):X;.3.3*W*U[XM&L#L&R!)J;4^8_P ;^;^;X^8?
M+MWRFW/;7E_&\O;-3@]+'30Q:6U[OV>GCQ^1Y*TT_:]K#VY,&UFQX=7!7!,3
M[D9>;<?R^/C?X_7K@]JNO?'T]VT]TVKT[K3.&/W=>L^DUB9M/7^G2)8IXXNX
ME<%0LUPN-56](D=:4U5D2?)QU/,$KI5-<U/95=7*"!QDJ(<1MS2\G2J>UBS:
M?WQWV[/3FC;$I7OFMDZ-'F7,?E#^/^'R')O>$8N8X7C+\KR?(;&+4X#6MCY#
M=Y'1W>,G;SSL^4WR8HU]3?V?L]76^WU<&7/FO[$]\TK3X^%Y6<45V9QY+Q2E
M(FV6>M*TM6_;'3!$3UM6O=:>MIB(]?1)=U<,]M75.[.D2HNE() >@R(6FZ>I
M*$=46*17]_E0-M11YIT_N;UQ.\3J##?(:UHV"0"C+HU;?6-&2F/]40=FBQ7P
M/\@O@3P/Q[B>,Q3SW(^1^-6VK<#RNUX_I3N</.W>V;)[./%Y3CU-N,6SDR;F
MG&]K['VFUEOEQ]8F*1/M<5RFUER7GVJ8<W;[M*Y;=N3MCI'69P3:O6L16W;,
M=U8B)=JT\;]FPR\5O5S# >?G3H8^7S>42*6[ZUM4E98U?R..%,+5S*]MRGCY
M-&T](0Y.R,YT<0@ G4-3RV!<]JQ*EKJ:MH]SYQ^"^=^/\?P[R/(^28?C2NEJ
MX,.M_CO'S72W,&><V3G<5Z^26SSRNS.79KNY9F]-C5SSJ1AC#KZ=,':O&\GB
MVIY"E,,[G=:9GWK_ +JS'2,4Q[/3LKTCMCTF+1W=>LVZQ=S/PAV-!.9^DZ>E
M'/7)[$U=C3FV9W.H@Z]2VLNDM2QNR2QM<-J2,R)CYKE;%I%2$9)3)F(]$I-1
MI596STX ZWZ,R[Y6_(?X/\A^5O%O-^(\E\RV-SP?C^.U-39Q\!Q],'(Y]&8R
M;/(Y\.7G-?-W<KGF]]NF6E<F3':,>2T].J#1XGDL6CGULF'7BNS>]K1.6_6D
M6]*TB8Q3'[(Z17I/2)]89C]1#N&-0;GJ/4NHI>BY[SA )56$7NJ(=.3:3SR:
MPZQU#"\VNFM)KL3A^50B9NUCS:,HI,K7C;25*21%>]I1%!,-),LG_P!#_ '*
M^0>3<GYW7G?(?'?*.2U]_/Q>SP6K@U-79TJYL7'VT,FEY5K[6KCTM7/ET<>&
M,]J9-*WLYHO-:7K)_$\K3%AIJ^UBS8*36+QEM-K1;I-^^+8)K:;6B+3/3K%O
M6/T8@O\ &1TF>RI(>UPNAV&"?5TC_.[['$?6UN+'21:@]K/%ZUW<ZB<.G&RN
M5MUV0NYY(XR4#DF/ A<')5Z5:,THL!6KUK_E?\68]^_-[>_Y%L>0_P"3YN:Q
M9[>.\=7'A^ZX_%Q.[QD:N/R:NO?B]KC,&'1G!>DY<.#'_LYZ7M:Z.>"W9K&.
MM<,8O9C',>]?K/;><E;]TX>L7K>9MUCTF9]86#JJ@_*%6Y#NK>+%J2RI=()=
M 'YXE4FZ&=6-$*,5\J,.(KEEKZ%\%,%>QB/3!.I4%2!P0MY3^Y[4>TTN*$2E
M]AK7S#Y&_$GRG)@PZ7%\UQ7"ZVEN8<6O@X;'EO[^Y6(G=R[FUY=FW,^;6M6E
MM/#ES6T\'9V_;WC)F]RLU]3GL$3-KX[Y)M69F<DQZ5_Z8K77BL1/KW3$=T_K
MZ1T@H?CE[!7HY-7\A_%6_P#,[UJY3F+E3ZX%J1^JX:XWRFE*>?*$+[%^+6BR
MY.U-YDW=U,;:GMY<6Z,K5@3T96C$B':784?D_P#"6OGU/).,_F-;Y6P?QD9O
M(/\ &^/S<ALTXBVO;3K?#G\HR:.#)>-76IO;&KK8<V]BQ3CSW[<VQ&6D_A>2
MF+8;^W.C/?TQ>]>*5G)U[O6,,6F/W3-8M:8K,]8^D=.Q0\"=T.@WMYN%[J6_
M; <QT$UMED6'T[+6R01B!\YW=&.@(5 V9L@G"\6C)B>2V'$TI\G=U*,]Z? !
M#H2DGV)'LZ78_([\?-2NOH^$:_,^.>-XHY?)DT=+@=?)AS[?-<5GX?:V\N3;
M\LV,\3@TMC)70UL>6FKJS,S&*_N9.[M'$<K;K;9G'FS3[<1:V68F*X[QDK6(
MK@B/6T1W3,=UOUCI"7U_)77C^^2EQ>:\YH2DSKL"G.R9$-LZ<M@X]%8%--U2
MLS&S,Z95R&44.*+$%0(!JDQQNE)QRA1H"HD(B_985K?,WPKQW'Z>KH\GY7?)
MQ_A/)^,X8R<%QT1;3Y._(Y<N7+:OD<S&Q6_)9HQY*U[*UIB[L-YBW?43QW(W
MO:UJ8.E]FF:>F6_]U(I$1'^S]/V1UCZ_7UAN0SPZR4P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M4=(E:D+2-FT7(I/5,SB;])D?N@]BV2O4'E;/_??5]I^ZP*8_L3N1/\T>_?\
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M]&K(?%"!2L'(4-.SV&I9*I*,;2])S5P#S$P!#"5L.C!ZV%4/V)W(G^:/?O\
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M4E*=8=#T+&SFQ.ZNCP!0Y1:HK%B# Z/0E3N:$:]0G,6#("44(S99180A6O\
M8G<B?YH]^_\ N0=N_GQP+CVEQG4]O\_P;FR4R:]VZOZ^+AY3&]PCHBZ8#:RP
M,(9%# S[DUQ1":L]ERP:I$I$-P$XN:D3DJT$]3LTX(1Z"G'[$[D3_-'OW_W(
M.W?SXX%QZ'XRJ?G6II_3,$DU\/43LE4^K']SM#HFZ;;GB$V0QI'%5P8I8EC3
M:236'$$MJ$!B4ML6I0)%FQJ2= /&(S84XUX3>1-:UK\:/?OW/N?\D';O_P":
M\=:P)_YL\<%!\K6*9:%;37J=_D1D=<XP)!<?7_25X1'3<[*&]2J/!"K6LN61
M<#L68VEZ)6Z2Z5$ $,)8PZ,'K88/;OB?YGNNRYC:TNL+LUKDLY>#'MX;X!W5
MUG6\-2+#"22!%1Z#0BVV.*1IOT @.])D*0@@(M[WH/IWO Q.,^&WE*)R2/2I
MLLONI0Y1E\:)"WIWKR%]FOS.>N97!.Y)"79C=[H6-3RV&J$P0GI5)1J=05L1
M9@! %O6PLAU-PG3/7[O$'JTI9T5&U<);G5K:"J0Z=OF@$"I,\*4BM4-_;J>G
MT-12-66:B!H@]: \T@&Q!+$$(A:V%5/V)W(G^:/?O_N0=N_GQP+C2+C*II/S
M$T<EN,FO@BL65(R(TDB:.B;I9+I-*8'TN0HA+[W:IJDMMQ/.7%Z I,.=QB5)
M?20;L1._4P*<_L3N1/\ -'OW_P!R#MW\^.!<7F'C"IN2F*<1ZL9-?,B0V"I;
ME;X==715TWPYHS&Q$N0)PQIVMR;2]QBA)A+@/9P&\Q.$XP(!CT(18-A"G>_"
M?R+O>][M#OWT[WO?W/)!V[_Z_=_SQP)HY^\8W/'-=I,=O5_.NMWR41](](T+
M=:W:'4%QP@XI]:5;,M$YP&S+2D\/=CRDBT8DQBA&8-*HT XK830 %H.-?/B\
MYTZ+M.2W!/)[UZRRF5Z: N3;5W;'4M1P=/IE96]A2?!J_KBU(W#F+9J)L+&H
M]T1D^\J1&'F^L:8,8@B0CPJ<CISR5 +0[ZV,@TLX&C/([VT:7L90PF!T849=
MX@& V(/W0[UO6]?<W@6_ZGXOJ7L!%"$%I2>^HV3 %#ZI9!T?T7== *%9DA):
M25P9*IIV;0T^5%$@9BMI0. E 4@A&[)T#9QOK!3O]B=R)_FCW[_[D';OY\<"
MX[;QE4[7RXKY$32:^#*N6I%Z,Z1K.B;I7W:$IQE8YDH$1?BR;'6^G. [#V44
M,#P$1*#T) ;TFU[+ IQ^Q.Y$_P T>_?_ '(.W?SXX%L^5^'*=X^635=5DJZ%
MDAT\2L21Z!>/3%Z= ITA4>-=3D(HXEN.=S(B+GG#>#=*C$ 4XU80E:.V/11>
M@A<; 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8%,?(1VK7_ (\>.[OZ^LEL62!@J&-)EJ"*MJHI"X3*7R%Y
M;8I!X@D7'$J2V[\(I:]HTQJO91VD:<9A^RS-%; (/,M2LQ^;7[MK:+=45A:O
M$O(U4W*U)9U5U232'-!T@2U_("].$2=SRWBHKGD)21[8SB%:<3B[%K#R3@FC
M3)]#"7H)5^KG\X7]O;Q]_P!QHU^J/@/JY_.%_;V\??\ <:-?JCX#ZN?SA?V]
MO'W_ '&C7ZH^ ^KG\X7]O;Q]_P!QHU^J/@/JY_.%_;V\??\ <:-?JCX#ZN?S
MA?V]O'W_ '&C7ZH^ ^KG\X7]O;Q]_P!QHU^J/@/JY_.%_;V\??\ <:-?JCX#
MZN?SA?V]O'W_ '&C7ZH^ ^KG\X7]O;Q]_P!QHU^J/@/JY_.%_;V\??\ <:-?
MJCX#ZN?SA?V]O'W_ '&C7ZH^ ^KG\X7]O;Q]_P!QHU^J/@/JY_.%_;V\??\
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MJCX#ZN?SA?V]O'W_ '&C7ZH^ ^KG\X7]O;Q]_P!QHU^J/@/JY_.%_;V\??\
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MP/B=*(RFD".)J)$Q$2EQ1'.3?&CG=O*D"YO3['I0O1LPU 7%4B(V6+US0%B
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M/SKY;.CX=7:ML=F=BOL##Y77]MF'-4L/4H->X_COIF:/9#*(>@C)>/ARL/H
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M#)"M2A.0*M:]=.>:7O0]A)N P& P& P& P& P& P& P& P& P& P& P& P&
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MZ0D'_*1?^!ZZ,!@><SYK?_A%Z<_\UYT_+]7>!M_X%_T*<5_HE\Y?D>AN!;3
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M\@C/05YN+VZ,:AM3.)"YU0B+5*THC"PGX%&J/NGJ*@. ?,#R#TP'K2"6]8'
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M_P#"+TY_YKSI^7ZN\#;_ ,"_Z%.*_P!$OG+\CT-P+:8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# X#HUMCVW+6AZ;D#NTN2<U(X-;HC3N#<O2'!V Y*M1*
MRS4RI.:#?H$ 81!%K[F]8'P^ L?Q% [_  5I^+-2!0U-;I\.1_$6UK5B3B5-
MJ!;['WE&@4B2%;,)+$$L>R@>G6_5UZ ZU#"(6V#3&-L0B[>8B1NS>C&A8&I(
M-(@?UVW1]0IA$)"]D(WIRWM0K*#Z *3_ -\,T(?W<#B0JN*\K9$N;:Z@<,@+
M<YKC71R00J+L<51.#D=O>SG%<E8D* A6N-WO?K'&!$8+T_=W@9"VLS.S^_\
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M_P#"+TY_YKSI^7ZN\#;_ ,"_Z%.*_P!$OG+\CT-P+:8# 8# 8# 8# 8# 8#
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M=S+VZ[MB94CS='G&NB8\:AJDVPH?6MC%(;0L(+Z,UM^+[:FI,E0G&FGF?="
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M-HT1B[9B5K8Y6OEC@@(,/(1B'ZJ?8>@7 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M.O9;94)GL7ES982>O:HZED2MRL^KZ'W-6L)J>.-R?:E UC&VIW "<8O2&[W
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'D7\$_\
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MI3I&QI:T"4L)9*<@HLHH =!"'6M>C R' 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MRZ;3Y5ZCK^,?@0ZW36H.-+<K>V>19C=D:K28(Y1W'25:R>B'V9VG7D"D$"L
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M)%5\OE-E0R(/$&C%+6>S6W$D];QNJZW@E:1J4N4O84QKQ)A,2B2N("P ]^+
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M2E0:]>;O(;Y&K,5^+Z2*JZ06Q8O04&\GILNJ=JMB'UO6T[)IJW:<9ZZL.?S
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MY['=SY:S&Y.L_MBH)4TLCJDCM5-T:"Y((:X-#KM2!V5NH#"UR8Y'[H,(0*C
MIK.?)!=E"=?>1M@M&MM3>B>?X+P@R\]0N"2B-;L*:7;U7,IG7$$AB)&Y1MC+
M"KNF?KD:12K='K:&+)60!^@G 6';*"\?-O7$VL^Y[5YFORC <]]"5? J[N$$
M:9;-;[D@$\IZSW67QF/S2%6"EBD!<#UC+,X [-#VVKV- >A5$DF$C5IE)1^P
MK;W[Y1WGA=SL5<YT)$GRN*EK-%9\DF-H=15?0+_:"+V#LYR&(\M5W)&F3O\
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M(C2!I2=E;]<*QV;Y'.CN7NI_*G(76EY1T'RORD_<IRJ7.8+4AT%.HRMIASK
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M8NJ=FFB>6O$2G<G,*:--(#"GW1!(PC3)U&U! 00W^4:T:>X9H3I&&\[2_HJ
MV8K<85%#;8Z?B+=TY9-V/]\6)7$3I:&PJ+448@L^7/>V,@]M$A+;RTS3L>U8
M0$MRM<(,TZ'\V$5Y_G-J01WJVK=/W,M?U[+^HHQ.>Q:7JJQ&*3S&NVFU7ZK>
M<H)*D8U72DSA$(>4Z@XW2F+M+DK4D(D"L]:(T@@,X:/+PS3SJD7/E0T['I^P
MHI#1#<I<'/H>O*WOV5PB^X!!['9[YIOF.>-;0]VW0D.C\_2[>GE&_IG(!J!S
M+2-BLQ%ZAP35Y3NANAN:Z"J^:<V,<>>YI*^O.1*D?"Y%(VJ.)_P*M>_H-!I"
MSI5;S$Y@C*438IY P"6:3:.92'0QS*]H8B"28%%ZC\CW2=56-UDHMBDY+;G-
M\6\K97)X[O';$.:GJG4=RN]!UM6D1@U1"C&GFPX!!+!LU&%X7G.;8L( Z&&)
M"'#28\!02&X^<NF&^WW%@W'ZK%2#/U"#DMSFYO5E1)^A@SP-JD42LL%OY $4
M.=.-)MUP'_#S733P!]$T%&/93*8UATH$'[(\OER.SC7BJ,\!2E\@UT=57UQ/
M3LJ%T-7S8YRCH&D9-<;&-9((JKC&SHC2;TCHY]4J))M4M=&XQ&,H#(L"),<J
M#8CQ9U.JZSJZ72U_K173]A5===O<]VQ7)TJ03QNC=F4Q+UD3DI<:G3<V,2>8
M19Q]B2L0+Q-[><:0HT$U,28 8-!J_P"=O)MU(M0S6"V#1#):_1UG^1SL;F7F
M6MV*V8Y$8HFKWG)ZF+K,5MCV "M22XE"J4AD4+1F.P&I^?).XK4VRD6C%/J%
M!M*Y"ZD#U%#['4/==.]/VK1UQ2Z@[PJQW?&V5ZAMEQ!NC\A$%@F+00B03.&R
MB&R]G>V=T"E1&*6]R+T>E3*0')RPUVR_S+*X,RWM/I7S&7%JDKGK2;\*U18,
MRZ(KR&I[HZ8AELN=<J4R\F0L2)AJ.F4["QN3^X2UZ=AF(4[2M3EMJHT*42P.
MC2>;]B<8V[LT6H>/6_?K%U'SIS HK?GWIJM+?JU^<>J6:9N50V!#^@T#*S1Y
M?%3%T#=$3VF=&EF=&0U I,.3B("G-5!GLO\ +'8<+*%5[CQNYK^PT?8E=\;N
MG/K1>L8/A0)'<=!37HJJ;8:;S6PIO3.-12&$0P\*U2='4;RUJDZTH3<<:D 4
MJ",+'\[U:55*[+33. 50SP?GB?1VINCSG#KZIFN[HY88$L9U;0Z5YV=F9!,;
MSKZEGN2B0N#O[W'E[T-L7C9FQ?H@L)P3Y5WE2_&QUW/N:XW24>&P5G>%AT=.
MG(_HJNF_HF%ZKQG<%YUYRODZ0-;%+4_-4K6MX2V63MKVZK%R-8E7_# I#1F%
M!$="><NG+RM"AF%+&:P:ZKZGL%RK.B)(Q]45-/+WU(#FJ2O=?.5W<NQ],&8T
MY%[3014X#<H"Z/BML5K$*=Z2MAJG>B@YM#^72U;T:>:7U1Q.[U?&>WZ0N6P^
M39!(+ZB#ZMDL^J*LUMFFPBT8\TPSUJRCLQ8&U2H9GXM2]B,((]*UO1&F (V%
MP_%G>=U=)>/3E"^^A$C6&U[2IB'3:3N+&O;5R24FOC0G<2)8! RQ^-M<;420
M@_2D3.G3F%M8C/=M''>I[005=KWR[+7WJ"G^;[,YZC58.M^"NQ) F%%U'5=D
M] 5^[TU7TMM(35TWS[$&L:NCSI="X4N$F$G?Y(% Y>R0+O=U ]A"&-4UYGE$
MI8:"M._>4)/SMS_T]R]<W4-068;;,7LZ0[C= UFW7!8S58-=QZ-M"B'!6UVI
M4.; J(<G03B2F]FK3MJDP*?0<:MNV>LKC[[\?D7GM&23E^EKYYAZPNQKBIEK
M1.S$]HM:%#SRNKU-93>T11D5UW;%9H)4:I6-"56[-8 /_JDN:PPD\! 3?USV
M+<G/'?/+4!V@C:3DQXY5[3OR_P!_6R)N2O:9)S_NF%RJ2I6D4,>'TPFM6"6'
M&EH$;@F"_#?![,V5\*!I2'<\^>1:>679/-<.NSE-_P">8QVM7TKL7E*6J;4C
M=DN4D3Q.(([-40:Y(HQQYEW3UFN=4K!/Z5 E7R9NV2A6IC7 I6GT2:$_V]V?
M"Z(Z/B%'6JQG1*'SGG"\.@([=*]Z1AC!ZKG5=%5MK5TK9]I0K4CXS5W+B9,0
MIV>(I2WHEVM #M*(0@I%%?*];MLQ1"_45PG*["?8GRO4W7/0,*?;QA\!?:MA
M-\-<LEU15A$_?XD[DV9?DGKF&JGM2R'?@^SM83DR52\ 4* !P(5-\PC_ !.X
M.K;SDT>1/O!$+X8X#Z+H0]#+8E'YU(I/V+++#CU>$.39(V)B(85]L20U S+=
MO4B):8>3']+CS-E."C:4+J<3^2V(]97'8W/#NT5$PV[ ZWC%QI?Q"],0/J^K
MI+7$D?E\34&DV/!V2*FQ^;Q"4(@)7AD<FI,(!:Y&I1*%R<X1A07JO&R7*GJB
ML.SV:O);;+O"(NY/[96\&-84\IF2](5_VC(UKI0[,4;:_>3Q!]NL7K$Z1$GT
M8>:/0"]^D-,P_.3'8S'NKMSZF:_<IMS#6]$VFH(YYZK@G152N\6OJV55,-YL
MXN-AA<63U"=5TI3;<)KMQ9U13)&="=2AK"-!",-EG&'4#]U77DCF[W7T-AY3
M'+SHZQR:J+W@?2=*6DR;9&9Z2S:J+>@Z5C$_,8374;>K(<V5E<4;DB/+VG&3
M[%0:&JWR >2/H<^G^BE?+5.29AJRD>O*'Y3E76J&SXLUR=ILLGHRD(Q;9,9I
M=RBKHK?JK;S94?"71[&[)G#3FJ4"3-AJ-.-> ) L/SGTM7]M6&PK(]5PZ6J+
MHX',%BS)TZGJA@Z#(FR&=MM63&;PSD=6E/G,QJ2!6(XB1.#C\61/*A&A6."!
MI6(R2S3PF6C/*,HOOJZ:<Z1:D& #%!KIN*CI>X%]%UT+HFNG&HQ2))JT[3Y,
M=FMCG$4HRQ7..[!&W]N='U2M3.3<K.0)TRD9A 5PHGRK3IZYOKUXHCFBX.H1
MUGQ%7_7G1+_:M]5RPV=%X58FK&.@$03/+?7C='+EOB6-%4OKD:B)0Q5G(0IT
M^QK0'JR$X@SJ2^7^Q5C*I>Z3XE?[91Q?Q[4!Y&[)4.5\0^ND45JB[V&QY$9
M68]RB#XIEEILC;6JT2%-[!"V.FPCT>N;O5*]N'8=5>8PGG6!_CH9Z"8'JCT?
M.T#Z5_"^XNFJNYWF-GQ*:Q8^<JHAS36$A;9:^W98\0BA96W! >?'4IKJK(;D
M:M4I$/1818[>6F>TU?'D)E-Q19F<.9ZCC7!2'F5G)GD)B#^[6#UHW*$L,9).
M[RQCC+)$6ZPG9^ O?GI^?=ML,;60P?JJ #,%H,^C/FPA;RV6/"]5A 9STM&I
MOSC :VJOG3J.M+_JRXWOJN5R:$U9MEZ!9&6.-L.*87Z"O@Y@2^,*-='VUMTM
M(3N)*I'L\);\?_0G2-R=@^2V$=#1M=6AE+2CE1AB5-ES=GLJ'P4$KHPV32%Z
MK^=MD9B2J21BPEIQ+D$U<@0K2C_:$')4QA0R\#^WEY/Y%5K[U1)X1RW)+9YH
MX4?FJ-];7@@LZ.1B11AU*@T3M2RP4]4BY@<E=ND4K6$Y;':1"5/,:$,1AR1L
M"X*2!E[#"+1\MTJKR6]$.C9R,^R[FWD_HJFJ#O"_$UT1)K<"B[M8J->F":5I
M59L96.T]21H%\-0WE&>Y,XBD?H-1G+C1&IB W1X# 8# 8# \B_@G_P";?YC3
M](2#_E(O_ ]=& P/.9\UO_PB].?^:\Z?E^KO V_\"_Z%.*_T2^<OR/0W MI@
M,!@,!@4'OOQ]5;T%U]S/UU*WY]2///,5LZ(.U=I4R!1#+D9YPQKFV(DV"!3K
M:LS53.S\[.C)HG>O56NAPA_<]&! = ^(BLN?:!Y)HE@MVP)']5CKDGKLV?R5
M S+)7;$J;XO9,#88Q,!A]5.B9H[7\W;F1&<F_?RFZ-HB]?<]? [OE?Q?I>:)
MGSS)3[]DMBM'+(>S(_3L><()&HX:DKOL&;UO8"V*2QY:UR@V2NM=2""*/<W8
M!*,;@G<]@/("). 8PN'R'S6T<C4+&Z'8I4[31LC<KMR5DR)[0H6YQ5'VW<4]
MN!<C-2-V]I $LJ^>&H2!!_=&$)@#'^[$+ I]R_XP4_.$VY]DRB_9+8;-RX[=
MI$4W'%\#C<<-0P#LF7P6=N<.ECVV+E)TG<:[DD35"0NP"$1BY.Y>S4$:VG"8
M,(];?$*CKMMJ)]HWH-3![EJE'TG$5$^G])U]<T/L&K.E>BI1TR\0:8U?(E;0
MF)7UY84A"../34ZMRY,6%06JTJ(6GI\#950U/K*,I2*50ML.8VX\1QL==/%C
M3PN.I91,'Y[<W)]=G-6W1-FCL79$.W)T,*0-S>C3HVUO+(2E:V G0MAI;\<W
MBRM=+RSQ'%^W[6FTHBG/5>2QVBW(4AA\#9R*XLRSZ_GU62-+/K+B;@YN=G,\
M"@%H2%LBZ0/N6FTITT:I4.!Z5*82%OJ&\9SO6<TYT<+;ZAG70]9<80N6P+DV
ML91 (1$MPUGEE?GT[\:MV6QS0E=W32.4TL4QEO7')&9-[FO5J%214O/]Z $'
M5AX*.?ZSCW(T>)M2RY"5R=TI,.@4:QX"W#4V>S.QT(,@M.SG01B+40*L04M7
M);>#6A^U+@R'0BP>M^]A+*WQ<O#5:MD/E5]1R>J:2N2_%72-BU:SU!6#W8Z>
MP))(V^7V8S5CT,^)%$NKNOK:DZ Q6]-^V]S7$;<5X&Q<W%J A*"Z7,?,[/S*
MBO-$S2MVE8;QZ;NKIAR,=T*%"*/O%TR F0.,4;M(=[TJ:6(TGV:<\W]_-#OT
MC^[@5,O[QA,]]7-TC9JF]II"F#I.M>;FMWB\;BL8-D=>7OQ_92JS^;^@ZYGK
MIM68W.4&?EIFUC O;'!K=_W/MA!!H90PF[FOD.45/;MH](7A>KKT9T/:4'KZ
MIE$S% H_54-A=0U@YRZ11B"P6O(\X/NFW;C+9Z[N[RX+'->I<5JDL(/=DR<A
M. *D]4>(A/TE:_6$[;>CWBLH[VG4C)4UU-9%+5=/K)96A@K9PJXE%2=R31.M
M>JHB$BCRS1CTREH%Y2E:8K5HSV]6M./P*[1KQ>="SR\?(Q ))T#8U0<H]#(^
M4:=F#.S0:NW-5TE45>\8U!4=E.M?RI4X+'ZD7^5+&IYBSVJ]T7>LWA#M$20H
M*)7X'<L?C)NRW[D\F,0G-P3BD.-NF>D*R2/5(,4,@3HGO"BX3RMS1"' <!L0
M3@=**G;9NX1)TALE"-&J4JVAI#I %O.%[Z:%D[+\5 )Z\7;!&OI6;P[CSIRZ
MFR_>@N7&Z!PU>?*YQI;$'6;,$,N14,N5U[65N/$&0*I,SE(UR@X9Z\+>M;BU
MQH-!GM=>,Z'UWT/#>A4EK2QS=8=U!V;T\GC2IC8R6Q<\]E0UDAL@B1ZPD7OA
M31!D[($] >']_4C,V$[]SK6!CT2\8*>NIQS/85?W])6:0\[]-]DWT>%V@<:D
M#98$0[?L=_L&VZG7I!KD!T>^&"=R4;._)3AJDH$VS#4Y^S1!"%O[:YI9[8O_
M )/OU=*G9F=.4I';\C8XXB0H5#;,3;=J1]J9>E>5BC?OC>4RH7P2P@2?]T8<
M7H _W&]X%-VKQ31-HD[!*&V_;9CSI'["\DUA-KU#"F*+RUF=O(_(3I#)546D
MY)"T^./E,*SM#CC@ DXPP\L!JD MZ]7899R7X[%?/O0\TZILRZD-S7;+J>:J
M,4R.+4=7?/Z"01%OE1$Q5RVUFJOC5OXUK@=7A GT)_6')DZ%-H\E @2 5J=&
M!CO<GC/=^VW.?,4BZ2>&6C[?A+)";$IB94Y6MT(XH)J*=&]9/^9)5.R]K^<[
M6?V5T]DJ>DJ=X"6L1HW!*G3KD^CQ!'=R>(UTLQZOZ/QCKZRJWY[Z3M^C>@[,
MI-'7<"E3DMN"CB*/;D+@AMF1Z.ER:%3)JY_CXG=H$6-4:X%&'E+RR3STAH<Q
M=XF'-VD]VQYXZSGKCRUTAUZ/L>Z.:S:T@(=2*9)9=")NWUZR6O\ NI5&ZK=9
M!7+..0-X4ZA6[E)S2B%2 "M9H\,H>?%XNFW359WE:?2L@LR(TCT&^='T[')#
M4M=E7?#)"[&2A:BJDWJ=&$NPW?GF..$O5!11C:,A08V$)&Q6X*D";1 @C>OO
M#+&HM6<;J25=&3>:1""<R=W<@P,9,%B<8?&:DNWW2N7-6D=7%$H7I7^956*!
M& 0NNTR<#II?O:E,'9.O:!\I1XD+0D3 Z-:'NZ;Q)VM?B>.<,=.OT:HJL CN
M"M:_+M%#7,KAZ!Z6/*>FIZRL5N.K<X*40G)*Y)AA&60C5%E*2@R&;>'N(S<<
MT9%=]S-MKZP^3^3>>Y)'6^$PXR2-UF<.S!9.N9NBX3,7(*\N/2*%R1Q/4+H^
MJ;7-D>1>S H#[( BC DEEX_ZWJN WI*(;ULGFW1TYA\)AU5*FRBJEINDZX*C
M,F"Z+WX=6-B65I'Z63$A>H!('=P7+3!HB2"6Q(BV06 86H[0Y>8NSN9;2YJD
M<L>X,UV4A8"]REA0M+PI:W&*2Z/SAD^(QU_3JF"6QA8]1I.G>65>6)$]-)JE
M"?Z"CQ;T&MYR\,9<TW=;K9G3[L\22\ZFYSJ-[3U[1=85)7,'8.9^C"NAX456
M%>1PQ8%@0NSH8L1.1+@XNZ@X:XQ0!27H!*<L++7]XUH??%F7Q;IMLS:#3ZUF
M[C=TKZ01MHC2M52-K<06'9]FU'9T=)>TC@@E)B^06:>F>&ES)&A7-19J7T@T
MI&8 ,XY(XRF'/-O].W]:'0[_ -!VQU5NEQ3=R6U_&*UBL6+I.,22)1UI@,5C
MBQT&TQY0U2#UQD+%J]5[T PX:DT9X]Z#"KD\;<0N./\ DD8'"TI6QE>1]A@#
M#+E*!D9%)M7%0&FH]3:51%0*=^H]F.3?'P+C=+?1H!YH@!_<:U@1_//%\\N-
MJW1+:?ZBDE'5YTK8+3:MX0QEIJJ)A/BK""PQ2*3>247=4K;U4AIA19T=A: #
MJ Q"_@2+_>%S7IN5*##,#.ICXR*SG=0]=U*_V'-"B^I>K&_L-JE[2WQHB14M
M;T524HHKIPAY#JW/3#($L+EE&-;G[%W2*4[D ]0D5%#3F;#L(CF?BOL*VZKL
M"%VWVI,5$RED]YIF\1EM04;4M-1.I%?,-MM=S1=U@U8(2).VK)Y+Y:V%[?'M
M[7NVCR$Z4A.D3)DVDXPPWHOC&6P'F#O*46$WV]Y#>G^V:WC=(.1%:0RN:K"T
M-D2C,P8*#9X;&728(X]6,'K>=35=(W60*79V<$[HXGN/J#*)(2$!?_@?FI7R
M%Q[0G/KV\ZD\VA$'3J[5F/O!ZPR<W3,URZ=75.SEJO6EBPV:6I)7=SV8=Z31
M:5:];[N!KX)\+Q*:6(3T74;ZW5Q&^X&+O&.1EOHVJ";*D%FM?01O0AL1NV^#
MB5$[N*OT+\Y+D#,2:%K<6Q#M$6:L6EMR<K S5N\3+RW6%"3@=>6$+GNK.[7G
MOVL^?-5G79>F:T9C,["L.:1*26EHH4NED .F-H/"MG3>S1J6O2@(#SE^B$VR
M0S>@O%^FI&PZ*EZJ_9)-H_S1?/:MP4W$E4"C3":UQWM<3Z[RVNY5(F]<H52L
M,,F4L=7!N=_8)%1Q"DM(<5L! 1B#JFWQ<.E;+X787//3\JJ2]X-879;^BL9V
MK2(V+&)'6O;=\'="V-44UKAQ<&,IY:HG/DC4JC[FE=&]>C/;/6-]N2J4IS D
MOG'QM0/FVR:*LU@M"?3!_J"I.HX%(ULR3,"ATMN>=>WI >B+CN&7.#2A:R&Z
M1.=C0P\U.@0)B6Y,E<=D%@"6G)U@5&C/AHL>L9+S5)*>[LE,8%RG65BP"H&:
M<\\U?:K!$G^W+$EDYLFUXXT2!U0HV.S94U20F.&.@ F*4[ D&D3C*+6K0G!,
M,^\7L]?K L>R:[Z^=ZLE71D1K1KZC>TG/E0S)\F=B5[7[+5ZB\*0<I64K!SU
M9DIA3"D2*/9$R%F3"1)%"= 6K)$H-!T)XI3^C9NF)G73<K>Z$*L*F[/15C,:
MMKZ<6I6\EIL<#4)D'/?2[L$BP*/BLZ<:Z1+'M*B2K5GO:YS&WK&_X@;H(7([
M5Y=-Z\HT54MMD.-0RIFLVE[C@-CMT9:)KJ+6%15K1&W(6M<H:_'I&J4L9S_#
MR25J$T]/H],:/6C0"] L"OKAXU(TZU3=E9+K=E(C+P[OK;O-]D::.,A"AGFU
M>6=0]HZA#0W;/-(_!EY=Z+(($<:8-400Y&^KL0B@;V&&QCQ@/->V>Z+*QZAD
M<!YW?>B7GIASIAIINJ55AII;++$46].JYC?1J]O/F4>I"<66N5KE[.%N.> (
M%ZEL2/"9 8$@L,\AWC9B$/C/,T:(M*5+2N:>X+V[<:%1S&R$F2J27JZ]+.KG
M 74HH6RT$>CQG2BP"941_P!T:%J(]?[IIN!9'F+F=GYE07B@9I6[2L-W]-7;
MTPY&.Z%"A$P/%V24,D<8HWZ0[WI4TL)P?9)SS?W\T'W1_=P**_LIWQBELHL6
MN.JI-"+$9^Q;J['YUDQM3PN1ET[(>F6V3MW1553-J6N:1-<]561J6'F$DGB9
M7=G,2HQIE_M$P3-A=;D7EI'RS#; 0+K"D5O6==-NRV^;OM>3MS0Q+IW:,R0L
M+&K6-D68"RV6'1./Q2)M+,S-*;9H438VDA,.4*-G*#0K'*_%O Y-1T\J@JU9
M:T2IV[DLCR U=:14:B+LXU->$YM226>W)2X>_H72)3J%LY<K7L2UO=2!!=V1
M:H+,$2<8 XL*E=2>.KJ5? Z)0Q/H.965;CGY%N5KHD5A0.K*FJZO^<*^J%EG
M24,FKJD1'N+$<P-SFYEJ9"0ZN3^XR :\PO8P$:**("UT9\8B,,SA=RVA?4IL
MOH!%V7".RK-LHN$1F'M$_>ZSYYGW--=50PP5M4KT=?5C#H!.1&IRRUCBYG.1
M9ZE2K/,6&["'22;Q=.P;7MR25%U!):8J/H&Y"KYMNN62GJMD]AIK#<S(^98Q
ME-WW)D2J553'[9'&R37I(8@>C4RE4M.:CVTQ5O8 _LY\6JBT^C8-;EJ=(R"Q
M:XJ[HLOIBLH1**EKI;<L%DB=>O?D=2L/4GLPV"CYR1R%R-V&+ 1 5&M&]-!S
MF:V^E/L/[SEXOGWFZ1U3'8MU-)U'-%"O#VXU-2:.GJNC\V$R*FY[:XC6UKW^
M@1FS.SZPK=*^[^%(-(VEP4B0H=NB]QVFW[4,VJ?QG0JJXAXYX>1:4M?47CNA
M=BPJ,*5;,R(U%HHK&I5ZI9<KD_NVQ 8E+<V/0UQ6D7I")0#0!?N/3@3AQARF
MZ<F\EU[R8\VX[VXQ59$CZTA<X,BS774H25F@3#:(6QN (PN4HU<EB\=T4F,>
M2=)C5QY?O(B2C!;U@:_Z \+Y5(R7DAP4=/NDAB/%#A/P4]"X[050UGJ6,MA4
M?8%$.SO?4HC"<R0VU;I47G&COPIV:V:4JR5!ZEO-4KCE&@FUM\3]2[JOARFI
M=/93,X%QASG<O,Y[2M;&MMW<\$NZADE 2PR5J&\P)\=5AC)!B@O3>+T>W.WK
MTZ"'6\!0?C>L.KKYYSNFTNRK!OQ%R;2UE<_T?"G^LH!#24=?6(CKQN/>9_(H
MT+;C.;1*;:S:TZQZT6WI%P$X1 ;TQHU!B@)IZDX=:>F[IHJVW"PE<:;JQKSH
MJD+(KP^)M<GCMU45T^RP5IL^!."Y2X-;Q"78X=<MIB-Y;S3#B"]GE"),"=Z0
M!%//?CCDU5V3SO-+?ZIGG1,<XS@,IKCDJ'/\ A4$.@C5+(FAK=9+;2D\4WM9
M<MFM]6M^H\D=3$[,D D5K3S$)JU4-2$)%\A_CXKOR)U;":RGDTE]<"A-A EJ
M:70+:0J2+XH_Q*45I;58*52GT;+B-OU7-W9A=@ %Z=D*@F:"(100[##;T\>\
MHF5J65:/.73LLY157_3<,H?H-DBM:P6>M\NA=<$RUL@$HKL<I]VW4]L1*,SQ
MU:4SN4!T;!HAI?;M1IJ).:$(?G/AKJF2BE,.B]LS. T3*N/N7N5=U@VQZ-O<
M@BCMQ)-G:><HW3"K)?M+%K=*ZS?7@9JUM7MSHUR PHK:P'J:,+-"1&;CSKFK
M(-=\JAW7*>;=%S2&PF%54H;*(J2FJ5KPF.2LEW=9&KJ]K22M)(IC,DBL\I^=
MURU5OW(DDIK1(A% ",+7]F\PL/9G,EL\SR65OT':+29VI 9*8ZE:W)<U+6"3
M,DO:!K&-\3JV.41U4[QX@AW9UQ8T3RTFJ4)^O8J!X%"(MXH9RP2VUK6!VG-H
MI<EET15=(-4EI.D:CIR"U<@I:XG&XX3N!U:VI']H40Y]<GIP;I8P/BMY*DC8
MY*DXU*8D1)9 69X@X2:>/'CH&=JILS3:R^EYC$IA9*J"55%:&JI(J@\6#$V+
M\#*>AJQU:F-V<48S5+V[*5[@Z/2PP(CS_9$)B20K9=GB8=K04W/"H;UM/ZGY
MLO[HZ&=:611+56T%DIY]W1F>5]8[^9'+,>C 2)@KBPYG7")Y=V+2<X[;R:H.
M3+B$J@]"8&2_LO7E@M:=O57=12:LJ,M/H5?TS.ZH:J?J]XL4F>RB8)K!LR,5
M[T.\I#Y=!:OM::DGK7ELVW.#@4!R7)VYQ0)U 2R0^COXO5\TZ<K.\[2Z5D%E
MQ*D>@7_HVG(Y(:EKPJ[X9('H4J5(JI4=4(]%V*]<\QI=,504,7VD(4&-A"1M
M6."M FT0(-9=W\(W]R1$R* Y09>SI"FE7 $+Y%=[AHADYGE;!T,I@IUQ-\,C
M-LL]JKX^MY6G,$)LHX*6P$ W=J6L+\I*&24N:$6]ALRHGQF%0RH7I@FUAKTD
MWM'Q=\S>.^PD,=0(%T=BFZ-KVU(NXSJ(+EP2USNJ<7*X%VRR580D^R;R-^CT
MF&:T$!3OP=-4H;;5B<<ZDD41A=]<JU1RQ;JA11M332V-QJI:)*H%"?4=M2I.
MM<*BC,TBJ8"E_8$Z!P3'KSUBE">WJ5AQ^!*4Z\/\>GLAMIQ<>A)@W,UK5;Q^
MW:0MM?P@U[@G1G#;BUKJ&Z*AKV]A>&S:=(!N&2\0]T:W-G=B5)A9AH"Q" (,
MI6^,:7S:#RTBVNLY(_W!NQ:-MFD[ K6EJOJ& \]6)SN_.4G@4HA5,-I4C:I,
MY2AT>UJ>8BD+JY_A T*/AY/P].43HL)[Y$XUE7.-G=/7=9/0+_T#:_5SY5,@
MGSTXP*,UQ'8\?4T#'7K"SP:+1I4X!:8S\#"5ZA"I6N5A- (PY4H--,,V$%WG
MXO%=LR/IMCB?4%@5-SAW ]-,AZ[H5AA,.>U4\=@0F+5A.SJRM%UV6_U 1<=:
M0AK9I0 "1XV<608H;Q-RL\T_89787C*A$^JOM>J=V?*&)H[0Z$JN_GA8W,+$
M8;7*NJ6/G)A:8?&4IV])W)F6I.<T7KFJ?0<7\1.T#[A9>!LXP& P& P&!Y%_
M!/\ \V_S&GZ0D'_*1?\ @>NC 8'G,^:W_P"$7IS_ ,UYT_+]7>!M_P"!?]"G
M%?Z)?.7Y'H;@6TP& P& P-#_ )"O(;T[0EO]M5#6$'#'8Q2'B5M?L6!W&K00
M5^+:;@8%T\1L#^YLSI+EKD[PY&KBI384V;8#%!KK[8T\(D&RCL"9XIY<ZRC4
M;L4WINFK]YP?*OYCAG5*4FR([ G)RN2I)9(DE=M;W &2L9[-SFN;O%G+D3.&
M)O6FEZ3K7A  9(='#]B%C.;>[(]?%LR.@9C4-B\]W>S5RBN5GKZQ7^HICN95
M(LD>XBIF$;E5)63:,0VKB\H,3('QI5K4KFUGKT8MDF$*2CA!C%L^1ZO:CZ*L
MZ@W:I;>=F>@:9CW1'2-\-Y5?HZ:HBEY,SV@ZMTPEJY[G;7-7Q4(=3.A7PMC9
M71R&$'M2R1E@'O00,Y^9:L(=%Y)*K4YMZ+K @N@Y]U!6+*\&T=)I/;U*U,EC
M#[:[@QL< N25GPZPJZ@DK3R-QBDD$T/.V@L\2<L\]*J(("<;F\G_ #O3,NL*
M(J6Z=S\^OJMYVL$QRKAOCCVV2V3];V0^5ES93$.4.,G9@N%HVLZ1U4X)2U'N
MC0A9=!7KEZ9,+9@0BA\\OE90F)V!NP^?;ZC=UUO8'.5?/'.;*II>PY_(3^M)
MFY5[0<F@,I@=M/M4RZ+3.;,RUH.-+?B536Y(%!*Q.3H)0S@[EE\IR!ZN=THU
M)R'TTNFM:'4BT])L\=-H^7RKGB27TTQI[BR-^KF+W ZV/9<6C#3+T"N1R6%M
M4@C[2D&<9I4?[DN"F#[NOEFIAIG;FG-K&TS>?&'H '+4@ZP+<*E!5C3=PK%1
MT\>W"AI]F%7@LKQNMY<7%54M(BYC&0]:'KVHD)1BX 64[*[)@_&4-K>0RN+R
M.<2.Y;=CE%U5"XX[06+CDUD2=BD\F;FYTF]HRV"US"VH+%#G X2QV=DP#3BR
MTJ<)ZM0008%79KY&8C$9#SE-K=0]"\LQA[@/=$WM6IK/J6"F%IV?D6(LS].Y
M!-)<C?9$Z:CL=;PG.L2=8*I>6F8HU@3-G;)V1K KRN\LTK9.JX0;<]0W3R9R
MZR^//J+LN>M-TQ6L75_FD:@TZYR05E+X\OK&96*\L\K:V28OB-RA2@]$\D+G
M5 6H2&&&IMA"]/.G?L<N^WB:&F]*VISI;$AK)TNJN(K:3S3LDW8E7,+Y'HY*
M'1M=*9M"SVN/2^$NTN:"WR..YJ%U0@=$Q@ 'E;.&2'ZZ"[V;J;MB1TI7G.U]
M=06!6U2M5\W6TT<DKC0*FJB0.DI:(NX.JJRK"K]/*IU-%$'>ALD68Q.#VX$-
M2@SV18=D;/"I%3]GW#U5Y.X%#Z?DD_:>&T/"5-]81IVCK#1*F)7V7T(Y6@BC
M$MG+K+5CG=T8B:-)&DR)I:V1&T.Q4A;%HW4'PXQ.(X,%\B/D3ZAH*U>]*GJZ
M$AC,;H#Q.2[L&N[B6-\#?BVZWDSY9K8U/KFSNLM7N#O$"CX82UIFP; ,\3J0
MJ.4AV@,3'"#-;)\K"%%2?2:&?UKU#Q_:]2<LQ'J6//DB@%$SJ8RVF99*@PA-
M9<!AI=D2R#%2%OE:0:1RB\L-:7)M"K($:1^[]  LA%/)3$Y_TG-Z#K[G^^Y[
M&ZPO?7,]FW7#T5<OL:KRWM,""0'"F59H;"-OJ/U.E+=$Z0V;J8J7&P+3=;TH
MVC_[S ZOR(=96YRW9/C[15=$Y;9**^>J)-4$YJB L<,=)I9+4=S/>LQBK$RN
M\Z=8\PPM*W6+%6AS<WDYS;R$#2A4F*#O=]&@&'/:/),V2VO].< Y9Z9FMV-=
MW3CG:PN=6]BKYOE%.6A6\1*GTN_&[:3O8"*@H5 10I<WN;/(C928@D*=Y;@-
MWO"A3L@L*+V]Y8)M8Q'/LNYO,?*L:9#$O*U%;GKRQ8Q7\AE,7O+B*D7-S:&0
MY[8G6;Q)R0Q.RVL:HM8QNJUJ?4!A6Q&&%#V6$)D@?EK)9J*@TB?:/OCHI^J/
MCWFSHCNBT::CM;(XI26K?I=GM)<L41R23F%/LYDWX,"4R=9'88V.ZMN83B#-
M%>T4)DQH3OR+VS8?2?9_;M.C@A1-!T?'^9Y#2-I-BN)'H9@RW-5Q=@Z=G Y!
M-G=^<0SE&Z%.3*(+6C)2-279:SV*PP)9@7BO*VDM&57+;25P6S;.U%T[?[G7
MU.0U;/K+E[J\O#>P,S%%(PB,3!5+%SLZDA-4*CTC<WIO:*UJE,C(//+#4+>/
ME-F;A7ERPZ#5O.N:>G.>NC/'#%++AEE&TO9R,VI.P^MH!56W6.R:L9S:,"<M
MR2'D29K/*$I3NS(M*";LH MISA!>;@&[[(O>O;^?[.>4CVZ0/N7M^E(R>D:&
MUE AKFENE+#KFNV<XEK3IBEBIGB3 E3FK#="4JQE[-.&(P0A;"%(;Y7ZZF[S
M73DU4!?R:C+[L.8T[S)TDZ)JO0UA?MLQ5-,3&>)L#<;97XP80UVJL@3FEAK[
M*&9F97XXHKT*" *D@CPZOQ 7STMTSR,\],]&N4[>Y;9UF6VNA\!>&*BHY&HC
M$X=/)7$V*)56;62PUR6Q\HME WGJIFY'/!SNC4G^T"A-3FF!0RG?+-V1/U/C
MPDKKSM.7YSZ1G/D^ALIH.LV^E=/-D?5IGC:QU$],TOE=I"CM<1R -X'!N?ES
MK(&W;B[H#QEDJ$ZEMV>%_P!N\M5736#4*Z5#2-TV9;5^,5Q21OH 2RH*WG-;
M,_/-EBIB[%=KRFT[1A]6Q<,,ML&XXF"0^K3'MRWZ6\*A, ]22%U.?.HZLZ4H
M-JZ+@!S\CA"HN:IWUIDC1M',H3):SD3_  ZRH1+&!K4/&B)9!9?%G%M6D(SE
MI!JA+L24Y02,HTP-5D^\N#];?!75_1_.U)W5529@X9O+J;F7HB9M%06+4DF#
M!H<8XQ\N0F5Y/[-15[9B=8YH7#4(F:5L>%"("G6TPC$:XA.%B:M\H#.]%3Z,
MVIS%U;6ME0#F".]7QV#+:\BD\G]]U [.&XH%[JR#TU-I^ZD3<Z:@*0GQ5X+:
M7A -P2C/***$:,@,1DOF*K.JFKIH'0?.G0-*S_ERHZXON65:J4TI9DJE526A
M8RJJX^]PY?45N3:+#DR"9MYZ5Q8')>W.A&]%B*+/+. /89)(O*;J.N1T.,XU
MZ3<+;A==);?OFGT<DYF(E]$5P^/\U:8*=(G%UOUNALXL"QV>!.+PS16+.;T]
M";BM;5EI#S4Y)P<8SR]4U*+ :H?0--7MTZQAJ+G^]YC+*8;( N<HW5'3:,QU
MJR6QVHY3/8S=UN) ,)0G%^#$HX\"8D@1 .]96 Q* +S=/=)0/E&HG.WI^WRN
M0I"Y%"8-%(1 6<J06!8]D6;+V: UQ7,%8U"UL2.,IF<RD*-"FTH5)4A/M1'*
M3R$Y1IP U#=P>4.[F;G2VH=2]'7=S]V1![LXTJN=0^5IN=)?*ZOKOKFYV*!P
MZYX&X.%F22CK,;IPG2/4;8SPKG AJF!6PO*-.C2'GX&T2W.A67C[FR'3^X3+
M.LV4Z%4=5L\?;6*$+[KN>[+)=H_ 8?#VZ/Q(^,UG^'\XFKP6!1[D<W1U#L1Z
MCVJ=O($8 *Z./DU)82&F$2;D'J2/=22BXOQ)07EI>U5?N4V%( 5B?<CA-83;
M95E#Y_?JAC=<I3E;U(BY1HEG6DB;5)0'$9"8X,;-\M]<+ 51%8ISETG,;\M2
MY+WYS'SDV-%8MEAUW>_/$#363/(38K](K.9ZT:64Z%N"1V;Y$D?%S(M:5R94
M6?L)Y81!^*'\N%>WI*N?VP'-'3E9P;H^<6524#M>R&.L6^)$])TXR6&]V91C
MNUL5GR":IW*."J:2MQ;^6UFQI>[,RA,F7&!]0T81I7GFLCEM)N?#ZZX:[/?M
M]@5Q*[!Y* I;*%9 76"N4[2NLIM-4NMYITU6I(DTO1*XESE@V=N>D>MB;351
MAB8I0$KQWRQU]:<7HE3SMSOT-?\ :-X55.[K,H^*HZNB,YJFNZOGQU3SUPM)
MYLRS(;7S0\(;40K(ZV-Z%X<%#XY(5.T>C$I!BD(8ZN\QE4R3<$2<\<Z=-=.O
M<]Y85]?)6.MV"MHNLC-71ZPWVL)ZR34=MV97Q#!9T'F<;6MJB/Z$>L5N1 TR
M7VPBS1%A>9!UO33GQZG[G2.+\;02GG;741;F7'EYTH_%5^+O=H#4?@JGT<Y#
MD)<7#OUF\'K'>]:V3KTBP-7W0'EOM!OX*Z*Z<ICDNW8I+8%4M>6S4K[8AM-3
M^FYW";.E1<:;Y,VV/4ETR:OU\CAQ0#%#Y$C7E-(4 5"0W250G.]?06)L_P J
M,0JQPMDYPYIZ.DL#Y;8H*Z]JV=$D=4O,6Y6<9K!6&RG",R5*"SR9%:K[5\"D
MJ)[F.H(BDB9D:5!9X35(A>RT&7O?DDBQ=K3*&U]SMT9=-5U3;-?T9<O1E3QN
M'2FN*\L^QTD)<&YH(BX)LGM^PF2'(+&95$K=XW''1NCI"W8SS!:2K?=@A7QX
M>1AQZ%&W4E*A/5T=!-]L=@ZN)]KQCB:"#\YU-6W55Y591.KI<DC@T-[#)[$B
M\"2HHXT(R%S^^$H%;L<0!$6<M$%R>DNOD-#SRJJ7AM/6=T5?USM,\E4(I^J3
MH$TN),!J[4;#8%AS"86A,X% H;$F)?,6AN*,6..E+BZNB9*E(-$(T1(:V)%Y
M!K@Z>Z[\;M<\PE795E#W,V=0SN_%_P"!U %6 1,.5[,KVKK#YZLEDMA[?WB!
MI*LF+HXH9L./HS79;M<@%'EZDL"DXL+S7A?5GPKR(\$\_P =?$:.J[SJ?M:4
MV6Q&LK6K6/3W3;;0:BO5*1[4IC'5F+:#ITY[-+2FE@5^W#H[0O9@] 1WU]TU
M<M3=D\Z5#!)"@;8%8/'OD#MN5,ZB/,SFJ<9Y0K902FKW,AT7)#G%"G93ITY^
MV2DC"0M]N'1X1^S!Z TY<O\ DKN^4PGQVSV(>5"M^V>A.EIARFQWCP2U4[ST
M8_QAAN4N-ZZ$<DCE0S"QV151G-K*\.;Z<Z20PYJ 0Q#2+2MG* >@-BE*/??/
MD&A5@=64[VJBY4K1PM2[(-RM3;#S]5=H1A[B%(6G,*@1S[I%]L-N7S^0K[2D
MD$6N!C1%72*!9692G)+4G+0F*,"-*7[UZF\B;US/0M0RQFXXF[SSA9U\]A6;
M&8C&[8D48DM5=%2;DD^IN?VZRTKU"T:*5V]7$J<Q/K\UO1B-@;D9):?:I6)0
M4$HW[9OD+XQYT?#K,N^O[<7E]Q\-5?3-^)H%&(]8\[H>^>BZ5KFTXS=58ML:
M35@Q3QD3RQX:4;U'0$$N* U.M"D;EI8M"#!>4_)/>JGR$=6<W].%L0J E_6M
MK\Z</VPWMC:S%LEM4K6L$L&6\TV*>A0HTYLAF\(E^I%"URPPQ4[B:GI%LTPT
MI(1H->\.\I/1$X9O'2*^O(.LX_8K\\<;[T;8%APKF2KK0<+$O-#>#%!DC8!A
M=*IL%+$F7\#G%4?LM$C2)]G)P^D?K"]40>C;A.<DV3S^V3-)U4_=D-SQ)Y/I
MNNB1U7%Z<<52=O6@:SHU^!<2A%?-I1$?7HC@!4C;@GJ-F;V(P8= W@:/[V\B
MWD398J<JYW/A]EVHW><;HSDZ/U6]QF)LJ>U.:J.IFS[:+H5 _P"VS>V&<2I%
M !HFN1;V%;\4-3A4';($;K83M;'F/3L4@5='5&Y!L'E0CP^WWV\R5LK96YFD
MSU>-=7O6E9LL.D[\)*ID,/?&!W?U\8D#7LP9;6Y 4;.*$>EU@6V@5+^5*&N]
M(6I(>S*]N]Q?99$1=.<WRBF(%65)QZOY*$(9R/F^=0J,NESMTMJT:OVK*&5O
M+^EDQ:79*T2$9X#TX;6\#S9*/*UUXH?(<L449,$I1/F>N/AH-8P5DJ5_E]OU
M)#J!ON01N#M2USLIR9XU+V2>P9F<9%(UCDR-9*39HR3]HRU( AL7BWDM0SVJ
MRI5 N4.GI;<"2_;)YEFO/+>R5V1):KM>HV=7(YZ*T;666$1S_#:^0Q\A.J0R
M(^4[0O&W-"G0Z/5J-)PA7-E\LTIN2\^ 8;1U$S4N&7UT1UESWTJSRY15@IE5
M$\YCA,DW)XTC>&FV5D2=T4:D"(#^I=F0]]1O$=2[+;AF+CP)1!:WL7J^X:%Z
M8\=5.US5:N=1'JKH"=UQ:3\E4P\I5'HU%Z+L>P$Y;/N23:,GI'!(X1XM[6'
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M1Q8D$0Y$:&2:IT68+6!G'$7"$OYRM.66Y.FSB:(N3I7"&LF:&\8\=1'G9C5
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MI&!K:0FO#FL4 5IT^RD( M]U=XSYET5(IY)HIT2OJ)UEG 9/%[>XL,;=3'-
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MZ(Y4Z;YHN2H:NL+FJ*]$0T;7=-1RVV8E*V;H!'5J1<<!%#+6J=V:7*/_ (M
MB*'[X<6;[UO0@:]7[H8H_<1W_<%F41=G0%W5,Z694U =J44_AJ:H99"H7)4W
M4H:G2Q9^:F>5VM/GEC.@*"L]Z7%&N"S3J:KT(K:,)?JC"U7''.*#E'E[G3GW
MW]EDSW1]%593CK.VN-IXT*9**ZA;'%54@$W!4."I"6]J6?WKW<Q4I$7L?H$8
M,6O6V%*&[B'M7G]59]=<0]9TY5O.%L6'8%FM45NCGA]MVQ.9)+;DC=)M9I=
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MIOE5MR36J_U]'J?.@B"$>8>I_'PY/,\B#^6BF-23&F]SI^D; Y"?$:<NR 2
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MYPGKVV:JNF .]9V= 9&Y1ADF\>^-QEVV<$QHE<,DB%T;%R0]2D5I%&O5,T8
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MC>5#>$0MA#8/@,!@,!@,#R+^"?\ YM_F-/TA(/\ E(O_  /71@,#SF?-;_\
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MK+(F('*76(B+5!V C7NQIQHO6]781!5**>%OI)_YL[BI"R)]"4CX74<'XO\
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MV>.^L+V>N@*VM#A?DKOYCGK_ "IRY!ZGG<^@]"VAR1&Y>U%!8H+,E+55JRU
METI,353@SR*%NRE[>6\1):D*9:6)0((LZ:\?GDHG<5LBACI3(>A(U,N#*NYT
M@-L-74[QR["@7$PT?(*XN&R>N8A!F(=M] +9W-U9;VTI#7%Z8QH5 VM6F1 &
ML5*@Y+OXY>SXPT32>QBO(++Y<R69X5;>B-:%6HT1U7.#>!X=%6R\H4"6+V?<
M>C+D)T;3RV=8J#M&N"7H>_9:%K6!M$\FU'W??O/%9(*(A3%-;,K#K#D'HPN
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MPFC^;;KD+[(KTC#@[PMOZ!@BB8A;+4CZMHCHJU3MBL)2%E6*U!NI0(1@TQ1
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MKB!(E X*$Y"0]<%.4%8<E3&'&IDQJG0-'F)TYJDP0 ;%L(!&"WK6MBWZ0Y6
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MRG)516B%AIVC"P!;? 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M@,!@,!@,!@,!@,!@,!@,!@>1?P3_ /-O\QI^D)!_RD7_ ('KHP&!YS/FM_\
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MRE:(U2WM[I(2#%@PC])"71AN];T#>L""G_RE\AQWO&G?'*KES\IZ.O.KM6Y
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M3W.?*-H[F,6G/5B>6DTG,5D;_P#Y42>60Q()Q=JX43G2[V#38*ENV4<A;U!
M-+_>"BR#!G#T7@?OF/MVD^O9GT?$Z._#"1-G+]L*Z/GMCJHY[A64@M!F(,-E
ML6KF5"7&ZF2B$&Z+)=C22"TY!J@GU!FA-"+86^P*5=V=YTIX\ZIAUNWDT6A(
M62P+=AU&PZ.T_!%ECSF0V//4$A7Q5B:HJWJTBU><[?@RH()"3L9QJH9))8!C
M-#K K'&/,34$AJZ_K><^3/(O7<1YPKHNTYT*V>-Y_63B[1 IW3MKXI@J:8*F
MLB7+XFWG&.SHF3FZ.2M"4]3Z!:+V'82#'/+7QI/;/K"J*KE<IMU^L_E=R[.
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M*6N+OR]VQ3+3"&JTIDO9$[>-7"HY=<1?5"YZVO* 60ZLI^CAIP)DQ9@?Z+&
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M*-Q/YA_P_P R>F)F;.MRV\F1R B+M,IE-*]!PZO#'U4X[:2$2NRY1533 6L
MG((B1'JG(E.6((O7&'01;T$I=!>;/QL\O7=.^<[EO:0LMQUF&-CG4/C5#]"6
M... E\<;9;&Q+GBN:ME;!Z':/NY"@K8%0O3H6P[] P#"$,YN#RV<!T/2%*]
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M@8V0YWD6E]DS!B46;'B;&951+2H&UJBMH22/;)M:/$/TA[#?&&$0/&QX^0C
M(L0>).5@B+&$0!EBU1D%UL PCUH81 WKT;UO7IUO_K@:'B.^^/."_/!Y>7GL
M*Y66GV.T*/X(;8.4^1J:2,<W516GGH^2-K,W1&,R0]Q5($[\E"(C8-#-VJ"
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MK*S/")H>=:"QN+TDV;LN*M+F5KUDQ[CM(0:5KUP"V#6]X'17GY-?&OSI8'X
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MK7IQ"26(S9"4)I_J $+U?0'>]!L5P& P& P&!Y%_!/\ \V_S&GZ0D'_*1?\
M@>NC 8'G,^:W_P"$7IS_ ,UYT_+]7>!M_P"!?]"G%?Z)?.7Y'H;@6TP& P&
MP/'-Y7):?$//Q4#@DZNX]X\/.\4"]$.T>V8)$K#J=S)/ZJ?S]0MF99C-Z_;$
M4\=Q(]JT:L#A[<*!O6E!+&$PSU0XG15_U+#[?\ =M6CVAQ5;\,@?9G8!=E=-
M\]A@%0\SMZD50$:1H59;;.Y;%(L[,Z!^:T2X9[ML9ZLXLP6@;. # S_SW]6\
MZ]$UMXQY[S1V!R@]QZ$^5ZE6I_O17+(#=-$4^_BJ^S'5,[W"D:9:ECQL>:$
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MAY*!UB"GJ!7449%0(^3@BE0GW3C/YR*4E/):A![J$'NGN/NIN]A%[;]R%$?
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M@"(+&?L8 V,?,+,?.\BY6Y]0=$6W8'.:5%V;2<@J#I-@K".6[5%'7FT)I5J
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MM>$QIY!9S<0<$9@ [V+0:3=O]ES;M[L%+2_0G)'=/3MV>%CJ^LJCM'QEL+3
M(I1*N)G'2LEALJ*0MUFR)ZL"UWI2D;(T\'24QP;E_NI(4A99R<TL,QZ#O#Q0
MSSY>6C^=.9%%*.O;2FON:X715$UNWL1?8\;[;:Y/7J2:O&HTT$%VC&YN7,"7
M@]U?%&DY#DG/'HM0:%6G :'5^5)+>/DN[%O2I(US%T?U@C\>_'Z+GVOIQS>J
MAA<>JGR<6(G@EHRJUI$\2:;PW:Q+#OP31QY:B:P+%A!B90+00#V3ZX27;O3%
MT^2V[?EL[KY_7T.R=/3^J?(Y&94@Z4@SS.ZBC]YU92\"CMY1V<0"/K&F1 &<
M[1YQ.:0A&6<B]\1*Q &6'U1!16]6]6'QF^?R:=(+XC /(8[=+<&0GK[FFOZ\
M9*KIJJ(M4W0-:LU-S^I&1M?'LR:0FWXX\J'(R4*Q%'N!^M^L5H(P*5@;T;EM
M7C3HCS#>'MP\;DSH&TK8KY[Z6?NFYKRLX0N0,L:YF/J$EH.:;GE%9B-8M-CO
M*UQ9#$@<SAF$N)WI)++&>#9@3W\P0*+L;GXN+'Z&:QO'!];=_0Y_Z^)<6E5(
M($S(%D5>6FI97;#&G3+DZZM&*:JS N/OA!R$6U!91@!C.++&%.>B;+Y+Z"\O
M_+,O\<<AJ*Q3*SX2[Y%W?97-)T:>J\!1\EI(UNY_A]DS& :-BSL[DVP )[:A
M-4F*T>]DC&#0-%>H$@?+D4-V4'CC@RVY%-.*G'E+=:2U:W1!JYM?$?4*<&W*
M?MC )3=QTT.8S79NF?LE"M0%IULYN -,'03!:.T%@?F)Y) H>V^(F4VD]1*.
M5M'?,=R@]SQ^GJMI00EGB#7'+372%SEJQ^$%E31Q U$&FK3%>])@)P"$9^XU
MO U4=YSGF&Z^L_([9GCW?*GFU-QOY?GL>-]@V+SJ9'G&FG>Q7TU]54I'I'(X
M-K<)D5KIR&TP\H83#W EI3C*$9H!!A8 C.L8;V1->U>7!\+M_*4EN.-_+)<,
MRL$0ZQ@3Q/(;-6=M?&[1,9B F=[9"8Q-'A\4HB4SFM,$WEDF& .]0!GMBPJ^
M[J*W9_&UXY)Q#;WKJL[>F_GY=K4ZS7WU546A-/\ '/5+Y"9JCL>NY?1NI2DC
ML4I^LB6)$K(;3W1&4L:CM*!B1:.VF3!L?[7E<SM'Q0=YL$5[CX3[R.9GCER8
M6W&O&_7$,KF:13F2.W,D7WIJ>H*YMBR':1,;U'20'^L/2(M*VMKGH>SBSC-%
MAM8AO2/@SN/L3@*!\VQ2F[ZZ'+@MHG<\27E&/M+LS\[5657@6^6%7H. /+ D
M@4,?(RK,:4C1)D"P1*TTPGW-,<<(0PPGDVM*T+^8,\J+2GKV EH8WRWPDZQY
M 7$(Z%*P.PF:0*AN30F W: UKAGZ+,&:1HLP0@@%O?I"'>@U:<'WKXPZ-\6_
M>%*>2=VH>/=LH+4[.*[5KJ[4$:+Z(MNSY#,INXP9XAC1)TPIS8)[K%W!G#'5
MS+I24E< ;4$&$C]8_85YH6I_(*MO_P .T"KPJA$G7L?\'5@.88YVU7\IG4/,
MAB6^'17 8:]L;6O:Y%%YF3"%#"B*6*-B$V%DJ"CR1"]8&!U4*C7*TK\8=ZOG
M7-SV+S)U%//,5"91TPI@G.T#_$]X]^U8S\6C=?"M.AEDO71A;R@I0-ZGWI_6
M*#T[XK6%!-+$>E,)V&WCPK7@=(O)#V94$B<N'>J;"1\XU)/I3Y#N#6%1$8E8
M+:1*CXQ&*?O&.QQY=:E_&JA2&'.*(YB"6(MN2FDFFGB"(*8.1\P):;A?70/#
MWC)A]$6SU='G64![<[)H2B3HX&?R3G&GGD$9@47<1R:2Q5F1Q.?6HZBTM&>O
M2& ^$D[($(X90=AI=E,[=+8\)Z_Q>]+QNQZ[LSBKR=<?\UR^OK"/96^XF;EN
M\++')J!=)!MH6O#(C>0UL_+&=*8E-4H@E,I)A1AI8@BV$D5V_P#0=:^2AHX#
MZB)?'^P_'WXP_(_44 O%Y."(KH3F.3P1)(^<;$%L6]B_"-M@B$;&\>J,X %C
M3L!AQBLM7O08O(;6XMM+Y?[QY<_<_3/GR=^4XF6\BH.>H-5CA"'_ *>@EWM=
M],+B\/#@BBFU,[A?PV"IW+XBK<?=2  &#VH_7V7O _T'2]&:++T;L(C= #HS
M8-;T#9GJZ]?8=;^[H.Q?]/\ ^F!^\!@,!@,#R+^"?_FW^8T_2$@_Y2+_ ,#U
MT8# \YGS6_\ PB].?^:\Z?E^KO V_P# O^A3BO\ 1+YR_(]#<"VF P& P&!2
MWI,_QV%2YF#V"=Q:7/-QTG<>UTF91H)=N)_$G+2?;-JT-Z>=QWXO[YZGL/\
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M)4J&2(M@RW805\G>"$9PTJ K8U2@!0]EEBT$6]!*. P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M,FBD*M OTNE[>4FT.3N6E34E'[TN&>H_[<K7K^@L.M!)MA\S<_6R94)UDU!
MIFIH&5,LXI):^Q]$L7U7+8\2G3LS]!E^P!6QU>A(1D@").8#0@D@T+0O4#Z
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MQQZGY_S\S416""D;5735TL>JRHDU"@\U<;&4&*YRND4?-(,0.2N3JC=FJC#
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M[P-O_ O^A3BO]$OG+\CT-P+:8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# \B_@G_P";
M?YC3](2#_E(O_ ]=& P/.9\UO_PB].?^:\Z?E^KO V_\"_Z%.*_T2^<OR/0W
M MI@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#R+^"?_ )M_F-/TA(/^4B_\#UT8# \Y
MGS6__"+TY_YKSI^7ZN\#;_P+_H4XK_1+YR_(]#<"VF P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P/(OX)_\ FW^8T_2$@_Y2+_P/71@,#SF?-;_\(O3G_FO.GY?J[P-O
M_ O^A3BO]$OG+\CT-P+:8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# \B_@G_P";?YC3
M](2#_E(O_ ]=& P/.9\UO_PB].?^:\Z?E^KO V_\"_Z%.*_T2^<OR/0W MI@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,#R+^"?_ )M_F-/TA(/^4B_\#UT8# \YGS6_
M_"+TY_YKSI^7ZN\#;_P+_H4XK_1+YR_(]#<"VF P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M*WR63*9R^0+CE;@XN*Q0I/-'Z/6T ( !")^L9!XBNT5,">+JOQA33*L 2=)
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M<QB;'8@]7&4VOWPL7H*,-+%Z0&[U@>8OYAZE(51W@J[F8:\*/(ATDZ'Y_E3
MG-L5QL9,A:]6%SY$FYG9S'-M2*(7'(Z@B93<VQX"IS3MB!(5HA2 DPM(E#T*
M<"_Z%.*_T2^<OR/0W MI@,!@,!@,!@:[Y6RN/;=QV15[N\.[7R'0;XE@=DL$
M<=E;&MZ6NXYD:Y+(8#)'UG5IG<FB:J8G] G>&U*:1^%<D5*6Y</X<TJT3H%Z
MXC#(?7\>;8E XI&H3%&<@*5HC,18FN-QYJ3 UH($[:RLR5$VH2 !#K6@%%!#
MK6O^F!DN P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M;6O^&\!]0/AG['?,?T&UK_AO ?4#X9^QWS']!M:_X;P'U ^&?L=\Q_0;6O\
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M*_\ [6DG_P @>/\ Z<IP*[<+?Z)..?T5^>_R21' M1@,!@,!@,!@>1?P3_\
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M.4X%=N%O]$G'/Z*_/?Y)(C@6HP& P& P& P/(OX)_P#FW^8T_2$@_P"4B_\
M ]=&!!]A\[5/;,R03"R8FT3C2*N)G5IL8E;0S2*)KXS.7R'O[P)2TO#:MV6X
M:5PM, !A!A(1E#%HT)FP$")#R\_,4URVT/XCO(#2[)(YK,FAVE/(-[I'VPY&
M"329E)D]XP"FVBNR7@QN3/#U&X9%Z00%H%[NJ<7D\!NP*U2@9>C1AZ0N!?\
M0IQ7^B7SE^1Z&X%M,!@,!@,!@,"D/&() 9R_)P1,]G2R@=[=R!CBF0I%J]@3
MOHNPN@M-)[VA;5K:XK&DI=LL2@HA00<83H00& %O0M!RM-'D5_\ 6P>*_3_Z
M^BGKS_/E@/A'D5_S XK^A^\_SY8#X1Y%?\P.*_H?O/\ /E@/A'D5_P P.*_H
M?O/\^6 ^$>17_,#BOZ'[S_/E@/A'D5_S XK^A^\_SY8#X1Y%?\P.*_H?O/\
M/E@/A'D5_P P.*_H?O/\^6 ^$>17_,#BOZ'[S_/E@/A'D5_S XK^A^\_SY8#
MX1Y%?\P.*_H?O/\ /E@/A'D5_P P.*_H?O/\^6 ^$>17_,#BOZ'[S_/E@/A'
MD5_S XK^A^\_SY8#X1Y%?\P.*_H?O/\ /E@/A'D5_P P.*_H?O/\^6 ^$>17
M_,#BOZ'[S_/E@/A'D5_S XK^A^\_SY8#X1Y%?\P.*_H?O/\ /E@/A'D5_P P
M.*_H?O/\^6 ^$>17_,#BOZ'[S_/E@/A'D5_S XK^A^\_SY8#X1Y%?\P.*_H?
MO/\ /E@/A'D5_P P.*_H?O/\^6 ^$>17_,#BOZ'[S_/E@/A'D5_S XK^A^\_
MSY8#X1Y%?\P.*_H?O/\ /E@/A'D5_P P.*_H?O/\^6 ^$>17_,#BOZ'[S_/E
M@/A'D5_S XK^A^\_SY8#X1Y%?\P.*_H?O/\ /E@/A'D5_P P.*_H?O/\^6 ^
M$>17_,#BOZ'[S_/E@/A'D5_S XK^A^\_SY8#X1Y%?\P.*_H?O/\ /E@/A'D5
M_P P.*_H?O/\^6 ^$>17_,#BOZ'[S_/E@/A'D5_S XK^A^\_SY8#X1Y%?\P.
M*_H?O/\ /E@/A'D5_P P.*_H?O/\^6 ^$>17_,#BOZ'[S_/E@/A'D5_S XK^
MA^\_SY8#X1Y%?\P.*_H?O/\ /E@/A'D5_P P.*_H?O/\^6 ^$>17_,#BOZ'[
MS_/E@/A'D5_S XK^A^\_SY8#X1Y%?\P.*_H?O/\ /E@/A'D5_P P.*_H?O/\
M^6 ^$>17_,#BOZ'[S_/E@/A'D5_S XK^A^\_SY8#X1Y%?\P.*_H?O/\ /E@/
MA'D5_P P.*_H?O/\^6 ^$>17_,#BOZ'[S_/E@/A'D5_S XK^A^\_SY8#X1Y%
M?\P.*_H?O/\ /E@/A'D5_P P.*_H?O/\^6 ^$>17_,#BOZ'[S_/E@/A'D5_S
M XK^A^\_SY8#X1Y%?\P.*_H?O/\ /E@/A'D5_P P.*_H?O/\^6 ^$>17_,#B
MOZ'[S_/E@/A'D5_S XK^A^\_SY8#X1Y%?\P.*_H?O/\ /E@/A'D5_P P.*_H
M?O/\^6 ^$>17_,#BOZ'[S_/E@/A'D5_S XK^A^\_SY8#X1Y%?\P.*_H?O/\
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M[[ /1OTF<;_K.8#ZQM_?8!Z-^DSC?]9S ?6-O[[ /1OTF<;_ *SF ^L;?WV
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M_K.8#ZQM_?8!Z-^DSC?]9S ?6-O[[ /1OTF<;_K.8#ZQM_?8!Z-^DSC?]9S
M?6-O[[ /1OTF<;_K.8#ZQM_?8!Z-^DSC?]9S ?6-O[[ /1OTF<;_ *SF ^L;
M?WV >C?I,XW_ %G,!]8V_OL ]&_29QO^LY@/K&W]]@'HWZ3.-_UG,!]8V_OL
M ]&_29QO^LY@/K&W]]@'HWZ3.-_UG,!]8V_OL ]&_29QO^LY@/K&W]]@'HWZ
M3.-_UG,!]8V_OL ]&_29QO\ K.8#ZQM_?8!Z-^DSC?\ 6<P..JZ+Z/&08!I\
M?]ZB<1Z]5+^$%O<DM#+HW>_1H3DY,]^RET2)0[WZ1B3MRPW6O_A*%O[F!UD0
MH6W;9LN)W7UTYPP.ZU<QR"DN;:R<7B0596TK-3*D9-G3^9R%HC;I=-P-3:M-
M3M"H3.S,49T<<8B0GKQ ==!># 8# 8# 8# 8'D7\$_\ S;_,:?I"0?\ *1?^
M!ZZ,#6MWQ8)E:O\ 4C_,II,F2G%;;.6IZC%/W' *6N.03D9T651Q:UO$QE$#
M?)3"VEH(<-.+:QOB,\M6<D4JDZPDL(DH:&?.$Z+)'\O-V'+P2,N3127=#4P\
M5^L<IY7]HV CB*>Y*48M-=L6'6NU,>E$^0R-F<="V:N=7-O:=H6]<M4*DAHM
M!Z6^!?\ 0IQ7^B7SE^1Z&X%M,!@,!@,!@,!@,!@,!@,"J/9-D2NNJFCZ>#NI
M\<E-JW=0-$-TN3)TJI1"TUU7!#Z]?I8B)7$J$(GIEC;XL,:_;EF$[=?=M& &
M#>P""N+A([+UY3'VNF*])@.)%\/?C88Z->7B*"K$-GFV(OKI$[.;>CBGXP=M
MVVI*4M.++==Z]Y$,X(?1O0,#(/&.^WY8-"O=Q=#6(FGDPL^SK05MZ9E7K!Q"
M)L<2LR;0M#'XHQ*V-HW'6M"4R:(+*T8K,/((*./-&I&>,808Y^3V;E+)O!6Z
MH8>3:503B/TE=A4CG#NS0*L[FN;J>.<^\U_%W[<9.<AP.Q:]7+;'4GZ3:6%,
M(FQ*4$1[D TH,2>_+',86Q=&%3&L*T#+.;JJM60/*UHL=>&#6!8=5WPAII6U
M0IS<F,A?J.NY3RB--"8 U>UO9AS48$\9(5!P7ZZHO.VJNE/-=:4I$JZDL\Z/
MM.8UN@<;2DDCCT3B*>(47:MTJG]67%6%^>GXXX%9^X 1%!3>MM9[79X E;T(
M*,5?Y2+'MI-6TW9JHJV/5]*IURO2$DC3S9[HNN!';'5E25_9;#)HI'DL81M4
M@JB$K;*1)5!AIJ9Q=FQK>7(G2<+?I,H#I83W[U+%>8ZFEE@1NK;:NR]^M;?Y
MV@NZX:IP;'(J3 I7T.M5K)K&&5N4R5T6ML?I!0U-;>W@)6+SAD&*C0F!4CV&
M'N/DCZ"N511JB$Q>O:+CA737!=97*UOUC(7RTY LZ EK"[2EFK5L(85L9D=8
MN,<4";25XCTSJO!\2-+"B/:32#0MKY$>^I%QDD(,A45AD]=F&G+5Z"FL6>5%
M@BD/XMJE41E,Z&I1Q&&O,8A#*ZJI#M,*321S1MZ%;H@@M&O&H'[N$,*O)-T0
M%XG*QIY\KB3Q;3_V_%ZC8&"PY0JLN8/'$,IT%_3O;8*&@942VTH>WN130D1G
MJAH7HA( \PTA89M&%]>9>IH]TE6<[OQFTRMM D366HZ@LC;L(:"QJL@S:W-[
M[;*H2HA(0S,"Z<M[^0@_=#"<TMY"T0]:4^H -0/,GDTZ'>%[W#)8TJ76Q>IK
M@K&S>4?K!Q5_I6#5U0G0B*SU[9$SG%/$T3E8\<J9MIU,2G<403SWI_G;6B$L
M $T(RPZ*LO(7UC/*6KEJ!)ZH1R"-] \B,5UV>KG"13)Y@S])>2>0TZ3%Z';$
ML.3Q67PUIK*&*(_MS5@2JGHI0H]UTF7-XS#@MRX^0OI-CH5%?SQ1M6'L%H7P
MGYLI6.0^8V%,Y2DG.[^EM(;EUCH4L#;2#XNZ)8D<[(VUH,,<Q+3DK1ZXC5.U
M9 =<V>3VT]R&A"9C2D2K^&RY^:8;<,N<Y'*)4EBTM>^FI3S*RH]((#'9/(JG
M12MWC1;DP*IJVH6]S<5VXZI6-KB@6GEA8/D'MR8= W3;-1V-"8A7+M&FU^F-
M>,K4\R>0.LGKM@M"25H9+VZ7D1X^H['C*LYM;SC'*-OYQS6X+QMB]O3G)]'G
MA32VK^M4,5\@-[*.QI!3T^HF?]94O3O.A956AAKR@JGEEZG]?(B([)8JHFKA
M:4C4%:L<A[+<#MZ:BBTVDPVH!P!AWZKR4=#0.-'5O.('2:KHAN45ZH:BH\]V
M].&&9PR4\[N5XN3FW1R+UL"3#D<6$PJ$;VK6#9XZA0G%NHE0-["V"#@Q[R[6
M:\1A)>1M 0PR@=*:W85C4P6.\/MU+9+9?CSCW=B'X"V B"2'+FQH/=MQ?0=K
M/>''1P7 O1&BMI3P^JOREWXU21NJ4ZHZ1FEK35[H])"'NE9W.[<KYO;;>I*\
M+[5 E+:QQ%)+E;\RQJF_<4"9#K6G@MQ [ZVF2 $EP)1K+R8SJ<W5SM$I7443
MJ^M+QC-3I/C[I,7:>+4]L6G7$HGA5>I996;!*(-&9 A41\HEI;94-A'*VE3M
MT;U>O4 A.#.O(1Y!I!QLXI4L0B4*GQT:JF07I8\<=%D_#)T]<Q^5L<6]LF51
MJ&.L+@36[JUZHDA_D;JG3[<$Y:0A"K$8:8F"$9%Y1;GAXWQ[?Z4J@4-E<RZF
MK.E%*6T)$F<$LJYQ[$@?)263W8K70L#1%:_DJFQ"']R/;!+SV! V'A%[T(\&
MTX9+2_1O1TVCMA0293F+*;@?O)\LYS8G&L7%N?(M$:KKN*P*X;,:8PI=61.N
MVG!6$1DJ<T+B2H7M;HZ[3C/,&249L.'/_)_9$&269-PU/5KY D)/?++6$91V
MBZ$6R5,.!&.PW:4G6\S&14QJBD2LTRLEH$QZ,2I1'].;+[T!6)RWI*&QF"2Z
M_2Z?ETTMN&UF7/$;6_2:'Q2I9)+)0UN;.7&R7I@8W1=)HQ&5^Y-MTV:@.$E)
M,3*0EEJ"_9;.VF)#532W4-D0NJ>4YHW=8,W2%Z=UPRA%AE7W'(*^C]9TW.K6
MB,ML!^LQKW6\0;)W%*Q"=%7&(,T6/TK$XOR9 C L)6B<5)@1HY^:2["),6F;
M>>Z=61.,O (G8;P"Y)(I4*I!%[(*@5@NU9&I*^$V2B%. "#%,:6JC$9JP"DD
M2DLD)9FAAP8;YJ+[=D3>1)>::Y*?+!'5\?JXJ!3Z<SH!$KL_?-+PG4S9I! V
MAV-9&:-=0-9!:=LV:L=7UI,2%;) XI3B0G%M\H]]N*I4O-Y\KEDC55LE$.5Z
MDOED/I,P6'W!V/='(2G\5S,CBRQ"D);3:GU)RR)"I1N!6E(F560G6%&JB@SN
M&]?];1ZI>SIY,FFE+7E=2]6O%(5+ X6XK8P^%HU%BPN&I$+J@?5+89+'!H8I
M>2XM30B,T_2I6'3>D'M0L1X%NZIZV:IGQF^=624Z%M!<&A]RO5@$B73N)Q&.
M/E%N\U8)TV2,Z>P!EL"#;8W:$*BGA.N8#UC(H+/)T!=[ )R@-8C)Y&.K;;MJ
MKZWBS/3=9SQ@NURBTL;;#<["K^LYY"Y=Q?/K_C&WQHG,%17"PN,;<X]HQ.'2
M%":Y(RRW,11*4)J382G7/E1M"Y6B$S^OZ6K9KA<^GU44"R0F8V>[EV^"[KIY
MJC?0$/D(VMMB6V973B%;,$3<>H*%\25L2==(B0A3IP(C@^._+5+)]&8&]4E1
MH7K5IV9#J'BZUX,ED@W';N9:"F=^])0Z3Q:&L)[^Y*:9$R(H9[NB$ \^4@>-
M';*):# '!M$YTNXB]:9IZRW1D2P*46G7+7/CJZ/D[')'%F"<2@+>BT#HS*!I
M9&RM;DX%% <4X E&EGD"&$H9NB]!3[LWN2R>;;/>8E#(+5,CC5=\EV5U_82N
M?V*ZQ"3OT5JR9Q^-NM=UJTH(\[I5DLD2)Z'M&O6&:1)G#25*<4+2T!A01[9W
M5TRY6E?D)GRU?/KBBE:5MQ_8U=U=*W!L3%Q27=$SRW($M:$+@V1H#RP0-*XM
M[,>N+/"YGMZ) I,*]<>]@$$'6CY<K?JZLI8\N]*0<NSJ@;[ZF=F0E8JM M9(
M:WHQJK!Z/E;(S-L-=SZ:97\-F :UCA/%[>%E>402BDKJ2M(/ &?VAY7973LO
MZ:(F=.L(HO5D)MJ1TPVM;]*%SW<*JI7.NF5V4))\S1605,4D1+)_[:4M!C@C
ME,(3I?2I;5_KF"3A<KF[J&P[1J>])-9]:)83.*'E$DC3DB1FN;>SR\MKKB+V
M4VNZ:/R,LN:P<PQ'*P(%+<[DZ5:-2[5DB-1JDPQ!K+JWS%7I-V\3;*Z6I&'S
M.8H:\3U,C8YS;EE"D4GEPH>^N[ 7#XE4YLSE+VWPV>$&(4#<64!4>S.!ZE8A
M1; <6%G>9._NA>M)!4;36U.TQ'VYWIJ/W%;;M,K.EPCVX@GHBXZ E\9K]J8(
M(X[6+3Q5$I>6U4XGE%D['I J+]8>U90<KQ/=J6-UA532UVDA4-4O@U0U([NB
M^?@+9+9N(^:-KDI/OAHB#0W)XJDH:4N+<I;(\YI5)RIR<6ERTI2M^B"2SP^M
ME^1N:5Q]9FR5,$I\ZE^=Y==E5 BCY;RJ*=!SFPZ6IPVW%KBQQA7%7&-"C3\0
M0/T(]*!."*,!W)1B-2A$A"'%#W+TZIL)!SLT5ISD^WJIO)AJ)5+FVTIP;1Z9
MJF7*=C=4,<H3G$0E7,5KVQM%;J&M>Q[+)&H*<&]S+5DD*]D$!FDD[,Z*B$DZ
MP='JGZA4U9Q%7:.97../V/-'6QITZF\OM]\NC%4C*=7B!H %ID!_PM,:\'IQ
M.B-2 _U$9I(R#@K>/RB=* K5<Z#YLBWX=I9; Q"-2.DQ=6D-;SFFIY;PY VU
M6@:Q7U-E,5'!](%YS$RK@F,SB7(TR<Y&F6(B [>0^6>31X^;V8FK>K)QSU#)
M+5D.2:KNS7Q]NF<*[:XGB/83),8?%'.&,*$Z%HT\D$VA"K"F7+&HI0\"+2A0
MFHC@[IO\A?3CQ9M7\[L]9\QO%S6\LK9]C\N8;AFL@I2/0&UN?^D[O90/3BVP
M;<F=9PPCYQ4)-IDY1"1Z:WI$Z$FI "&F $4I/)/>U_+N69%7C-75,UY)>DN*
MZXM)E<Y[MXMF2./0-&-%[OK'%&59%"6=VJXM#+TC04N -*[.(FQR6DZ3%HQ$
M&A-,4[(Z32L*6)H(S6<NNV?>1^WN/23Y=.9&DJN'HX;2UAW!N2,6V>"ERY0Q
MH$-<;3IV-0$U6,Y69ZSGH&@B &'U]Y5;-L=34;VWU13D:BDAL3CJG+(CLGMU
MT(LL4YZI6M!*Z15&TE1,M#+X!!@.!A:0Q9[FK?343B+04>FPT"@)R[EZAN_G
M6[H$LK)15[K"X_QWV3?]DP&TYD="$<K24+)^:7%,.(NK='GQRW,RF&5NR%.:
M=L#2@+<AJ5A9^P$ T$<M?DMLN2JB9"T0"D8W7]B/'5D$JE-8]M.D5GL(FW*<
M*FDP?7_I5N'&CVFN:VDP8 M+5JDIJM5&$Z]H4*0*].&RTP6UXP[ -ZTYK6=-
MJ("K@+$O=YL)AK$]:8[6Q&&2%:^'J&"U6 *5(3%K66.K:K4"8R1'Z2H52'0C
MAFF#] 4.;/*/?CYNAV!GJ"@W"8]6LO-UAT\8W6]*':*P2O.CETY0(VRWEJ.$
M_$3IS"P1,"@OX64%!(S ."5.)'MO$H.#8=25\V->_(P+F9XW"XC;1[3:3()@
M7.KW)*\1V'5<TF5<.QY3HB;6J2.$.<I'"SU2;_M25VD1Q8# :-T+ U<E=H]S
M$UCX]++;WF@9W+;2XDZ.Z-MR/#=WZ+5Y-TM=U7S+/V=:>I9XM('IGGX54S<D
MVDZ(*9F1"=C#A / F)3&!8RB/)C-;TZ&CL&:*&5M--2:Q#*>)EC@XKT\G:)D
MGYX;>@C9(I5+42*&OC H3+OA13,W*#GWW49#WZHD)AI2<+06'>]]!ZV8N;*@
M@52N3(EIV*WC.IK8\XEC(XD1YQM!Z@#Q%8O'8S#G\*I]-;F[:]$N5*2TH#B!
M)SB=Z/ >4%":R\MUCS*-.5L2+GM%%:5!&&JZQR-R>WIJ>X5SRUWK':CM21RQ
M$ZM109!(*YB$EW+URAF+-949+*[-2D\M40E/6!SI%Y7;4(?(8**<XD/46>:X
MBW0R]0H>W9,N>^?+=Z#L"I*1=6)X/;4<3BTLDU>P8N6JQ/JHAM H>6]F+,]L
M<-84$X*.R.J0U)?MXHJ4I1SA]?VK:E&5A%&ZUGW\8TPF];]4+.<"']T0R",1
MB+G)9&C;ECJBC*!R$_+5Z9.THS%2MR*]V"NC]Y=K$(0PL$+HQFG[PQUC,+1O
M$*(=DQ)"@+@W0<PY\D->1\JQ(5$'2N9ZS/D%7'/.YB4D;&-S,2-8U"H"H+F$
M-A7;W1UD\WP"$OU5UVVV/)9A/!QA4WK3'AT6,+ WPB8S5WDK97<.)6V59HT8
M(H!.J01M&O<VY"J.=1ICTK>H+$$!KNU)038]06,$EBEE$V'X]+YZ\B;35<@>
MG5RE)M<H>;Y(L2&(9/!V)1)0N"*R!DQ=:2)E4!+./TX-XC%!.D@4S;/);U*P
MVZ]LCW&*JGK_ '=&^)D](P>J)')[-KRL/QRUAV/>4JD$I''XBBL&229YB-,H
MFPA&E]5,ZC(2.*7:1.8I)T&YCFN]2[XI:H++?&-%7TNL^#_A:=71LH9)&M;A
MMZ@AND&VAS:C]E2)B;W%23ZBTHL'[RJ3^W+(-,]D$,*Y*LJ6S9/T/"IHZ'R)
MUH3IZRJ>;Y6J 0!7(XH)GAMJPH:[W4A,F/<HO$;21,"H\  [4J6@PX?[X8/
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M[II!9C&15<&):;"?T:\QU1ODV;BV(*24O"-U.&J*5+@'GEJ1B-"+1@MBV'>
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M_"+TY_YKSI^7ZN\#;_P+_H4XK_1+YR_(]#<"VF P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P*4^1+M**^/;C6[^N);'%TT354PM>V&$-JL*!;-
M9Q+Y(S0> Q0MP$G6?#B'R8R1$2I5:(/$E2B,."4;L&BQ!3+G>UO-Y';QI-'V
M)SWQY.^?[R2.VIHY\IR&=,-@\>O);$8^L1-G!MZ4FM%MQ]4IV6T*SXV5I04N
MT8> (B % 4A*<%\T'CUL:^V+GR+6^_J7V8V2[4O7MEKJJL]IY\LVY6$XU*[U
M37%_.<32U5,9NF6$#(+3(W,PM:H#HI*8>8,L(PQQF\Y'CC?;;C=,M]L3?\(Y
M'T,\\G[DBRCKE;ZPCW135(UL515+*K470A/ F*7RAW;S/A:<U?OWI+L"K>P)
MC"SA!1=X\_#7-6/R IX,SL?/[KQOTW5U*QR=]$4QTK+*\ET3D-C5O6TD=94E
MK^&L;O&;!D4FF"E(QQX)HUB--I.YK0C0;.& +V7EYPO'3SK9EKU/:-ISQME-
M"SV(5_>JMEHJYY3$*95SM Q+HI);*G,=@[E$8M"WL<C2IDSB>LT6I6>U))T8
M,@[186"FGDEY$@#GV8T26Q'-.LX$KRNK3Z<TCA,Q<D\-A%K0U;/H.[LJM RJ
M$TWV[Q=O,4;)9Q+32=ZT P(1BUK80[='F;X!H1]B;#/+,FJDQ_K"OKKE#K":
M7MRPH]2U16H2E/K^P[^?H7#7MMIN/28I6 1&WLQ,H"5^^F% )V$S81%Y#/-G
MRYQW%.A(5"I@HL+I6KN:GJZV5H8*KM2SZ?B+Q)(0XO\ 0R>\K$K9F51FO6"V
MGC2$I -<ZH/;IEI)NSB"U!!PPN55O9D30^.ZH.[^F7J/UG&GKE:I^A;?<V=N
M?E<>BZB:UU&I:_)(\S)]2"3KTH'A[VE;D1>EJ]0(11(?:FBUZP5_B_FLX'D=
M2=)7$Y3*U*[9N1V: 2B_(A:]!7'6UHPF(VHM3H*XE^JVE4.;Y6^1J9&J0C1J
MD"=2'V/H,,T6 0-B#(*H\R'C[M[?0(V:XGN().::N(O6REULU7:=2D'46MT9
M\-N:%$6!$&!PG==/ P  A7-A"@2T2A-[ LS2I-LT*N<_>:6*=<>22C>5N?&=
MP'1]B\CV9?TI=+:IJX:AN!*^QZ6L#=7[I&6^Q$<6;W:KIS%G82Y$XIF]>2M]
M7?LU18RC2M!-%J^6V 55Y5:Z\:S[7LP3)910+K;DDN843GRUA99&H?69+%V+
M0V^)&1U!7J.-F+ES_,U3EIB:%8"F]080I]KZ S7GCS)\!=0W+%J-JFTI6.5V
M6&8F4B_S6H+5KFM^A2:]&>";&T)9,XB+%#K3U'-)33#0MBLT9I!8S2 FE!$/
M01CY$?*,LX'[.\?U.RF/)G2C.H6/JA39:^.5U9=I72&1U#"8>Z59&:AAE:Z=
M'-\=YA+I0%&J($TN&]D;T/0DP"S#M!)"SS-< @H*J^A6*SY?.F*[)U**MJ^M
M:]J"TIKT!*[/@1)BFPZ^34.PQ199J*35ZC*V>]%JFX@E"G&2:,WV:E*(X+A4
M5UGSYTCS\V=1U#9#3(:/<&:2/:F9+TSG&=1PB%J')'-4,Q99*B:7V'O4-7,Z
MLAT1.29,I1&IQZ,!K6M;V%0J8\NG(_2ZUVC--O=J-+\[U'/+BI^56]SA?5:U
MA<L!@R,TQVL"KI?*X.PM5BQ)J.$4<<!N4Z7*$HMC(*$'6Q!"$JS\UG,$5YPX
M]G/1MNM,XMKI^KGJU$B;EJ@>C)6PG5]%WYS9I7<(JX4163VM7511DQ%[-6X2
M$HH6C"% R]&%E&;+"3G'S=>.Y#6O-UK)+1G<EC'7J*[U7-J.%T7<\TEUMJN?
M9.5#K#98Q"HO!W64B? R X)3<F/2$B<2O2>3ZR< S0AW2CS,\";YVIGI9ALJ
M93F*="2V45]35?U[3]HS:]Y[/H(-:"P8:ST?'HJNL?3U 0-QQCQLU 6E1$Z+
M,$=L"A-LX/U+?,SX_8M47/=RHK5E=@LO4SS+V"CX75-/VQ95Q3!VK<PPFU$(
MJ:B</<K)9%55'$B+D12YM3G-INM%C!LP981A\/$3WU*/(US]<5YR!#"DS-%N
MN>@:8K5?!FJ3,S?)*HKE\:R*_E+JWRUP7NY,C?F)T >L]8*0'K[UK28C>A T
M'[AWF@\>L[OUFYZCMP/Y[[*[.<Z0@MFK:JL]LYZL2[68TQ.YU' .@'"*)JIE
MD\3JR1D%I4CF,M8H#HI,8<8, 1!C0?.5XXMVVEIG=L3@N2?6/?>2'V1'4;<Q
M%90OH9FDZR')*TFMI'0<$"CKY)WYO. U:-7^HK3E[5>D"3>C]A;[LKN3FS@2
MMXO;?4<V<(% IA8[!4[$\-L/E\V.4SB3-4@>65J$T0ID?W@L"U%&%?JG;(]G
M[0(2_3ZY@-""GDP\Y7CT@((6.7S>W&8,E@$2M29;'SG>2[7/U=SUW4L<,EO3
M(FN"K@T,V21P2#VEU(=I#AI?45;!I(:4>,)LF?E0XBKZ*]?S*86T>RLO"SG7
M+9T8(Z'R\Y;&Q7$@9W.I'"-($K,>JG[+9R1^2"8UC(%<F<?:Z]D/?HWZ PBU
M?,?P52MQ&TE8UDS-BDC$96:*T).73EK.M64(^W*G0*:NBW0-JM416P2G9/,0
M.B?V*-[7)34WM@;5>P"+0L#K9UYIO'K6U[V[SK,K8EC387/_ .%AUZ*P4W;;
MC!JB;HA7([15/$[L!KAJV),[6^1LHPEG,]Z&)W="A(4H357H+V&5U+Y:N+[6
MCMPR=9);0I5MHNJ4E\V#KI*B+AH)4GI!R >-IMB/$65#6+\+X:[[3[ F-:]J
MU!IHRR_8Z,.*",,ZX^\DO*O<+Y+XA2<BGC=/83'8[.'BN;?J2RJ2GRJMYB,X
MN'6A'XM:$9C+G):YE!A @I'9"$]-Z^P!-V4,PL(PCV\/+IQ7S]=$SHZ=2.UW
M*0U2MK]LO&75W0%T6=5- N5J%(U->(+LLZ"0E^B%?JY2C<4YY %2GTEDG@$=
M[+6\# GORC5+2-N>2;ZRMW5$Q4IQ&MY>0E-D0KNY_P ;$4<;_K\V0-$:FJM>
M@<8M;,HL1^&3N,I(00>-,E$(MPT$[6QA"M=)^=2HK!Z9[N3V ZMU1\:\=\W4
M-;SO-+1JNW:KNR*S.RG=V9I+#;'@,Z1(9"%RVO"W$,C<A8=*W(Q>G]U,6:4D
M^D-F'(7D YM[<,L5II9YG#;.:C4QLJS:JMVKK!I6V(4CFK<H=X0_/->V9'XW
M(PQF:-20U0V.)1)J-4 H>@F>N 8 A=7 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# \B_@G_YM_F-/TA(/^4B_P# ]=& P/.9\UO_ ,(O3G_F
MO.GY?J[P-O\ P+_H4XK_ $2^<OR/0W MI@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,"C_ )'^*8]Y#>+KQY'D,G5085HL;.;&9RB2?$#X7/87
M)V2=P&3";M*$8G%"UR^-(QJTP3B1J4?M2@F%B'H80H[25.>;JRKNHL?9MV\F
M5/SU12&1 LANY)46*_3CLYZ<8THC#3^'A%FQ%M::KAQ ]A=E!#2:-:%<8860
M( =D'(PHS5'AR[V9JRXP\>=A37ED/ W#/8,=ZEAM\1!QL7ZT=K1RO+*F5I5]
M6;S6RR*(X!!),J?9NI3/C^C?%6A)"RQIRQF[.TH#/OV.'3PN7PTV.54J&7#\
MYW[2Y0L+?Y4%D,H_=P;G@F#WK\"??169IC]!6D>R/</:AT7[]ZFM#P(^Z'\/
MG>5F(_*-3<2=N9A4WVGV92G:%73U_GEBML]9I!"['I!XDU>3"(HZZ=V1O;$D
M0KYRVE7I5RHQ2O\ =@" 64:8),$O=)^('I2WZQ\[D/C,HIQ(\>32><^2:AU+
MP_2A.EC[;4[#"&Y](L\])#%I[*H/51U3M$%O Z@WH81"$7L0M!".>O?$WY#I
MI:7DL!S=(.35=6>3;D_GBG)W(+@E%GLLTJ&5\[U$MK+;=%H]%(,^M,I:[#(4
MCT!Q5+$PFK:C1^TI^TONRP(COWP1];N5K3^7U9OG2U8]U'RUR51-UM-O]%]B
MTW&ZIE_/%0QZDI,[D5_S>\1%FZ<K"8PUK--+9)0H;S2%I@@E[((.4>V"9+F\
M0G<U>NOD"K'BI[Y+7\^^2+EFFZ-GJ^\7:V62;<_O5&\XJ.<D95?,S,RS_4[B
MLRAWJ^X[>'K:MC6FZ.-$L F$!>&R:S.0NP"O#O$^*^;;NCM(=>PKE&B*88K>
M:G)\)C2"5UI'($QSI*RRE,QCD["VS-HCCDUHWHEN^(-P%X%8" G%Z"$-)RKP
M0=M2>L/*0RJ-T! 7WOSF;FVN(2Q.7472_1[E"K"I:R$;])3[1NR[H*NG\U_"
M]H).7_$4Q(2$BHT" E"$@G2D87=[+\,%N]=WCU7(%5C0"$UM?7B1KKAJ,.*=
M0_+Y1'KOKJ]D=S-+^[Q\IC2-YM7FJ6=*0I&0OVO-*&: *8/W!;#->7N(?(\Z
M>0_F_M[LK7'T59Z.XJG7)AT'YXE-F25W<75=(8R\M\^-7S. 1=%MNE2I$L,T
MU%C %B3E$EA,5FGG"*#..X_'?TA??D*A/1-9KZH4T59G MT>/+HY'*Y;+(M9
ML"@%S30R2O5I5,E9HJ_,4NE3<W'^Q1M[@J;B-*"O289H(PF%!63G7Q:>059+
M/&%5G5LFY.9>:_$L[%/U83:B'*R7*X.DGB'P8VNJDW*(W*HJPL%2-37'=%*)
M,20YO8GA> 02_5+,T84%R/(KQKV1;?:GCW[1Y 5\]+)!Q*Q]6?&H/T _SB/-
M-@'7M!X="4$;:G6$Q"5*V(Q2U-SEZ7881?#E7NP]IE9(CB]!JA=O ?UTD9Z4
MZ8!*Z5G77[/U[VWU?>%'L]W]'<YTBZA[D11!ODL%J7H"E2&FZX>NK,J"-YI"
MSW-.0]^W5)U@1IP@"H#>%X\.'Y7R5PT[4'+&FC&NVK&<K=GMC((07<-ETE^,
M.US%GO 7'5Y6#)+*LAK]R"C+?35CBV[?CPJ30DI-J-[P-0O$'AH[5YVZ!1RU
MO/I#E.D$%.]"P>X*5YSZ?Z<M:A>JIW9\-=HU6\D9>?[KC&FSF*.0)[7 >S24
M3Y(U6E!8$J;U$VS,"C4M@5F^$B?>.1\D=\\Y5O>K;XTISPY:DDONM^DI;RB.
M*-=Z2J[FJ45=:E2UT[NKM;[ _.@-'Q%U0,P7Q&-*4!26)2 TH+7>&KQW]#N5
M(_+\=)O[<S06.<:0;R5.EHPVP$S]&;+<F_L"4RL%/O$4BNV!0C()<&<\IQ5E
MK52 :=O6E>RT=L6PZ#YN?@<ZVC]>\QS6-O\ 3<XNGF'K3R 6L"K!7]T50,,L
MFGNV),WN)*9#?E&M<=MJN;(AB=A1'#+1IQMRX!AZ12:<1K0#@F.M?$'VGRLJ
MX5Z7YL0\=K^HJ$6]7EWS2<BG/1R"@YDBZW7,ZUW?H3;L\/NRX-3V&*(^C,<W
M-P2Z+D@]GF!3H]B]D>&RKQ&<17EQ/S?=U7=(R6L938=N=:=%7\N>*8,D26'"
M:+H=VQU)+;D4D;&QUCZH"@A0+2+TJ@HRQ%@TI.V'8\#5K67AL[T9ZIY(\<\Y
MFW+>O'_QGV(R=11*^HPY6+OJJS(C"+3F%N0FKW>N5442P&&2]5(9JI2O$C2O
MJG6T18!D%&&^V"H"0GSPW]/.G+MW4T5*J5+E]F><MV\EC6L^/RL#&52#A<$9
MG@&!R5!A(EI=E@9&8PK:,!!J#1OJ%Z6[!^[T&RWR@\769VHQ<3-%:.D';?JZ
M^1'E_J^>@G*YV1)W6MJ87RA5*6B/::F1[]^EBT+R3[DG4Z3)#=A%[0\O6M>D
M-4?>?A6Z=MWLSKN\J++H:S*U[UB-)QVS&:^.A^PJ=2TX[57$TM:O:A=6'-,E
MC$7Z:@4L@A.QE,LC7HAHG 8RR3"4XSMGA,G3/@\?;5[5XWLZM)S$8AR7%(7S
MM#NWZ8.-D!!]Y)N'7(Z6<G_#&Q8EE(Y F(?%06IXT[O99Y3(C(UHY8;H7I"M
M_4'@KZ/L;JGL%SA";GRSN;.Z[IKVX)RY77T#V=!W"HBVPB/D6A%'7F^AIO"*
MGZ*)>ML 3XPJ>'-L4M!XBPFF: 06/ V 0KQGW!&G'S0'JB^<),B\A4KB;A2T
M>M5GF5CP'<:B])HJX!&[^C2 4-?CFM4Z$G!W\)=E"H@D[:LL[W@.BQ!K!K'P
M$]<R.F^SZ"E=@P_DKGJ_^2&VF8;S#6W4/0O6U/I.D8]9,6LIFZ";MW?$XD]5
M)!0"B0&749;C'=<)L<5&SEIFRB@##8IXLO&W?O.O0DVZ9Z>@7/\ #YX#G^,<
MXPI35_1W9?4,X>&%%(4$MFCL^3WJ";'-D3@3U)&A.J:(JVLIHFPT1H_?@^L8
M!0%7?(WX?NP>C>O;5OWF=EYPIJ?V*7595;=KU=T/U!S'T94>H@D:$$F,N^K:
M_;IU5O5AX43;[!B4>WBBDE$$E(J&(LK0]AW72?A:ZFM^Q_(G;,7M:GPSVYKT
M\8?3/+CC,MR0QG?[0X%K(^*RILZ!8F6.E%QZ.V8^+5)A/P4UTTGT< P18=%^
MRV$;7GX8N_.W7'R/V)TA,>5:BL'L^E./6BKXY3TFMB612N["Y.LX$\:8Q8LB
M<X?"I+(X[*$[,06L?&TLI6D,<!>ZI!:;R1J0V'>++@"ZN;[=Z'Z-Z-@5(P"Q
MK;C-<US&6>KNA>NNI961"X04L7.QMA7/U/-G):]D.<G5>\,K8WLJ/X*DV84-
M6IV;L( W9X# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'D7\$
M_P#S;_,:?I"0?\I%_P"!ZZ,!@><SYK?_ (1>G/\ S7G3\OU=X&W_ (%_T*<5
M_HE\Y?D>AN!;3 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# _!A19H?5-+ 8'0@B]4P 1A]8 M" +T"UO7
MK!%K6];_ /3>!^\!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@>1?P3_ /-O\QI^D)!_RD7_ ('KHP&!YS/F
MM_\ A%Z<_P#->=/R_5W@;?\ @7_0IQ7^B7SE^1Z&X%M,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@>1;P3[UOS;?,:^C>M__P"PL'U]S>M_=U9%_P"MZ^Y_ZZWKT;P/
M73@,"I7=?'59]^\FW5R-;AR]!#+CBP68;\T (->8G(FIS02.'3)G*5?]L>XQ
M26,Z)>629O12GV&R3/WLP6!Y@ZCY&^:[XE@$=YBY^O[BB]:,J1 3%*CFMEED
M_A83 &T&D\;CJTN01A$_(R&%N+ G(2*5+II"0$"8E8:G**T$)*]R^<8^_'CJ
M_@F/^R\![E\XQ]^/'5_!,?\ 9> ]R^<8^_'CJ_@F/^R\![E\XQ]^/'5_!,?]
MEX#W+YQC[\>.K^"8_P"R\![E\XQ]^/'5_!,?]EX#W+YQC[\>.K^"8_[+P'N7
MSC'WX\=7\$Q_V7@/<OG&/OQXZOX)C_LO >Y?.,??CQU?P3'_ &7@/<OG&/OQ
MXZOX)C_LO >Y?.,??CQU?P3'_9> ]R^<8^_'CJ_@F/\ LO >Y?.,??CQU?P3
M'_9> ]R^<8^_'CJ_@F/^R\![E\XQ]^/'5_!,?]EX#W+YQC[\>.K^"8_[+P'N
M7SC'WX\=7\$Q_P!EX#W+YQC[\>.K^"8_[+P'N7SC'WX\=7\$Q_V7@/<OG&/O
MQXZOX)C_ ++P'N7SC'WX\=7\$Q_V7@/<OG&/OQXZOX)C_LO >Y?.,??CQU?P
M3'_9> ]R^<8^_'CJ_@F/^R\![E\XQ]^/'5_!,?\ 9> ]R^<8^_'CJ_@F/^R\
M![E\XQ]^/'5_!,?]EX#W+YQC[\>.K^"8_P"R\![E\XQ]^/'5_!,?]EX#W+YQ
MC[\>.K^"8_[+P'N7SC'WX\=7\$Q_V7@/<OG&/OQXZOX)C_LO >Y?.,??CQU?
MP3'_ &7@/<OG&/OQXZOX)C_LO >Y?.,??CQU?P3'_9> ]R^<8^_'CJ_@F/\
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MC_LO >Y?.,??CQU?P3'_ &7@/<OG&/OQXZOX)C_LO >Y?.,??CQU?P3'_9>
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IKL_DG/2QLCD>5/!9+VZMK8YR=U7*')84G4N2]R.,$004$@DL-U>!_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
